Drug Expenditure in Canada, 1985 to 2010 pic Spending and Health Workforce

Drug Expenditure in Canada, 1985 to 2010 pic Spending and Health Workforce
pic
Drug Expenditure in Canada, 1985 to 2010
Spending and Health Workforce
Who We Are
Established in 1994, CIHI is
an independent, not-for-profit
corporation that provides essential
information on Canada’s health
system and the health of Canadians.
Funded by federal, provincial and
territorial governments, we are guided
by a Board of Directors made up
of health leaders across the country.
Our Vision
To help improve Canada’s health
system and the well-being of Canadians
by being a leading source of unbiased,
credible and comparable information
that will enable health leaders to make
better-informed decisions.
Table of Contents
Executive Summary ................................................................................................. v Introduction ............................................................................................................. 1 National Drug Expenditure Overview ..................................................................... 2 The Share of Drugs in Total Health Expenditure ............................................. 2 Total Drug Expenditure ..................................................................................... 5 Total Drug Expenditure per Capita ................................................................... 6 Drug Expenditure: Prescribed and Non-Prescribed Drugs ............................. 7 Prescribed Drug Expenditure by Source of Finance ....................................... 9 Drug Expenditure in the Provinces and Territories .............................................. 15 The Share of Drugs in Total Health Expenditure ........................................... 16 Total Drug Expenditure by Source of Finance ............................................... 18 Total Drug Expenditure per Capita by Source of Finance ............................. 19 Drug Expenditure by Type of Drug and by Source of Finance ..................... 20 International Comparisons ................................................................................... 25 Comparability of Health Expenditure Across Countries ................................ 25 Share of Drugs in Total Health Expenditure................................................... 26 Share of Public Expenditure in Total Expenditure on Drugs ......................... 29 Share of Drugs in Public Expenditure on Health ........................................... 31 Factors Affecting Drug Expenditure in Canada ................................................... 33 Methodological Notes........................................................................................... 37 Background .................................................................................................... 37 Data Limitations .............................................................................................. 43 Collection and Non-Response ....................................................................... 45 Sources of Data .............................................................................................. 53 Series A—Expenditure on Drugs by Type, by Source of Finance and as
a Share of Public, Private and Total Health Expenditure, Canada,
1985 to 2010 ......................................................................................................... 55 Series B—Expenditure on Drugs by Type, by Source of Finance and as a
Share of Public, Private and Total Health Expenditure, by Province/
Territory, 1985 to 2010 .......................................................................................... 61 Series C—International Comparisons ................................................................ 115 Appendix A—Comparison of Provincial and Territorial Drug
Subsidy Programs .............................................................................................. 121 References .......................................................................................................... 143 Drug Expenditure in Canada, 1985 to 2010
List of Figures
Figure 1 Total Drug Expenditure as a Percentage of Total Health
Expenditure, Canada, 1985 to 2010 ................................................... 2 Figure 2 Annual Growth Rate for Total Drug Expenditure and Total Health
Expenditure, Canada, 1985 to 2010 ................................................... 3 Figure 3
Total Health Expenditure, by Use of Funds, Canada, 2010 ............... 4 Figure 4
Total Drug Expenditure, Canada, 1985 to 2010 ................................. 5 Figure 5 Total Drug Expenditure per Capita, Current and Constant
Dollars, Canada, 1985 to 2010 ........................................................... 6 Figure 6 Total Drug Expenditure, by Type (Prescribed and
Non-Prescribed), Canada, 1985 to 2010 ............................................ 8 Figure 7 Total Drug Expenditure, by Source of Finance and Type of
Expenditure, Canada, 2010 ................................................................ 9 Figure 8 Prescribed Drug Expenditure, by Source of Finance, Canada,
1985 to 2010 ...................................................................................... 10 Figure 9 Annual Growth Rate for Prescribed Drug Expenditure,
by Source of Finance, Canada, 1985 to 2010 .................................. 11 Figure 10 Prescribed Drug Expenditure, by Private-Sector Source
of Finance, Canada, 1988 to 2010 .................................................... 13 Figure 11 Drug Expenditure as a Percentage of Total Health Expenditure,
by Province/Territory and Canada, 1985 and 2010.......................... 17 Figure 12 Percentage of Total Drug Expenditure by Source of Finance,
by Province/Territory and Canada, 2010 .......................................... 18 Figure 13 Total Drug Expenditure per Capita, by Type and by Source of
Finance, by Province/Territory and Canada, 2010 ........................... 19 Figure 14 Annual Growth Rate for Public- and Private-Sector Prescribed
and Non-Prescribed Drug Expenditure per Capita, by
Province/Territory and Canada, 2010 ............................................... 21 Figure 15 Average Annual Growth Rate for Prescribed Drug Expenditure
per Capita, by Source of Finance, by Province/Territory and
Canada, Between 1985 and 2010..................................................... 22 Figure 16 Public-Sector Prescribed Drug Expenditure as a Percentage
of Total Prescribed Drug Expenditure, by Province/Territory,
1985 to 2010 ...................................................................................... 23 ii
Drug Expenditure in Canada, 1985 to 2010
Figure 17 Drug Expenditure per Capita, Selected Countries, 1985 to 2008 .... 28 Figure 18
Composition of Total Health Expenditure, by Source of Finance .... 39 Figure 19 Patented Medicine Price Index (PMPI), Consumer Price
Index (CPI) and Industrial Product Price Index (IPPI),
1985 to 2010 (1987 = 100) ............................................................... 44
List of Tables
Table 1 Distribution of Prescribed Drug Expenditure, by Source of
Finance, Canada, 1988 and 2010 ......................................................... 12 Table 2 Drug Expenditure Summary, by Province/Territory and
Canada, 2010......................................................................................... 15 Table 3 Total Expenditure on Pharmaceutical Goods per Capita and as
a Percentage of Total Health Expenditure, Reporting OECD
Comparator Countries, 2008 ................................................................. 27 Table 4 Public Expenditure on Pharmaceutical Goods per Capita and
as a Percentage of Total Expenditure on Pharmaceutical Goods,
Reporting OECD Comparator Countries, 2008..................................... 30 Table 5 Public Expenditure on Pharmaceutical Goods per Capita and as a
Percentage of Public-Sector Health Expenditure, Reporting OECD
Comparator Countries, 2008 ................................................................. 32 Table 6 Factors That May Influence Drug Expenditure in Canada .................... 36 Table 7 Provincial/Territorial Government Drug Expenditure Data ................... 46 Table 8 Comparison of Provincial and Territorial Drug Subsidy Programs
as of December 2010 .......................................................................... 122 iii
Drug Expenditure in Canada, 1985 to 2010
Executive Summary
Total expenditure on drugsi in Canada was $28.0 billionii in 2008, and is forecast
to have reached $31.1 billion in 2010. Between 1985 and 2008, the share of
drugs in total health expenditure increased from 9.5% to 16.3%. It is forecast to
have remained stable at 16.3% in 2010. Since 1997, among major categories
of health expenditure, drugs have accounted for the second-largest share,
after hospitals.1
At the national level, 2009 and 2010 forecast data indicates that
• The share of drugs in total health expenditure is forecast to have stabilized in
2009 and 2010 at 16.3%.
• Total drug expenditure is forecast to have reached $29.7 billion in 2009 and
$31.1 billion in 2010, representing annual increases of 6.3% and 4.8%, respectively.
• Total drug expenditure per capita in Canada is expected to have reached
$881 in 2009 and $912 in 2010, representing annual rates of increase of 5.0%
and 3.6%, respectively.
• The share of prescribed drugs in total drug expenditure is forecast to have
reached 84.0% in 2009 and 83.8% in 2010.
• Expenditure on prescribed drugs is expected to have reached $25.0 billion
in 2009 and $26.1 billion in 2010, representing growth rates of 6.4% and
4.6%, respectively.
• Expenditure on non-prescribed drugs is forecast to have reached $4.8 billion
in 2009 and $5.0 billion in 2010, representing increases of 5.3% and
5.8%, respectively.
• Public-sector expenditure on prescribed drugs is forecast to have reached
$11.5 billion in 2009 and $12.1 billion in 2010, representing annual growth
rates of 6.7% and 5.2%, respectively. Private-sector expenditure on prescribed
drugs is forecast to have reached $13.4 billion in 2009 and $14.0 billion in
2010, with corresponding annual growth rates of 6.2% and 4.2%.
i.
ii.
Drug expenditure data in this report is obtained from the National Health Expenditure Database (NHEX)
and is composed of estimates that represent the final costs to Canadian consumers, including dispensing
fees, markups and appropriate taxes. Total drug expenditure, in this report, includes expenditure on
prescribed drugs and non-prescribed drugs (over-the-counter drugs and personal health supplies).
For more information on over-the-counter drugs and personal health supplies, see the General Methods
section of the Methodological Notes.
All figures are in current dollars (unadjusted for inflation) unless otherwise stated.
v
Drug Expenditure in Canada, 1985 to 2010
At the provincial level, 2010 forecast data indicates that
• Total drug expenditure per capita is forecast to have ranged from $701 in
British Columbia and $777 in Alberta to $1,003 in Nova Scotia and $1,017
in Quebec.
• The share of prescribed drug spending in total drug expenditure is forecast
to have ranged from 79.6% in Alberta and 80.2% in Prince Edward Island to
86.8% in Quebec and 87.0% in Newfoundland and Labrador.
• The proportion of prescribed drugs financed by the public sector in 2010
varied across the provinces and is forecast to have ranged from 33.3% in
New Brunswick and 36.9% in Newfoundland and Labrador to 51.7% in
Quebec and 56.3% in Saskatchewan.
At the international level in 2008, the most recent year for which data was
available, among 25 Organisation for Economic Co-operation and Development
(OECD) comparator countriesiii
• Canada had the second-highest level of total drug expenditure per capita,
after the United States.
• The public sector funded 38.4% of total drug expenditure in Canada. This was
the fourth-lowest share, ahead of Poland (38.3%), the U.S. (32.8%) and Mexico
(20.1%). The share of public drug expenditure in total drug expenditure was
highest in the United Kingdom, at 84.7%.
• Public drug expenditure accounted for 9.4% of public-sector health
expenditure in Canada. This proportion places Canada ahead of Sweden
(9.3%), Luxembourg (9.1%), Iceland (8.5%), the U.S. (8.4%), New Zealand
(7.7%), Denmark (5.7%)iv and Norway (4.8%). The share of public drug
expenditure in public-sector health expenditure was highest in the
Slovak Republic, at 29.1%.
Factors affecting drug expenditure:
• Numerous factors, many of which are interrelated, may influence drug
expenditure. Since drug prices, as measured by several price indices, have
been relatively stable over the past 10 years, factors affecting increased drug
spending in Canada essentially relate to the volume of drug use and the entry
of new drugs (typically introduced to the market at higher prices).
iii.
iv.
vi
Comparator countries are Australia, Austria, Belgium, Canada, the Czech Republic, Denmark, Finland,
France, Germany, Hungary, Iceland, Japan, Korea, Luxembourg, Mexico, New Zealand, Norway, Poland,
the Slovak Republic, Slovenia, Spain, Sweden, Switzerland, the United Kingdom and the United States.
2007 data has been used for Denmark due to unavailability of current data.
Drug Expenditure in Canada, 1985 to 2010
Introduction
Pharmaceutical drugs play an essential role in modern medicine. Through the
treatment of various diseases, they have become an increasingly significant
component of the Canadian health care system.
Drug expenditure data in this report is primarily obtained from the National Health
Expenditure Database (NHEX) maintained by the Canadian Institute for Health
Information (CIHI). This database contains a historical series of macro-level
health expenditure statistics by province and territory, beginning in 1975.
Drug expenditure data in NHEX is macro-level data and does not allow for
decomposition of prescription costs or drug classes.
The Drugs category in NHEX is intended to measure final consumption, outside
an institutional setting, of drugs purchased by consumers or third-party payers
on their behalf, generally from retail outlets. Drug expenditure data in NHEX
consists of estimates that represent the final costs to Canadian consumers,
including dispensing fees, markups and appropriate taxes. NHEX data does not
include drug expenditure by non-Canadian residents. This classification system
used in NHEX is consistent with international standards developed by the
Organisation for Economic Co-operation and Development (OECD).
Drug expenditure estimates within NHEX provide insight into total drug
expenditurev by public and private payers and by type of drugs (prescribed
and non-prescribed) at the provincial/territorial and national levels. All drug
expenditure estimates stated in this report are in current dollars (unadjusted
for inflation) unless otherwise stated.
Drug Expenditure in Canada, 1985 to 2010 is an annual publication and provides
updated information on drug expenditure trends in Canada. This publication includes
• National drug expenditure;
• Provincial and territorial drug expenditure;
• International comparisons; and
• Factors that may affect drug expenditure.
For more information on drug expenditure and the methods used in the
preparation of this document, contact the Pharmaceuticals department
at CIHI by phone at 613-241-7860 or by email at [email protected]
v.
Total drug expenditure in this report includes expenditure on prescribed drugs and non-prescribed drugs.
Non-prescribed drugs consist of over-the-counter drugs (such as cold remedies, cough remedies
and headache remedies) and personal health supplies (such as antiperspirants, dental floss and
disposable diabetic syringes). For more information on over-the-counter drugs and personal health
supplies, see the General Methods section of the Methodological Notes.
1
Drug Expenditure in Canada, 1985 to 2010
National Drug Expenditure Overview
The Share of Drugs in Total Health Expenditure
Outlook—2009 and 2010
The share of drugs in total health expenditure is forecast to be 16.3% in both
2009 and 2010 (Figure 1).
Figure 1: Total Drug Expenditure as a Percentage of Total Health Expenditure,
Canada, 1985 to 2010
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
Highlights—2008
Drugs have been one of the growing components of total health expenditure in
Canada. From 1985 to 2008, total health spending grew at an average annual
rate of 6.6%. During this period, total drug expenditure increased at an average
annual rate of 9.1%. In every year prior to 2005, the annual rate of growth for
drugs exceeded the rate for total health expenditure (Figure 2). From 2005 to
2008, the annual rate of growth for drugs was slightly less than the rate for total
health expenditure every year, with the exception of 2006.
2
Drug Expenditure in Canada, 1985 to 2010
Figure 2: Annual Growth Rate for Total Drug Expenditure and Total Health
Expenditure, Canada, 1985 to 2010
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
3
Drug Expenditure in Canada, 1985 to 2010
Figure 3: Total Health Expenditure, by Use of Funds, Canada, 2010f
Notes
f: forecast.
$ billions; percentage share of total health expenditure.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
NHEX provides an overview of all health spending in Canada by spending
category and source of funding. Total health expenditure comprises nine
major spending categories. Since 1997, among major categories of health
expenditure, drugs have accounted for the second-largest share, after
hospitals (Figure 3).
Total drug expenditure grew faster than total hospital expenditure every year
between 1985 and 2006.1 In 2007 and 2008, total hospital expenditure had a
slightly higher rate of growth (5.7% and 7.1%, respectively) than total drug
expenditure (5.2% and 5.9%). Between 1985 and 2008, total drug expenditure
grew at an average annual rate of 9.1%, while total hospital expenditure grew at
an average annual rate of 4.9%.
Total drug expenditure grew at a higher rate than total physician expenditure
every year between 1985 and 2006, with the exception of 2005.1 In 2007 and
2008, total physician expenditure had a significantly higher rate of growth (7.6%
and 10.2%, respectively) than total drug expenditure (5.2% and 5.9%). Between
1985 and 2008, total drug expenditure grew at an average annual rate of 9.1%,
while total physician expenditure grew at an average annual rate of 6.0%.
See the data tables in Series A for more data on national drug expenditure from
1985 to 2010.
4
Drug Expenditure in Canada, 1985 to 2010
Total Drug Expenditure
Outlook—2009 and 2010
Total drug expenditure is forecast to have reached $29.7 billionvi in 2009 and
$31.1 billion in 2010, representing annual increases of 6.3% and 4.8%, respectively.
Figure 4: Total Drug Expenditure, Canada, 1985 to 2010
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
Highlights—2008
Canada’s total drug expenditure increased steadily from $3.8 billion in 1985 to
$28.0 billion in 2008 (Figure 4). The average annual rate of growth during this
period was 9.1%.
See the data tables in Series A for more data on national drug expenditure from
1985 to 2010.
vi. All figures are in current dollars (unadjusted for inflation) unless otherwise stated.
5
Drug Expenditure in Canada, 1985 to 2010
Total Drug Expenditure per Capita
Outlook—2009 and 2010
Total drug expenditure per capita in Canada is expected to have reached $881
in 2009 and $912 in 2010, representing annual rates of increase of 5.0% and
3.6%, respectively.
Figure 5: Total Drug Expenditure per Capita, Current and Constant* Dollars,
Canada, 1985 to 2010
Note
* Figures are deflated using the Consumer Price Index to reflect 1985 dollars.
Sources
National Health Expenditure Database, 2010, Canadian Institute for Health Information; Consumer Price Index,
Statistics Canada.
Highlights—2008
Per capita drug expenditure trends are similar to those of total drug spending,
reflecting a 1.1% average annual rate of growth in the overall population in
Canada from 1985 to 2008. Total drug expenditure increased from $147 per
capita in 1985 to $839 in 2008 (Figure 5). The average annual growth rate
during this period was 7.9%.
6
Drug Expenditure in Canada, 1985 to 2010
Typically, expenditure is deflated by a price index to measure change in
quantity. There is no authoritative composite price index for all drugs sold in
Canada.vii However, measuring drug expenditure in constant dollars (adjusted
for inflation) using the CPIviii reported by Statistics Canada gives a sense of
change in drug expenditure in the context of economy-wide inflation. Readers
should cautiously interpret inflation-adjusted trends in expenditure, since
drug-specific inflation may differ from that depending upon the broad basket
of goods and services purchased by Canadians.
In terms of constant (1985) dollars, per capita drug expenditure increased from
$147 in 1985 to $463 in 2008, reflecting an average annual growth rate of 5.1%.
Trends in per capita drug expenditure measured in constant dollars are similar
to those of per capita drug expenditure measured in current dollars, though
growth between 1985 and 2008 is less pronounced when it is considered
relative to economy-wide inflation (Figure 5).
See the data tables in Series A for more data on national drug expenditure from
1985 to 2010.
Drug Expenditure: Prescribed and Non-Prescribed Drugs
Outlook—2009 and 2010
Expenditure on prescribed drugsix is expected to have reached $25.0 billion
in 2009 and $26.1 billion in 2010, representing growth rates of 6.4% and 4.6%,
respectively. Expenditure on non-prescribed drugs is forecast to have reached
$4.8 billion in 2009 and $5.0 billion in 2010, representing increases of 5.3% and
5.8%, respectively.
Non-prescribed drugs, which are typically financed by consumers (households),
include over-the-counter drugs (such as cold remedies, cough remedies and
headache remedies) and personal health supplies (such as antiperspirants,
dental floss and disposable diabetic syringes).x Since NHEX consists of
macro-level health expenditure data, some over-the-counter drugs and
personal health supplies that are covered under some drug benefit plans
may be counted as prescribed drug expenditures.xi
vii. For more information on drug prices, see the Data Limitations section of the Methodological Notes.
viii. A measure of the average percentage change over time in the cost of a fixed basket of goods and services
purchased by Canadian consumers.
ix. A prescribed drug is a substance considered to be a drug under the Food and Drugs Act, which is sold for
human use as the result of a prescription from a health professional.
x. For more information on over-the-counter drugs and personal health supplies, see the General Methods
section of the Methodological Notes.
xi. For example, diabetic test strips, where covered under drug benefit plans, may be included in prescribed
drug expenditure, subject to source of data.
7
Drug Expenditure in Canada, 1985 to 2010
Prescribed drugs are expected to have accounted for 84.0% of total drug expenditure in
Canada in 2009 and 83.8% in 2010. Conversely, the share of non-prescribed drugs in
total drug expenditure is expected to have accounted for 16.0% in 2009 and 16.2% in 2010.
Figure 6: Total Drug Expenditure, by Type (Prescribed and Non-Prescribed),
Canada, 1985 to 2010
Notes
f: forecast.
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
Non-prescribed drug expenditure includes spending on over-the-counter drugs and personal health supplies.
This expenditure is financed by the private sector, typically out-of-pocket by consumers (households).
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
Highlights—2008
From 1985 to 2008, expenditure on prescribed drugs grew from $2.6 billion to
$23.4 billion, at an average annual rate of 10.1%. Spending on non-prescribed
drugs increased from $1.2 billion to $4.5 billion, at an average of 5.8% per year
(Figure 6). During this period, with the exception of 1987 and 1994, annual
growth in drug spending was higher in prescribed drugs than in non-prescribed
drugs. As a result, prescribed drugs captured a larger share of total drug spending,
rising from 67.5% in 1985 to 83.8% in 2008.
Non-prescribed drug expenditure represented 16.2% of total drug expenditure
in 2008. Over-the-counter drugs accounted for $2.5 billion, or 9.1% of total drug
expenditure, and personal health supplies accounted for $2.0 billion, or 7.1%.
8
Drug Expenditure in Canada, 1985 to 2010
See the data tables in Series A for more data on national drug expenditure from
1985 to 2010.
Prescribed Drug Expenditure by Source of Finance
While non-prescribed drugs are typically financed out-of-pocket by consumers
(households), multiple payers are involved in the financing of prescribed drugs. In
the public sector, these payers include provincial/territorial and federal drug subsidy
programs and social security funds (such as workers’ compensation boards, or
WCBs). In the private sector, they include private insurers and households.
In 2010, $12.1 billion in prescribed drugs are expected to have been financed by
the public sector, while expenditure by the private sector is for both prescribed
drugs ($14.0 billion) and non-prescribed drugs ($5.0 billion). In the private
sector, prescribed drugs financed by private insurers are expected to have been
$9.4 billion, with the remainder financed by Canadian households ($4.6 billion).
Non-prescribed drugs are composed of over-the-counter drugs ($2.8 billion)
and personal health supplies ($2.2 billion) (Figure 7).
Figure 7: Total Drug Expenditure, by Source of Finance and Type of Expenditure,
Canada, 2010f
Notes
f: forecast.
$ billions; percentage share of total drug expenditure.
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
Non-prescribed drugs include over-the-counter drugs and personal health supplies.
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
9
Drug Expenditure in Canada, 1985 to 2010
Outlook—2009 and 2010
Public-sector expenditure on prescribed drugs is forecast to have reached
$11.5 billion in 2009 and $12.1 billion in 2010 (Figure 8), representing annual
growth rates of 6.7% and 5.2%, respectively. Private-sector expenditure on
prescribed drugs is forecast to have reached $13.4 billion in 2009 and
$14.0 billion in 2010, with corresponding annual growth rates of 6.2% and 4.2%.
The share of prescribed drug expenditure financed by the public sector is
forecast to be 46.2% in 2009 and 46.5% in 2010.
Figure 8: Prescribed Drug Expenditure, by Source of Finance, Canada,
1985 to 2010
Notes
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
Highlights—2008
The intersections of the two series depicted in Figure 9 (excluding forecasts for
2009 and 2010) identify four distinct periods of growth in publicly and privately
financed prescribed drug expenditure.
10
Drug Expenditure in Canada, 1985 to 2010
Figure 9: Annual Growth Rate for Prescribed Drug Expenditure, by Source of
Finance, Canada, 1985 to 2010
Notes
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
Between 1985 and 1992, expenditure on prescribed drugs in the public sector grew
by an average annual rate of 14.6%, while this rate was 12.0% for prescribed drug
expenditure financed by the private sector. Consequently, the share of prescribed
drugs financed from public sources increased from 43.6% in 1985 to 47.7% in 1992.
From 1992 to 1997, spending on prescribed drugs by the private sector grew at an
average annual rate of 9.1%, more than twice the 4.3% average annual rate of
growth in publicly financed prescribed drug expenditure. Fiscal restraint introduced
in several provinces led to negative growth in publicly financed prescribed drug
expenditure in 1996. By 1997, the share of prescribed drugs financed from public
sources had declined to 42.2%, below its share in 1985 (43.6%).
Between 1997 and 2005, expenditure on prescribed drugs by the public sector grew at
an average annual rate of 12.0%, compared with 9.5% in the private sector. The share
of prescribed drug expenditure financed by the public sector reached 46.6% in 2005.
A fourth period appears to have commenced in 2006. In 2006, the annual growth
of private-sector funding (10.0%) of prescribed drugs exceeded that of the public
sector (7.9%). In 2007 and 2008, the growth in both private- and public-sector
spending slowed, and the growth rate of prescribed drug spending funded
11
Drug Expenditure in Canada, 1985 to 2010
by the private sector continued to be only slightly higher (5.5% and 6.8%,
respectively) than that funded by the public sector (5.4% and 6.7%, respectively).
The share of prescribed drug expenditure financed by the public sector declined
slightly between 2006 and 2008, from 46.2% to 46.1%.
See the data tables in Series A for more data on national drug expenditure from
1985 to 2010.
Two levels of government—provincial/territorial and federal—as well as social
security funds, such as workers’ compensation boards (WCBs) and the
premium component of the Fonds de l’assurance médicaments (Drug Insurance
Fund) in Quebec,xii finance spending on prescribed drugs by the public sector.
Private-sector expenditure on prescribed drugs is financed by two sources: private
insurers and households (out-of-pocket). Table 1 shows the distribution of
prescribed drug expenditure by these sources of finance.
Table 1: Distribution of Prescribed Drug Expenditure, by Source of Finance,
Canada, 1988 and 2010f
2010f
1988
$ Millions
Provincial/Territorial Governments
Percent
$ Millions
Percent
1,592.7
42.6
10,520.1
40.3
Federal Direct
89.3
2.4
660.0
2.5
Social Security Funds:
Workers’ Compensation Boards
Quebec Drug Insurance Fund*
(Premium Component)
20.8
N/A
0.6
N/A
190.9
761.8
0.7
2.9
Subtotal Public Sources
1,702.8
45.6
12,132.8
46.5
Private Insurers
1,130.3
30.2
9,396.4
36.0
Households (Out-of-Pocket)
903.7
24.2
4,584.0
17.6
Subtotal Private Sources
2,034.0
54.4
13,980.4
53.5
Total All Sources
3,736.8
100.0
26,113.2
100.0
Notes
* Data not available prior to January 1, 1997, when the program was first introduced in Quebec.
f: forecast.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
xii.
12
Since July 1, 2002, the public plan has been financed both by the expenditure allocated to this program
by the Quebec government (provincial government sector) and by the amounts collected by the Drug
Insurance Fund as premiums and proceeds (social security funds sector). The premium component of
the Quebec Drug Insurance Fund is considered to be a social security scheme, while the remaining
portion of the program that is paid through the ministère de la Santé et des Services sociaux is included
as a provincial government expenditure. For more information, see the General Methods section of the
Methodological Notes.
Drug Expenditure in Canada, 1985 to 2010
Provincial/territorial government expenditure on prescribed drugs was almost
$1.6 billion in 1988, accounting for 42.6% of total expenditure on prescribed
drugs. By 2010, provincial/territorial government expenditure is forecast to have
grown to $10.5 billion, while its share of total expenditure on prescribed drugs is
expected to have diminished to 40.3%.
All provinces/territories provide some form of prescribed drug coverage to
seniors and social assistance recipients (see Appendix A for an overview of
provincial and territorial drug subsidy programs).
Federal direct expenditure was $89.3 million in 1988, equivalent to 2.4% of total
expenditure on prescribed drugs. Federal direct expenditure is forecast to have
increased to $660.0 million in 2010, representing 2.5% of total expenditure on
prescribed drugs. The federal government provides drug benefits to Aboriginal
Canadians (as of the end of March 2009, about 815,800 Aboriginal Canadians
had drug coverage through the Non-Insured Health Benefits Program of Health
Canada),2 veterans, members of the military and the RCMP, prisoners in federal
correctional facilities and refugees.
Figure 10: Prescribed Drug Expenditure, by Private-Sector Source of Finance,
Canada, 1988* to 2010
Note
* Expenditure by private insurers and out-of-pocket spending by households were available separately for the
first time in 1988.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
13
Drug Expenditure in Canada, 1985 to 2010
Expenditure by social security funds was $20.8 million in 1988, equivalent to
0.6% of total prescribed drug expenditure. In 2010, expenditure by social
security funds is forecast to have reached $952.7 million and to have accounted
for 3.6% of total expenditure on prescribed drugs. Social security funds’ figures
have largely represented spending by the premium component of the Quebec
Drug Insurance Fund since its institution in 1997. Seniors (65 and older) and
other residents (those who do not receive social assistance benefits and are not
covered by private group insurance) are required to pay a premium. The amount
of the premium varies according to net family income.
Expenditure by private insurers and out-of-pocket spending by households were
available separately for the first time in 1988.
Expenditure on prescribed drugs by private insurers amounted to more than
$1.1 billion in 1988, or 30.2% of prescribed drug expenditure. Private insurers’
spending increased to $9.4 billion in 2010, and their share of prescribed drug
expenditure increased to 36.0%. Private insurers include group and individual
insurance. Many employers offer group benefit plans covering prescribed drugs
for employees and their families. In some cases, individuals will continue to be
covered by a group plan even after they retire.
Out-of-pocket spending by households was an estimated $0.9 billion in 1988,
representing 24.2% of total expenditure on prescribed drugs. By 2010, out-ofpocket prescribed drug expenditure is estimated to have risen to $4.6 billion,
while its share of prescribed drug expenditure will have decreased to 17.6%
(Figure 10).
See the data tables in Series A for more data on national drug expenditure from
1985 to 2010.
14
Drug Expenditure in Canada, 1985 to 2010
Drug Expenditure in the Provinces
and Territories
There is considerable variation in the level and growth of drug expenditure across
the provinces and territories. These variations are influenced by several factors (see
Table 6), including differences in provincial/territorial drug subsidy programs (see
Appendix A for an overview of provincial and territorial drug subsidy programs), the
extent of private insurance coverage, age and sex distribution of provincial/territorial
populations, the health needs of targeted populations and the manner in which
health care is delivered (including the balance between institutional and ambulatory
care).3 Other possible sources of variation in drug expenditure are described in the
section Factors Affecting Drug Expenditure in Canada. Table 2 provides an overview
of provincial/territorial drug expenditure forecast for 2010.
Table 2: Drug Expenditure Summary, by Province/Territory and Canada, 2010f
Total Drug Expenditure
per Capita
Prescribed Drug Expenditure
per Capita
Public Prescribed Drug
Expenditure per Capita
Percentage
Percentage
Percentage of
Percentage
of Total
Percentage of Total Drug
Percentage Prescribed
Amount
Change
Health Exp. Amount
Change
Exp. per
Amount
Change Drug Exp. per
(Dollars) Over 2009 per Capita (Dollars) Over 2009
Capita
(Dollars) Over 2009
Capita
N.L.
P.E.I.
917.75
6.7
15.0
798.69
6.2
87.0
294.58
6.7
36.9
858.52
3.5
14.5
688.15
3.1
80.2
275.33
7.7
40.0
N.S.
1,003.45
3.3
16.5
837.66
3.2
83.5
362.95
5.4
43.3
N.B.
991.81
5.1
17.0
835.09
4.4
84.2
278.35
3.7
33.3
Que.
1,016.78
5.6
20.0
882.88
5.4
86.8
456.21
5.9
51.7
Ont.
967.14
2.3
17.1
807.49
2.3
83.5
363.90
2.6
45.1
Man.
808.17
4.8
12.9
667.25
5.1
82.6
317.79
2.8
47.6
Sask.
846.60
4.5
14.4
709.25
4.2
83.8
399.11
4.5
56.3
Alta.
776.89
4.3
12.4
618.59
3.9
79.6
289.89
4.6
46.9
B.C.
701.08
2.4
13.1
573.65
1.8
81.8
230.52
2.9
40.2
Y.T.
743.37
1.5
9.3
593.77
1.2
79.9
381.08
-1.1
64.2
N.W.T.
643.90
0.8
6.9
537.63
0.8
83.5
329.73
0.1
61.3
Nun.
573.51
0.5
4.6
468.48
0.7
81.7
305.28
0.6
65.2
Canada
912.26
3.6
16.3
764.93
3.4
83.8
355.40
3.9
46.5
Notes
f: forecast.
Total drug expenditure consists of prescribed drugs and non-prescribed products purchased outside an institutional setting.
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional. This expenditure can be
financed by either the public or the private sector.
Public prescribed drug expenditure is the amount of prescribed drug expenditure financed by provincial, territorial and federal
governments, as well as spending from social security funds.
For detailed definitions please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2010, Canadian Institute for Health Information; Population, Statistics Canada.
15
Drug Expenditure in Canada, 1985 to 2010
In 2010, per capita expenditure on drugs is forecast to have accounted for 16.3%
of total health expenditure in Canada. Among the provinces and territories, the
share of drugs in total health expenditure per capita is expected to have ranged
from 4.6% in Nunavut and 6.9% in the Northwest Territories to 17.1% in Ontario
and 20.0% in Quebec.
Total drug expenditure per capita in Canada is expected to have been $912 in
2010. Per capita spending on drugs in the provinces and territories is forecast to
have ranged from $574 and $644 by the residents of Nunavut and the Northwest
Territories, respectively, to $1,003 and $1,017 by the residents of Nova Scotia
and Quebec, respectively.
Prescribed drug expenditure per capita is forecast to have accounted for 83.8%
of total expenditure on drugs in Canada in 2010. Among the provinces and
territories, the share of prescribed drugs in total drug expenditure is forecast to
have ranged from 79.6% in Alberta and 79.9% in Yukon to 86.8% in Quebec and
87.0% in Newfoundland and Labrador.
In 2010, the proportion of prescribed drugs in Canada financed by the public
sector is expected to have been 46.5%. It is forecast that the proportion will have
been highest in Nunavut and Yukon, at 65.2% and 64.2%, respectively, and the
lowest in Newfoundland and Labrador and New Brunswick, at 36.9% and
33.3%, respectively.
The Share of Drugs in Total Health Expenditure
The share of drugs in total health expenditure is forecast to have been higher
in 2010 than in 1985 in all provinces and territories except P.E.I., Newfoundland
and Labrador and the Northwest Territories and Nunavut (Figure 11). It should
be noted that in Newfoundland and Labrador between 1986 and 2010, the share
of drug expenditure in total health expenditure is expected to have grown.
In 1985, expenditure on drugs accounted for 9.5% of total health expenditure in
Canada. Newfoundland and Labrador, P.E.I., Nova Scotia, New Brunswick and
Ontario exceeded the national average. P.E.I. had the highest share, at 18.0%,
followed by Newfoundland and Labrador, at 16.3%, while among the provinces
and territories with total health expenditure below the national average, shares
ranged from 7.1% in the Northwest Territories and Nunavut to 9.3% in Manitoba.
16
Drug Expenditure in Canada, 1985 to 2010
Figure 11: Drug Expenditure as a Percentage of Total Health Expenditure,
by Province/Territory and Canada, 1985 and 2010f
Notes
* On April 1, 1999, Nunavut was formed from the eastern part of the Northwest Territories.
f: forecast.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
In 2010, Nova Scotia, New Brunswick, Quebec and Ontario are forecast to have
had drug expenditure as a percentage of total health expenditure above the
Canadian average (16.3%), with Quebec (20.0%) and Ontario (17.1%) having
the highest share. Newfoundland and Labrador, P.E.I., Manitoba, Saskatchewan,
Alberta and B.C. are expected to have been below the Canadian average, with
Alberta (12.4%) and Manitoba (12.9%) having the lowest share among the
provinces. Yukon and the combined territories of Northwest Territories and
Nunavut are forecast to have had lower shares than the provinces, at 9.3%
and 5.8%, respectively.
See the data tables in Series B for more data on drug expenditure by
province/territory from 1985 to 2010.
17
Drug Expenditure in Canada, 1985 to 2010
Total Drug Expenditure by Source of Finance
In 2010, Quebec, Manitoba, Saskatchewan, Yukon, the Northwest Territories and
Nunavut are forecast to have had public shares of total drug expenditure that
exceeded the national average (39.0%). The share of total drug expenditure funded
by the public sector is expected to have ranged from 28.1% in New Brunswick and
32.1% in P.E.I. to 51.3% in Yukon and 53.2% in Nunavut (Figure 12).
Figure 12: Percentage of Total Drug Expenditure by Source of Finance,
by Province/Territory and Canada, 2010f
Note
f: forecast.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
18
Drug Expenditure in Canada, 1985 to 2010
Total Drug Expenditure per Capita by Source of Finance
In 2010, total drug expenditure per capita in Canada is forecast to have been
$912. Per capita prescribed drug spending financed by the public and private
sectors is forecast to have amounted to $355 and $410, respectively (Figure 13).
Figure 13: Total Drug Expenditure per Capita, by Type and by Source of Finance,
by Province/Territory and Canada, 2010f
Canada
$381
$213
$150
$330
$208
$106
Y.T.
$305
$163
$105
N.W.T.
$231
$343
$127
B.C.
$290
$329
$158
Alta.
Public Rx
Private Rx
N.L.
$295
$504
$119
Nun.
$399
$310
$137
Sask.
$318
$349
$141
Man.
$355
$410
$147
Ont.
$364
$444
$160
$456
$427
$134
P.E.I.
$275
$413
$170
Que.
N.S.
N.B.
$278
$557
$157
$363
$475
$166
Private Non-Rx
Notes
f: forecast.
Prescribed drug expenditure (Rx) is based on drugs sold as the result of a prescription from a health
professional. This expenditure can be financed by either the public or the private sector.
Non-prescribed drug expenditure (Non-Rx) includes spending on over-the-counter drugs and personal health
supplies. This expenditure is financed by the private sector, typically out-of-pocket by consumers (households).
For detailed definitions, please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2010, Canadian Institute for Health Information; Population,
Statistics Canada.
19
Drug Expenditure in Canada, 1985 to 2010
In 2010, per capita spending on drugs by the public sector is forecast to have
ranged from $231 in B.C. and $275 in P.E.I. to $399 in Saskatchewan and $456 in
Quebec. Along with Saskatchewan and Quebec, it is expected that Nova Scotia
($363), Ontario ($364) and Yukon ($381) will also have had publicly financed
drug expenditure per capita above the Canadian average ($355).
Prescribed drug expenditure per capita financed by the private sector is expected
to have ranged from $163 in Nunavut and $208 in the Northwest Territories to
$504 in Newfoundland and Labrador and $557 in New Brunswick. In addition to
Newfoundland and Labrador and New Brunswick, P.E.I. ($413), Nova Scotia
($475), Quebec ($427) and Ontario ($444) are also forecast to have had privately
financed prescribed drug expenditure per capita higher than the Canadian
average ($410).
It should be noted that public spending per capita may or may not accurately
reflect the amount spent per person eligible for coverage because the
proportion of the population eligible for coverage by the public sector varies
significantly across provinces and territories.
See the data tables in Series B for more data on drug expenditure by
province/territory from 1985 to 2010.
Drug Expenditure by Type of Drug and by Source
of Finance
Public- and Private-Sector Prescribed and Non-Prescribed
Drugxiii Expenditure
In 2010, in Newfoundland and Labrador, P.E.I., Nova Scotia, Quebec, Ontario,
Saskatchewan, Alberta and B.C., the annual growth rate for prescribed drug
spending per capita is forecast to have been higher in the public sector than in
the private sector (Figure 14). For the remaining provinces and territories, privatesector growth is forecast to have been higher than that of the public sector.
The annual growth rate for prescribed drug spending per capita in the public
sector ranged from -1.1% in Yukon and 0.1% in the Northwest Territories to 6.7%
in Newfoundland and Labrador and 7.7% in P.E.I. The annual growth rate for
prescribed drug spending per capita in the private sector ranged from 0.3% in
P.E.I. and 1.0% in Nunavut to 5.9% in Newfoundland and Labrador and 7.2%
in Manitoba.
xiii. Non-prescribed drugs consist of over-the-counter drugs (such as cold remedies, cough remedies
and headache remedies) and personal health supplies (such as antiperspirants, dental floss and
disposable diabetic syringes). For more information on over-the-counter drugs and personal health
supplies, see the General Methods section of the Methodological Notes.
20
Drug Expenditure in Canada, 1985 to 2010
In 2010, four provinces (B.C., Manitoba, Ontario and New Brunswick) and all
three territories are expected to have had annual growth of publicly financed
prescribed drug expenditure per person below the Canadian average (3.9%).
The remaining six provinces are expected to have had a higher rate of annual
growth than the Canadian average.
Figure 14: Annual Growth Rate for Public- and Private-Sector Prescribed and
Non-Prescribed Drug Expenditure per Capita, by Province/Territory
and Canada, 2010f
Notes
f: forecast.
Prescribed drug expenditure (Rx) is based on drugs sold as the result of a prescription from a health
professional. This expenditure can be financed by either the public or the private sector.
Non-prescribed drug expenditure (Non-Rx) includes spending on over-the-counter drugs and personal health
supplies. This expenditure is financed by the private sector, typically out-of-pocket by consumers (households).
For detailed definitions, please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2010, Canadian Institute for Health Information; Population,
Statistics Canada.
The analysis of annual growth rates should be interpreted cautiously. The actual
change in drug spending associated with a given growth rate varies based on
the initial level of expenditure. For example, a 10% growth rate for a higher initial
level of expenditure would translate into a larger growth in dollar amounts than
for a lower initial level of expenditure.
21
Drug Expenditure in Canada, 1985 to 2010
Public- and Private-Sector Prescribed Drug Expenditure
Between 1985 and 2010, publicly financed prescribed drug expenditure per
capita grew at a lower average annual rate than privately financed prescribed drug
expenditure per capita in Nova Scotia, New Brunswick, Saskatchewan and B.C.
(Figure 15). During this period, average annual growth in public-sector prescribed
drug spending per capita ranged from 6.6% in the Northwest Territories and
Nunavut (combined) and B.C. to 11.2% in P.E.I. and 12.2% in Yukon.
Per capita prescribed drug expenditure financed by the private sector grew at
average annual rates ranging from 4.1% in P.E.I. and 5.2% in Newfoundland and
Labrador to 10.0% in Nova Scotia and 10.4% in Saskatchewan.
Figure 15: Average Annual Growth Rate for Prescribed Drug Expenditure per
Capita, by Source of Finance, by Province/Territory and Canada,
Between 1985 and 2010f
Notes
* On April 1, 1999, Nunavut was formed from the eastern part of the Northwest Territories.
f: forecast.
Prescribed drug expenditure (Rx) is based on drugs sold as the result of a prescription from a health
professional. This expenditure can be financed by either the public or the private sector.
For detailed definitions, please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2010, Canadian Institute for Health Information; Population,
Statistics Canada.
Figure 16 illustrates provincial/territorial trends in the share of publicly financed
prescribed drug expenditure as a percentage of prescribed drug expenditure,
from 1985 to 2008, with forecasts to 2010.
22
Drug Expenditure in Canada, 1985 to 2010
Figure 16: Public-Sector Prescribed Drug Expenditure as a Percentage of Total Prescribed Drug
Expenditure, by Province/Territory,1985 to 2010
23
Drug Expenditure in Canada, 1985 to 2010
Figure 16: Public-Sector Prescribed Drug Expenditure as a Percentage of Total Prescribed Drug
Expenditure, by Province/Territory,1985 to 2010 (cont’d)
Note
* On April 1, 1999, Nunavut was formed from the eastern part of the Northwest Territories.
Source
National Health Expenditure Database, 2010, Canadian Institute for Health Information.
24
Drug Expenditure in Canada, 1985 to 2010
Between 1985 and 2008, the share of prescribed drug expenditure financed by
the public sector increased in Newfoundland and Labrador, P.E.I., Quebec,
Ontario, Manitoba, Alberta, Yukon and the Northwest Territories. Increases
ranged from 1.7 and 2.4 percentage points in the Northwest Territories and
Ontario, respectively, to 25.1 and 37.2 percentage points in P.E.I. and Yukon,
respectively. Decreases in the share of prescribed drug expenditure financed by
the public sector occurred in Nova Scotia, New Brunswick, Saskatchewan and
B.C. Decreases ranged from less than 11.7 percentage points in B.C. to 18.5
percentage points in Saskatchewan.
In 2010, the share of prescribed drug expenditure financed by the public sector
in Canada is expected to have been 46.5%. This is forecast to have been
exceeded by Quebec (51.7%), Manitoba (47.6%), Saskatchewan (56.3%),
Alberta (46.9%), Yukon (64.2%), the Northwest Territories (61.3%) and
Nunavut (65.2%).
International Comparisons
Comparability of Health Expenditure Across Countries
For the last 10 annual updates of the health database maintained by the
Organisation for Economic Co-operation and Development (OECD), member
countries were asked to report health expenditure according to concepts
presented in the OECD manual A System of Health Accounts (SHA), released in
May 2000. Countries are at varying stages of reporting total health expenditure
according to the boundary of health care proposed in the SHA manual. This
means that data presented in OECD Health Data 2010 is at varying levels
of comparability.
There are 28 countries with health expenditure information that most closely
follow the health care boundary proposed in the OECD manual. The OECD
states that the data for those countries is believed to be fairly comparable,
although some deviations from SHA definitions may still exist among the
sub-aggregate variables of total health expenditure. The 28 countries are
Australia, Austria, Belgium, Canada, the Czech Republic, Denmark, Finland,
France, Germany, Hungary, Iceland, Japan, Korea, Luxembourg, Mexico,
the Netherlands, New Zealand, Norway, Poland, Portugal, the Slovak Republic,
Slovenia, Spain, Sweden, Switzerland, Turkey, the United Kingdom and the
United States.
Analysis in this section will exclude the Netherlands, Portugal and Turkey due to the
unavailability of data at the level of detail used in this report from 2007 onwards.
25
Drug Expenditure in Canada, 1985 to 2010
In general, international comparisons should be interpreted with caution, as
variation exists between countries with regard to reporting, inclusion and
classification of health expenditure. Level of income, institutional characteristics
and service delivery across countries also cause differences in the share of
drugs in total health expenditure.
Share of Drugs in Total Health Expenditure
The OECD maintains a comparative database on health-related statistics,
including health expenditure. This database captures information on expenditure
for pharmaceuticals and other medical non-durables outside an institutional
setting (equivalent to drugs purchased in retail establishments in Canada).
Pharmaceutical and other medical non-durables comprise prescribed drugs,
over-the-counter drugs and a wide range of medical non-durables such as
bandages, elastic stockings, incontinence articles, condoms and other
mechanical contraceptive devices.
In 1985, drug expenditure in Canada represented 9.6%xiv of total health
expenditure. Korea had the largest share of drug expenditure in total health
expenditure, at 25.2%, and Denmark had the lowest, at 6.6%.xv, xvi
By 2008, the most recent year for which data was available, drug expenditure in
Canada had increased its share in total health expenditure by about eight percentage
points, to 17.2%. Norway had the lowest share of drug expenditure in total health
expenditure, at 7.6%, and Hungary had the highest, at 31.6% (Table 3).
xiv.
xv.
xvi.
26
OECD data is standardized for international comparability; consequently, figures calculated from this
data may differ from those calculated from the national health accounts of member countries. Specific to
Canada, expenditure on health research and the training of health care workers with concomitant care of
patients is included in the national health accounts but excluded from OECD health expenditure data.
Drug and health expenditure data was not available for the Czech Republic, Hungary, Mexico, Poland,
the Slovak Republic and Slovenia in 1985. Only health expenditure data was available for Austria for
that year.
Of the comparator countries, only Canada and Korea conformed to SHA guidelines in 1985.
Drug Expenditure in Canada, 1985 to 2010
Table 3: Total Expenditure on Pharmaceutical Goods per Capita and as a
Percentage of Total Health Expenditure, Reporting OECD Comparator
Countries, 2008
GDP per Capita
(CA$,
PPP)†
Country
‡
Australia
48,534
Austria
Belgium
Canada*
Czech Republic
Total Drug
Expenditure
per Capita
(CA$,
PPP)†
Rank
Total Drug
Expenditure as
a Percentage of
Total Health
Expenditure
Total Health
Expenditure
per Capita
(CA$,
PPP)†
Rank
Rank
Percent
Rank
5
591
10
4,126
13
14.3
15
46,606
7
652
8
4,885
7
13.3
17
44,215
12
743
4
4,916
6
15.1
12
48,348
6
863
2
5,020
5
17.2
10
30,806
21
447
21
2,192
21
20.4
7
Denmark
45,320
10
373
22
4,356
10
8.6
24
Finland
44,121
13
535
15
3,702
15
14.4
14
France
40,775
16
747
3
4,548
9
16.4
11
Germany
43,607
14
693
6
4,599
8
15.1
12
Hungary
24,290
23
559
14
1,768
23
31.6
1
Iceland
45,525
8
576
11
4,134
12
13.9
16
Japan‡
42,003
15
674
7
3,358
17
20.1
8
Korea
34,036
19
529
17
2,216
20
23.9
4
Luxembourg
76,443
1
476
18
5,214
4
9.1
23
Mexico
17,846
25
297
25
1,048
25
28.3
2
New Zealand
33,528
20
316
24
3,304
18
9.6
22
Norway
72,108
2
469
19
6,157
2
7.6
25
Poland
21,282
24
337
23
1,493
24
22.6
5
Slovak Republic
27,311
22
602
9
2,178
22
27.6
3
Slovenia
34,405
18
535
15
2,866
19
18.7
9
Spain
39,830
17
733
5
3,571
16
20.5
6
Sweden
45,466
9
562
13
4,270
11
13.2
18
Switzerland§
53,077
4
567
12
5,694
3
10.3
21
United Kingdom
44,459
11
453
20
3,851
14
11.8
20
United States
58,076
3
1,104
1
9,276
1
11.9
19
‡
Notes
* Canadian data reported by the OECD is as of November 2009. In November 2010, updated and revised
Canadian data was released in Canada. This updated information will not be incorporated into the OECD database
until the summer of 2011.
† Converted to Canadian dollars using purchasing power parities (PPPs) for gross domestic product (GDP).
‡ 2007 data used for Total Drug Expenditure per Capita, Total Health Expenditure per Capita and Total Drug
Expenditure as a Percentage of Total Health Expenditure.
§ 2007 data used for Total Drug Expenditure per Capita and Total Drug Expenditure as a Percentage of Total
Health Expenditure.
Source
Organisation for Economic Co-operation and Development and IRDES, OECD Health Data 2010 (Paris, France:
OECD and IRDES, October 2010).
27
Drug Expenditure in Canada, 1985 to 2010
Figure 17 illustrates the trends of drug expenditure per capita (constant 2000
CA$, PPP)xvii in six selected OECD comparator countries.xviii
Figure 17: Drug Expenditure per Capita,* Selected Countries,† 1985 to 2008‡, §
Notes
* Converted to constant 2000 Canadian dollars using purchasing power parities (PPPs) for gross domestic
product (GDP).
† Comparator countries that are also G8 members.
‡ 2008 data not available for Japan.
§ Derived values have been used where data were not available for some countries in certain years:
(Germany: 1991; France: 1986–1989; UK: 1998–1999).
Source
Organisation for Economic Co-operation and Development and IRDES, OECD Health Data 2010 (Paris, France:
OECD and IRDES, October 2010).
Between 1985 and 2008, per capita drug expenditure grew at a faster average
annual rate in Korea (7.79%) and Australia (5.35%) than in Canada (5.32%).
During this period, all other comparative countries experienced a lower average
annual growth rate in per capita drug expenditure than Canada, with Switzerland
being the lowest (2.05%).xix Constant 2000 Canadian dollar purchasing power
parity has been used to compare per capita drug expenditure among the
selected comparator countries.
xvii.
For purpose of this comparison, the constant 2000 CA$ PPP has been used. The figures are calculated
from US$ at a 2000 GDP price level that have been adjusted to CA$ at 2000 PPP rates.
xviii. Comparator countries that are also G8 members.
xix. The average annual rate between 1985 and 2008 could not be calculated for Austria, the Czech
Republic, Hungary, Luxembourg, Mexico, Poland, the Slovak Republic and Slovenia as data for 1985
was not available.
28
Drug Expenditure in Canada, 1985 to 2010
Share of Public Expenditure in Total Expenditure on Drugs
The OECD database on health contains statistics on total expenditure on
pharmaceutical goods and public expenditure on pharmaceutical goods.
In Canada, drug expenditure by the public sector rose from 29.4% of total
expenditure on pharmaceutical goods in 1985 to 38.4% in 2008.
In OECD countries, with the exception of those in North America, the entire
population usually has coverage for prescribed drugs through public insurance.
Most countries have formularies restricting the number of drugs covered under
public insurance and impose cost-sharing (deductibles, co-insurance or
copayments) with waivers for certain groups of beneficiaries.
Table 4 shows that, among the 25 OECD comparator countries in 2008, Spain
had the highest level of public drug spending per capita ($535), the U.S. had
the highest level of total drug expenditure per capita ($1,104) and the United
Kingdom had the highest public share of total drug spending (84.7%).
The high share of total drug expenditure financed by the public sector in some
European countries (for example, Luxembourg and Germany) reflects the inclusion
of drug benefits provided through employment-related social security funds in
publicly financed drug expenditure (see Series C for more data on international
comparisons). These funds are social insurance programs covering the entire
community or large sections of the community, and are imposed or controlled
by a government authority. They generally involve compulsory contributions by
employees, employers or both, and the government authority determines the
terms upon which benefits are paid to recipients. In some European countries,
expenditure by social security funds represents the major share of public expenditure
on drugs (for example, 94.5% in Germany4 and 98.2% in France4 in 2008).
By contrast, in Canada, until 1996, drug benefits under social security funds
included only spending by WCBs and they represented less than 2% of public
expenditure on drugs in retail establishments. Starting in 1997, they also included
expenditure by the premium component of the Quebec Drug Insurance Fund.xx
The share of social security funds in public expenditure on drugs in Canada
increased from 5.9% in 1997 to 8.2% in 2008.4 The premium component of the
Quebec Drug Insurance Fund is financed by the mandatory payment of premiums
by seniors (65 and older) and other residents not covered by private group
insurance. Social assistance recipients are not required to pay a premium.
xx.
Since July 1, 2002, the public plan has been financed both by the expenditure allocated to this program
by the Quebec government (provincial government sector) and by the amounts collected by the Drug
Insurance Fund as premiums and proceeds (social security funds sector). The premium component of the
Quebec Drug Insurance Fund is considered to be a social security scheme, while the remaining portion
of the program that is paid through the ministère de la Santé et des Services sociaux is included as
a provincial government expenditure. For more information, see the General Methods section of the
Methodological Notes.
29
Drug Expenditure in Canada, 1985 to 2010
Group insurance plans offered by employers, unions and professional associations
that resemble the European model do exist in Canada; however, since a government
authority does not impose group health insurance in Canada, and policy-holders may
voluntarily opt out (except in Quebec), they are considered privately financed. Private
health insurance, composed mainly of group insurance, accounted for 30.6% of total
drug expenditure in retail establishments in Canada in 2008.
Table 4: Public Expenditure on Pharmaceutical Goods per Capita and as a
Percentage of Total Expenditure on Pharmaceutical Goods, Reporting
OECD Comparator Countries, 2008‡,§
Public Drug
Expenditure
per Capita
Country
Australia‡
Austria
Belgium
Canada*
Czech Republic
Denmark‡
Finland
France
Germany
Hungary
Iceland
Japan‡
Korea
Luxembourg
Mexico
New Zealand
Norway
Poland
Slovak Republic
Slovenia
Spain
Sweden
Switzerland‡
United Kingdom
United States
(CA$, PPP)†
319
437
441
331
276
208
298
497
530
316
292
482
293
400
59
204
250
129
429
317
535
326
383
384
362
Rank
14
6
5
12
20
22
17
3
2
16
19
4
18
8
25
23
21
24
7
15
1
13
10
9
11
Public Drug
Expenditure as a
Percentage of Total
Drug Expenditure
Total Drug
Expenditure
per Capita
(CA$, PPP)†
591
652
743
863
447
373
535
747
693
559
576
674
529
476
297
316
469
337
602
535
733
562
567
453
1,104
Rank
10
8
4
2
21
22
15
3
6
14
11
7
17
18
25
24
19
23
9
15
5
13
12
20
1
Percent
54.0
67.0
59.3
38.4
61.6
55.8
55.7
66.5
76.6
56.7
50.8
71.5
55.4
84.0
20.1
64.8
53.4
38.3
71.4
59.3
72.9
58.1
67.6
84.7
Rank
19
8
12
22
11
16
17
9
3
15
21
5
18
2
25
10
20
23
6
12
4
14
7
1
32.8
24
Notes
* Canadian data reported by the OECD is as of November 2009. In November 2010, updated and revised
Canadian data was released in Canada. This updated information will not be incorporated into the OECD database
until the summer of 2011.
† Converted to Canadian dollars using purchasing power parities (PPPs) for gross domestic product (GDP).
‡ 2007 data.
Source
Organisation for Economic Co-operation and Development and IRDES, OECD Health Data 2010 (Paris, France:
OECD and IRDES, October 2010).
30
Drug Expenditure in Canada, 1985 to 2010
Share of Drugs in Public Expenditure on Health
In Canada, drugs accounted for only 3.8% of health expenditure by the public
sector in 1985. This proportion increased to 9.4% in 2008, reflecting substantially
higher growth in drug expenditure than in other types of public-sector health
expenditure between 1985 and 2008. Among the comparator countries for
which data was availablexxi in 1985, the share of drugs in public-sector health
expenditure ranged from 2.1% in the U.S. to 15.7% in Spain. In 2008, the share
of drugs in public-sector health expenditure ranged from 4.8% in Norway to
29.1% in the Slovak Republic.
In 2008, the share of drug spending in public-sector health expenditure was
lower than the share of drug spending in total health expenditure in each of the
comparator countries except the Slovak Republic, Spain, Switzerland and the
United Kingdom, reflecting generally higher cost-sharing for drugs than for other
health expenditure.xxii In the case of Canada, the low share of drugs in total
public expenditure on health (9.4% in 2008), compared with the share of drugs
in total health expenditure (17.2% in 2008), also reflects the absence of universal
coverage of prescribed drugs by public insurance, while there exists universal
and full coverage of medically necessary hospital and physician services.
xxi.
Data for Austria, Belgium, the Czech Republic, Hungary, Mexico, Poland, the Slovak Republic, Slovenia
and Switzerland was not available for 1985.
xxii. Data for public drug expenditure as a percentage of public health expenditure was not available
for Belgium.
31
Drug Expenditure in Canada, 1985 to 2010
Table 5: Public Expenditure on Pharmaceutical Goods per Capita and as a
Percentage of Public-Sector Health Expenditure, Reporting OECD
Comparator Countries, 2008
Public Drug
Expenditure
per Capita
Country
Australia‡
Austria
Belgium§
Canada*
Czech Republic
Denmark‡
Finland
France
Germany
Hungary
Iceland
Japan‡
Korea
Luxembourg
Mexico
New Zealand
Norway
Poland
Slovak Republic
Slovenia
Spain
Sweden
Switzerland**
United Kingdom
United States
(CA$, PPP)†
319
437
441
331
276
208
298
497
530
316
292
482
293
400
59
204
250
129
429
317
535
326
383
384
362
Rank
14
6
5
12
20
22
17
3
2
16
19
4
18
8
25
23
21
24
7
15
1
13
10
9
11
Public Sector
Health Expenditure
per Capita
(CA$, PPP)†
2,785
3,757
N/A
3,523
1,809
3,681
2,748
3,538
3,531
1,256
3,441
2,749
1,227
4,382
492
2,657
5,185
1,078
1,475
2,071
2,590
3,496
3,367
3,181
4,316
Rank
13
4
N/A
8
19
5
15
6
7
21
10
14
22
2
24
16
1
23
20
18
17
9
11
12
3
Public Drug Expenditure
as a Percentage of Public
Sector Health Expenditure
Percent
11.5
11.6
N/A
9.4
15.2
5.7
10.8
14.0
15.0
25.2
8.5
17.5
23.9
9.1
12.1
7.7
4.8
12.0
29.1
15.3
20.7
9.3
11.8
12.1
8.4
Rank
15
14
N/A
17
7
23
16
9
8
2
20
5
3
19
10
22
24
12
1
6
4
18
13
10
21
Notes
* Canadian data reported by the OECD is as of November 2009. In November 2010, updated and revised
Canadian data was released in Canada. This updated information will not be incorporated into the OECD
database until the summer of 2011.
† Converted to Canadian dollars using purchasing power parities (PPPs) for gross domestic product (GDP).
‡ 2007 data.
§ Belgium did not provide data on public health expenditure from 1997 onwards.
** 2007 data used for Public Drug Expenditure per Capita and Public Drug Expenditure as a Percentage of
Public Sector Health Expenditure.
Source
Organisation for Economic Co-operation and Development and IRDES, OECD Health Data 2010 (Paris, France:
OECD and IRDES, October 2010).
32
Drug Expenditure in Canada, 1985 to 2010
Factors Affecting Drug Expenditure
in Canada
Numerous factors (see Table 6), many of which are interrelated, may influence
drug expenditure. Since drug prices, as measured by several price indices,xxiii
have been relatively stable over the past 10 years, factors affecting increased
drug spending in Canada essentially relate to the volume of drug use and the
entry of new drugs (typically introduced to the market at higher prices).
Although some literature exists on the effects of various factors on drug
expenditure, more research is required to quantify the effect of each factor and to
inform the relationship between drug expenditure and other health care spending.
The following review of some of the factors affecting drug expenditure is
intended to facilitate discussion and is not meant to be a systemic review of
all relevant literature.
Cost-Related Factors
Although the ingredient prices of drugs, once on the market, are relatively
stable, the introductory price and overall cost of drugs may be influenced by
several factors. These factors include international pricing, inflation, changes in
retail or wholesale markups and other market forces. Market forces can be
competitive forces (for example, the introduction of new products can increase
drug expenditures while generics can decrease drug expenditure by offering a
lower-priced alternative) or regulatory forces (for example, changes in price
controls or extending patent legislation that prevents a less expensive alternative
from coming to the market).
Quantity-Related Factors
There are many factors that can affect the quantity of drugs dispensed. A change
in quantity can be the result of a change in the number of users or in the volume
of drugs used.
Population-Related Factors
Population size affects the number of potential users in an area (for example,
P.E.I. versus Ontario). Demographics such as age, gender and ethnic distribution,
as well as changes in health status, also play a role in determining levels of drug
expenditure. Changes in the health status of the population can be the result of the
emergence of new diseases, epidemics and changes in the prevalence or severity
of existing disease. Healthier populations may use fewer drugs.
xxiii. For more information on price indices, see the Data Limitations section of the Methodological Notes.
33
Drug Expenditure in Canada, 1985 to 2010
Health System–Related Factors
The health system also plays a role in drug expenditure. Changes in policies and
programs, including regulations around drug plan eligibility and co-insurance,
the extent of formulary listings and the availability of and access to third-party
insurance coverage can all affect drug spending.5 In general, the more
accessible and more generous insurance coverage is, the less costly drugs
are to the end consumer and the more likely people are to consume drugs.
New Drugs
New drugs introduced to the market have an influence on drug expenditure.
New drugs can result in switching between classes of drugs used to treat
similar conditions or switching between drugs within a class. Provided there
is a difference in price, any switching will affect drug expenditure.
New drugs may be safer or have fewer potential side effects than existing drugs.
As well, they may offer an alternative to, or even a replacement for, existing
non-drug therapies (for example, surgery). In addition, new drugs may be used
to treat or slow the progression of diseases or symptoms of diseases that were
previously undertreated or untreatable.
Generic Drugs
Generic drugs are usually introduced to the market following the expiration of
patents for brand name drugs. They provide a lower-priced alternative, which
often results in switching from the brand name to the generic product.
Other Factors
Aside from the development of new drugs, the pharmaceutical industry plays a
role in influencing the trends in drug expenditure. Pharmaceutical companies
promote their products to prescribers (for example, physicians, dentists, nurse
practitioners) and pharmacists through a practice known as detailing, as well as
by advertising to the general public, known as direct-to-consumer advertising
(DTCA). Although DTCA is regulated in Canada, Canadians are exposed to it
through international media.
Changes in clinical practice guidelines, government regulation on generic drugs or
pricing, prescribing practices and consumer preferences can also lead to changes in
the amount or types of drugs dispensed. Changes in pharmaceutical care practices
by pharmacists can improve a person’s compliance with a treatment regimen,
resulting in improved health outcomes, improved utilization of first-line therapies
(thereby reducing the use of more costly alternative treatments) or decreased
use of other health care resources that may be more costly, such as hospital visits.
Adoption of primary prevention strategies, such as improved diet, exercise or
other forms of healthy living, can improve the health status of the population.
34
Drug Expenditure in Canada, 1985 to 2010
What We Know
• Drug expenditure rose every year between 1985 and 2010, with an average
annual growth rate of 8.8%.
• New drugs are often introduced at much higher prices than those of
existing therapies.6
• In 2009, 81 new patented drugs were introduced to the market for human
consumption in Canada.7
• Since 1988, the price of patented medicines in Canada rose at a lower rate
than economy-wide inflation in every year but one (1992).8, xxiv
• Some new drugs have reduced overall medical expenditures.8, 9
• An increasing number of drug therapies are being administered outside of
the hospital setting, thereby shifting costs from hospitalsxxv to the community
(for example, in-home cancer treatments).10
• The Canadian population has been growing at roughly 1.1% per year since
1985. The proportion of the population age 65 and older increased by slightly
less than two percentage points between 1997 and 2010.11 These changes
were gradual and did not have a great impact on drug expenditure.12
• Several high expenditure drugs in Canada have patents that have just expired
or are about to expire (for example, Lipitor [atorvastatin], Crestor [rosuvastatin]
and Plavix [clopidogrel]).
• Some public drug programs have recently implemented changes to generic
pricing policies.13, 14
What We Don’t Know
• Whether increases in total drug expenditure negatively or positively affect
overall health outcomes.
• How drug use impacts spending in other sectors of health care (for example,
decreased hospitalization).
• The degree to which each of the possible influencing factors discussed in the
section above affects drug expenditure.
• How direct-to-consumer advertising affects the marketplace, prescribing
practices, physician–patient communication and the public’s understanding
of drug therapy in Canada.15
xxiv. For more information on drug prices, see the Data Limitations section of the Methodological Notes.
xxv. Drugs paid through hospital budgets are not identified separately in the NHEX database but are
classified as hospital expenditure.
35
Drug Expenditure in Canada, 1985 to 2010
Table 6: Factors That May Influence Drug Expenditure in Canada
Prices
• Changes in the unit prices of drugs (both patented and non-patented)
• Changes in retail and wholesale markups and professional fees
• Availability of generics
• International prices
• Inflation
Entry of New Drug Chemicals
Volume of Drug Use
• Population-Related
– Changes in population size
– Changes in population structure/distribution
– Age, gender and ethnicity
– Changes in health status of a population
– Emergence of new diseases
– Epidemics
– Prevalence and severity of disease
• System-Related
– Changes and transition associated with health system reform
– Availability of and access to third-party insurance coverage
– Changes in policies and programs
– The extent of formulary listings
– Eligibility and copayments
• Research- and Technology-Related
– New treatment approaches
– Drugs replacing surgery
– Drug therapy for previously untreatable or undertreated diseases
– Availability of more and/or improved diagnostic technology
– Outcomes research, evidence-based preventive or curative approaches
in diagnosis or treatment
– Use of programs and technology in monitoring patients
36
Drug Expenditure in Canada, 1985 to 2010
Table 6: Factors That May Influence Drug Expenditure in Canada (cont’d)
• Pharmaceutical Industry
– Development of new drug products (for example, new strengths,
new drug forms and presentations)
– Promotion of drugs to physicians
– Drug sampling
– Direct-to-consumer advertising
• Practice- and People-Related (Health Care Providers and Consumers)
– Changes in prescribing and dispensing practices
– Number and mix of prescribers (specialists, general practitioners,
nurse practitioners and others)
– Multiple doctoring
– Consumers’ expectations and behaviours
– Adherence to treatment
Methodological Notes
Background
Drug expenditure data in this report is obtained from the National Health
Expenditure Database (NHEX), which is maintained by the Canadian Institute for
Health Information (CIHI). This database contains a historical series of macro-level
health expenditure statistics by province and territory, beginning in 1975. Drug
expenditure data in NHEX is macro-level data and does not allow for
decomposition of prescription costs or drug classes.
The Drugs category in NHEX is intended to measure final consumption, outside an
institutional setting, of drugs purchased by consumers or third-party payers on
their behalf, generally from community pharmacies. Drug expenditure data in
NHEX consists of estimates that represent the final costs to Canadian consumers,
which include dispensing fees, markups and appropriate taxes. NHEX data does
not account for drug expenditure by non-Canadians (for example, Americans’
purchases from Canadian pharmacies). The classification system employed is
consistent with international standards developed by the Organisation for
Economic Co-operation and Development (OECD).
37
Drug Expenditure in Canada, 1985 to 2010
National Health Expenditure Database
The mandate of the NHEX database is twofold:
1. To support the development and evaluation of health programs in Canada
by all levels of government and within the private sector.
2. To compile information on health expenditure that will accurately portray
the importance of health care as a component of national expenditure.
Health Expenditure—includes any type of expenditure for which the primary
objective is to improve or prevent the deterioration of health status.
This definition allows economic activities to be measured according to primary purpose
and secondary effects. Activities that are undertaken with the direct purpose of improving
or maintaining health are included. Other activities are not included, even though they may
impact health. For example, housing and income support policies have social welfare
goals as their primary purpose and are not considered to be health expenditure, yet they
are recognized as powerful factors in determining population health.
Source of Finance
National health expenditures are reported based on the principle of responsibility
for payment rather than on the source of the funds. It is for this reason, for example,
that federal health transfers to the provinces/territories are included in the provincial/
territorial government sector, since it is the responsibility of provincial/territorial
governments to expend federal transfers on health services. The exception to
this principle is that provincial/territorial government health transfers to municipal
governments are included in the provincial/territorial government sector. The following
figure depicts the composition of total health expenditure by source of finance.
38
Drug Expenditure in Canada, 1985 to 2010
Figure 18: Composition of Total Health Expenditure, by Source of Finance*
Note
* The remaining funds in the Quebec Drug Insurance Fund are financed through the Consolidated
Revenue Fund; these expenditures are captured under the provincial government sector.
Public Sector—includes health care spending by governments and government
agencies.xxvi It is subdivided into provincial government sector and other public
sector, as described below:
1. The provincial government sector includes health spending from provincial/
territorial government funds, federal health transfers to the provinces/territories
and provincial/territorial government health transfers to municipal governments.
2. The federal direct sector refers to direct health care spending by the federal
government in relation to health care services for special groups, such as
Aboriginal People, the Canadian Forces and veterans, as well as expenditures
for health research, health promotion and health protection. Federal direct
health expenditure does not include federal health transfers to the provinces.
3. The municipal government sector expenditure includes health care spending
by municipal governments for institutional services, public health, capital
construction and equipment, and dental services provided by municipalities in
the provinces of Nova Scotia, Manitoba and British Columbia. Designated funds
xxvi. Statistics Canada (Public Sector Statistics Division) publishes estimates of government health expenditure as part
of its comprehensive reporting system of all government expenditure, the Financial Management System (FMS).
The FMS public-sector health spending estimates are lower than those reported by CIHI because different
classification methods are applied and a narrower definition of health expenditure is used in the FMS.
39
Drug Expenditure in Canada, 1985 to 2010
transferred by provincial governments for health purposes are not included in
the municipal sector but are included with provincial government expenditure.
Currently, no estimates of drug spending are included in this sector.
4. Social security funds are social insurance programs that are imposed and
controlled by a government authority. They generally involve compulsory
contributions by employees, employers or both, and the government
authority determines the terms upon which benefits are paid to recipients.
Social security funds are distinguished from other social insurance
programs, the terms of which are determined by mutual agreement between
individual employers and their employees. In Canada, social security funds
include the health care spending by workers’ compensation boards (WCBs)
and the premium component of the Quebec Drug Insurance Fund.
• Health spending by WCBs includes what the provincial boards commonly
refer to as medical aid. Non–health related items often reported by the
WCBs as medical aid expenditure—such as funeral expenses, travel and
clothing—are removed.
• On January 1, 1997, the government of Quebec created a basic drug
insurance plan with the objective of ensuring the population of Quebec
has access to drugs as required by health status. All residents of Quebec
must be covered by drug insurance, whether by private group insurance
or by the public plan administered by the Régie de l’assurance maladie du
Québec (RAMQ). At the beginning of the plan, the Drug Insurance Fund
was the chosen mechanism to pay all drug and pharmaceutical service
costs provided to subscribersxxvii insured by the RAMQ, as well as their
children. Since July 1, 2002, the Drug Insurance Fund has also covered
persons age 65 or older and social assistance recipients insured by the
RAMQ. Accordingly, the public plan has been financed since then both
by the expenditure allocated to this program by the Quebec government
(provincial government sector) and by the amounts collected by the Drug
Insurance Fund as premiums and proceeds (social security funds sector).
The premiums are paid by the subscribers of the Quebec Drug Insurance
Fund and by persons age 65 or older insured by this plan.
Private Sector—includes health care spending by individuals and private
sources as described below:
1. Non-consumption includes non-patient revenues received by health care
institutions, such as donations and investment income, private spending on
health-related capital construction and equipment, as well as health research
funded by private sources. Currently, no estimates of drug spending are
included in this portion of the private sector.
xxvii.
40
Subscribers are defined as Quebec residents younger than age 65 who do not receive social
assistance benefits and who do not have access to private group insurance.
Drug Expenditure in Canada, 1985 to 2010
2. Out-of-pocket includes health expenditures made by individuals for health
care goods and services.
3. Private health insurance includes health expenditure paid by commercial and
not-for-profit insurance firms, as well as the cost of administering those claims.
Hierarchy of Classification
National health expenditure in Canada is based on a system of classification that
is consistent with international standards developed by the OECD for reporting
health expenditure.
National health expenditure is grouped within the broad categories of personal
health care or other health expenses:
• Personal health care consists of expenditure for health goods and services
used by individuals.
• Other health expenses consist of expenditure on behalf of society, such
as public health; expenditure made as investments for purposes of future
consumption, such as capital expenditure; the administrative expenses of
planning and managing the health care system; and research.
Personal health expenditure is classified within categories that describe the type
of health care used. Certain categories overlap. The hierarchy of classification
that is used to allocate overlapping categories of expenditure is as follows:
• Institutional setting—Health care services consumed in hospitals or
other institutions are allocated to the institutional category if the institution
purchases the services on behalf of its patients. For example, drugs paid
through hospital budgets are classified as hospital expenditure. This allocates
expenditure to the supplier actually paid by patients or their agents in the form
of government or insurance companies. It also reflects data availability.
• Self-employed provider of service—For example, all expenses of
physicians’ practices are considered to be expenditure for physician services,
even though some of these expenses would be for employment of other
health professionals, drugs or personal health supplies.
• Type of good or service—Drugs and personal health supplies are examples.
One of the categories of health expenditure within NHEX is Drugs. Other
categories include Hospitals, Other Institutions, Physicians, Other Professionals,
Capital, Public Health and Administration, and Other Health Spending. In NHEX,
these categories are also named Use of Funds.
Below is a description of the Drugs category within NHEX; it is not a definition
supplied by the OECD.
41
Drug Expenditure in Canada, 1985 to 2010
• Drugs—At the aggregate level, include expenditure on prescribed drugs and
non-prescribed products purchased in retail stores. Estimates represent the
final costs to consumers, including dispensing fees, markups and appropriate
taxes. The breakdown of prescribed drugs, over-the-counter drugs and
personal health supplies in NHEX is parallel with the breakdown in the OECD.
This category has been disaggregated at the Canada level in the data tables
to provide information on the following sub-categories:
– Prescribed drugs—substances considered as drugs under the Food and
Drugs Act and sold for human use as the result of a prescription from a
health professional.
– Non-prescribed drugsxxviii—include two sub-components: over-the-counter
drugs and personal health supplies.
– Over-the-counter drugs—therapeutic drug products not requiring a
prescription and purchased as such.
– Personal health supplies—include items used primarily to promote or
maintain health; for example, oral hygiene products, diagnostic items such
as diabetic test strips and medical items such as incontinence products.
The Drugs category in NHEX does not include drugs dispensed in hospitals and
generally in other institutions. These are included in health expenditure figures
for Hospitals or Other Institutions.
Other Terms
Gross domestic product (GDP)16—GDP implicit price index (in 1997 dollars) is
used to compare annual percentage change of drug expenditure with inflation in the
Canadian economy. GDP is the unduplicated value of production originating within
the boundaries of Canada, regardless of the ownership of the factors of production.
Purchasing power parity (PPP)17—PPPs are the rates of currency conversion
that equalize the purchasing power of different currencies. This means that a
given sum of money, when converted into different currencies at the PPP rates,
will buy the same basket of goods and services in all countries. Thus PPPs are
the rates of currency conversion, which eliminate differences in price levels
between countries.
xxviii. For more information on over-the-counter drugs and personal health supplies, see the General
Methods section of the Methodological Notes.
42
Drug Expenditure in Canada, 1985 to 2010
Data Limitations
Data contained in NHEX is estimated. The data is collected from diverse sources
and includes varying classes of financial information. The data is collected
and classified according to methods established by a review committee. CIHI
analysts and external experts continue to improve the comprehensiveness,
accuracy and currency of the data in order to provide the most complete and
objective estimates possible. Notwithstanding these improvements, national
health expenditure data consists of estimates and should be used accordingly.
Most private-sector expenditure is estimated from survey data. Prior to 1996,
the Family Expenditure Survey by Statistics Canada,18 an important source of
private-sector data, was not carried out annually; therefore, trend data was
imputed for years between surveys. Private-sector data was revised following
a methodology review in the early 1990s. The revised private-sector data
incorporated information estimated directly from new sources for 1988 and
subsequent years. Prior years were estimated using trend data. As a result,
readers should use caution when using the private-sector expenditure data
for small provinces and for years prior to 1988.
Drugs in Hospitals
The NHEX database at CIHI uses a classification system that is consistent with
international standards developed by the OECD for the reporting of health
expenditure. Similar to the functional category Pharmaceutical and Other
Medical Non-Durables in the OECD System of Health Accounts, the Drugs
category in NHEX is intended to measure final consumption, outside an
institutional setting, of drugs purchased by consumers or third-party payers
on their behalf, generally from retail outlets. Drugs in hospitals are considered as
inputs (intermediate consumption) to the production of health care in hospitals.
Consequently, drugs paid through hospital budgets are not identified separately
in NHEX but are classified as hospital expenditure. Similarly, drugs purchased
by residential care facilities for their residents are classified as institutional
expenditure. All expenses of physicians’ and dentists’ practices, including
drugs, are considered to be expenditure for physicians’ and dentists’ services.
Some drug expenditure is also included in the NHEX category of public health
(for example, vaccines). While the above hierarchy of classification is essential in
allocating overlapping categories of expenditure, it also reflects data availability.
For example, data on expenditure by provincial/territorial governments is usually
extracted from provincial/territorial government public accounts. In the accounts,
it is generally not possible to isolate drug spending from other categories of
expenditure within program areas (for example, hospitals or public health).
Although other possible data sources exist, the use of a single data source for
the different categories of provincial government health expenditure—such as
the provincial/territorial public accounts—has the major advantage of minimizing
the risk of double counting.
43
Drug Expenditure in Canada, 1985 to 2010
Measuring Drug Prices
There is no authoritative composite price index for all drugs sold in Canada.
The difficulty lies in the fact that traditional statistical measurement considers the
price of tablets or capsules rather than measuring the nature of the product itself
(that is, its therapeutic properties). In pure economic terms, the price of a drug is
the price per unit of health gain attained. From a practical perspective, however,
people buy tablets, capsules or other forms of medication, some of which may
contain multiple active ingredients.
Figure 19: Patented Medicine Price Index (PMPI), Consumer Price Index (CPI) and
Industrial Product Price Index (IPPI), 1985 to 2010 (1987 = 100),‡,§
Sources
Consumer Price Index and Industrial Product Price Index, Statistics Canada; Patented Medicine Price Index,
Patented Medicine Prices Review Board.
There are several commonly accepted price indices that can potentially be used
to measure shifts in drug prices at the retail level. These include the Consumer
Price Index (CPI), the pharmaceutical component of the Industrial Product Price
Index (IPPI [pharma]) and the Patented Medicine Price Index (PMPI). Each
index is built upon a unique set of assumptions pertaining to inclusion criteria,
definitions, updating and weighting methodologies. As a result, these indices
produce differing results (Figure 19).
44
Drug Expenditure in Canada, 1985 to 2010
It is important to determine whether two different products with similar therapeutic
elements used to treat similar health conditions are essentially different. Several
price indices assume they are different products. The consequence is that when
new products enter the market, price indices do not compare their prices to
existing products; they are simply added to the basket of goods.
Collection and Non-Response
The definitions and methods used in the preparation of this document are for the
most part based on those adopted in 1994 by the National Health Expenditure
Methodology Review Committee. This committee included representation from
Health Canada, Statistics Canada, the Quebec ministère de la Santé et des
Services sociaux, the Canadian Medical Association and the Canadian
Healthcare Association. Some of the recommendations for change made
during that process are still under development.
General Methods
The following is intended as a general overview of the methods applied to
calculate estimates of drug expenditure in Canada. More detailed information
can be obtained by contacting the National Health Expenditures program area
by phone at 613-241-7860, by fax at 613-241-8120 or by email at [email protected]
Provincial/Territorial Government
Provincial/territorial government expenditure principally includes drugs that are
dispensed through provincial/territorial drug subsidy programs (see Appendix A).
This drug expenditure data is extracted predominantly from audited and
consolidated provincial/territorial documents detailing provincial government
expenditure (Table 7).
Provincial/territorial government drug spending figures include spending
by the provincial/territorial ministry responsible for health, as well as by other
departments that may provide drug coverage. CIHI’s estimates of provincial and
territorial government drug expenditure were submitted to provincial and
territorial departments of health for review and validation.
Provincial/territorial government figures identified as forecasts are based on the
growth rates of major programs reported in provincial and territorial government
main estimates and budgets.
45
Drug Expenditure in Canada, 1985 to 2010
Table 7: Provincial/Territorial Government Drug Expenditure Data
Province/Territory
Description
Newfoundland and Drug Expenditure Drug expenditure data is collected from the Provincial
Labrador
Data Source
Public Accounts Volume III, Consolidated Revenue Fund
Supplementary Statements and Schedules for three
drug programs: indigents, seniors and the special
drug programs.
46
Prince Edward
Island
Drug Expenditure The Drug Cost Assistance Program is reported under
Data Source
the Provincial Pharmacy program in the Queens Region
Health and Community Services operating statement,
which is reported in the P.E.I. Provincial Public Accounts
Volume II.
Nova Scotia
Drug Expenditure Drugs data is extracted from three sources: the
Data Source
Nova Scotia Estimates Supplementary Detail, special
tabulations from the N.S. Seniors’ Pharmacare Program
and the N.S. Department of Community Services, Income
Assistance and Employment Support Services.
New Brunswick
Drug Expenditure Drugs data is provided through special reports from the
Data Source
Department of Health and Community Services and the
Department of Human Resources. A small component of
drug expenditure by the provincial government is from the
N.B. Public Accounts Volume 2, under Payments to
Vendors and Grants and Contribution Payments.
Quebec
Drug Expenditure Provincial government expenditure is extracted from
Data Source
Volume 2 of the Quebec provincial public accounts.
Spending on drugs by the provincial government is
represented by total transfers of Program 5, Régie de
l’assurance maladie du Québec, for “médicaments et
services pharmaceutiques.” See also the section
below on social security funds and the Quebec Drug
Insurance Fund.
Ontario
Drug Expenditure Data is collected from Volume 1 of the Ontario Provincial
Data Source
Public Accounts. Information is collected for the drug
programs provided by the Ministry of Health and
Long-Term Care (Ontario Drug Benefit Program, Trillium
Drug Program, Special Drug Program) and by the
Ministry of Community and Social Services, under
Social Assistance and Employment under the Adult and
Children’s Service Program.
Manitoba
Drug Expenditure Data is from Manitoba Health’s Pharmacare Program
Data Source
under the Health Services Insurance Fund. Data is
also collected from the annual report of the Manitoba
Department of Family Services under Income Assistance
of the Employment and Income Assistance Program.
Drug Expenditure in Canada, 1985 to 2010
Table 7: Provincial/Territorial Government Drug Expenditure Data (cont’d)
Province/Territory
Description
Saskatchewan
Drug Expenditure Data sources include the Saskatchewan Public Accounts
Data Source
Volume 2 and the Saskatchewan Health Annual Statistical
Report for the Drug Plan and Extended Benefits Branch.
Data is collected for the Saskatchewan Prescription Drug
Plan from the annual report. A total for the Supplementary
Health Program (SHP) is also extracted from the annual
report. The distribution of detailed expenditure of the SHP
provided in the Statistical Report for the Drug Plan and
Extended Benefits Branch is applied to the total for the
SHP extracted from the public accounts. One of the
components of the SHP that is also collected is
“non-formulary drugs.” Drug expenditure amounts are
collected under the Ministry of Social Services in the
Supplier Payments section of the public accounts.
Alberta
Drug Expenditure Drug expenditure data from Alberta Health and Wellness
Data Source
is extracted from its annual report. Detailed claims
summary data is provided by Alberta Blue Cross NonGroup Benefits. The largest single expenditure
component of Alberta Blue Cross Non-Group Benefits is
drug benefits. The detailed claims distribution is applied
to the total for Blue Cross Non-Group Benefits under
Practitioner Services, extracted from the annual report of
the Ministry of Health and Wellness.
Drug expenditure information is also collected from
Children’s Services, the Department of Community
Development and the Department of Human Resources
and Employment. Drug expenditure amounts are
compiled from various income assistance programs,
including Income Support to Individuals and Families,
Social Support to Individuals and Families and Services to
Persons With Disabilities.
British Columbia
Drug Expenditure Data is received in the Financial Management Reports
Data Source
(FMRs) from the Ministry of Health Services. Control totals
for major programs are from the public accounts. With few
exceptions, expenditure items from the FMRs sum to the
control totals. The Ministry of Health Services administers
drug subsidization for all targeted groups (seniors,
income assistance recipients and families) under the
Medical Services Program.
Yukon
Drug Expenditure Control totals on major programs are extracted from
Data Source
Yukon’s public accounts. Additional details are in a
special tabulation provided by the territorial Ministry of
Health and Social Services on spending for pharmacare,
prescription drugs, under the Chronic Disease Program
and Extended Health Benefits for Seniors.
Northwest
Territories
Drug Expenditure Drug expenditure data is provided by the Finance Division
Data Source
of the Department of Health and Social Services under
the Extended Health Benefits of the Supplementary
Health Programs.
47
Drug Expenditure in Canada, 1985 to 2010
Table 7: Provincial/Territorial Government Drug Expenditure Data (cont’d)
Province/Territory
Nunavut
Description
Drug Expenditure The government of Nunavut is unable to provide drug
Data Source
expenditure amounts to CIHI. The method used to
estimate expenditure in Nunavut was to allocate the same
proportion that drugs were in the Northwest Territories
of the aggregate of individual programs in the Northwest
Territories that make up the Supplementary Health
Benefits Program in Nunavut.
Federal Direct
Prescribed drug data is derived from information provided by federal
government organizations supplemented with information from the National
public accounts. Federal government health care spending is generally provided
according to the province in which the expenditure was made. Some data,
however, is provided only at the national level; in these cases, it is distributed
by the appropriate provincial or territorial population.
Social Security Funds
Social security funds are financially autonomous social insurance schemes
that are imposed and controlled by a government authority. They generally
involve compulsory contributions by employees, employers or both, and the
government authority determines the terms by which benefits are paid to
recipients. Social security funds are distinguished from other social insurance
programs, the terms of which are determined by mutual agreement between
individual employers and their employees. In Canada, social security funds
include the health care spending by WCBs and the premium component of the
Quebec Drug Insurance Fund.
Workers’ compensation boards—Prescribed drug expenditure for the WCBs
and the Commission de la santé et de la sécurité du travail du Québec is
collected through special tabulations from contacts in each provincial or
territorial WCB.
Quebec Drug Insurance Fund—On January 1, 1997, the government of
Quebec created a basic drug insurance plan with the objective of ensuring the
population of Quebec has access to drugs as required by health status. All
residents of Quebec must be covered by drug insurance, whether by private
group insurance or by the public plan administered by the RAMQ. At the
beginning of the plan, the Drug Insurance Fund was the chosen mechanism to
pay all drug and pharmaceutical service costs provided to subscribersxxix insured
by the RAMQ, as well as their children. Since July 1, 2002, the Drug Insurance
xxix. Subscribers are defined as Quebec residents younger than age 65 who do not receive social assistance
benefits and who do not have access to private group insurance.
48
Drug Expenditure in Canada, 1985 to 2010
Fund has also covered persons age 65 or older and social assistance recipients
insured by the RAMQ. Accordingly, the public plan has been financed since
then, both by the expenditure allocated to this program by the Quebec
government (provincial government sector) and by the amounts collected by the
Drug Insurance Fund as premiums and proceeds (social security funds sector).
The premiums are paid by the subscribers of the Quebec Drug Insurance Fund
and by persons age 65 or older insured by this plan.
The premium component of the Quebec drug program is considered to be a
social security scheme, while the remaining portion of the program that is paid
through the ministère de la Santé et des Services sociaux (MSSS) is included as
a provincial government expenditure.
Private Sector
Private-sector drug data was revised in 1995 following a methodology review
that began in the early 1990s. Private-sector data under the revised methodology
incorporated information estimated directly from new sources for 1988 and
subsequent years. Expenditure amounts prior to 1988 were estimated using
trend data. Therefore, readers should exercise caution when using the
private-sector expenditure data for small provinces and for years prior to 1988.
The recommendations pertaining to prescribed and non-prescribed drugs that
were ultimately implemented included the following:
• Data on drug benefits paid by private insurers was to be estimated based on
information provided by the Canadian Life and Health Insurance Association
(CLHIA) and from surveys of non-profit insurers.
• Out-of-pocket expenditure on prescribed drugs was to be estimated from
Statistics Canada’s Family Expenditure in Canada survey (FAMEX), renamed
in 1997 to the Survey of Household Spending (SHS).
• Non-prescribed drug estimates would include two components: over-thecounter drugs and personal health supplies. Estimates would be based on
information from the market research firm The Nielsen Company.
As part of the original agreement with the not-for-profit insurance firms that
provide data to NHEX, the administrators of NHEX agreed not to report the
components of the private sector—insurance and out-of-pocket expenditure—at
the provincial/territorial level. The purpose was to protect the proprietary nature
of the information of the not-for-profit insurance firms. Consequently, CIHI only
reports the private-sector sum of components by province and the out-of-pocket
and insurance components of the private sector at the national level.
49
Drug Expenditure in Canada, 1985 to 2010
The data sources and methodologies related to these recommendations are
described below.
Health insurance drug claims paid are collected from nine not-for-profit
insurance companies and the CLHIA. The CLHIA data is based on its survey
of member companies. Currently, drug spending that may occur by insurance
companies providing casualty insurance is not included in the estimates.
Out-of-pocket prescribed drug expenditure is based on purchased data from the
SHS fielded by Statistics Canada. Specifically, average household costs associated
with question 220, in Section PH of the SHS 2008 Questionnaire, relating to
medicines, drugs and pharmaceutical products prescribed by a doctor are the
basis of the estimates. The average household expenditure of prescribed drugs is
multiplied by the number of estimated households reported in the survey.
The SHS is an annual survey that began in 1996. Prior to 1996, full surveys that
included both urban and rural areas were carried out in 1986 and 1992. In 1990,
a survey was conducted that included only metropolitan areas. For the years in
which complete surveys were carried out, data is available for the 10 provinces
and for 17 urban centres. Two of the urban centres, Yellowknife and Whitehorse,
were used to derive estimates of expenditure in the territories. Metropolitan
expenditure per household tends to be somewhat higher than provincial
estimates. All relevant categories were updated in complete survey years.
For the years in which only urban surveys were carried out, the percentage
changes in urban expenditure within each province or territory were used to
update category estimates from complete survey years. Between 1992 and 1996,
when no surveys were conducted, historical provincial growth rates of the SHS
variables of drug and drug sundries were used to impute missing years.
The non-prescribed drug estimate is based on data from the market research
firm The Nielsen Company, which tracks consumer sales of non-prescribed
drugs sold in Canada at retail. Each year, The Nielsen Company reports retail
sales data for two consistent years for more than 48 non-prescribed drug
categories. Data is reported by sales channel,xxx total dollar sales volume and
regional sales distribution for five regions that include nine provinces.
Newfoundland and Labrador and the territories are not included. The data is
processed by classifying the non-prescribed drug categories as either overthe-counter drugs or personal health supplies. Regional sales amounts are
separated into nine provinces, and estimates for Newfoundland and Labrador
and the territories are calculated using provincial distributions of “direct costs for
health care” from the SHS. Appropriate provincial and federal sales taxes are
incorporated into the estimates.
xxx.
50
As a general rule, Statistics Canada definitions govern the classification of stores by class of trade. Sales
channels include drug stores; food stores with pharmacies; grocery banners; and mass merchandiser
and warehouse clubs, which are estimated from The Nielsen Company’s household panel data.
Drug Expenditure in Canada, 1985 to 2010
The following list provides the various drug classes that are supplied to CIHI by
The Nielsen Company. The choice of classes to be included in the nonprescribed drug expenditure estimate and the classification according to which
drugs are included as over-the-counter or personal health supplies was made by
the NHEX Drug Expenditure Review Committee during the NHEX methodology
review and adopted in 1995.
Over-the-Counter Drugs
Personal Health Supplies
Analgesic rubs
Adhesive bandages and dressing strips
Anti-fungals (external)
Antiperspirants
Athletes’ foot products (included in
anti-fungals in later years)
Artificial sweeteners
Athletic supports/braces
Cold remedies
Condoms
Cough remedies
Contact lens preparations
Diarrhea remedies
Cotton swabs
Dietary aids
Cover and tape products
Headache remedies
Dental floss
Headache remedies—child’s acetaminophen
Dentifrice
Hemorrhoidal remedies
Denture adhesives
Infant feeding products
Denture cleansers
Laxatives
Diabetic test strips
Medical nutritional supplements
Disposable diabetic syringes
Milk-intolerant products
Elastic bandages
Nasal preparations
Eye drops and lotions
Oral backache remedies
Feminine hygiene products
Pediculicides
Fever thermometers
Personal lubricants
Incontinence products
Premenstrual products
Medical supports/braces
Sleeping aids
Oral antiseptics
Throat remedies
Pregnancy test kits
Topical wound care
Sanitary pads
Upset stomach remedies
Selected hot/cold compresses
Vitamins—children’s
Selected insoles
Vitamins—adults’
Tampons
Wart removers
Toothbrushes (includes denture brushes)
51
Drug Expenditure in Canada, 1985 to 2010
Calculation Methods
Calculation of Average Annual Rate of Growth
The average annual rate of growth is the constant annual rate necessary for a
value at the beginning of a period to grow to a value at the end of a period over
the number of compounding years in the period. The formula used to calculate
the average annual rate of growth is
=e
ln( value at end of period ) − In(value at beginning of period )
T
−1
Where the constant e equals 2.718, which is the base of the natural logarithm,
and T equals the number of years in the period (that is, year at end of period –
year at beginning of period).
Calculation of Calendar Year
Some information sources provide data in fiscal years. Calendar-year data was
derived by adding three-quarters of one fiscal year to one-quarter of the previous
fiscal year.
Calculation of per Capita Dollars
Per capita expenditure was calculated using the most recent revised population
estimates and forecasts from the Demography Division of Statistics Canada.
These take into account the results of the census adjustment for net census
under-count, non-permanent residents and returning Canadians.
Calculation of Total Health Expenditure
“Total health expenditure” refers to the sum of the public and private sectors.
“Canada” refers to the sum of the 10 provinces and three territories. “Canada
average” is the sum of provincial and territorial expenditure divided by the sum
of provincial and territorial data of another variable, such as population.
Calculation of Deflated Drug Expenditure per Capita Using CPI
Where drug expenditure per capita is presented in constant 1985 dollars,
constant dollar drug expenditure per capita was calculated using the CPI,
provided by Statistics Canada. A more complete explanation of the methodology
for calculating the CPI is available from Statistics Canada.19
52
Drug Expenditure in Canada, 1985 to 2010
Forecasting Methods
Provincial government–sector drug spending forecasts are based on the growth
rates of drug subsidy programs of provincial health departments reported in
provincial main estimates and budgets. In the case of territorial government
forecasts of the Northwest Territories and Nunavut, estimates were based on
amounts reported in their main estimates. In other sectors, the figures for these two
territories were calculated by developing a forecast for the Northwest Territories,
including Nunavut. The share of Nunavut spending in the last year of actual data
of the combined total of the Northwest Territories and Nunavut was used as a proxy
to break out the forecasts for the Northwest Territories and Nunavut.
Forecasts for federal direct, WCBs and private sector were entirely based on
econometric analysis of time series trends. For each series, up to 40 different
univariate forecasting specifications were evaluated, and the best one (based
on the root mean square error of prediction) was selected. The functional forms
studied included the exponential smoothing family (simple, double, Holt,
Brown, Winters, damped trend, etc.); time trends; and ARIMA specifications.
Logarithmic transformations were used when the data warranted their use.
Forecasts of health expenditure are identified in the figures by special symbols
and in the data tables by the letter f.
Sources of Data
Drug expenditure estimates from NHEX are compiled based on information from
the following sources.
Provincial Government Sector
• Provincial public accounts and main estimates
• Provincial departments of health annual reports and statistical supplements,
where available
• Annual reports of various foundations, agencies and commissions
• Special tabulations and specific information from various provincial
departments reporting health expenditure
Federal Direct Sector
• Public Accounts of Canada
• Special tabulations and information from
– Health Canada
– Veterans Affairs Canada
– Department of National Defence
53
Drug Expenditure in Canada, 1985 to 2010
– Solicitor General of Canada
– Statistics Canada
– Citizenship and Immigration Canada
Social Security Funds Sector
• Special tabulations on medical aid spending provided by the provincial and
territorial WCBs
• Annual reports of provincial and territorial WCBs
• Annual report of the RAMQ
Private Sector
• Private insurance component:
– The not-for-profit portion is captured from special tabulations provided by
the not-for-profit insurance companies.
– The commercial portion is captured by a special tabulation provided by
the CLHIA.
• Out-of-pocket component:
– SHS, Statistics Canada (formerly the FAMEX)
– Over-the-Counter Drugs and Personal Health Supplies—Market Review of
Selected Drug Categories at Retail, a special tabulation purchased from The
Nielsen Company Canada
Economic and Demographic Data
• Gross domestic product:
– Purchased from National Accounts and Environment Division, Statistics
Canada, for all years except the latest
– Purchased from The Conference Board of Canada (GDP growth rates) for
the latest year
• Population—purchased from Demography Division, Statistics Canada
• Provincial government expenditure—special tabulation purchased from Public
Institutions Division, Statistics Canada
• Price indices:
– PMPI: from Patented Medicine Prices Review Board
– CPI and Industrial IPPI: purchased from the Prices Division, Statistics Canada
54
–
Series A—Expenditure on Drugs by Type,
by Source of Finance and as a Share of Public,
Private and Total Health Expenditure, Canada,
1985 to 2010
Drug Expenditure in Canada, 1985 to 2010
Table A Canada—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Canada, 1985 to 2010
Provincial/
Territorial
CA
Federal
Prescribed Drugs
Public
Social Security Funds
Subtotal
Insurers
WCBs
Drug Insurance
Public
Funds
(Premium Component)
Private
Out-ofPocket
Subtotal
Private
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
Total
Prescribed
Drugs
($ Millions)
Year
1985
1986
1987
1988
1989
1,048.1
1,240.6
1,406.7
1,592.7
1,838.0
58.0
63.3
68.2
89.3
110.0
12.6
15.2
17.8
20.8
22.9
-----------
1,118.7
1,319.2
1,492.7
1,702.8
1,970.9
------1,130.3
1,260.6
------903.7
1,031.4
1,447.7
1,698.8
1,800.4
2,034.0
2,292.0
2,566.5
3,018.0
3,293.1
3,736.8
4,262.9
-----------
-----------
1,235.9
1,399.0
1,621.7
1,784.9
1,975.6
1990
1991
1992
1993
1994
2,120.2
2,428.0
2,710.7
2,817.0
2,845.0
130.3
145.6
159.7
187.6
207.1
27.5
33.2
38.1
40.2
35.5
-----------
2,278.0
2,606.7
2,908.5
3,044.9
3,087.6
1,466.8
1,671.5
1,947.3
2,089.3
2,105.2
1,127.0
1,190.4
1,244.9
1,469.4
1,568.2
2,593.9
2,861.9
3,192.3
3,558.7
3,673.3
4,871.8
5,468.7
6,100.7
6,603.5
6,760.9
----1,290.0
1,373.0
1,475.1
----1,128.1
1,203.1
1,288.9
2,058.7
2,236.6
2,418.1
2,576.0
2,764.0
1995
1996
1997
1998
1999
3,099.7
3,053.4
3,133.7
3,462.5
3,914.2
227.8
234.0
252.5
283.7
321.0
37.8
41.4
42.7
47.9
53.7
----169.1
213.4
262.7
3,365.3
3,328.8
3,598.1
4,007.5
4,551.6
2,350.1
2,476.6
2,785.2
3,220.5
3,387.0
1,683.6
1,796.7
2,148.0
2,223.0
2,302.0
4,033.8
4,273.3
4,933.2
5,443.5
5,689.0
7,399.0
7,602.1
8,531.3
9,451.1
10,240.6
1,474.2
1,508.0
1,568.2
1,661.7
1,782.1
1,314.2
1,338.8
1,407.6
1,509.7
1,576.7
2,788.4
2,846.7
2,975.7
3,171.3
3,358.8
2000
2001
2002
2003
2004
4,559.3
5,228.8
5,839.0
6,376.6
6,996.6
343.3
392.0
448.2
508.2
528.6
64.8
75.8
86.5
102.8
121.1
327.9
367.4
433.2
577.8
615.5
5,295.3
6,064.1
6,807.0
7,565.4
8,261.8
3,866.8
4,489.0
5,009.4
5,692.6
6,229.2
2,562.5
2,613.5
2,934.4
3,155.9
3,364.8
6,429.3
7,102.5
7,943.9
8,848.5
9,594.0
11,724.7
13,166.6
14,750.9
16,413.9
17,855.8
1,815.3
1,882.4
1,972.2
2,047.6
2,159.3
1,605.0
1,654.0
1,712.5
1,714.6
1,770.9
3,420.3
3,536.4
3,684.7
3,762.2
3,930.2
2005
2006
2007
2008
2009 f
2010 f
7,594.9
8,188.6
8,672.0
9,239.7
9,967.7
10,520.1
564.3
609.9
626.7
638.4
641.6
660.0
133.5
148.6
157.3
169.2
181.8
190.9
618.7
669.0
676.4
762.8
746.2
761.8
8,911.5
9,616.1
10,132.2
10,810.1
11,537.2
12,132.8
6,714.3
7,269.4
7,896.8
8,467.2
8,981.3
9,396.4
3,484.1
3,945.5
3,934.9
4,167.8
4,437.3
4,584.0
10,198.4
11,214.9
11,831.7
12,634.9
13,418.7
13,980.4
19,109.9
20,830.9
21,963.9
23,445.0
24,955.8
26,113.2
2,245.5
2,348.8
2,478.3
2,531.9
2,702.7
2,819.6
1,838.5
1,914.4
1,961.7
1,983.8
2,051.5
2,210.1
4,084.0
4,263.2
4,439.9
4,515.7
4,754.1
5,029.7
1985
1986
1987
1988
1989
--18.4
13.4
13.2
15.4
--9.2
7.7
30.9
23.2
--20.9
16.9
16.6
10.0
-----------
--17.9
13.2
14.1
15.7
--------11.5
--------14.1
--17.3
6.0
13.0
12.7
--17.6
9.1
13.5
14.1
-----------
-----------
1990
1991
1992
1993
1994
15.4
14.5
11.6
3.9
1.0
18.4
11.7
9.7
17.5
10.4
20.0
20.8
14.8
5.7
-11.9
-----------
15.6
14.4
11.6
4.7
1.4
16.4
14.0
16.5
7.3
0.8
9.3
5.6
4.6
18.0
6.7
13.2
10.3
11.5
11.5
3.2
14.3
12.3
11.6
8.2
2.4
------6.4
7.4
------6.6
7.1
4.2
8.6
8.1
6.5
7.3
1995
1996
1997
1998
1999
9.0
-1.5
2.6
10.5
13.0
10.0
2.7
7.9
12.4
13.1
6.5
9.6
3.3
12.0
12.1
------26.2
23.1
9.0
-1.1
8.1
11.4
13.6
11.6
5.4
12.5
15.6
5.2
7.4
6.7
19.6
3.5
3.6
9.8
5.9
15.4
10.3
4.5
9.4
2.7
12.2
10.8
8.4
-0.1
2.3
4.0
6.0
7.2
2.0
1.9
5.1
7.3
4.4
0.9
2.1
4.5
6.6
5.9
2000
2001
2002
2003
2004
16.5
14.7
11.7
9.2
9.7
7.0
14.2
14.3
13.4
4.0
20.8
17.0
14.1
18.8
17.8
24.8
12.1
17.9
33.4
6.5
16.3
14.5
12.3
11.1
9.2
14.2
16.1
11.6
13.6
9.4
11.3
2.0
12.3
7.5
6.6
13.0
10.5
11.8
11.4
8.4
14.5
12.3
12.0
11.3
8.8
1.9
3.7
4.8
3.8
5.5
1.8
3.1
3.5
0.1
3.3
1.8
3.4
4.2
2.1
4.5
2005
2006
2007
2008
2009 f
2010 f
8.6
7.8
5.9
6.5
7.9
5.5
6.8
8.1
2.8
1.9
0.5
2.9
10.2
11.3
5.8
7.6
7.4
5.0
0.5
8.1
1.1
12.8
-2.2
2.1
7.9
7.9
5.4
6.7
6.7
5.2
7.8
8.3
8.6
7.2
6.1
4.6
3.5
13.2
-0.3
5.9
6.5
3.3
6.3
10.0
5.5
6.8
6.2
4.2
7.0
9.0
5.4
6.7
6.4
4.6
4.0
4.6
5.5
2.2
6.7
4.3
3.8
4.1
2.5
1.1
3.4
7.7
3.9
4.4
4.1
1.7
5.3
5.8
1985
1986
1987
1988
1989
27.6
28.1
28.6
28.8
29.5
1.5
1.4
1.4
1.6
1.8
0.3
0.3
0.4
0.4
0.4
-----------
29.4
29.9
30.4
30.8
31.6
------20.5
20.2
------16.4
16.5
38.1
38.5
36.6
36.8
36.7
67.5
68.3
67.0
67.7
68.3
-----------
-----------
32.5
31.7
33.0
32.3
31.7
1990
1991
1992
1993
1994
30.6
31.5
31.8
30.7
29.9
1.9
1.9
1.9
2.0
2.2
0.4
0.4
0.4
0.4
0.4
-----------
32.9
33.8
34.1
33.2
32.4
21.2
21.7
22.9
22.8
22.1
16.3
15.4
14.6
16.0
16.5
37.4
37.1
37.5
38.8
38.6
70.3
71.0
71.6
71.9
71.0
----15.1
15.0
15.5
----13.2
13.1
13.5
29.7
29.0
28.4
28.1
29.0
1995
1996
1997
1998
1999
30.4
29.2
27.2
27.4
28.8
2.2
2.2
2.2
2.2
2.4
0.4
0.4
0.4
0.4
0.4
----1.5
1.7
1.9
33.0
31.9
31.3
31.7
33.5
23.1
23.7
24.2
25.5
24.9
16.5
17.2
18.7
17.6
16.9
39.6
40.9
42.9
43.1
41.8
72.6
72.8
74.1
74.9
75.3
14.5
14.4
13.6
13.2
13.1
12.9
12.8
12.2
12.0
11.6
27.4
27.2
25.9
25.1
24.7
2000
2001
2002
2003
2004
30.1
31.3
31.7
31.6
32.1
2.3
2.3
2.4
2.5
2.4
0.4
0.5
0.5
0.5
0.6
2.2
2.2
2.4
2.9
2.8
35.0
36.3
36.9
37.5
37.9
25.5
26.9
27.2
28.2
28.6
16.9
15.6
15.9
15.6
15.4
42.5
42.5
43.1
43.9
44.0
77.4
78.8
80.0
81.4
82.0
12.0
11.3
10.7
10.1
9.9
10.6
9.9
9.3
8.5
8.1
22.6
21.2
20.0
18.6
18.0
0.6
0.6
0.6
0.6
0.6
0.6
2.7
2.7
2.6
2.7
2.5
2.4
38.4
38.3
38.4
38.7
38.8
39.0
28.9
29.0
29.9
30.3
30.2
30.2
15.0
15.7
14.9
14.9
14.9
14.7
44.0
44.7
44.8
45.2
45.2
44.9
82.4
83.0
83.2
83.8
84.0
83.8
9.7
9.4
9.4
9.1
9.1
9.1
7.9
7.6
7.4
7.1
6.9
7.1
17.6
17.0
16.8
16.2
16.0
16.2
(Annual Percentage Change)
--13.2
15.9
10.1
10.7
(Percentage Share of Total Drug Expenditure)
2005
32.7
2.4
2006
32.6
2.4
2007
32.8
2.4
2008
33.0
2.3
2009 f
33.5
2.2
2010 f
33.8
2.1
f: forecast.
WCB: workers’ compensation boards.
56
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table A Canada—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Canada, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
(Percentage Share)
1985
1986
1987
1988
1989
1,118.7
1,319.2
1,492.7
1,702.8
1,970.9
2,683.6
3,097.9
3,422.2
3,818.9
4,267.7
3,802.3
4,417.1
4,914.9
5,521.7
6,238.5
30,094.9
32,528.6
35,054.7
38,162.8
41,911.1
9,746.9
10,808.7
11,733.5
12,796.4
14,184.3
39,841.8
43,337.3
46,788.2
50,959.2
56,095.5
3.7
4.1
4.3
4.5
4.7
27.5
28.7
29.2
29.8
30.1
9.5
10.2
10.5
10.8
11.1
1990
1991
1992
1993
1994
2,278.0
2,606.7
2,908.5
3,044.9
3,087.6
4,652.5
5,098.5
5,610.4
6,134.7
6,437.4
6,930.5
7,705.3
8,518.8
9,179.6
9,524.9
45,445.5
49,382.2
51,637.3
51,920.8
52,535.5
15,577.1
16,906.9
18,112.0
19,578.1
20,574.2
61,022.6
66,289.1
69,749.2
71,498.9
73,109.7
5.0
5.3
5.6
5.9
5.9
29.9
30.2
31.0
31.3
31.3
11.4
11.6
12.2
12.8
13.0
1995
1996
1997
1998
1999
3,365.3
3,328.8
3,598.1
4,007.5
4,551.6
6,822.2
7,120.0
7,908.9
8,614.9
9,047.9
10,187.4
10,448.9
11,507.0
12,622.4
13,599.4
52,719.1
52,808.6
55,205.6
59,190.5
63,188.0
21,370.1
21,910.5
23,532.1
24,768.3
26,998.8
74,089.2
74,719.1
78,737.6
83,958.8
90,186.9
6.4
6.3
6.5
6.8
7.2
31.9
32.5
33.6
34.8
33.5
13.8
14.0
14.6
15.0
15.1
2000
2001
2002
2003
2004
5,295.3
6,064.1
6,807.0
7,565.4
8,261.8
9,849.6
10,638.9
11,628.6
12,610.7
13,524.2
15,144.9
16,703.0
18,435.6
20,176.1
21,786.0
69,260.4
74,999.7
79,950.9
86,660.7
92,285.0
29,160.7
32,061.0
34,997.1
36,869.3
39,357.4
98,421.1
107,060.7
114,947.9
123,530.0
131,642.4
7.6
8.1
8.5
8.7
9.0
33.8
33.2
33.2
34.2
34.4
15.4
15.6
16.0
16.3
16.5
2005
2006
2007
2008
2009 f
2010 f
8,911.5
9,616.1
10,132.2
10,810.1
11,537.2
12,132.8
14,282.4
15,478.1
16,271.6
17,150.6
18,172.8
19,010.1
23,193.8
25,094.1
26,403.8
27,960.7
29,710.0
31,142.9
98,649.5
105,155.9
112,562.7
121,052.1
128,576.2
135,069.4
41,892.7
45,645.7
47,760.1
50,724.7
53,523.9
56,569.7
140,542.2
150,801.6
160,322.8
171,776.8
182,100.1
191,639.1
9.0
9.1
9.0
8.9
9.0
9.0
34.1
33.9
34.1
33.8
34.0
33.6
16.5
16.6
16.5
16.3
16.3
16.3
1985
1986
1987
1988
1989
--17.9
13.2
14.1
15.7
--15.4
10.5
11.6
11.8
--16.2
11.3
12.3
13.0
--8.1
7.8
8.9
9.8
--10.9
8.6
9.1
10.8
--8.8
8.0
8.9
10.1
1990
1991
1992
1993
1994
15.6
14.4
11.6
4.7
1.4
9.0
9.6
10.0
9.3
4.9
11.1
11.2
10.6
7.8
3.8
8.4
8.7
4.6
0.5
1.2
9.8
8.5
7.1
8.1
5.1
8.8
8.6
5.2
2.5
2.3
1995
1996
1997
1998
1999
9.0
-1.1
8.1
11.4
13.6
6.0
4.4
11.1
8.9
5.0
7.0
2.6
10.1
9.7
7.7
0.3
0.2
4.5
7.2
6.8
3.9
2.5
7.4
5.3
9.0
1.3
0.9
5.4
6.6
7.4
2000
2001
2002
2003
2004
16.3
14.5
12.3
11.1
9.2
8.9
8.0
9.3
8.4
7.2
11.4
10.3
10.4
9.4
8.0
9.6
8.3
6.6
8.4
6.5
8.0
9.9
9.2
5.3
6.7
9.1
8.8
7.4
7.5
6.6
2005
2006
2007
2008
2009 f
2010 f
7.9
7.9
5.4
6.7
6.7
5.2
5.6
8.4
5.1
5.4
6.0
4.6
6.5
8.2
5.2
5.9
6.3
4.8
6.9
6.6
7.0
7.5
6.2
5.1
6.4
9.0
4.6
6.2
5.5
5.7
6.8
7.3
6.3
7.1
6.0
5.2
CA
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
29.4
29.9
30.4
30.8
31.6
70.6
70.1
69.6
69.2
68.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.9
33.8
34.1
33.2
32.4
67.1
66.2
65.9
66.8
67.6
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
33.0
31.9
31.3
31.7
33.5
67.0
68.1
68.7
68.3
66.5
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
35.0
36.3
36.9
37.5
37.9
65.0
63.7
63.1
62.5
62.1
100.0
100.0
100.0
100.0
100.0
61.6
61.7
61.6
61.3
61.2
61.0
100.0
100.0
100.0
100.0
100.0
100.0
2005
38.4
2006
38.3
2007
38.4
2008
38.7
2009 f
38.8
2010 f
39.0
f: forecast.
WCB: workers’ compensation boards.
Canadian Institute for Health Information, 2010.
57
Drug Expenditure in Canada, 1985 to 2010
Table A Canada—per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Canada, 1985 to 2010
Provincial/
Territorial
Federal
Year
CA
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
Total
Prescribed
Drugs
1985
1986
1987
1988
1989
40.56
47.53
53.18
59.44
67.37
2.24
2.43
2.58
3.33
4.03
0.49
0.58
0.67
0.78
0.84
-----------
43.29
50.54
56.44
63.55
72.24
------42.18
46.21
------33.72
37.81
56.02
65.09
68.07
75.91
84.01
99.31
115.63
124.51
139.46
156.25
-----------
-----------
47.82
53.60
61.32
66.61
72.42
1990
1991
1992
1993
1994
76.55
86.62
95.56
98.22
98.11
4.70
5.19
5.63
6.54
7.14
0.99
1.18
1.34
1.40
1.22
-----------
82.24
92.99
102.53
106.16
106.47
52.96
59.63
68.65
72.84
72.59
40.69
42.47
43.89
51.23
54.08
93.65
102.10
112.53
124.07
126.67
175.89
195.09
215.07
230.23
233.14
----45.48
47.87
50.87
----39.77
41.95
44.45
74.33
79.79
85.24
89.81
95.31
1995
1996
1997
1998
1999
105.78
103.12
104.78
114.81
128.74
7.78
7.90
8.44
9.41
10.56
1.29
1.40
1.43
1.59
1.77
----5.65
7.08
8.64
114.85
112.42
120.31
132.89
149.70
80.20
83.64
93.13
106.79
111.40
57.46
60.68
71.82
73.71
75.71
137.66
144.32
164.95
180.51
187.12
252.51
256.73
285.26
313.39
336.82
50.31
50.93
52.43
55.10
58.61
44.85
45.21
47.07
50.06
51.86
95.16
96.14
99.50
105.16
110.47
2000
2001
2002
2003
2004
148.57
168.56
186.12
201.31
218.68
11.19
12.64
14.29
16.04
16.52
2.11
2.44
2.76
3.24
3.79
10.68
11.84
13.81
18.24
19.24
172.55
195.48
216.97
238.84
258.22
126.00
144.71
159.68
179.71
194.69
83.50
84.25
93.53
99.63
105.17
209.50
228.96
253.21
279.34
299.86
382.05
424.44
470.18
518.18
558.08
59.15
60.68
62.86
64.64
67.49
52.30
53.32
54.59
54.13
55.35
111.45
114.00
117.45
118.77
122.84
2005
2006
2007
2008
2009 f
2010 f
235.05
251.37
263.33
277.24
295.43
308.16
17.46
18.72
19.03
19.15
19.02
19.33
4.13
4.56
4.78
5.08
5.39
5.59
19.15
20.54
20.54
22.89
22.12
22.31
275.79
295.19
307.67
324.36
341.94
355.40
207.80
223.15
239.79
254.06
266.19
275.25
107.83
121.11
119.49
125.06
131.52
134.28
315.62
344.27
359.28
379.12
397.71
409.52
591.42
639.45
666.95
703.48
739.65
764.93
69.49
72.10
75.25
75.97
80.10
82.59
56.90
58.77
59.57
59.52
60.80
64.74
126.39
130.87
134.82
135.49
140.91
147.33
1985
1986
1987
1988
1989
--17.2
11.9
11.8
13.3
--8.1
6.3
29.2
21.0
--19.7
15.4
15.1
8.1
-----------
--16.8
11.7
12.6
13.7
--------9.5
--------12.1
--16.2
4.6
11.5
10.7
--16.4
7.7
12.0
12.0
-----------
-----------
1990
1991
1992
1993
1994
13.6
13.2
10.3
2.8
-0.1
16.7
10.4
8.4
16.2
9.2
18.2
19.4
13.4
4.5
-12.8
-----------
13.8
13.1
10.3
3.5
0.3
14.6
12.6
15.1
6.1
-0.3
7.6
4.4
3.3
16.7
5.6
11.5
9.0
10.2
10.3
2.1
12.6
10.9
10.2
7.1
1.3
------5.3
6.3
------5.5
6.0
2.6
7.3
6.8
5.4
6.1
1995
1996
1997
1998
1999
7.8
-2.5
1.6
9.6
12.1
8.9
1.6
6.8
11.4
12.2
5.4
8.5
2.2
11.1
11.2
------25.2
22.1
7.9
-2.1
7.0
10.5
12.7
10.5
4.3
11.3
14.7
4.3
6.3
5.6
18.4
2.6
2.7
8.7
4.8
14.3
9.4
3.7
8.3
1.7
11.1
9.9
7.5
-1.1
1.2
3.0
5.1
6.4
0.9
0.8
4.1
6.4
3.6
-0.2
1.0
3.5
5.7
5.1
2000
2001
2002
2003
2004
15.4
13.5
10.4
8.2
8.6
6.0
13.0
13.1
12.3
3.0
19.6
15.7
12.8
17.7
16.7
23.6
10.9
16.6
32.1
5.5
15.3
13.3
11.0
10.1
8.1
13.1
14.8
10.3
12.5
8.3
10.3
0.9
11.0
6.5
5.6
12.0
9.3
10.6
10.3
7.3
13.4
11.1
10.8
10.2
7.7
0.9
2.6
3.6
2.8
4.4
0.9
1.9
2.4
-0.8
2.3
0.9
2.3
3.0
1.1
3.4
2005
2006
2007
2008
2009 f
2010 f
7.5
6.9
4.8
5.3
6.6
4.3
5.7
7.2
1.6
0.7
-0.7
1.7
9.1
10.4
4.7
6.3
6.1
3.8
-0.5
7.2
0.0
11.4
-3.4
0.9
6.8
7.0
4.2
5.4
5.4
3.9
6.7
7.4
7.5
6.0
4.8
3.4
2.5
12.3
-1.3
4.7
5.2
2.1
5.3
9.1
4.4
5.5
4.9
3.0
6.0
8.1
4.3
5.5
5.1
3.4
3.0
3.8
4.4
1.0
5.4
3.1
2.8
3.3
1.4
-0.1
2.1
6.5
2.9
3.5
3.0
0.5
4.0
4.6
1985
1986
1987
1988
1989
--14.4
7.1
7.2
8.8
--5.3
1.6
24.7
16.4
--16.9
10.6
10.6
3.5
-----------
--14.0
6.9
8.1
9.1
-----------
-----------
--13.4
-0.2
7.0
6.1
--13.6
2.9
7.5
7.5
1990
1991
1992
1993
1994
10.6
10.4
9.1
1.3
-1.2
13.6
7.6
7.1
14.7
8.1
15.2
16.6
12.2
3.1
-13.9
-----------
10.8
10.3
9.0
2.1
-0.8
-----------
-----------
8.4
6.3
9.0
8.8
1.0
1995
1996
1997
1998
1999
5.5
-4.2
0.6
10.0
10.3
6.5
0.0
5.8
11.9
10.4
3.0
6.8
1.2
11.5
9.4
------25.6
20.3
5.5
-3.8
6.0
10.9
10.8
-----------
-----------
2000
2001
2002
2003
2004
11.3
12.1
9.4
5.3
6.0
1.9
11.6
12.0
9.4
0.4
15.5
14.4
11.8
14.8
14.1
19.5
9.5
15.6
29.2
2.9
11.2
11.9
9.9
7.2
5.5
-----------
6.1
7.7
1.1
1.6
8.2
0.4
-3.5
4.5
-3.6
6.7
-1.3
-2.5
3.8
4.3
0.6
0.7
7.5
0.5
-------------
(Annual Percentage Change)
--12.1
14.4
8.6
8.7
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
2005
4.5
2.7
2006
4.2
4.5
2007
1.2
-2.0
2008
0.5
-4.1
2009 f
8.7
1.4
2010 f
0.9
-1.7
f: forecast.
WCB: workers’ compensation boards.
58
-----------
-----------
--9.3
9.7
4.1
4.1
9.5
8.2
9.0
5.6
0.2
------3.8
5.2
------4.0
4.9
-0.4
4.6
5.6
3.9
5.0
6.3
3.2
13.3
9.9
1.9
6.0
0.0
10.1
10.3
5.7
-3.4
-0.4
2.0
5.5
4.6
-1.4
-0.9
3.1
6.8
1.8
-2.5
-0.6
2.5
6.1
3.2
-----------
7.9
7.9
9.5
7.4
4.8
9.3
9.7
9.7
7.3
5.1
-3.2
1.2
2.6
-0.1
1.8
-3.3
0.6
1.3
-3.7
-0.3
-3.2
0.9
2.0
-1.8
0.8
-------------
2.2
6.4
0.8
0.8
7.0
-0.4
3.0
5.4
0.7
0.7
7.3
0.0
0.0
1.0
0.8
-3.8
7.6
-0.3
-0.2
0.6
-2.2
-4.8
4.3
3.1
-0.1
0.8
-0.6
-4.2
6.1
1.1
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table A Canada—per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Canada, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Year
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
(1997 = 100)
1985
1986
1987
1988
1989
43.29
50.54
56.44
63.55
72.24
103.84
118.69
129.39
142.52
156.43
147.13
169.23
185.82
206.07
228.67
1,164.54
1,246.25
1,325.38
1,424.23
1,536.23
377.16
414.11
443.63
477.56
519.92
1,541.70
1,660.36
1,769.01
1,901.79
2,056.15
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
82.24
92.99
102.53
106.16
106.47
167.98
181.89
197.78
213.89
221.98
250.22
274.88
300.31
320.05
328.46
1,640.78
1,761.68
1,820.34
1,810.23
1,811.62
562.40
603.14
638.49
682.59
709.48
2,203.18
2,364.82
2,458.83
2,492.83
2,521.10
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
114.85
112.42
120.31
132.89
149.70
232.82
240.45
264.45
285.67
297.59
347.67
352.87
384.75
418.56
447.29
1,799.15
1,783.42
1,845.88
1,962.74
2,078.29
729.30
739.95
786.83
821.31
888.01
2,528.45
2,523.36
2,632.72
2,784.05
2,966.29
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
172.55
195.48
216.97
238.84
258.22
320.95
342.96
370.66
398.12
422.69
493.50
538.44
587.63
636.95
680.92
2,256.84
2,417.69
2,548.43
2,735.84
2,884.34
950.20
1,033.52
1,115.53
1,163.95
1,230.10
3,207.04
3,451.20
3,663.96
3,899.79
4,114.44
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
275.79
295.19
307.67
324.36
341.94
355.40
442.01
475.14
494.10
514.61
538.61
556.86
717.81
770.32
801.77
838.97
880.56
912.26
3,053.02
3,228.01
3,418.04
3,632.22
3,810.81
3,956.55
1,296.50
1,401.20
1,450.27
1,522.01
1,586.37
1,657.08
4,349.52
4,629.21
4,868.30
5,154.23
5,397.18
5,613.63
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--16.8
11.7
12.6
13.7
--14.3
9.0
10.2
9.8
--15.0
9.8
10.9
11.0
--7.0
6.3
7.5
7.9
--9.8
7.1
7.6
8.9
--7.7
6.5
7.5
8.1
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
13.8
13.1
10.3
3.5
0.3
7.4
8.3
8.7
8.1
3.8
9.4
9.9
9.3
6.6
2.6
6.8
7.4
3.3
-0.6
0.1
8.2
7.2
5.9
6.9
3.9
7.2
7.3
4.0
1.4
1.1
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
7.9
-2.1
7.0
10.5
12.7
4.9
3.3
10.0
8.0
4.2
5.8
1.5
9.0
8.8
6.9
-0.7
-0.9
3.5
6.3
5.9
2.8
1.5
6.3
4.4
8.1
0.3
-0.2
4.3
5.7
6.5
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
15.3
13.3
11.0
10.1
8.1
7.8
6.9
8.1
7.4
6.2
10.3
9.1
9.1
8.4
6.9
8.6
7.1
5.4
7.4
5.4
7.0
8.8
7.9
4.3
5.7
8.1
7.6
6.2
6.4
5.5
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
6.8
7.0
4.2
5.4
5.4
3.9
4.6
7.5
4.0
4.2
4.7
3.4
5.4
7.3
4.1
4.6
5.0
3.6
5.8
5.7
5.9
6.3
4.9
3.8
5.4
8.1
3.5
4.9
4.2
4.5
5.7
6.4
5.2
5.9
4.7
4.0
3.0
2.7
3.6
4.7
-2.1
3.4
CA
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--14.0
6.9
8.1
9.1
--11.5
4.3
5.6
5.2
--12.2
5.1
6.4
6.4
--4.2
1.6
2.9
3.3
--7.0
2.4
3.1
4.3
--4.9
1.8
3.0
3.6
1990
1991
1992
1993
1994
10.8
10.3
9.0
2.1
-0.8
4.4
5.5
7.5
6.7
2.7
6.4
7.1
8.0
5.1
1.5
3.8
4.6
2.1
-2.0
-1.0
5.1
4.5
4.6
5.5
2.8
4.1
4.6
2.7
-0.1
0.0
1995
1996
1997
1998
1999
5.5
-3.8
6.0
10.9
10.8
2.5
1.6
9.0
8.5
2.4
3.5
-0.2
8.0
9.2
5.1
-3.0
-2.5
2.5
6.8
4.1
0.5
-0.2
5.3
4.8
6.3
-2.0
-1.9
3.3
6.2
4.7
2000
2001
2002
2003
2004
11.2
11.9
9.9
7.2
5.5
3.7
5.5
7.0
4.5
3.6
6.2
7.8
8.1
5.5
4.3
4.5
5.8
4.4
4.5
2.8
2.9
7.4
6.9
1.4
3.1
4.0
6.3
5.1
3.5
2.9
1.6
4.8
0.4
-0.6
6.8
0.0
2.4
4.6
0.5
-0.1
7.1
0.2
2.8
3.0
2.3
1.5
7.0
0.4
2.4
5.4
-0.1
0.2
6.3
1.0
2.7
3.7
1.6
1.1
6.8
0.6
2005
3.8
2006
4.3
2007
0.6
2008
0.7
2009 f
7.5
2010 f
0.5
f: forecast.
WCB: workers’ compensation boards.
Canadian Institute for Health Information, 2010.
59
Series B—Expenditure on Drugs by Type, by
Source of Finance and as a Share of Public,
Private and Total Health Expenditure,
by Province/Territory, 1985 to 2010
Drug Expenditure in Canada, 1985 to 2010
Table B N.L.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2010
Provincial
Federal
Year
N.L.
Prescribed Drugs
Public
Private
Social Security Funds
Insurers*
Out-ofSubtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
Total
Prescribed
Drugs
1985
1986
1987
1988
1989
18.0
21.4
24.7
28.2
31.2
2.3
2.7
3.1
1.6
1.3
0.1
0.2
0.3
0.4
0.4
-----------
20.4
24.4
28.1
30.2
32.9
-----------
-----------
82.8
51.6
55.1
58.7
62.5
103.2
76.0
83.2
88.9
95.4
-----------
-----------
24.9
28.2
32.7
32.3
32.0
1990
1991
1992
1993
1994
35.3
40.3
43.9
47.8
52.1
1.6
1.7
1.7
2.2
2.5
0.6
0.8
1.1
1.2
1.2
-----------
37.5
42.8
46.6
51.1
55.8
-----------
-----------
64.7
65.8
72.9
76.1
77.9
102.2
108.5
119.5
127.2
133.7
----20.6
21.7
22.9
----17.9
18.2
18.3
34.3
37.8
38.6
39.9
41.2
1995
1996
1997
1998
1999
54.5
54.5
53.6
56.1
60.0
2.8
2.7
3.3
3.7
4.1
1.5
1.8
1.9
2.4
2.8
-----------
58.8
59.0
58.8
62.1
66.9
-----------
-----------
85.6
90.0
87.9
93.7
103.3
144.4
149.0
146.7
155.8
170.2
22.5
24.7
21.1
23.3
25.6
19.9
21.9
18.9
21.0
22.5
42.3
46.7
40.0
44.3
48.1
2000
2001
2002
2003
2004
68.0
77.9
86.9
96.0
101.7
5.8
6.6
7.4
8.1
7.8
3.8
4.2
5.0
4.9
4.9
-----------
77.6
88.7
99.3
109.0
114.4
-----------
-----------
119.9
129.2
150.2
169.0
178.4
197.5
217.9
249.5
278.0
292.8
26.1
25.8
26.6
27.0
27.8
22.2
22.6
23.0
22.5
23.1
48.3
48.3
49.7
49.5
50.9
2005
2006
2007
2008
2009 f
2010 f
106.0
108.1
116.9
122.3
127.2
137.1
8.0
7.7
7.3
7.1
7.1
7.1
5.1
5.1
5.1
5.2
6.2
5.2
-------------
119.0
121.0
129.4
134.5
140.5
149.5
-------------
-------------
196.7
208.4
241.2
229.2
242.3
255.8
315.8
329.4
370.6
363.7
382.8
405.3
27.4
28.3
29.6
29.6
31.4
33.9
22.3
23.0
23.3
23.1
23.7
26.6
49.7
51.3
52.8
52.7
55.1
60.4
1985
1986
1987
1988
1989
--19.2
15.4
13.9
10.6
--20.4
13.5
-48.0
-20.2
--35.5
34.3
50.0
14.5
-----------
--19.4
15.3
7.4
9.0
-----------
-----------
---37.6
6.7
6.6
6.6
---26.3
9.4
6.8
7.4
-----------
-----------
--13.2
16.0
-1.0
-1.0
1990
1991
1992
1993
1994
13.4
14.1
8.8
8.9
9.1
21.5
9.6
-3.5
31.4
12.4
38.7
25.5
40.5
9.2
7.4
-----------
14.0
14.1
8.9
9.7
9.2
-----------
-----------
3.4
1.7
10.8
4.5
2.3
7.1
6.2
10.1
6.5
5.1
------5.4
5.3
------1.1
0.8
7.1
10.3
2.0
3.4
3.3
1995
1996
1997
1998
1999
4.6
0.0
-1.6
4.6
7.0
12.3
-2.7
23.0
10.5
12.0
22.5
18.8
3.4
28.6
16.0
-----------
5.4
0.4
-0.4
5.6
7.7
-----------
-----------
9.9
5.1
-2.3
6.5
10.3
8.0
3.2
-1.5
6.2
9.3
-1.8
10.1
-14.5
10.1
9.9
8.6
10.3
-14.0
11.5
7.0
2.8
10.2
-14.3
10.8
8.5
2000
2001
2002
2003
2004
13.4
14.5
11.5
10.6
5.9
40.7
15.5
11.9
8.3
-3.0
37.7
8.8
20.2
-1.8
-1.2
-----------
16.1
14.3
12.0
9.8
4.9
-----------
-----------
16.0
7.8
16.2
12.5
5.5
16.0
10.3
14.5
11.4
5.3
2.2
-1.4
3.3
1.2
3.2
-1.4
1.7
2.1
-2.3
2.5
0.5
0.1
2.8
-0.4
2.8
2005
2006
2007
2008
2009 f
2010 f
4.2
2.0
8.1
4.6
4.0
7.8
1.8
-3.1
-5.0
-3.6
0.3
0.5
4.6
1.5
-0.8
1.0
20.7
-15.9
-------------
4.1
1.6
6.9
4.0
4.4
6.4
-------------
-------------
10.3
5.9
15.7
-5.0
5.7
5.6
7.9
4.3
12.5
-1.9
5.3
5.9
-1.6
3.4
4.4
0.2
5.9
7.9
-3.2
2.9
1.3
-0.6
2.6
11.9
-2.3
3.2
3.0
-0.2
4.5
9.6
1985
1986
1987
1988
1989
14.0
20.6
21.3
23.2
24.4
1.8
2.6
2.7
1.3
1.0
0.1
0.2
0.2
0.3
0.3
-----------
15.9
23.4
24.3
24.9
25.8
-----------
-----------
64.6
49.6
47.5
48.4
49.1
80.6
73.0
71.8
73.3
74.9
-----------
-----------
19.4
27.0
28.2
26.7
25.1
1990
1991
1992
1993
1994
25.9
27.5
27.8
28.6
29.8
1.2
1.2
1.1
1.3
1.4
0.4
0.5
0.7
0.7
0.7
-----------
27.5
29.2
29.5
30.6
31.9
-----------
-----------
47.4
44.9
46.1
45.6
44.6
74.9
74.2
75.6
76.1
76.5
----13.0
13.0
13.1
----11.4
10.9
10.5
25.1
25.8
24.4
23.9
23.5
1995
1996
1997
1998
1999
29.2
27.9
28.7
28.0
27.5
1.5
1.4
1.8
1.8
1.9
0.8
0.9
1.0
1.2
1.3
-----------
31.5
30.2
31.5
31.0
30.6
-----------
-----------
45.9
46.0
47.1
46.8
47.3
77.3
76.2
78.6
77.9
78.0
12.0
12.6
11.3
11.6
11.7
10.6
11.2
10.1
10.5
10.3
22.7
23.8
21.4
22.1
22.0
2000
2001
2002
2003
2004
27.7
29.3
29.0
29.3
29.6
2.3
2.5
2.5
2.5
2.3
1.6
1.6
1.7
1.5
1.4
-----------
31.6
33.3
33.2
33.3
33.3
-----------
-----------
48.8
48.5
50.2
51.6
51.9
80.3
81.8
83.4
84.9
85.2
10.6
9.7
8.9
8.2
8.1
9.0
8.5
7.7
6.9
6.7
19.7
18.2
16.6
15.1
14.8
2005
29.0
2.2
1.4
--2006
28.4
2.0
1.4
--2007
27.6
1.7
1.2
--2008
29.4
1.7
1.2
--2009 f
29.0
1.6
1.4
--2010 f
29.4
1.5
1.1
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
32.6
31.8
30.6
32.3
32.1
32.1
-------------
-------------
53.8
54.7
57.0
55.0
55.3
54.9
86.4
86.5
87.5
87.3
87.4
87.0
7.5
7.4
7.0
7.1
7.2
7.3
6.1
6.0
5.5
5.6
5.4
5.7
13.6
13.5
12.5
12.7
12.6
13.0
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
62
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.L.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
20.4
24.4
28.1
30.2
32.9
107.7
79.8
87.8
91.0
94.6
128.1
104.2
115.9
121.2
127.4
588.8
642.9
693.6
733.8
787.7
197.1
169.6
188.0
197.1
203.9
785.8
812.5
881.6
930.9
991.6
3.5
3.8
4.1
4.1
4.2
54.6
47.1
46.7
46.2
46.4
16.3
12.8
13.1
13.0
12.9
1990
1991
1992
1993
1994
37.5
42.8
46.6
51.1
55.8
99.0
103.6
111.4
116.0
119.1
136.5
146.4
158.0
167.1
174.9
875.9
905.7
928.3
924.9
948.1
220.6
247.5
269.1
284.2
301.1
1,096.4
1,153.2
1,197.4
1,209.1
1,249.3
4.3
4.7
5.0
5.5
5.9
44.9
41.8
41.4
40.8
39.6
12.4
12.7
13.2
13.8
14.0
1995
1996
1997
1998
1999
58.8
59.0
58.8
62.1
66.9
128.0
136.7
127.9
138.0
151.4
186.7
195.6
186.7
200.1
218.3
973.1
974.4
1,020.8
1,107.8
1,250.8
296.4
279.0
284.2
324.1
330.4
1,269.4
1,253.4
1,305.1
1,431.9
1,581.2
6.0
6.1
5.8
5.6
5.3
43.2
49.0
45.0
42.6
45.8
14.7
15.6
14.3
14.0
13.8
2000
2001
2002
2003
2004
77.6
88.7
99.3
109.0
114.4
168.2
177.5
199.8
218.5
229.2
245.8
266.2
299.2
327.5
343.6
1,318.7
1,415.5
1,507.6
1,588.4
1,626.4
366.4
385.7
415.0
469.3
507.4
1,685.1
1,801.2
1,922.6
2,057.7
2,133.8
5.9
6.3
6.6
6.9
7.0
45.9
46.0
48.2
46.5
45.2
14.6
14.8
15.6
15.9
16.1
2005
2006
2007
2008
2009 f
2010 f
119.0
121.0
129.4
134.5
140.5
149.5
246.4
259.7
294.0
281.9
297.4
316.3
365.5
380.7
423.4
416.4
437.9
465.8
1,683.1
1,782.0
1,925.6
2,088.5
2,222.6
2,411.6
548.7
560.4
631.5
636.2
651.0
683.6
2,231.8
2,342.4
2,557.1
2,724.7
2,873.6
3,095.1
7.1
6.8
6.7
6.4
6.3
6.2
44.9
46.3
46.6
44.3
45.7
46.3
16.4
16.3
16.6
15.3
15.2
15.0
1985
1986
1987
1988
1989
--19.4
15.3
7.4
9.0
---25.9
9.9
3.7
3.9
---18.6
11.2
4.6
5.1
--9.2
7.9
5.8
7.4
---13.9
10.9
4.8
3.4
--3.4
8.5
5.6
6.5
1990
1991
1992
1993
1994
14.0
14.1
8.9
9.7
9.2
4.7
4.7
7.6
4.1
2.7
7.1
7.3
8.0
5.8
4.7
11.2
3.4
2.5
-0.4
2.5
8.2
12.2
8.7
5.6
6.0
10.6
5.2
3.8
1.0
3.3
1995
1996
1997
1998
1999
5.4
0.4
-0.4
5.6
7.7
7.4
6.8
-6.4
7.8
9.7
6.8
4.8
-4.6
7.2
9.1
2.6
0.1
4.8
8.5
12.9
-1.6
-5.9
1.9
14.0
1.9
1.6
-1.3
4.1
9.7
10.4
2000
2001
2002
2003
2004
16.1
14.3
12.0
9.8
4.9
11.1
5.6
12.6
9.3
4.9
12.6
8.3
12.4
9.5
4.9
5.4
7.3
6.5
5.4
2.4
10.9
5.2
7.6
13.1
8.1
6.6
6.9
6.7
7.0
3.7
2005
2006
2007
2008
2009 f
2010 f
4.1
1.6
6.9
4.0
4.4
6.4
7.5
5.4
13.2
-4.1
5.5
6.3
6.4
4.2
11.2
-1.6
5.2
6.4
3.5
5.9
8.1
8.5
6.4
8.5
8.1
2.1
12.7
0.8
2.3
5.0
4.6
5.0
9.2
6.6
5.5
7.7
N.L.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
15.9
23.4
24.3
24.9
25.8
84.1
76.6
75.7
75.1
74.2
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
27.5
29.2
29.5
30.6
31.9
72.5
70.8
70.5
69.4
68.1
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
31.5
30.2
31.5
31.0
30.6
68.5
69.8
68.5
69.0
69.4
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
31.6
33.3
33.2
33.3
33.3
68.4
66.7
66.8
66.7
66.7
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
32.6
31.8
30.6
32.3
32.1
32.1
67.4
68.2
69.4
67.7
67.9
67.9
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
63
Drug Expenditure in Canada, 1985 to 2010
Table B N.L.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2010
Provincial
Federal
Year
N.L.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
Total
Prescribed
Drugs
1985
1986
1987
1988
1989
31.05
37.19
43.00
49.00
54.05
3.94
4.77
5.42
2.82
2.25
0.24
0.32
0.44
0.66
0.75
-----------
35.23
42.28
48.86
52.48
57.04
-----------
-----------
142.89
89.58
95.77
102.08
108.52
178.12
131.86
144.63
154.56
165.56
-----------
-----------
42.96
48.89
56.82
56.25
55.53
1990
1991
1992
1993
1994
61.11
69.56
75.61
82.36
90.69
2.72
2.97
2.87
3.77
4.28
1.03
1.30
1.82
1.99
2.15
-----------
64.87
73.83
80.30
88.12
97.12
-----------
-----------
111.92
113.48
125.66
131.28
135.64
176.79
187.30
205.95
219.40
232.75
----35.54
37.46
39.83
----30.94
31.30
31.86
59.30
65.26
66.48
68.77
71.69
1995
1996
1997
1998
1999
96.05
97.36
97.30
103.81
112.49
4.86
4.80
6.00
6.76
7.67
2.67
3.22
3.38
4.43
5.20
-----------
103.58
105.37
106.67
115.01
125.36
-----------
-----------
150.89
160.78
159.58
173.46
193.70
254.47
266.15
266.25
288.47
319.07
39.59
44.17
38.38
43.13
47.96
35.02
39.17
34.22
38.93
42.18
74.61
83.34
72.60
82.06
90.14
2000
2001
2002
2003
2004
128.84
149.21
167.25
185.27
196.64
10.90
12.73
14.32
15.54
15.11
7.24
7.97
9.63
9.48
9.38
-----------
146.98
169.91
191.20
210.29
221.14
-----------
-----------
226.98
247.46
289.07
325.97
344.79
373.96
417.37
480.27
536.27
565.92
49.52
49.41
51.30
52.01
53.78
42.00
43.21
44.35
43.41
44.57
91.52
92.63
95.65
95.42
98.35
2005
2006
2007
2008
2009 f
2010 f
206.17
211.91
230.88
241.47
249.87
270.23
15.48
15.11
14.47
13.96
13.93
14.04
9.87
10.09
10.09
10.19
12.23
10.32
-------------
231.52
237.10
255.43
265.61
276.04
294.58
-------------
-------------
382.64
408.42
476.13
452.51
476.12
504.11
614.16
645.53
731.56
718.13
752.16
798.69
53.25
55.48
58.37
58.50
61.67
66.72
43.42
45.00
45.94
45.65
46.63
52.33
96.67
100.48
104.31
104.15
108.30
119.06
1985
1986
1987
1988
1989
--19.8
15.6
14.0
10.3
--21.0
13.7
-48.0
-20.4
--36.2
34.7
50.0
14.2
-----------
--20.0
15.6
7.4
8.7
-----------
-----------
---37.3
6.9
6.6
6.3
---26.0
9.7
6.9
7.1
-----------
-----------
--13.8
16.2
-1.0
-1.3
1990
1991
1992
1993
1994
13.1
13.8
8.7
8.9
10.1
21.2
9.3
-3.5
31.4
13.4
38.3
25.2
40.4
9.3
8.4
-----------
13.7
13.8
8.8
9.7
10.2
-----------
-----------
3.1
1.4
10.7
4.5
3.3
6.8
5.9
10.0
6.5
6.1
------5.4
6.3
------1.2
1.8
6.8
10.0
1.9
3.4
4.3
1995
1996
1997
1998
1999
5.9
1.4
-0.1
6.7
8.4
13.7
-1.3
25.0
12.8
13.4
24.1
20.4
5.1
31.2
17.4
-----------
6.7
1.7
1.2
7.8
9.0
-----------
-----------
11.2
6.6
-0.7
8.7
11.7
9.3
4.6
0.0
8.3
10.6
-0.6
11.6
-13.1
12.4
11.2
9.9
11.8
-12.6
13.8
8.3
4.1
11.7
-12.9
13.0
9.8
2000
2001
2002
2003
2004
14.5
15.8
12.1
10.8
6.1
42.2
16.8
12.5
8.5
-2.8
39.1
10.1
20.8
-1.6
-1.0
-----------
17.2
15.6
12.5
10.0
5.2
-----------
-----------
17.2
9.0
16.8
12.8
5.8
17.2
11.6
15.1
11.7
5.5
3.2
-0.2
3.8
1.4
3.4
-0.4
2.9
2.6
-2.1
2.7
1.5
1.2
3.3
-0.2
3.1
2005
2006
2007
2008
2009 f
2010 f
4.8
2.8
9.0
4.6
3.5
8.1
2.5
-2.4
-4.2
-3.5
-0.2
0.7
5.2
2.2
0.0
1.0
20.1
-15.7
-------------
4.7
2.4
7.7
4.0
3.9
6.7
-------------
-------------
11.0
6.7
16.6
-5.0
5.2
5.9
8.5
5.1
13.3
-1.8
4.7
6.2
-1.0
4.2
5.2
0.2
5.4
8.2
-2.6
3.6
2.1
-0.6
2.1
12.2
-1.7
3.9
3.8
-0.1
4.0
9.9
1985
1986
1987
1988
1989
--17.0
10.9
9.4
5.7
--18.2
9.0
-52.5
-25.0
--33.4
29.9
45.5
9.6
-----------
--17.2
10.8
2.9
4.1
-----------
-----------
---40.1
2.2
2.1
1.7
---28.8
4.9
2.3
2.6
-----------
-----------
--11.0
11.5
-5.5
-5.8
1990
1991
1992
1993
1994
10.0
11.1
7.4
7.5
9.0
18.2
6.6
-4.8
29.9
12.3
35.3
22.4
39.1
7.8
7.3
-----------
10.7
11.1
7.5
8.3
9.1
-----------
-----------
0.1
-1.4
9.5
3.0
2.2
3.8
3.2
8.7
5.1
5.0
------4.0
5.2
-------0.3
0.7
3.8
7.3
0.6
2.0
3.2
1995
1996
1997
1998
1999
3.6
-0.3
-1.1
7.1
6.6
11.4
-3.0
24.0
13.2
11.6
21.7
18.7
4.1
31.7
15.6
-----------
4.3
0.1
0.2
8.3
7.2
-----------
-----------
8.9
4.9
-1.7
9.1
9.9
7.0
2.9
-1.0
8.8
8.8
-2.9
9.9
-14.1
12.8
9.4
7.6
10.2
-13.6
14.2
6.5
1.7
10.0
-13.9
13.5
8.0
2000
2001
2002
2003
2004
10.4
14.5
11.0
7.9
3.5
38.1
15.4
11.4
5.6
-5.4
35.0
8.8
19.8
-4.5
-3.6
-----------
13.1
14.2
11.5
7.1
2.6
-----------
-----------
13.1
7.7
15.8
9.9
3.2
13.1
10.3
14.0
8.8
2.9
-0.9
-1.6
2.8
-1.5
0.8
-4.5
1.5
1.6
-5.0
0.1
-2.6
-0.1
2.2
-3.1
0.5
2005
2006
2007
2008
2009 f
2010 f
1.8
0.1
5.4
-0.2
5.6
4.7
-0.6
-5.1
-7.8
-8.3
2.0
-2.7
2.2
-0.5
-3.6
-3.7
22.2
-19.1
-------------
1.7
-0.3
4.1
-0.8
6.0
3.3
-------------
-------------
8.0
4.0
13.0
-9.7
7.3
2.5
5.5
2.4
9.7
-6.6
6.9
2.8
-4.0
1.5
1.6
-4.5
7.5
4.8
-5.6
0.9
-1.5
-5.4
4.3
8.8
-4.7
1.2
0.2
-4.9
6.1
6.5
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
64
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.L.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
Year
(1997 = 100)
1985
1986
1987
1988
1989
35.23
42.28
48.86
52.48
57.04
185.85
138.46
152.59
158.33
164.05
221.08
180.75
201.45
210.81
221.09
1,016.34
1,115.18
1,205.91
1,276.14
1,366.63
340.16
294.15
326.89
342.81
353.75
1,356.50
1,409.34
1,532.79
1,618.95
1,720.39
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
64.87
73.83
80.30
88.12
97.12
171.22
178.73
192.14
200.04
207.33
236.09
252.56
272.44
288.16
304.44
1,515.29
1,562.86
1,600.38
1,594.84
1,650.45
381.55
427.13
463.99
489.99
524.20
1,896.84
1,989.99
2,064.37
2,084.83
2,174.65
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
103.58
105.37
106.67
115.01
125.36
225.50
244.12
232.18
255.52
283.85
329.08
349.49
338.85
370.54
409.21
1,714.87
1,740.60
1,852.68
2,051.73
2,344.87
522.27
498.31
515.86
600.30
619.49
2,237.14
2,238.91
2,368.54
2,652.03
2,964.36
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
146.98
169.91
191.20
210.29
221.14
318.50
340.09
384.72
421.39
443.14
465.48
510.00
575.92
631.69
664.27
2,497.29
2,711.82
2,902.32
3,063.80
3,144.07
693.97
738.88
798.83
905.28
980.77
3,191.26
3,450.70
3,701.15
3,969.07
4,124.84
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
231.52
237.10
255.43
265.61
276.04
294.58
479.31
508.91
580.44
556.67
584.42
623.17
710.84
746.01
835.87
822.28
860.45
917.75
3,273.60
3,491.94
3,801.63
4,123.83
4,367.18
4,751.85
1,067.14
1,098.17
1,246.62
1,256.31
1,279.24
1,346.97
4,340.74
4,590.11
5,048.26
5,380.14
5,646.43
6,098.81
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--20.0
15.6
7.4
8.7
---25.5
10.2
3.8
3.6
---18.2
11.5
4.6
4.9
--9.7
8.1
5.8
7.1
---13.5
11.1
4.9
3.2
--3.9
8.8
5.6
6.3
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
13.7
13.8
8.8
9.7
10.2
4.4
4.4
7.5
4.1
3.6
6.8
7.0
7.9
5.8
5.6
10.9
3.1
2.4
-0.3
3.5
7.9
11.9
8.6
5.6
7.0
10.3
4.9
3.7
1.0
4.3
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
6.7
1.7
1.2
7.8
9.0
8.8
8.3
-4.9
10.1
11.1
8.1
6.2
-3.0
9.4
10.4
3.9
1.5
6.4
10.7
14.3
-0.4
-4.6
3.5
16.4
3.2
2.9
0.1
5.8
12.0
11.8
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
17.2
15.6
12.5
10.0
5.2
12.2
6.8
13.1
9.5
5.2
13.7
9.6
12.9
9.7
5.2
6.5
8.6
7.0
5.6
2.6
12.0
6.5
8.1
13.3
8.3
7.7
8.1
7.3
7.2
3.9
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
4.7
2.4
7.7
4.0
3.9
6.7
8.2
6.2
14.1
-4.1
5.0
6.6
7.0
4.9
12.0
-1.6
4.6
6.7
4.1
6.7
8.9
8.5
5.9
8.8
8.8
2.9
13.5
0.8
1.8
5.3
5.2
5.7
10.0
6.6
4.9
8.0
3.0
2.7
3.6
4.7
-2.1
3.4
N.L.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--17.2
10.8
2.9
4.1
---28.3
5.5
-0.8
-1.0
---21.0
6.7
0.1
0.3
--6.9
3.4
1.3
2.5
---16.3
6.4
0.4
-1.4
--1.1
4.0
1.1
1.7
1990
1991
1992
1993
1994
10.7
11.1
7.5
8.3
9.1
1.3
1.6
6.2
2.7
2.5
3.8
4.2
6.6
4.3
4.6
7.9
0.4
1.1
-1.8
2.4
4.8
9.2
7.4
4.2
5.9
7.2
2.2
2.5
-0.4
3.2
1995
1996
1997
1998
1999
4.3
0.1
0.2
8.3
7.2
6.4
6.6
-5.9
10.5
9.3
5.8
4.5
-4.0
9.8
8.6
1.6
-0.2
5.4
11.2
12.5
-2.7
-6.3
2.5
16.8
1.4
0.5
-1.6
4.8
12.4
10.0
2000
2001
2002
2003
2004
13.1
14.2
11.5
7.1
2.6
8.1
5.4
12.1
6.6
2.6
9.6
8.2
11.9
6.8
2.6
2.4
7.2
6.0
2.7
0.0
7.9
5.1
7.1
10.4
5.7
3.6
6.8
6.2
4.3
1.3
2005
2006
2007
2008
2009 f
2010 f
1.7
-0.3
4.1
-0.8
6.0
3.3
5.2
3.5
10.5
-8.8
7.1
3.2
4.0
2.2
8.5
-6.4
6.8
3.2
1.1
4.0
5.3
3.7
8.0
5.4
5.8
0.2
9.9
-4.0
3.9
1.9
2.2
3.0
6.4
1.8
7.1
4.6
f: forecast.
Canadian Institute for Health Information, 2010.
65
Drug Expenditure in Canada, 1985 to 2010
Table B P.E.I.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2010
Provincial
Federal
Year
P.E.I.
Prescribed Drugs
Public
Private
Insurers*
Out-ofSocial Security Funds
Subtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
1.7
2.1
3.5
4.6
5.5
0.8
0.9
1.0
0.6
0.5
0.0
0.1
0.1
0.1
0.1
-----------
2.5
3.1
4.6
5.3
6.0
-----------
-----------
19.5
12.9
10.2
12.4
15.0
22.0
16.0
14.7
17.7
21.0
-----------
-----------
10.7
12.1
14.0
11.8
9.9
1990
1991
1992
1993
1994
6.5
7.4
7.6
7.5
7.7
0.6
0.7
0.7
0.8
0.9
0.1
0.1
0.4
0.3
0.3
-----------
7.3
8.2
8.6
8.6
8.9
-----------
-----------
18.0
17.1
18.8
21.8
23.8
25.3
25.3
27.5
30.5
32.8
----8.6
9.0
9.2
----7.8
8.4
8.7
10.6
13.5
16.4
17.4
17.9
1995
1996
1997
1998
1999
8.5
8.5
9.1
10.4
12.0
1.0
1.0
1.0
1.2
1.4
0.4
0.4
0.4
0.5
0.6
-----------
9.8
9.8
10.6
12.2
13.9
-----------
-----------
28.4
29.7
28.8
33.0
33.6
38.3
39.5
39.4
45.1
47.6
8.5
6.8
7.1
8.6
9.1
8.3
6.3
6.9
8.5
8.5
16.8
13.1
14.0
17.1
17.6
2000
2001
2002
2003
2004
14.0
15.7
16.9
18.4
19.9
2.3
2.7
2.7
2.9
2.9
0.7
0.8
0.7
0.7
0.7
-----------
17.0
19.1
20.3
22.0
23.4
-----------
-----------
36.0
43.0
38.1
43.7
47.8
53.0
62.2
58.4
65.7
71.2
8.8
9.7
10.4
10.7
10.7
8.0
8.4
9.0
9.0
8.9
16.8
18.1
19.4
19.7
19.6
2005
2006
2007
2008
2009 f
2010 f
22.3
24.2
25.8
28.7
32.3
35.1
2.9
2.8
2.8
2.8
2.9
3.0
0.7
0.8
0.9
0.9
0.9
0.9
-------------
25.9
27.8
29.4
32.4
36.0
39.0
-------------
-------------
52.2
56.8
56.9
56.7
58.0
58.4
78.1
84.6
86.3
89.1
94.1
97.4
10.2
10.6
11.3
12.2
13.0
13.6
8.3
8.7
9.0
9.6
9.9
10.5
18.5
19.3
20.4
21.8
22.9
24.1
1985
1986
1987
1988
1989
--27.8
63.7
32.4
17.9
--16.1
12.6
-40.9
-17.4
--44.0
39.7
20.2
0.9
-----------
--24.4
48.5
16.1
13.7
-----------
-----------
---34.1
-21.0
21.5
21.5
---27.5
-7.6
19.8
19.1
-----------
-----------
--13.2
16.0
-16.1
-16.1
1990
1991
1992
1993
1994
19.8
13.5
2.5
-1.7
2.8
30.7
7.0
-4.5
24.8
12.0
20.5
-0.4
218.0
-13.7
-1.5
-----------
20.7
12.7
5.2
-0.3
3.5
-----------
-----------
19.8
-4.7
10.0
15.9
9.2
20.1
0.3
8.5
10.8
7.6
------4.9
1.7
------7.8
3.7
7.5
27.3
21.5
6.3
2.7
1995
1996
1997
1998
1999
10.2
0.0
7.4
14.6
14.7
8.6
-3.8
8.3
16.2
14.0
9.8
4.4
14.7
21.0
11.9
-----------
10.0
-0.2
7.8
15.1
14.5
-----------
-----------
19.2
4.3
-3.0
14.5
2.0
16.7
3.2
-0.3
14.6
5.4
-7.1
-20.6
5.4
21.2
5.7
-5.1
-24.1
9.2
23.2
0.1
-6.1
-22.3
7.2
22.2
3.0
2000
2001
2002
2003
2004
16.8
12.4
7.7
9.2
7.7
66.4
16.8
0.7
6.4
0.4
26.3
4.4
-9.4
-1.6
-2.8
-----------
22.1
12.6
6.0
8.4
6.5
-----------
-----------
7.2
19.4
-11.5
14.8
9.3
11.6
17.2
-6.1
12.6
8.3
-3.7
10.0
7.4
2.5
0.6
-6.0
5.3
7.2
0.2
-0.9
-4.8
7.7
7.3
1.4
-0.1
2005
2006
2007
2008
2009 f
2010 f
12.4
8.2
6.6
11.3
12.6
8.5
-0.1
-1.4
-1.0
-1.5
3.9
3.1
7.6
9.7
7.0
10.8
-7.9
7.9
-------------
10.7
7.1
5.9
10.1
11.3
8.1
-------------
-------------
9.3
8.8
0.3
-0.4
2.3
0.7
9.8
8.2
2.1
3.2
5.6
3.5
-5.2
4.3
7.0
7.4
7.0
4.5
-6.5
4.7
3.4
6.5
2.6
6.3
-5.8
4.5
5.4
7.0
5.1
5.2
1985
1986
1987
1988
1989
5.1
7.6
12.1
15.7
17.6
2.3
3.2
3.5
2.0
1.6
0.1
0.2
0.3
0.3
0.3
-----------
7.6
11.0
15.9
18.1
19.6
-----------
-----------
59.7
45.9
35.3
42.0
48.5
67.3
56.9
51.3
60.0
68.1
-----------
-----------
32.7
43.1
48.7
40.0
31.9
1990
1991
1992
1993
1994
18.2
19.1
17.3
15.6
15.2
1.8
1.8
1.5
1.7
1.8
0.3
0.3
0.9
0.7
0.7
-----------
20.3
21.2
19.7
18.0
17.6
-----------
-----------
50.1
44.1
42.9
45.6
47.1
70.4
65.2
62.6
63.6
64.7
----19.6
18.8
18.1
----17.8
17.6
17.2
29.6
34.8
37.4
36.4
35.3
1995
1996
1997
1998
1999
15.4
16.1
17.0
16.8
18.4
1.8
1.8
1.9
1.9
2.1
0.7
0.7
0.8
0.9
0.9
-----------
17.8
18.7
19.8
19.5
21.4
-----------
-----------
51.6
56.5
54.0
53.0
51.6
69.5
75.1
73.8
72.5
73.0
15.5
12.9
13.4
13.9
14.0
15.1
12.0
12.9
13.6
13.0
30.5
24.9
26.2
27.5
27.0
2000
2001
2002
2003
2004
20.0
19.6
21.7
21.6
21.9
3.3
3.3
3.5
3.3
3.2
1.1
1.0
0.9
0.8
0.7
-----------
24.4
23.9
26.1
25.8
25.8
-----------
-----------
51.6
53.6
49.0
51.2
52.6
76.0
77.5
75.1
77.0
78.4
12.6
12.1
13.4
12.5
11.8
11.4
10.5
11.6
10.6
9.8
24.0
22.5
24.9
23.0
21.6
2005
23.1
3.0
0.8
--2006
23.3
2.7
0.8
--2007
24.1
2.6
0.8
--2008
25.9
2.5
0.9
--2009 f
27.6
2.4
0.7
--2010 f
28.9
2.4
0.8
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
26.8
26.7
27.6
29.2
30.8
32.1
-------------
-------------
54.0
54.6
53.3
51.1
49.6
48.1
80.9
81.4
80.9
80.3
80.4
80.2
10.5
10.2
10.6
11.0
11.1
11.2
8.6
8.4
8.5
8.7
8.4
8.6
19.1
18.6
19.1
19.7
19.6
19.8
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
66
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B P.E.I.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
2.5
3.1
4.6
5.3
6.0
30.2
25.0
24.2
24.1
24.9
32.7
28.0
28.8
29.4
30.9
128.3
138.0
149.7
163.0
174.4
52.9
49.6
53.3
56.5
64.9
181.2
187.6
202.9
219.5
239.3
1.9
2.2
3.1
3.3
3.5
57.1
50.3
45.4
42.6
38.3
18.0
15.0
14.2
13.4
12.9
1990
1991
1992
1993
1994
7.3
8.2
8.6
8.6
8.9
28.6
30.6
35.2
39.3
41.8
35.9
38.8
43.9
47.9
50.7
186.3
203.8
209.2
218.2
217.0
70.0
76.8
85.8
93.5
96.7
256.2
280.6
295.0
311.7
313.7
3.9
4.0
4.1
4.0
4.1
40.9
39.9
41.1
42.0
43.2
14.0
13.8
14.9
15.4
16.2
1995
1996
1997
1998
1999
9.8
9.8
10.6
12.2
13.9
45.2
42.7
42.8
50.1
51.2
55.1
52.5
53.4
62.2
65.2
222.8
233.0
229.9
245.5
259.0
104.6
106.1
110.4
115.9
119.7
327.4
339.1
340.3
361.4
378.7
4.4
4.2
4.6
5.0
5.4
43.2
40.3
38.8
43.2
42.8
16.8
15.5
15.7
17.2
17.2
2000
2001
2002
2003
2004
17.0
19.1
20.3
22.0
23.4
52.8
61.1
57.5
63.4
67.4
69.8
80.2
77.7
85.4
90.8
277.7
328.5
365.6
379.7
375.9
123.7
147.5
139.8
161.3
162.3
401.4
475.9
505.4
541.0
538.2
6.1
5.8
5.6
5.8
6.2
42.7
41.4
41.1
39.3
41.5
17.4
16.9
15.4
15.8
16.9
2005
2006
2007
2008
2009 f
2010 f
25.9
27.8
29.4
32.4
36.0
39.0
70.7
76.1
77.3
78.5
80.9
82.5
96.6
103.9
106.7
110.9
117.0
121.5
413.0
434.2
466.2
510.5
588.8
629.7
163.2
187.7
188.4
196.2
207.4
210.3
576.2
621.9
654.6
706.7
796.3
840.0
6.3
6.4
6.3
6.3
6.1
6.2
43.3
40.5
41.0
40.0
39.0
39.2
16.8
16.7
16.3
15.7
14.7
14.5
1985
1986
1987
1988
1989
--24.4
48.5
16.1
13.7
---17.3
-3.1
-0.3
3.1
---14.2
2.6
2.3
5.0
--7.6
8.5
8.9
7.0
---6.3
7.4
6.2
14.8
--3.5
8.2
8.2
9.0
1990
1991
1992
1993
1994
20.7
12.7
5.2
-0.3
3.5
14.9
7.2
15.1
11.4
6.3
16.0
8.3
13.0
9.1
5.8
6.8
9.4
2.7
4.3
-0.6
7.7
9.8
11.6
9.0
3.4
7.0
9.5
5.1
5.7
0.6
1995
1996
1997
1998
1999
10.0
-0.2
7.8
15.1
14.5
8.4
-5.6
0.2
17.0
2.3
8.7
-4.6
1.6
16.6
4.7
2.7
4.6
-1.3
6.8
5.5
8.2
1.4
4.1
5.0
3.3
4.4
3.5
0.4
6.2
4.8
2000
2001
2002
2003
2004
22.1
12.6
6.0
8.4
6.5
3.1
15.7
-6.0
10.3
6.4
7.1
14.9
-3.1
9.8
6.4
7.2
18.3
11.3
3.8
-1.0
3.3
19.3
-5.2
15.4
0.6
6.0
18.6
6.2
7.0
-0.5
2005
2006
2007
2008
2009 f
2010 f
10.7
7.1
5.9
10.1
11.3
8.1
4.9
7.6
1.6
1.5
3.1
2.0
6.4
7.5
2.7
3.9
5.5
3.9
9.9
5.1
7.4
9.5
15.3
6.9
0.6
15.0
0.3
4.2
5.7
1.4
7.1
7.9
5.2
8.0
12.7
5.5
P.E.I.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
7.6
11.0
15.9
18.1
19.6
92.4
89.0
84.1
81.9
80.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
20.3
21.2
19.7
18.0
17.6
79.7
78.8
80.3
82.0
82.4
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
17.8
18.7
19.8
19.5
21.4
82.2
81.3
80.2
80.5
78.6
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
24.4
23.9
26.1
25.8
25.8
75.6
76.1
73.9
74.2
74.2
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
26.8
26.7
27.6
29.2
30.8
32.1
73.2
73.3
72.4
70.8
69.2
67.9
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
67
Drug Expenditure in Canada, 1985 to 2010
Table B P.E.I.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2010
Provincial
Federal
Year
P.E.I.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
13.08
16.61
27.17
35.77
41.92
6.01
6.94
7.80
4.59
3.77
0.33
0.47
0.66
0.79
0.79
-----------
19.42
24.02
35.62
41.15
46.48
-----------
-----------
152.95
100.25
79.09
95.54
115.34
172.37
124.27
114.72
136.69
161.82
-----------
-----------
83.63
94.14
109.04
90.98
75.86
1990
1991
1992
1993
1994
50.03
56.89
58.12
56.53
57.56
4.91
5.26
5.01
6.18
6.86
0.95
0.94
2.99
2.56
2.49
-----------
55.88
63.09
66.12
65.27
66.91
-----------
-----------
137.70
131.41
144.08
165.28
178.75
193.59
194.50
210.20
230.55
245.65
----65.73
68.24
68.75
----59.68
63.70
65.44
81.26
103.63
125.41
131.94
134.19
1995
1996
1997
1998
1999
62.95
62.35
66.82
76.76
87.75
7.39
7.04
7.61
8.86
10.07
2.72
2.81
3.21
3.90
4.35
-----------
73.06
72.20
77.64
89.52
102.17
-----------
-----------
211.56
218.51
211.50
242.67
246.71
284.62
290.71
289.13
332.19
348.88
63.37
49.84
52.38
63.65
67.05
61.67
46.35
50.46
62.32
62.19
125.04
96.19
102.85
125.97
129.24
2000
2001
2002
2003
2004
102.36
114.85
123.41
134.35
144.18
16.74
19.53
19.63
20.82
20.83
5.48
5.72
5.17
5.08
4.91
-----------
124.58
140.10
148.21
160.24
169.92
-----------
-----------
264.09
314.79
278.01
318.33
346.45
388.67
454.89
426.22
478.57
516.37
64.46
70.80
75.90
77.57
77.74
58.37
61.36
65.64
65.60
64.73
122.84
132.16
141.54
143.17
142.46
2005
2006
2007
2008
2009 f
2010 f
161.68
175.23
186.57
205.72
229.15
247.78
20.75
20.49
20.26
19.77
20.32
20.88
5.28
5.80
6.20
6.80
6.20
6.67
-------------
187.71
201.52
213.03
232.28
255.67
275.33
-------------
-------------
377.81
411.68
412.11
406.54
411.53
412.82
565.52
613.20
625.15
638.83
667.20
688.15
73.51
76.85
82.13
87.40
92.46
96.22
60.35
63.33
65.37
68.95
70.01
74.15
133.86
140.18
147.50
156.35
162.47
170.37
1985
1986
1987
1988
1989
--27.0
63.5
31.7
17.2
--15.4
12.4
-41.2
-17.9
--43.2
39.5
19.5
0.3
-----------
--23.7
48.3
15.5
13.0
-----------
-----------
---34.5
-21.1
20.8
20.7
---27.9
-7.7
19.2
18.4
-----------
-----------
1990
1991
1992
1993
1994
19.3
13.7
2.2
-2.7
1.8
30.2
7.2
-4.8
23.5
10.9
20.1
-0.2
216.8
-14.6
-2.4
-----------
20.2
12.9
4.8
-1.3
2.5
-----------
-----------
19.4
-4.6
9.6
14.7
8.1
19.6
0.5
8.1
9.7
6.6
------3.8
0.8
------6.7
2.7
7.1
27.5
21.0
5.2
1.7
1995
1996
1997
1998
1999
9.4
-0.9
7.2
14.9
14.3
7.8
-4.7
8.0
16.5
13.6
9.0
3.4
14.4
21.3
11.5
-----------
9.2
-1.2
7.5
15.3
14.1
-----------
-----------
18.4
3.3
-3.2
14.7
1.7
15.9
2.1
-0.5
14.9
5.0
-7.8
-21.4
5.1
21.5
5.3
-5.8
-24.8
8.9
23.5
-0.2
-6.8
-23.1
6.9
22.5
2.6
2000
2001
2002
2003
2004
16.7
12.2
7.5
8.9
7.3
66.2
16.7
0.5
6.1
0.0
26.2
4.3
-9.6
-1.8
-3.2
-----------
21.9
12.5
5.8
8.1
6.0
-----------
-----------
7.0
19.2
-11.7
14.5
8.8
11.4
17.0
-6.3
12.3
7.9
-3.9
9.8
7.2
2.2
0.2
-6.1
5.1
7.0
-0.1
-1.3
-5.0
7.6
7.1
1.2
-0.5
2005
2006
2007
2008
2009 f
2010 f
12.1
8.4
6.5
10.3
11.4
8.1
-0.3
-1.3
-1.1
-2.4
2.8
2.8
7.4
9.9
6.9
9.8
-8.9
7.6
-------------
10.5
7.4
5.7
9.0
10.1
7.7
-------------
-------------
9.1
9.0
0.1
-1.4
1.2
0.3
9.5
8.4
1.9
2.2
4.4
3.1
-5.4
4.5
6.9
6.4
5.8
4.1
-6.8
4.9
3.2
5.5
1.5
5.9
-6.0
4.7
5.2
6.0
3.9
4.9
1985
1986
1987
1988
1989
--24.2
58.8
27.2
12.6
--12.6
7.7
-45.7
-22.4
--40.4
34.8
15.0
-4.3
-----------
--20.9
43.6
11.0
8.4
-----------
-----------
---37.3
-25.8
16.3
16.2
---30.7
-12.4
14.6
13.8
-----------
-----------
1990
1991
1992
1993
1994
16.3
10.9
0.9
-4.2
0.7
27.2
4.4
-6.1
22.1
9.8
17.1
-3.0
215.6
-16.1
-3.5
-----------
17.2
10.1
3.5
-2.7
1.4
-----------
-----------
16.4
-7.3
8.4
13.3
7.0
16.6
-2.3
6.8
8.2
5.5
------2.4
-0.3
------5.3
1.6
4.1
24.8
19.8
3.8
0.6
1995
1996
1997
1998
1999
7.0
-2.6
6.2
15.3
12.5
5.5
-6.4
7.1
16.9
11.8
6.7
1.7
13.4
21.7
9.7
-----------
6.9
-2.8
6.5
15.7
12.3
-----------
-----------
16.0
1.6
-4.2
15.2
-0.1
13.5
0.5
-1.5
15.3
3.2
-10.2
-23.0
4.1
21.9
3.5
-8.1
-26.5
7.9
23.9
-2.0
-9.2
-24.7
5.9
22.9
0.8
2000
2001
2002
2003
2004
12.5
10.8
6.4
6.0
4.7
62.1
15.3
-0.6
3.2
-2.6
22.1
3.0
-10.6
-4.7
-5.8
-----------
17.8
11.1
4.7
5.2
3.5
-----------
-----------
2.9
17.8
-12.7
11.6
6.2
7.3
15.7
-7.3
9.4
5.3
-8.0
8.5
6.1
-0.7
-2.4
-10.2
3.8
5.9
-3.0
-3.9
-9.1
6.2
6.1
-1.7
-3.1
2005
2006
2007
2008
2009 f
2010 f
9.1
5.7
2.9
5.5
13.5
4.7
-3.4
-4.0
-4.7
-7.2
4.9
-0.7
4.4
7.2
3.3
5.0
-6.8
4.1
-------------
7.5
4.6
2.1
4.3
12.2
4.3
-------------
-------------
6.0
6.3
-3.5
-6.1
3.3
-3.1
6.5
5.7
-1.6
-2.6
6.6
-0.3
-8.4
1.8
3.3
1.7
7.9
0.7
-9.8
2.2
-0.4
0.7
3.6
2.5
-9.0
2.0
1.6
1.3
6.0
1.5
(Annual Percentage Change)
--12.6
15.8
-16.6
-16.6
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
68
--9.8
11.1
-21.1
-21.2
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B P.E.I.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Year
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
(1997 = 100)
1985
1986
1987
1988
1989
19.42
24.02
35.62
41.15
46.48
236.58
194.39
188.13
186.53
191.20
256.00
218.41
223.76
227.67
237.68
1,004.74
1,074.57
1,164.10
1,260.71
1,340.84
414.66
386.13
414.24
437.42
499.18
1,419.40
1,460.70
1,578.34
1,698.12
1,840.01
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
55.88
63.09
66.12
65.27
66.91
218.96
235.04
269.50
297.22
312.94
274.84
298.14
335.62
362.49
379.85
1,426.83
1,563.81
1,599.57
1,651.43
1,626.43
535.91
589.69
655.88
707.51
724.66
1,962.74
2,153.50
2,255.45
2,358.94
2,351.09
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
73.06
72.20
77.64
89.52
102.17
336.60
314.70
314.34
368.63
375.95
409.66
386.90
391.98
458.15
478.12
1,657.77
1,716.36
1,689.18
1,807.78
1,900.33
778.40
781.25
811.16
853.14
878.29
2,436.16
2,497.61
2,500.34
2,660.92
2,778.63
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
124.58
140.10
148.21
160.24
169.92
386.93
446.95
419.55
461.50
488.91
511.51
587.05
567.76
621.74
658.83
2,034.63
2,403.43
2,669.89
2,764.67
2,726.79
905.97
1,078.93
1,020.75
1,174.86
1,176.96
2,940.60
3,482.35
3,690.64
3,939.53
3,903.75
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
187.71
201.52
213.03
232.28
255.67
275.33
511.68
551.86
559.62
562.89
574.00
583.19
699.38
753.37
772.65
795.18
829.66
858.52
2,988.66
3,148.12
3,375.10
3,660.76
4,176.57
4,450.49
1,180.97
1,361.24
1,363.81
1,407.20
1,471.27
1,486.21
4,169.63
4,509.36
4,738.92
5,067.96
5,647.84
5,936.70
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--23.7
48.3
15.5
13.0
---17.8
-3.2
-0.9
2.5
---14.7
2.4
1.7
4.4
--7.0
8.3
8.3
6.4
---6.9
7.3
5.6
14.1
--2.9
8.1
7.6
8.4
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
20.2
12.9
4.8
-1.3
2.5
14.5
7.3
14.7
10.3
5.3
15.6
8.5
12.6
8.0
4.8
6.4
9.6
2.3
3.2
-1.5
7.4
10.0
11.2
7.9
2.4
6.7
9.7
4.7
4.6
-0.3
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
9.2
-1.2
7.5
15.3
14.1
7.6
-6.5
-0.1
17.3
2.0
7.8
-5.6
1.3
16.9
4.4
1.9
3.5
-1.6
7.0
5.1
7.4
0.4
3.8
5.2
2.9
3.6
2.5
0.1
6.4
4.4
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
21.9
12.5
5.8
8.1
6.0
2.9
15.5
-6.1
10.0
5.9
7.0
14.8
-3.3
9.5
6.0
7.1
18.1
11.1
3.5
-1.4
3.2
19.1
-5.4
15.1
0.2
5.8
18.4
6.0
6.7
-0.9
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
10.5
7.4
5.7
9.0
10.1
7.7
4.7
7.9
1.4
0.6
2.0
1.6
6.2
7.7
2.6
2.9
4.3
3.5
9.6
5.3
7.2
8.5
14.1
6.6
0.3
15.3
0.2
3.2
4.6
1.0
6.8
8.1
5.1
6.9
11.4
5.1
3.0
2.7
3.6
4.7
-2.1
3.4
P.E.I.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--20.9
43.6
11.0
8.4
---20.6
-8.0
-5.4
-2.1
---17.5
-2.3
-2.8
-0.2
--4.1
3.6
3.8
1.8
---9.7
2.5
1.1
9.6
--0.1
3.3
3.1
3.8
1990
1991
1992
1993
1994
17.2
10.1
3.5
-2.7
1.4
11.5
4.6
13.4
8.8
4.2
12.6
5.7
11.3
6.6
3.7
3.4
6.8
1.0
1.8
-2.6
4.3
7.3
10.0
6.4
1.3
3.6
7.0
3.5
3.1
-1.4
1995
1996
1997
1998
1999
6.9
-2.8
6.5
15.7
12.3
5.2
-8.2
-1.1
17.7
0.2
5.5
-7.2
0.3
17.3
2.5
-0.4
1.9
-2.6
7.5
3.3
5.1
-1.3
2.8
5.6
1.1
1.3
0.9
-0.9
6.9
2.6
2000
2001
2002
2003
2004
17.8
11.1
4.7
5.2
3.5
-1.2
14.2
-7.2
7.1
3.3
2.9
13.4
-4.3
6.6
3.4
3.0
16.8
10.0
0.7
-4.0
-1.0
17.7
-6.4
12.2
-2.4
1.7
17.1
4.9
3.8
-3.5
2005
2006
2007
2008
2009 f
2010 f
7.5
4.6
2.1
4.3
12.2
4.3
1.6
5.1
-2.2
-4.2
4.1
-1.8
3.1
5.0
-1.0
-1.8
6.5
0.1
6.6
2.6
3.6
3.7
16.2
3.1
-2.7
12.6
-3.4
-1.6
6.7
-2.4
3.8
5.4
1.5
2.2
13.6
1.7
f: forecast.
Canadian Institute for Health Information, 2010.
69
Drug Expenditure in Canada, 1985 to 2010
Table B N.S.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2010
Provincial
Federal
Year
N.S.
Prescribed Drugs
Public
Private
Insurers*
Out-ofSocial Security Funds
Subtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
45.5
53.1
62.3
72.2
82.1
2.3
2.4
2.6
3.4
4.2
0.2
0.2
0.2
0.3
0.3
-----------
48.0
55.7
65.1
76.0
86.6
-----------
-----------
38.7
59.6
67.7
74.8
82.5
86.7
115.3
132.8
150.8
169.1
-----------
-----------
61.1
69.2
80.2
78.9
77.7
1990
1991
1992
1993
1994
83.0
83.0
89.0
88.5
83.2
5.0
5.6
5.9
6.8
7.3
0.3
0.5
0.5
0.6
0.6
-----------
88.3
89.1
95.4
95.9
91.1
-----------
-----------
96.0
106.2
118.4
132.7
137.8
184.2
195.3
213.8
228.6
228.9
----48.7
51.3
51.8
----44.3
47.9
49.3
79.3
80.6
93.0
99.1
101.1
1995
1996
1997
1998
1999
83.9
83.3
86.8
99.5
110.7
8.9
8.4
9.8
14.4
14.8
0.7
0.7
0.7
0.8
1.1
-----------
93.5
92.5
97.3
114.7
126.5
-----------
-----------
148.7
159.4
170.5
198.7
201.5
242.2
251.8
267.9
313.4
328.0
47.8
53.8
49.2
54.8
55.5
46.5
50.0
47.4
53.7
51.5
94.2
103.8
96.5
108.5
107.0
2000
2001
2002
2003
2004
117.3
128.7
140.8
156.2
170.0
18.8
22.3
24.2
25.9
26.4
1.4
1.9
2.2
2.5
3.0
-----------
137.4
152.9
167.2
184.6
199.4
-----------
-----------
227.3
247.5
282.2
299.5
324.5
364.7
400.4
449.5
484.1
523.9
55.3
60.5
64.6
68.7
72.1
50.1
52.4
55.9
58.1
60.0
105.4
112.9
120.5
126.9
132.1
2005
2006
2007
2008
2009 f
2010 f
186.1
231.8
252.3
269.0
287.0
303.7
27.4
34.7
30.4
28.2
27.9
28.3
3.4
4.8
5.6
6.8
8.3
8.7
-------------
216.8
271.3
288.3
304.0
323.1
340.7
-------------
-------------
359.9
396.8
423.5
423.0
438.5
445.6
576.7
668.1
711.8
727.0
761.6
786.2
71.6
73.7
80.1
80.4
85.2
87.9
58.8
60.8
63.7
63.4
64.5
67.7
130.4
134.5
143.8
143.9
149.7
155.6
1985
1986
1987
1988
1989
--16.7
17.2
16.0
13.7
--3.8
8.3
32.7
21.9
--16.4
4.2
48.7
-7.8
-----------
--16.1
16.8
16.8
14.0
-----------
-----------
--54.0
13.6
10.4
10.4
--33.0
15.1
13.5
12.2
-----------
-----------
--13.2
16.0
-1.6
-1.6
1990
1991
1992
1993
1994
1.0
0.1
7.2
-0.5
-6.0
20.1
12.4
5.3
15.4
6.6
6.4
41.5
2.6
20.2
6.1
-----------
1.9
0.9
7.1
0.6
-5.0
-----------
-----------
16.3
10.6
11.5
12.1
3.9
8.9
6.0
9.5
6.9
0.1
------5.2
1.0
------8.1
3.0
2.1
1.7
15.4
6.6
1.9
1995
1996
1997
1998
1999
0.8
-0.7
4.2
14.5
11.3
21.6
-5.0
16.2
47.4
2.5
15.7
5.2
-1.0
16.2
27.0
-----------
2.6
-1.1
5.3
17.9
10.3
-----------
-----------
7.9
7.2
7.0
16.5
1.4
5.8
4.0
6.4
17.0
4.7
-7.8
12.7
-8.6
11.6
1.2
-5.7
7.7
-5.4
13.4
-4.1
-6.8
10.2
-7.1
12.5
-1.5
2000
2001
2002
2003
2004
5.9
9.8
9.4
10.9
8.8
27.1
18.6
8.6
7.0
2.0
28.6
39.0
18.0
12.3
19.2
-----------
8.6
11.3
9.4
10.4
8.0
-----------
-----------
12.8
8.9
14.0
6.1
8.4
11.2
9.8
12.2
7.7
8.2
-0.3
9.3
6.8
6.4
4.9
-2.7
4.6
6.6
4.0
3.3
-1.5
7.1
6.7
5.3
4.2
2005
2006
2007
2008
2009 f
2010 f
9.5
24.6
8.9
6.6
6.7
5.8
3.7
26.9
-12.5
-7.1
-1.1
1.2
12.0
41.6
17.6
21.3
21.5
4.8
-------------
8.7
25.1
6.3
5.4
6.3
5.4
-------------
-------------
10.9
10.2
6.7
-0.1
3.7
1.6
10.1
15.8
6.5
2.1
4.8
3.2
-0.7
3.0
8.6
0.4
6.0
3.2
-2.1
3.4
4.9
-0.5
1.7
4.9
-1.3
3.2
6.9
0.0
4.1
3.9
1985
1986
1987
1988
1989
30.8
28.8
29.2
31.5
33.3
1.5
1.3
1.2
1.5
1.7
0.1
0.1
0.1
0.1
0.1
-----------
32.5
30.2
30.5
33.1
35.1
-----------
-----------
26.2
32.3
31.8
32.5
33.4
58.7
62.5
62.3
65.6
68.5
-----------
-----------
41.3
37.5
37.7
34.4
31.5
1990
1991
1992
1993
1994
31.5
30.1
29.0
27.0
25.2
1.9
2.0
1.9
2.1
2.2
0.1
0.2
0.2
0.2
0.2
-----------
33.5
32.3
31.1
29.3
27.6
-----------
-----------
36.4
38.5
38.6
40.5
41.8
69.9
70.8
69.7
69.8
69.4
----15.9
15.6
15.7
----14.4
14.6
14.9
30.1
29.2
30.3
30.2
30.6
1995
1996
1997
1998
1999
24.9
23.4
23.8
23.6
25.4
2.6
2.4
2.7
3.4
3.4
0.2
0.2
0.2
0.2
0.2
-----------
27.8
26.0
26.7
27.2
29.1
-----------
-----------
44.2
44.8
46.8
47.1
46.3
72.0
70.8
73.5
74.3
75.4
14.2
15.1
13.5
13.0
12.8
13.8
14.1
13.0
12.7
11.8
28.0
29.2
26.5
25.7
24.6
2000
2001
2002
2003
2004
24.9
25.1
24.7
25.6
25.9
4.0
4.3
4.2
4.2
4.0
0.3
0.4
0.4
0.4
0.5
-----------
29.2
29.8
29.3
30.2
30.4
-----------
-----------
48.4
48.2
49.5
49.0
49.5
77.6
78.0
78.9
79.2
79.9
11.8
11.8
11.3
11.2
11.0
10.7
10.2
9.8
9.5
9.2
22.4
22.0
21.1
20.8
20.1
2005
26.3
3.9
0.5
--2006
28.9
4.3
0.6
--2007
29.5
3.6
0.7
--2008
30.9
3.2
0.8
--2009 f
31.5
3.1
0.9
--2010 f
32.2
3.0
0.9
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
30.7
33.8
33.7
34.9
35.5
36.2
-------------
-------------
50.9
49.4
49.5
48.6
48.1
47.3
81.6
83.2
83.2
83.5
83.6
83.5
10.1
9.2
9.4
9.2
9.4
9.3
8.3
7.6
7.4
7.3
7.1
7.2
18.4
16.8
16.8
16.5
16.4
16.5
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
70
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.S.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
48.0
55.7
65.1
76.0
86.6
99.8
128.8
147.9
153.7
160.2
147.8
184.5
213.0
229.7
246.8
947.2
1,023.2
1,165.5
1,165.0
1,281.5
285.3
353.7
395.0
420.3
470.3
1,232.5
1,376.9
1,560.6
1,585.2
1,751.8
5.1
5.4
5.6
6.5
6.8
35.0
36.4
37.4
36.6
34.1
12.0
13.4
13.6
14.5
14.1
1990
1991
1992
1993
1994
88.3
89.1
95.4
95.9
91.1
175.3
186.8
211.4
231.8
238.9
263.5
275.9
306.8
327.7
330.0
1,376.6
1,451.2
1,477.0
1,445.5
1,413.1
490.4
518.8
554.5
579.5
610.2
1,866.9
1,970.0
2,031.6
2,025.0
2,023.4
6.4
6.1
6.5
6.6
6.4
35.7
36.0
38.1
40.0
39.1
14.1
14.0
15.1
16.2
16.3
1995
1996
1997
1998
1999
93.5
92.5
97.3
114.7
126.5
242.9
263.2
267.1
307.2
308.5
336.4
355.7
364.4
421.9
435.0
1,440.0
1,438.2
1,669.3
1,786.8
1,899.7
621.3
650.8
694.5
757.3
765.6
2,061.3
2,089.0
2,363.8
2,544.2
2,665.3
6.5
6.4
5.8
6.4
6.7
39.1
40.4
38.5
40.6
40.3
16.3
17.0
15.4
16.6
16.3
2000
2001
2002
2003
2004
137.4
152.9
167.2
184.6
199.4
332.7
360.4
402.7
426.4
456.7
470.1
513.3
569.9
611.0
656.1
1,968.4
2,082.7
2,264.3
2,484.1
2,587.6
856.0
921.8
1,035.3
1,106.3
1,131.0
2,824.3
3,004.5
3,299.6
3,590.4
3,718.6
7.0
7.3
7.4
7.4
7.7
38.9
39.1
38.9
38.5
40.4
16.6
17.1
17.3
17.0
17.6
2005
2006
2007
2008
2009 f
2010 f
216.8
271.3
288.3
304.0
323.1
340.7
490.3
531.3
567.3
566.8
588.2
601.2
707.1
802.6
855.6
870.9
911.4
941.8
2,823.4
3,171.9
3,400.1
3,582.7
3,767.6
4,012.3
1,202.5
1,328.5
1,408.9
1,488.4
1,613.7
1,698.9
4,025.9
4,500.4
4,809.0
5,071.0
5,381.3
5,711.2
7.7
8.6
8.5
8.5
8.6
8.5
40.8
40.0
40.3
38.1
36.5
35.4
17.6
17.8
17.8
17.2
16.9
16.5
1985
1986
1987
1988
1989
--16.1
16.8
16.8
14.0
--29.1
14.9
3.9
4.2
--24.9
15.4
7.8
7.5
--8.0
13.9
-0.1
10.0
--24.0
11.7
6.4
11.9
--11.7
13.3
1.6
10.5
1990
1991
1992
1993
1994
1.9
0.9
7.1
0.6
-5.0
9.4
6.6
13.2
9.6
3.1
6.8
4.7
11.2
6.8
0.7
7.4
5.4
1.8
-2.1
-2.2
4.3
5.8
6.9
4.5
5.3
6.6
5.5
3.1
-0.3
-0.1
1995
1996
1997
1998
1999
2.6
-1.1
5.3
17.9
10.3
1.7
8.3
1.5
15.0
0.4
2.0
5.7
2.4
15.8
3.1
1.9
-0.1
16.1
7.0
6.3
1.8
4.7
6.7
9.0
1.1
1.9
1.3
13.2
7.6
4.8
2000
2001
2002
2003
2004
8.6
11.3
9.4
10.4
8.0
7.9
8.3
11.7
5.9
7.1
8.1
9.2
11.0
7.2
7.4
3.6
5.8
8.7
9.7
4.2
11.8
7.7
12.3
6.9
2.2
6.0
6.4
9.8
8.8
3.6
2005
2006
2007
2008
2009 f
2010 f
8.7
25.1
6.3
5.4
6.3
5.4
7.4
8.4
6.8
-0.1
3.8
2.2
7.8
13.5
6.6
1.8
4.7
3.3
9.1
12.3
7.2
5.4
5.2
6.5
6.3
10.5
6.0
5.6
8.4
5.3
8.3
11.8
6.9
5.4
6.1
6.1
N.S.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
32.5
30.2
30.5
33.1
35.1
67.5
69.8
69.5
66.9
64.9
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
33.5
32.3
31.1
29.3
27.6
66.5
67.7
68.9
70.7
72.4
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
27.8
26.0
26.7
27.2
29.1
72.2
74.0
73.3
72.8
70.9
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
29.2
29.8
29.3
30.2
30.4
70.8
70.2
70.7
69.8
69.6
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
30.7
33.8
33.7
34.9
35.5
36.2
69.3
66.2
66.3
65.1
64.5
63.8
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
71
Drug Expenditure in Canada, 1985 to 2010
Table B N.S.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2010
Provincial
Federal
Year
N.S.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
51.41
59.72
69.69
80.51
90.89
2.59
2.67
2.88
3.81
4.61
0.21
0.24
0.25
0.37
0.34
-----------
54.21
62.63
72.82
84.68
95.83
-----------
-----------
43.74
67.05
75.80
83.31
91.30
97.94
129.68
148.61
167.99
187.13
-----------
-----------
69.01
77.77
89.77
87.95
85.92
1990
1991
1992
1993
1994
91.20
90.73
96.80
95.81
89.76
5.50
6.14
6.44
7.39
7.86
0.36
0.50
0.51
0.61
0.65
-----------
97.05
97.37
103.75
103.82
98.27
-----------
-----------
105.50
116.04
128.74
143.56
148.69
202.55
213.41
232.49
247.38
246.96
----53.01
55.48
55.85
----48.13
51.79
53.16
87.16
88.07
101.14
107.28
109.01
1995
1996
1997
1998
1999
90.40
89.46
93.13
106.74
118.53
9.54
9.03
10.48
15.46
15.82
0.75
0.78
0.78
0.90
1.14
-----------
100.69
99.28
104.39
123.11
135.49
-----------
-----------
160.23
171.12
182.88
213.19
215.75
260.92
270.39
287.28
336.30
351.24
51.45
57.77
52.72
58.85
59.42
50.07
53.72
50.79
57.63
55.12
101.52
111.49
103.51
116.48
114.55
2000
2001
2002
2003
2004
125.55
138.03
150.66
166.78
181.22
20.11
23.89
25.89
27.63
28.16
1.47
2.05
2.41
2.70
3.21
-----------
147.13
163.96
178.95
197.11
212.59
-----------
-----------
243.42
265.49
302.01
319.83
346.01
390.56
429.45
480.96
516.95
558.60
59.24
64.85
69.13
73.39
76.87
53.64
56.20
59.79
62.06
64.01
112.88
121.05
128.92
135.45
140.88
2005
2006
2007
2008
2009 f
2010 f
198.78
247.14
269.64
287.23
305.87
323.59
29.26
37.04
32.47
30.13
29.76
30.11
3.60
5.09
6.00
7.27
8.82
9.24
-------------
231.64
289.27
308.10
324.63
344.44
362.95
-------------
-------------
384.51
422.99
452.47
451.61
467.38
474.71
616.15
712.26
760.56
776.24
811.82
837.66
76.49
78.60
85.56
85.85
90.83
93.67
62.80
64.77
68.11
67.74
68.77
72.13
139.29
143.38
153.67
153.59
159.60
165.79
1985
1986
1987
1988
1989
--16.2
16.7
15.5
12.9
--3.3
7.8
32.1
21.0
--15.8
3.7
48.1
-8.5
-----------
--15.5
16.3
16.3
13.2
-----------
-----------
--53.3
13.0
9.9
9.6
--32.4
14.6
13.0
11.4
-----------
-----------
--12.7
15.4
-2.0
-2.3
1990
1991
1992
1993
1994
0.3
-0.5
6.7
-1.0
-6.3
19.3
11.7
4.8
14.8
6.3
5.8
40.7
2.1
19.7
5.7
-----------
1.3
0.3
6.5
0.1
-5.3
-----------
-----------
15.6
10.0
10.9
11.5
3.6
8.2
5.4
8.9
6.4
-0.2
------4.7
0.7
------7.6
2.6
1.4
1.0
14.8
6.1
1.6
1995
1996
1997
1998
1999
0.7
-1.0
4.1
14.6
11.0
21.4
-5.3
16.0
47.5
2.3
15.6
4.8
-1.1
16.3
26.7
-----------
2.5
-1.4
5.2
17.9
10.1
-----------
-----------
7.8
6.8
6.9
16.6
1.2
5.7
3.6
6.2
17.1
4.4
-7.9
12.3
-8.7
11.6
1.0
-5.8
7.3
-5.5
13.5
-4.3
-6.9
9.8
-7.2
12.5
-1.7
2000
2001
2002
2003
2004
5.9
9.9
9.1
10.7
8.7
27.1
18.8
8.4
6.8
1.9
28.5
39.3
17.7
12.0
19.0
-----------
8.6
11.4
9.1
10.2
7.9
-----------
-----------
12.8
9.1
13.8
5.9
8.2
11.2
10.0
12.0
7.5
8.1
-0.3
9.5
6.6
6.2
4.8
-2.7
4.8
6.4
3.8
3.1
-1.5
7.2
6.5
5.1
4.0
2005
2006
2007
2008
2009 f
2010 f
9.7
24.3
9.1
6.5
6.5
5.8
3.9
26.6
-12.3
-7.2
-1.2
1.2
12.2
41.2
17.8
21.2
21.3
4.8
-------------
9.0
24.9
6.5
5.4
6.1
5.4
-------------
-------------
11.1
10.0
7.0
-0.2
3.5
1.6
10.3
15.6
6.8
2.1
4.6
3.2
-0.5
2.8
8.9
0.3
5.8
3.1
-1.9
3.1
5.1
-0.5
1.5
4.9
-1.1
2.9
7.2
-0.1
3.9
3.9
1985
1986
1987
1988
1989
--13.4
11.9
11.0
8.3
--0.5
3.1
27.6
16.4
--13.0
-1.0
43.6
-13.1
-----------
--12.7
11.5
11.8
8.6
-----------
-----------
--50.5
8.3
5.4
5.0
--29.6
9.9
8.5
6.8
-----------
-----------
--9.9
10.7
-6.5
-6.9
1990
1991
1992
1993
1994
-2.7
-3.3
5.4
-2.5
-7.4
16.3
9.0
3.6
13.4
5.2
2.7
37.9
0.9
18.2
4.6
-----------
-1.8
-2.4
5.3
-1.4
-6.4
-----------
-----------
12.5
7.2
9.7
10.1
2.5
5.2
2.6
7.7
5.0
-1.3
------3.2
-0.4
------6.2
1.5
-1.6
-1.7
13.6
4.6
0.5
1995
1996
1997
1998
1999
-1.6
-2.7
3.1
15.0
9.2
19.1
-7.0
15.1
48.0
0.5
13.3
3.1
-2.1
16.7
24.9
-----------
0.1
-3.1
4.2
18.4
8.2
-----------
-----------
5.4
5.1
5.9
17.0
-0.6
3.3
2.0
5.3
17.5
2.6
-10.2
10.6
-9.7
12.1
-0.8
-8.2
5.6
-6.5
13.9
-6.2
-9.2
8.2
-8.1
13.0
-3.5
2000
2001
2002
2003
2004
1.8
8.6
8.1
7.8
6.1
23.0
17.4
7.3
3.9
-0.7
24.4
37.9
16.7
9.1
16.4
-----------
4.5
10.1
8.1
7.3
5.3
-----------
-----------
8.7
7.7
12.7
3.0
5.6
7.1
8.6
11.0
4.6
5.5
-4.4
8.1
5.6
3.3
2.2
-6.8
3.4
5.3
0.9
0.5
-5.6
5.9
5.5
2.2
1.4
2005
2006
2007
2008
2009 f
2010 f
6.7
21.6
5.5
1.8
8.6
2.4
0.9
23.9
-15.9
-11.9
0.9
-2.2
9.2
38.5
14.2
16.5
23.4
1.4
-------------
6.0
22.2
2.9
0.6
8.2
2.0
-------------
-------------
8.1
7.3
3.4
-4.9
5.6
-1.8
7.3
12.9
3.2
-2.7
6.7
-0.2
-3.5
0.1
5.3
-4.4
7.9
-0.3
-4.9
0.4
1.6
-5.3
3.6
1.5
-4.1
0.2
3.6
-4.8
6.0
0.5
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
72
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.S.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Year
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
(1997 = 100)
1985
1986
1987
1988
1989
54.21
62.63
72.82
84.68
95.83
112.74
144.82
165.57
171.26
177.23
166.95
207.46
238.39
255.94
273.06
1,070.18
1,150.53
1,304.53
1,298.16
1,417.87
322.36
397.71
442.14
468.32
520.32
1,392.54
1,548.24
1,746.68
1,766.48
1,938.19
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
97.05
97.37
103.75
103.82
98.27
192.66
204.11
229.88
250.84
257.70
289.71
301.48
333.62
354.66
355.97
1,513.31
1,585.86
1,606.22
1,564.33
1,524.47
539.08
566.94
603.05
627.19
658.31
2,052.39
2,152.81
2,209.26
2,191.52
2,182.78
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
100.69
99.28
104.39
123.11
135.49
261.74
282.61
286.40
329.67
330.30
362.43
381.89
390.79
452.78
465.79
1,551.41
1,544.13
1,790.15
1,917.40
2,034.29
669.35
698.71
744.81
812.66
819.86
2,220.76
2,242.84
2,534.96
2,730.06
2,854.15
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
147.13
163.96
178.95
197.11
212.59
356.30
386.53
430.93
455.28
486.90
503.43
550.50
609.88
652.40
699.49
2,107.72
2,233.74
2,422.95
2,652.46
2,758.77
916.57
988.65
1,107.86
1,181.34
1,205.78
3,024.29
3,222.38
3,530.81
3,833.80
3,964.55
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
231.64
289.27
308.10
324.63
344.44
362.95
523.80
566.37
606.14
605.20
626.98
640.51
755.44
855.64
914.23
929.83
971.42
1,003.45
3,016.49
3,381.48
3,633.01
3,825.23
4,015.81
4,274.81
1,284.70
1,416.33
1,505.39
1,589.16
1,720.03
1,810.00
4,301.19
4,797.81
5,138.40
5,414.39
5,735.84
6,084.82
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--15.5
16.3
16.3
13.2
--28.5
14.3
3.4
3.5
--24.3
14.9
7.4
6.7
--7.5
13.4
-0.5
9.2
--23.4
11.2
5.9
11.1
--11.2
12.8
1.1
9.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
1.3
0.3
6.5
0.1
-5.3
8.7
5.9
12.6
9.1
2.7
6.1
4.1
10.7
6.3
0.4
6.7
4.8
1.3
-2.6
-2.5
3.6
5.2
6.4
4.0
5.0
5.9
4.9
2.6
-0.8
-0.4
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
2.5
-1.4
5.2
17.9
10.1
1.6
8.0
1.3
15.1
0.2
1.8
5.4
2.3
15.9
2.9
1.8
-0.5
15.9
7.1
6.1
1.7
4.4
6.6
9.1
0.9
1.7
1.0
13.0
7.7
4.5
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
8.6
11.4
9.1
10.2
7.9
7.9
8.5
11.5
5.7
6.9
8.1
9.3
10.8
7.0
7.2
3.6
6.0
8.5
9.5
4.0
11.8
7.9
12.1
6.6
2.1
6.0
6.5
9.6
8.6
3.4
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
9.0
24.9
6.5
5.4
6.1
5.4
7.6
8.1
7.0
-0.2
3.6
2.2
8.0
13.3
6.8
1.7
4.5
3.3
9.3
12.1
7.4
5.3
5.0
6.4
6.5
10.2
6.3
5.6
8.2
5.2
8.5
11.5
7.1
5.4
5.9
6.1
3.0
2.7
3.6
4.7
-2.1
3.4
N.S.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--12.7
11.5
11.8
8.6
--25.7
9.6
-1.1
-1.1
--21.5
10.2
2.8
2.1
--4.7
8.6
-5.0
4.7
--20.6
6.4
1.4
6.5
--8.4
8.1
-3.4
5.2
1990
1991
1992
1993
1994
-1.8
-2.4
5.3
-1.4
-6.4
5.7
3.2
11.4
7.7
1.6
3.1
1.3
9.4
4.9
-0.7
3.7
2.0
0.0
-4.0
-3.6
0.6
2.4
5.1
2.6
3.9
2.9
2.1
1.4
-2.2
-1.5
1995
1996
1997
1998
1999
0.1
-3.1
4.2
18.4
8.2
-0.8
6.3
0.3
15.5
-1.6
-0.5
3.7
1.3
16.3
1.1
-0.6
-2.1
14.9
7.5
4.3
-0.7
2.7
5.6
9.5
-0.9
-0.6
-0.7
12.0
8.1
2.7
2000
2001
2002
2003
2004
4.5
10.1
8.1
7.3
5.3
3.8
7.1
10.4
2.8
4.4
4.0
8.0
9.7
4.1
4.6
-0.5
4.6
7.4
6.6
1.4
7.7
6.5
11.0
3.7
-0.5
1.9
5.2
8.5
5.7
0.8
2005
2006
2007
2008
2009 f
2010 f
6.0
22.2
2.9
0.6
8.2
2.0
4.6
5.4
3.4
-4.9
5.7
-1.3
5.0
10.6
3.3
-3.0
6.6
-0.1
6.3
9.4
3.8
0.6
7.1
3.0
3.5
7.5
2.7
0.8
10.3
1.8
5.5
8.8
3.5
0.6
8.1
2.7
f: forecast.
Canadian Institute for Health Information, 2010.
73
Drug Expenditure in Canada, 1985 to 2010
Table B N.B.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2010
Provincial
Federal
Year
N.B.
Prescribed Drugs
Public
Private
Social Security Funds
Insurers*
Out-ofSubtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
33.9
39.6
46.2
48.5
52.7
1.7
1.8
1.9
2.7
3.1
0.1
0.2
0.2
0.2
0.3
-----------
35.7
41.5
48.4
51.4
56.0
-----------
-----------
38.8
45.6
56.1
61.4
67.1
74.4
87.1
104.5
112.7
123.1
-----------
-----------
48.4
54.8
63.6
61.6
59.6
1990
1991
1992
1993
1994
58.3
62.4
60.0
56.8
56.0
3.7
4.1
4.2
5.2
5.7
0.4
0.4
0.5
0.6
0.6
-----------
62.4
67.0
64.8
62.5
62.3
-----------
-----------
80.3
88.8
102.2
111.3
118.4
142.7
155.8
167.0
173.8
180.7
----35.6
37.0
37.3
----32.3
34.5
35.5
61.0
66.1
67.9
71.5
72.8
1995
1996
1997
1998
1999
58.3
54.8
56.1
62.1
69.0
6.4
6.4
7.1
8.6
10.8
0.6
0.7
0.7
0.9
1.1
-----------
65.4
61.9
64.0
71.6
80.8
-----------
-----------
127.8
126.7
143.9
149.7
167.0
193.1
188.6
207.9
221.3
247.8
34.4
32.9
44.2
42.5
47.6
33.5
30.6
42.6
41.6
44.1
67.9
63.6
86.7
84.2
91.7
2000
2001
2002
2003
2004
78.4
90.1
101.3
112.3
124.4
14.2
17.2
18.8
21.0
21.6
1.4
1.7
2.1
2.6
3.3
-----------
94.0
109.0
122.2
135.9
149.3
-----------
-----------
187.7
218.9
241.9
271.4
276.1
281.6
327.9
364.1
407.2
425.4
47.6
46.5
49.7
50.6
52.2
43.1
40.3
43.0
42.8
43.5
90.7
86.9
92.6
93.4
95.7
2005
2006
2007
2008
2009 f
2010 f
135.8
146.4
152.7
160.9
171.9
178.9
22.3
22.7
23.3
24.2
25.0
25.5
3.7
4.0
4.0
4.2
4.4
4.5
-------------
161.9
173.0
180.0
189.4
201.2
208.8
-------------
-------------
327.0
343.7
349.6
378.3
398.3
417.7
488.9
516.7
529.6
567.8
599.5
626.6
50.1
52.7
56.8
57.8
61.3
65.9
41.1
43.4
45.2
45.6
46.4
51.6
91.2
96.0
102.1
103.4
107.8
117.6
1985
1986
1987
1988
1989
--16.9
16.8
5.0
8.6
--7.6
9.3
36.1
17.3
--14.5
15.9
18.5
15.6
-----------
--16.4
16.4
6.3
9.1
-----------
-----------
--17.6
23.0
9.3
9.3
--17.1
19.9
7.9
9.2
-----------
-----------
--13.2
16.0
-3.1
-3.1
1990
1991
1992
1993
1994
10.7
7.0
-3.9
-5.4
-1.4
18.6
12.5
2.0
22.5
10.6
56.5
11.2
24.7
3.7
5.4
-----------
11.4
7.4
-3.4
-3.5
-0.4
-----------
-----------
19.7
10.6
15.1
8.9
6.4
15.9
9.2
7.1
4.1
4.0
------3.9
0.9
------6.8
2.9
2.2
8.3
2.8
5.3
1.8
1995
1996
1997
1998
1999
4.2
-6.0
2.5
10.7
11.0
11.6
0.1
11.0
21.1
25.2
8.4
13.1
0.1
19.3
23.4
-----------
4.9
-5.2
3.3
12.0
12.9
-----------
-----------
7.9
-0.8
13.6
4.0
11.6
6.9
-2.3
10.2
6.4
12.0
-7.8
-4.2
34.1
-3.7
11.8
-5.7
-8.5
38.9
-2.1
6.0
-6.8
-6.3
36.4
-3.0
8.9
2000
2001
2002
2003
2004
13.6
14.9
12.5
10.8
10.8
31.9
20.8
9.3
11.7
3.1
28.3
25.8
19.0
25.8
25.2
-----------
16.2
16.0
12.1
11.2
9.9
-----------
-----------
12.4
16.6
10.5
12.2
1.8
13.6
16.4
11.0
11.8
4.5
0.1
-2.3
6.7
1.9
3.2
-2.3
-6.5
6.5
-0.3
1.6
-1.0
-4.2
6.6
0.9
2.4
2005
2006
2007
2008
2009 f
2010 f
9.2
7.8
4.3
5.4
6.8
4.1
3.3
1.7
2.4
4.2
3.1
1.9
13.9
6.6
1.5
5.7
2.7
2.9
-------------
8.4
6.9
4.0
5.3
6.2
3.8
-------------
-------------
18.4
5.1
1.7
8.2
5.3
4.9
14.9
5.7
2.5
7.2
5.6
4.5
-4.1
5.1
8.0
1.7
6.1
7.5
-5.4
5.5
4.3
0.8
1.8
11.2
-4.7
5.3
6.3
1.3
4.2
9.1
1985
1986
1987
1988
1989
27.6
27.9
27.5
27.8
28.8
1.3
1.3
1.2
1.5
1.7
0.1
0.1
0.1
0.1
0.1
-----------
29.0
29.2
28.8
29.5
30.7
-----------
-----------
31.6
32.1
33.4
35.2
36.7
60.6
61.4
62.2
64.7
67.4
-----------
-----------
39.4
38.6
37.8
35.3
32.6
1990
1991
1992
1993
1994
28.6
28.1
25.5
23.1
22.1
1.8
1.9
1.8
2.1
2.3
0.2
0.2
0.2
0.2
0.2
-----------
30.6
30.2
27.6
25.5
24.6
-----------
-----------
39.4
40.0
43.5
45.4
46.7
70.1
70.2
71.1
70.9
71.3
----15.2
15.1
14.7
----13.8
14.1
14.0
29.9
29.8
28.9
29.1
28.7
1995
1996
1997
1998
1999
22.3
21.7
19.1
20.3
20.3
2.5
2.5
2.4
2.8
3.2
0.2
0.3
0.2
0.3
0.3
-----------
25.0
24.6
21.7
23.4
23.8
-----------
-----------
49.0
50.2
48.9
49.0
49.2
74.0
74.8
70.6
72.4
73.0
13.2
13.1
15.0
13.9
14.0
12.8
12.1
14.4
13.6
13.0
26.0
25.2
29.4
27.6
27.0
2000
2001
2002
2003
2004
21.0
21.7
22.2
22.4
23.9
3.8
4.1
4.1
4.2
4.1
0.4
0.4
0.5
0.5
0.6
-----------
25.2
26.3
26.7
27.1
28.6
-----------
-----------
50.4
52.8
53.0
54.2
53.0
75.6
79.1
79.7
81.3
81.6
12.8
11.2
10.9
10.1
10.0
11.6
9.7
9.4
8.6
8.3
24.4
20.9
20.3
18.7
18.4
2005
23.4
3.9
0.6
--2006
23.9
3.7
0.6
--2007
24.2
3.7
0.6
--2008
24.0
3.6
0.6
--2009 f
24.3
3.5
0.6
--2010 f
24.0
3.4
0.6
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
27.9
28.2
28.5
28.2
28.4
28.1
-------------
-------------
56.4
56.1
55.3
56.4
56.3
56.1
84.3
84.3
83.8
84.6
84.8
84.2
8.6
8.6
9.0
8.6
8.7
8.9
7.1
7.1
7.2
6.8
6.6
6.9
15.7
15.7
16.2
15.4
15.2
15.8
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
74
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.B.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
35.7
41.5
48.4
51.4
56.0
87.2
100.4
119.7
122.9
126.7
122.9
142.0
168.1
174.3
182.8
752.2
805.3
888.9
961.0
1,047.7
274.1
285.9
305.1
330.5
352.4
1,026.2
1,091.1
1,194.0
1,291.5
1,400.1
4.7
5.2
5.4
5.3
5.3
31.8
35.1
39.2
37.2
36.0
12.0
13.0
14.1
13.5
13.1
1990
1991
1992
1993
1994
62.4
67.0
64.8
62.5
62.3
141.2
154.9
170.1
182.8
191.2
203.7
221.9
234.9
245.3
253.5
1,136.1
1,186.9
1,233.1
1,236.1
1,272.2
397.4
442.4
466.7
503.0
520.8
1,533.5
1,629.3
1,699.8
1,739.1
1,793.0
5.5
5.6
5.3
5.1
4.9
35.5
35.0
36.4
36.3
36.7
13.3
13.6
13.8
14.1
14.1
1995
1996
1997
1998
1999
65.4
61.9
64.0
71.6
80.8
195.6
190.3
230.7
233.8
258.7
261.0
252.2
294.6
305.5
339.5
1,323.0
1,325.3
1,305.7
1,370.6
1,469.5
496.4
488.4
551.1
553.6
607.0
1,819.3
1,813.7
1,856.8
1,924.2
2,076.5
4.9
4.7
4.9
5.2
5.5
39.4
39.0
41.9
42.2
42.6
14.3
13.9
15.9
15.9
16.4
2000
2001
2002
2003
2004
94.0
109.0
122.2
135.9
149.3
278.4
305.8
334.6
364.8
371.8
372.3
414.7
456.7
500.7
521.1
1,580.0
1,740.0
1,829.1
1,947.6
2,115.2
638.6
727.8
786.5
840.9
864.5
2,218.6
2,467.8
2,615.6
2,788.5
2,979.8
5.9
6.3
6.7
7.0
7.1
43.6
42.0
42.5
43.4
43.0
16.8
16.8
17.5
18.0
17.5
2005
2006
2007
2008
2009 f
2010 f
161.9
173.0
180.0
189.4
201.2
208.8
418.2
439.7
451.7
481.7
506.1
535.3
580.0
612.7
631.6
671.1
707.3
744.2
2,310.9
2,528.1
2,649.2
2,818.7
2,926.9
3,061.9
984.2
1,054.7
1,075.5
1,143.8
1,256.8
1,323.4
3,295.1
3,582.8
3,724.7
3,962.6
4,183.7
4,385.3
7.0
6.8
6.8
6.7
6.9
6.8
42.5
41.7
42.0
42.1
40.3
40.4
17.6
17.1
17.0
16.9
16.9
17.0
1985
1986
1987
1988
1989
--16.4
16.4
6.3
9.1
--15.2
19.2
2.7
3.1
--15.6
18.4
3.7
4.8
--7.1
10.4
8.1
9.0
--4.3
6.7
8.3
6.6
--6.3
9.4
8.2
8.4
1990
1991
1992
1993
1994
11.4
7.4
-3.4
-3.5
-0.4
11.5
9.6
9.8
7.4
4.6
11.4
9.0
5.8
4.4
3.3
8.4
4.5
3.9
0.2
2.9
12.8
11.3
5.5
7.8
3.5
9.5
6.2
4.3
2.3
3.1
1995
1996
1997
1998
1999
4.9
-5.2
3.3
12.0
12.9
2.3
-2.7
21.2
1.4
10.6
3.0
-3.3
16.8
3.7
11.1
4.0
0.2
-1.5
5.0
7.2
-4.7
-1.6
12.8
0.5
9.6
1.5
-0.3
2.4
3.6
7.9
2000
2001
2002
2003
2004
16.2
16.0
12.1
11.2
9.9
7.6
9.8
9.4
9.0
1.9
9.7
11.4
10.1
9.6
4.1
7.5
10.1
5.1
6.5
8.6
5.2
14.0
8.1
6.9
2.8
6.8
11.2
6.0
6.6
6.9
2005
2006
2007
2008
2009 f
2010 f
8.4
6.9
4.0
5.3
6.2
3.8
12.5
5.1
2.7
6.6
5.1
5.8
11.3
5.6
3.1
6.3
5.4
5.2
9.3
9.4
4.8
6.4
3.8
4.6
13.8
7.2
2.0
6.4
9.9
5.3
10.6
8.7
4.0
6.4
5.6
4.8
N.B.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
29.0
29.2
28.8
29.5
30.7
71.0
70.8
71.2
70.5
69.3
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
30.6
30.2
27.6
25.5
24.6
69.4
69.8
72.4
74.5
75.4
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
25.0
24.6
21.7
23.4
23.8
75.0
75.4
78.3
76.6
76.2
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
25.2
26.3
26.7
27.1
28.6
74.8
73.7
73.3
72.9
71.4
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
27.9
28.2
28.5
28.2
28.4
28.1
72.1
71.8
71.5
71.8
71.6
71.9
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
75
Drug Expenditure in Canada, 1985 to 2010
Table B N.B.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2010
Provincial
Federal
Year
N.B.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
46.80
54.59
63.50
66.43
71.66
2.29
2.46
2.68
3.63
4.23
0.19
0.22
0.25
0.30
0.34
-----------
49.28
57.26
66.43
70.36
76.23
-----------
-----------
53.60
62.92
77.12
84.01
91.22
102.88
120.18
143.55
154.37
167.45
-----------
-----------
66.89
75.59
87.33
84.30
81.12
1990
1991
1992
1993
1994
78.82
83.75
80.19
75.83
74.59
4.99
5.57
5.66
6.92
7.64
0.53
0.59
0.73
0.75
0.79
-----------
84.34
89.90
86.57
83.50
83.03
-----------
-----------
108.44
119.11
136.60
148.60
157.80
192.78
209.01
223.17
232.11
240.84
----47.57
49.37
49.72
----43.20
46.09
47.33
82.40
88.62
90.77
95.47
97.05
1995
1996
1997
1998
1999
77.65
72.83
74.59
82.80
91.89
8.52
8.51
9.45
11.47
14.36
0.86
0.97
0.97
1.16
1.43
-----------
87.02
82.31
85.01
95.43
107.68
-----------
-----------
170.11
168.45
191.27
199.42
222.50
257.14
250.76
276.28
294.85
330.18
45.80
43.79
58.69
56.66
63.36
44.57
40.72
56.54
55.47
58.77
90.37
84.51
115.24
112.13
122.13
2000
2001
2002
2003
2004
104.41
120.09
135.05
149.49
165.45
18.94
22.90
25.01
27.91
28.74
1.84
2.31
2.75
3.46
4.33
-----------
125.19
145.31
162.81
180.86
198.52
-----------
-----------
250.06
291.92
322.44
361.25
367.17
375.25
437.23
485.25
542.11
565.69
63.43
62.06
66.19
67.38
69.43
57.44
53.78
57.25
56.99
57.81
120.87
115.84
123.44
124.37
127.25
2005
2006
2007
2008
2009 f
2010 f
180.77
196.29
204.80
215.40
229.31
238.44
29.73
30.47
31.20
32.45
33.34
33.94
4.93
5.30
5.38
5.67
5.81
5.97
-------------
215.43
232.05
241.38
253.53
268.45
278.35
-------------
-------------
435.23
460.87
468.90
506.37
531.46
556.74
650.66
692.93
710.28
759.89
799.91
835.09
66.65
70.61
76.24
77.35
81.83
87.89
54.72
58.18
60.68
61.02
61.96
68.83
121.37
128.79
136.92
138.37
143.79
156.72
1985
1986
1987
1988
1989
--16.6
16.3
4.6
7.9
--7.4
8.9
35.6
16.6
--14.3
15.5
18.1
14.8
-----------
--16.2
16.0
5.9
8.3
-----------
-----------
--17.4
22.6
8.9
8.6
--16.8
19.4
7.5
8.5
-----------
-----------
1990
1991
1992
1993
1994
10.0
6.3
-4.3
-5.4
-1.6
17.8
11.6
1.6
22.4
10.4
55.5
10.4
24.3
3.6
5.2
-----------
10.6
6.6
-3.7
-3.5
-0.6
-----------
-----------
18.9
9.8
14.7
8.8
6.2
15.1
8.4
6.8
4.0
3.8
------3.8
0.7
------6.7
2.7
1.6
7.6
2.4
5.2
1.7
1995
1996
1997
1998
1999
4.1
-6.2
2.4
11.0
11.0
11.5
-0.1
11.0
21.4
25.2
8.3
12.9
0.1
19.6
23.4
-----------
4.8
-5.4
3.3
12.3
12.8
-----------
-----------
7.8
-1.0
13.5
4.3
11.6
6.8
-2.5
10.2
6.7
12.0
-7.9
-4.4
34.0
-3.5
11.8
-5.8
-8.6
38.8
-1.9
5.9
-6.9
-6.5
36.4
-2.7
8.9
2000
2001
2002
2003
2004
13.6
15.0
12.5
10.7
10.7
31.9
20.9
9.2
11.6
3.0
28.3
25.9
18.9
25.7
25.0
-----------
16.3
16.1
12.0
11.1
9.8
-----------
-----------
12.4
16.7
10.5
12.0
1.6
13.6
16.5
11.0
11.7
4.4
0.1
-2.2
6.7
1.8
3.0
-2.3
-6.4
6.5
-0.5
1.5
-1.0
-4.2
6.6
0.8
2.3
2005
2006
2007
2008
2009 f
2010 f
9.3
8.6
4.3
5.2
6.5
4.0
3.4
2.5
2.4
4.0
2.7
1.8
14.0
7.4
1.5
5.5
2.3
2.7
-------------
8.5
7.7
4.0
5.0
5.9
3.7
-------------
-------------
18.5
5.9
1.7
8.0
5.0
4.8
15.0
6.5
2.5
7.0
5.3
4.4
-4.0
5.9
8.0
1.5
5.8
7.4
-5.4
6.3
4.3
0.6
1.5
11.1
-4.6
6.1
6.3
1.1
3.9
9.0
1985
1986
1987
1988
1989
--13.8
11.6
0.1
3.3
--4.6
4.2
31.1
12.0
--11.5
10.7
13.6
10.3
-----------
--13.4
11.3
1.4
3.8
-----------
-----------
--14.6
17.8
4.4
4.0
--14.0
14.7
3.0
3.9
-----------
-----------
--10.2
10.8
-8.0
-8.3
1990
1991
1992
1993
1994
7.0
3.5
-5.5
-6.9
-2.7
14.8
8.9
0.3
21.0
9.3
52.5
7.6
23.0
2.2
4.1
-----------
7.6
3.8
-5.0
-5.0
-1.7
-----------
-----------
15.8
7.1
13.4
7.3
5.1
12.1
5.7
5.5
2.6
2.7
------2.3
-0.4
------5.3
1.6
-1.5
4.8
1.2
3.7
0.6
1995
1996
1997
1998
1999
1.8
-7.9
1.4
11.4
9.2
9.1
-1.8
10.0
21.8
23.4
6.0
11.2
-0.9
20.1
21.5
-----------
2.5
-7.1
2.3
12.7
11.0
-----------
-----------
5.5
-2.7
12.6
4.7
9.8
4.4
-4.2
9.2
7.2
10.2
-10.2
-6.1
33.1
-3.0
10.0
-8.2
-10.3
37.9
-1.5
4.1
-9.2
-8.2
35.4
-2.3
7.1
2000
2001
2002
2003
2004
9.5
13.7
11.4
7.8
8.1
27.8
19.6
8.2
8.7
0.4
24.2
24.6
17.9
22.8
22.4
-----------
12.2
14.7
11.0
8.2
7.2
-----------
-----------
8.3
15.4
9.4
9.1
-0.9
9.5
15.2
9.9
8.8
1.8
-4.0
-3.5
5.6
-1.1
0.5
-6.4
-7.7
5.4
-3.4
-1.1
-5.1
-5.5
5.5
-2.1
-0.3
2005
2006
2007
2008
2009 f
2010 f
6.2
5.9
0.7
0.4
8.6
0.6
0.4
-0.2
-1.2
-0.7
4.8
-1.6
11.0
4.7
-2.1
0.7
4.4
-0.7
-------------
5.5
5.0
0.4
0.3
8.0
0.3
-------------
-------------
15.5
3.2
-1.9
3.2
7.1
1.3
12.0
3.8
-1.1
2.2
7.4
1.0
-7.0
3.2
4.4
-3.3
7.9
4.0
-8.4
3.6
0.7
-4.2
3.6
7.7
-7.6
3.4
2.7
-3.7
6.0
5.6
(Annual Percentage Change)
--13.0
15.5
-3.5
-3.8
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
76
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.B.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
Year
(1997 = 100)
1985
1986
1987
1988
1989
49.28
57.26
66.43
70.36
76.23
120.48
138.51
164.45
168.31
172.34
169.76
195.77
230.88
238.67
248.57
1,039.37
1,110.46
1,221.26
1,315.80
1,425.04
378.68
394.24
419.14
452.46
479.28
1,418.05
1,504.71
1,640.40
1,768.26
1,904.32
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
84.34
89.90
86.57
83.50
83.03
190.84
207.73
227.37
244.07
254.85
275.18
297.63
313.94
327.57
337.88
1,535.00
1,592.01
1,648.30
1,650.79
1,695.79
536.96
593.38
623.91
671.67
694.18
2,071.96
2,185.39
2,272.21
2,322.46
2,389.97
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
87.02
82.31
85.01
95.43
107.68
260.48
252.96
306.51
311.55
344.63
347.50
335.27
391.52
406.98
452.31
1,761.67
1,761.66
1,735.08
1,826.14
1,957.71
660.95
649.20
732.28
737.64
808.66
2,422.62
2,410.86
2,467.36
2,563.77
2,766.37
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
125.19
145.31
162.81
180.86
198.52
370.93
407.76
445.88
485.62
494.42
496.12
553.07
608.69
666.48
692.94
2,105.17
2,320.35
2,437.73
2,592.60
2,812.68
850.90
970.56
1,048.19
1,119.37
1,149.59
2,956.07
3,290.91
3,485.93
3,711.97
3,962.27
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
215.43
232.05
241.38
253.53
268.45
278.35
556.60
589.67
605.83
644.74
675.24
713.46
772.03
821.72
847.21
898.26
943.69
991.81
3,075.82
3,390.35
3,553.35
3,772.65
3,905.26
4,080.89
1,309.94
1,414.38
1,442.49
1,530.94
1,676.95
1,763.83
4,385.76
4,804.73
4,995.84
5,303.59
5,582.21
5,844.72
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--16.2
16.0
5.9
8.3
--15.0
18.7
2.4
2.4
--15.3
17.9
3.4
4.1
--6.8
10.0
7.7
8.3
--4.1
6.3
7.9
5.9
--6.1
9.0
7.8
7.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
10.6
6.6
-3.7
-3.5
-0.6
10.7
8.9
9.5
7.3
4.4
10.7
8.2
5.5
4.3
3.1
7.7
3.7
3.5
0.2
2.7
12.0
10.5
5.1
7.7
3.4
8.8
5.5
4.0
2.2
2.9
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
4.8
-5.4
3.3
12.3
12.8
2.2
-2.9
21.2
1.6
10.6
2.8
-3.5
16.8
3.9
11.1
3.9
0.0
-1.5
5.2
7.2
-4.8
-1.8
12.8
0.7
9.6
1.4
-0.5
2.3
3.9
7.9
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
16.3
16.1
12.0
11.1
9.8
7.6
9.9
9.3
8.9
1.8
9.7
11.5
10.1
9.5
4.0
7.5
10.2
5.1
6.4
8.5
5.2
14.1
8.0
6.8
2.7
6.9
11.3
5.9
6.5
6.7
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
8.5
7.7
4.0
5.0
5.9
3.7
12.6
5.9
2.7
6.4
4.7
5.7
11.4
6.4
3.1
6.0
5.1
5.1
9.4
10.2
4.8
6.2
3.5
4.5
13.9
8.0
2.0
6.1
9.5
5.2
10.7
9.6
4.0
6.2
5.3
4.7
3.0
2.7
3.6
4.7
-2.1
3.4
N.B.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--13.4
11.3
1.4
3.8
--12.2
14.0
-2.2
-2.2
--12.5
13.2
-1.1
-0.4
--4.0
5.2
3.2
3.7
--1.3
1.6
3.4
1.4
--3.3
4.3
3.3
3.1
1990
1991
1992
1993
1994
7.6
3.8
-5.0
-5.0
-1.7
7.7
6.1
8.2
5.9
3.3
7.7
5.4
4.2
2.9
2.0
4.7
1.0
2.3
-1.3
1.6
9.0
7.7
3.9
6.2
2.3
5.8
2.7
2.7
0.8
1.8
1995
1996
1997
1998
1999
2.5
-7.1
2.3
12.7
11.0
-0.1
-4.6
20.2
2.1
8.8
0.5
-5.2
15.8
4.4
9.3
1.5
-1.7
-2.5
5.7
5.4
-7.1
-3.4
11.8
1.2
7.8
-1.0
-2.2
1.4
4.3
6.1
2000
2001
2002
2003
2004
12.2
14.7
11.0
8.2
7.2
3.5
8.6
8.3
6.0
-0.8
5.6
10.1
9.0
6.6
1.4
3.4
8.9
4.0
3.5
5.9
1.1
12.7
7.0
3.9
0.1
2.8
10.0
4.9
3.6
4.2
2005
2006
2007
2008
2009 f
2010 f
5.5
5.0
0.4
0.3
8.0
0.3
9.6
3.2
-0.9
1.7
6.8
2.2
8.4
3.7
-0.5
1.3
7.2
1.7
6.3
7.5
1.2
1.4
5.6
1.1
10.9
5.3
-1.6
1.4
11.7
1.8
7.7
6.8
0.4
1.4
7.4
1.3
f: forecast.
Canadian Institute for Health Information, 2010.
77
Drug Expenditure in Canada, 1985 to 2010
Table B Que.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Quebec, 1985 to 2010
Provincial
Federal
Year
Que.
Prescribed Drugs
Public
Private
Social Security Funds
Insurers*
Out-ofSubtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
250.4
291.2
333.8
384.1
437.1
7.4
8.1
8.8
10.7
12.8
2.1
2.7
3.2
3.2
3.5
-----------
260.0
301.9
345.8
398.0
453.4
-----------
-----------
342.6
463.0
466.6
523.3
582.4
602.6
764.9
812.4
921.4
1,035.8
-----------
-----------
230.5
261.0
302.7
366.9
444.8
1990
1991
1992
1993
1994
502.9
604.0
650.5
686.1
742.1
15.3
16.7
18.1
21.1
23.0
4.2
4.9
5.1
5.0
5.6
-----------
522.4
625.6
673.7
712.3
770.7
-----------
-----------
638.9
709.4
770.9
882.3
898.5
1,161.2
1,335.0
1,444.6
1,594.6
1,669.2
----306.5
312.4
326.8
----264.2
280.8
306.6
468.3
534.5
570.7
593.1
633.4
1995
1996
1997
1998
1999
807.0
734.5
700.6
779.8
918.6
24.1
24.0
26.0
29.5
34.4
6.3
6.9
7.4
8.1
9.3
----169.1
213.4
262.7
837.4
765.4
903.1
1,030.8
1,225.0
-----------
-----------
1,005.9
1,079.9
1,227.2
1,228.4
1,433.5
1,843.3
1,845.2
2,130.2
2,259.2
2,658.5
334.4
322.1
293.5
312.2
334.1
314.5
314.6
294.6
316.7
332.4
649.0
636.7
588.1
628.9
666.6
2000
2001
2002
2003
2004
1,118.4
1,309.4
1,439.5
1,538.9
1,678.1
35.0
38.4
44.7
50.7
53.5
11.1
13.5
15.4
18.0
21.1
327.9
367.4
433.2
577.8
615.5
1,492.5
1,728.6
1,932.8
2,185.4
2,368.2
-----------
-----------
1,612.8
1,752.2
1,968.7
2,130.9
2,357.0
3,105.3
3,480.8
3,901.6
4,316.3
4,725.2
321.2
337.0
347.1
350.7
371.7
324.3
331.7
340.6
340.4
352.4
645.4
668.7
687.6
691.0
724.1
2005
2006
2007
2008
2009 f
2010 f
1,798.7
1,955.6
2,164.9
2,348.5
2,517.6
2,724.3
57.2
62.2
66.2
70.6
71.5
74.6
23.0
26.4
29.6
32.8
36.1
39.6
618.7
669.0
676.4
762.8
746.2
761.8
2,497.8
2,713.1
2,936.9
3,214.7
3,371.3
3,600.3
-------------
-------------
2,492.4
2,706.9
2,894.0
3,017.1
3,185.7
3,367.1
4,990.1
5,420.0
5,830.9
6,231.7
6,557.1
6,967.4
426.3
439.4
464.2
491.7
538.5
574.5
385.1
399.1
402.4
421.8
440.9
482.2
811.4
838.5
866.6
913.5
979.4
1,056.7
1985
1986
1987
1988
1989
--16.3
14.6
15.1
13.8
--8.4
9.1
21.6
20.0
--27.3
19.2
1.0
7.2
-----------
--16.1
14.5
15.1
13.9
-----------
-----------
--35.1
0.8
12.2
11.3
--26.9
6.2
13.4
12.4
-----------
-----------
--13.2
16.0
21.2
21.2
1990
1991
1992
1993
1994
15.0
20.1
7.7
5.5
8.2
19.2
9.4
8.2
16.7
8.7
20.8
16.6
3.3
-0.1
11.7
-----------
15.2
19.8
7.7
5.7
8.2
-----------
-----------
9.7
11.0
8.7
14.4
1.8
12.1
15.0
8.2
10.4
4.7
------1.9
4.6
------6.3
9.2
5.3
14.1
6.8
3.9
6.8
1995
1996
1997
1998
1999
8.7
-9.0
-4.6
11.3
17.8
5.0
-0.7
8.5
13.4
16.6
12.1
9.7
6.2
10.0
15.1
------26.2
23.1
8.7
-8.6
18.0
14.1
18.8
-----------
-----------
11.9
7.4
13.6
0.1
16.7
10.4
0.1
15.4
6.1
17.7
2.3
-3.7
-8.9
6.4
7.0
2.6
0.0
-6.4
7.5
5.0
2.5
-1.9
-7.6
6.9
6.0
2000
2001
2002
2003
2004
21.8
17.1
9.9
6.9
9.0
1.9
9.6
16.6
13.4
5.5
19.7
20.8
14.3
17.1
17.3
24.8
12.1
17.9
33.4
6.5
21.8
15.8
11.8
13.1
8.4
-----------
-----------
12.5
8.6
12.4
8.2
10.6
16.8
12.1
12.1
10.6
9.5
-3.9
4.9
3.0
1.0
6.0
-2.5
2.3
2.7
-0.1
3.5
-3.2
3.6
2.8
0.5
4.8
2005
2006
2007
2008
2009 f
2010 f
7.2
8.7
10.7
8.5
7.2
8.2
6.9
8.6
6.4
6.7
1.3
4.3
9.0
14.7
11.9
10.8
10.1
9.9
0.5
8.1
1.1
12.8
-2.2
2.1
5.5
8.6
8.2
9.5
4.9
6.8
-------------
-------------
5.7
8.6
6.9
4.3
5.6
5.7
5.6
8.6
7.6
6.9
5.2
6.3
14.7
3.1
5.6
5.9
9.5
6.7
9.3
3.6
0.8
4.8
4.5
9.4
12.1
3.3
3.3
5.4
7.2
7.9
1985
1986
1987
1988
1989
30.1
28.4
29.9
29.8
29.5
0.9
0.8
0.8
0.8
0.9
0.3
0.3
0.3
0.3
0.2
-----------
31.2
29.4
31.0
30.9
30.6
-----------
-----------
41.1
45.1
41.8
40.6
39.3
72.3
74.6
72.9
71.5
70.0
-----------
-----------
27.7
25.4
27.1
28.5
30.0
1990
1991
1992
1993
1994
30.9
32.3
32.3
31.4
32.2
0.9
0.9
0.9
1.0
1.0
0.3
0.3
0.3
0.2
0.2
-----------
32.1
33.5
33.4
32.6
33.5
-----------
-----------
39.2
37.9
38.3
40.3
39.0
71.3
71.4
71.7
72.9
72.5
----15.2
14.3
14.2
----13.1
12.8
13.3
28.7
28.6
28.3
27.1
27.5
1995
1996
1997
1998
1999
32.4
29.6
25.8
27.0
27.6
1.0
1.0
1.0
1.0
1.0
0.3
0.3
0.3
0.3
0.3
----6.2
7.4
7.9
33.6
30.8
33.2
35.7
36.8
-----------
-----------
40.4
43.5
45.1
42.5
43.1
74.0
74.3
78.4
78.2
80.0
13.4
13.0
10.8
10.8
10.0
12.6
12.7
10.8
11.0
10.0
26.0
25.7
21.6
21.8
20.0
2000
2001
2002
2003
2004
29.8
31.6
31.4
30.7
30.8
0.9
0.9
1.0
1.0
1.0
0.3
0.3
0.3
0.4
0.4
8.7
8.9
9.4
11.5
11.3
39.8
41.7
42.1
43.6
43.5
-----------
-----------
43.0
42.2
42.9
42.6
43.3
82.8
83.9
85.0
86.2
86.7
8.6
8.1
7.6
7.0
6.8
8.6
8.0
7.4
6.8
6.5
17.2
16.1
15.0
13.8
13.3
2005
31.0
1.0
0.4
10.7
2006
31.2
1.0
0.4
10.7
2007
32.3
1.0
0.4
10.1
2008
32.9
1.0
0.5
10.7
2009 f
33.4
0.9
0.5
9.9
2010 f
34.0
0.9
0.5
9.5
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
43.1
43.4
43.9
45.0
44.7
44.9
-------------
-------------
43.0
43.3
43.2
42.2
42.3
42.0
86.0
86.6
87.1
87.2
87.0
86.8
7.3
7.0
6.9
6.9
7.1
7.2
6.6
6.4
6.0
5.9
5.8
6.0
14.0
13.4
12.9
12.8
13.0
13.2
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
78
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Que.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Quebec, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
260.0
301.9
345.8
398.0
453.4
573.1
724.0
769.3
890.3
1,027.2
833.0
1,025.9
1,115.1
1,288.3
1,480.7
7,927.6
8,051.3
8,636.4
9,428.4
10,108.6
2,104.4
2,486.1
2,632.2
2,850.8
3,181.7
10,031.9
10,537.4
11,268.6
12,279.2
13,290.3
3.3
3.7
4.0
4.2
4.5
27.2
29.1
29.2
31.2
32.3
8.3
9.7
9.9
10.5
11.1
1990
1991
1992
1993
1994
522.4
625.6
673.7
712.3
770.7
1,107.1
1,243.8
1,341.6
1,475.4
1,532.0
1,629.5
1,869.5
2,015.3
2,187.7
2,302.6
10,814.1
11,815.3
12,234.5
12,459.6
12,674.4
3,497.4
3,819.3
4,141.5
4,444.6
4,653.5
14,311.5
15,634.6
16,376.1
16,904.2
17,327.9
4.8
5.3
5.5
5.7
6.1
31.7
32.6
32.4
33.2
32.9
11.4
12.0
12.3
12.9
13.3
1995
1996
1997
1998
1999
837.4
765.4
903.1
1,030.8
1,225.0
1,654.9
1,716.6
1,815.2
1,857.3
2,100.1
2,492.3
2,481.9
2,718.3
2,888.0
3,325.1
12,708.9
12,254.7
13,038.3
14,128.3
14,462.3
4,663.6
4,727.9
4,976.0
5,000.5
5,551.0
17,372.5
16,982.6
18,014.3
19,128.8
20,013.3
6.6
6.2
6.9
7.3
8.5
35.5
36.3
36.5
37.1
37.8
14.3
14.6
15.1
15.1
16.6
2000
2001
2002
2003
2004
1,492.5
1,728.6
1,932.8
2,185.4
2,368.2
2,258.3
2,420.9
2,656.4
2,822.0
3,081.0
3,750.7
4,149.5
4,589.2
5,007.4
5,449.3
15,705.7
16,992.0
17,869.0
18,917.5
20,136.6
5,905.4
6,561.5
7,079.2
7,606.9
7,833.0
21,611.1
23,553.5
24,948.2
26,524.4
27,969.6
9.5
10.2
10.8
11.6
11.8
38.2
36.9
37.5
37.1
39.3
17.4
17.6
18.4
18.9
19.5
2005
2006
2007
2008
2009 f
2010 f
2,497.8
2,713.1
2,936.9
3,214.7
3,371.3
3,600.3
3,303.8
3,545.4
3,760.6
3,930.6
4,165.1
4,423.8
5,801.5
6,258.6
6,697.5
7,145.2
7,536.4
8,024.1
21,214.5
22,519.7
23,874.1
25,467.3
27,300.4
28,730.3
8,513.5
9,051.4
9,506.9
10,220.1
10,912.3
11,486.7
29,728.0
31,571.1
33,381.0
35,687.4
38,212.7
40,217.0
11.8
12.0
12.3
12.6
12.3
12.5
38.8
39.2
39.6
38.5
38.2
38.5
19.5
19.8
20.1
20.0
19.7
20.0
1985
1986
1987
1988
1989
--16.1
14.5
15.1
13.9
--26.3
6.3
15.7
15.4
--23.2
8.7
15.5
14.9
--1.6
7.3
9.2
7.2
--18.1
5.9
8.3
11.6
--5.0
6.9
9.0
8.2
1990
1991
1992
1993
1994
15.2
19.8
7.7
5.7
8.2
7.8
12.3
7.9
10.0
3.8
10.0
14.7
7.8
8.6
5.3
7.0
9.3
3.5
1.8
1.7
9.9
9.2
8.4
7.3
4.7
7.7
9.2
4.7
3.2
2.5
1995
1996
1997
1998
1999
8.7
-8.6
18.0
14.1
18.8
8.0
3.7
5.7
2.3
13.1
8.2
-0.4
9.5
6.2
15.1
0.3
-3.6
6.4
8.4
2.4
0.2
1.4
5.2
0.5
11.0
0.3
-2.2
6.1
6.2
4.6
2000
2001
2002
2003
2004
21.8
15.8
11.8
13.1
8.4
7.5
7.2
9.7
6.2
9.2
12.8
10.6
10.6
9.1
8.8
8.6
8.2
5.2
5.9
6.4
6.4
11.1
7.9
7.5
3.0
8.0
9.0
5.9
6.3
5.4
2005
2006
2007
2008
2009 f
2010 f
5.5
8.6
8.2
9.5
4.9
6.8
7.2
7.3
6.1
4.5
6.0
6.2
6.5
7.9
7.0
6.7
5.5
6.5
5.4
6.2
6.0
6.7
7.2
5.2
8.7
6.3
5.0
7.5
6.8
5.3
6.3
6.2
5.7
6.9
7.1
5.2
Que.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
31.2
29.4
31.0
30.9
30.6
68.8
70.6
69.0
69.1
69.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.1
33.5
33.4
32.6
33.5
67.9
66.5
66.6
67.4
66.5
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
33.6
30.8
33.2
35.7
36.8
66.4
69.2
66.8
64.3
63.2
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
39.8
41.7
42.1
43.6
43.5
60.2
58.3
57.9
56.4
56.5
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
43.1
43.4
43.9
45.0
44.7
44.9
56.9
56.6
56.1
55.0
55.3
55.1
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
79
Drug Expenditure in Canada, 1985 to 2010
Table B Que.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Quebec, 1985 to 2010
Provincial
Federal
Year
Que.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
37.57
43.40
49.21
56.16
63.09
1.12
1.20
1.30
1.56
1.85
0.32
0.40
0.47
0.47
0.50
-----------
39.00
45.00
50.98
58.20
65.44
-----------
-----------
51.40
69.01
68.80
76.52
84.06
90.40
114.02
119.78
134.72
149.50
-----------
-----------
34.58
38.91
44.62
53.65
64.20
1990
1991
1992
1993
1994
71.80
85.50
91.52
95.89
103.18
2.18
2.37
2.55
2.95
3.20
0.60
0.69
0.71
0.71
0.78
-----------
74.58
88.56
94.78
99.55
107.16
-----------
-----------
91.21
100.41
108.46
123.31
124.94
165.80
188.97
203.23
222.86
232.10
----43.12
43.65
45.44
----37.17
39.24
42.63
66.86
75.65
80.29
82.89
88.07
1995
1996
1997
1998
1999
111.78
101.35
96.31
106.88
125.43
3.34
3.31
3.57
4.04
4.69
0.88
0.96
1.01
1.11
1.27
----23.25
29.25
35.88
116.00
105.61
124.14
141.28
167.27
-----------
-----------
139.34
149.01
168.69
168.37
195.75
255.33
254.62
292.83
309.65
363.02
46.32
44.45
40.34
42.79
45.62
43.57
43.42
40.50
43.40
45.40
89.89
87.86
80.84
86.19
91.02
2000
2001
2002
2003
2004
152.02
177.02
193.33
205.33
222.29
4.76
5.19
6.01
6.77
7.09
1.51
1.82
2.07
2.40
2.80
44.57
49.67
58.19
77.10
81.53
202.86
233.69
259.59
291.60
313.71
-----------
-----------
219.22
236.88
264.41
284.32
312.23
422.09
470.57
524.00
575.92
625.94
43.66
45.56
46.61
46.79
49.24
44.07
44.84
45.74
45.41
46.68
87.73
90.40
92.35
92.20
95.91
2005
2006
2007
2008
2009 f
2010 f
236.74
256.25
281.62
302.90
321.58
345.21
7.53
8.15
8.61
9.10
9.13
9.45
3.03
3.46
3.84
4.22
4.61
5.02
81.43
87.66
87.99
98.38
95.31
96.53
328.74
355.52
382.06
414.61
430.63
456.21
-------------
-------------
328.03
354.70
376.47
389.13
406.92
426.67
656.77
710.22
758.53
803.74
837.55
882.88
56.11
57.58
60.39
63.42
68.78
72.80
50.68
52.30
52.34
54.40
56.31
61.11
106.79
109.87
112.73
117.82
125.10
133.90
1985
1986
1987
1988
1989
--15.5
13.4
14.1
12.3
--7.7
7.9
20.6
18.4
--26.4
17.9
0.1
5.8
-----------
--15.4
13.3
14.1
12.4
-----------
-----------
--34.3
-0.3
11.2
9.8
--26.1
5.1
12.5
11.0
-----------
-----------
--12.5
14.7
20.2
19.7
1990
1991
1992
1993
1994
13.8
19.1
7.0
4.8
7.6
17.9
8.4
7.6
15.9
8.2
19.5
15.6
2.6
-0.8
11.2
-----------
14.0
18.7
7.0
5.0
7.6
-----------
-----------
8.5
10.1
8.0
13.7
1.3
10.9
14.0
7.5
9.7
4.1
------1.2
4.1
------5.6
8.6
4.1
13.2
6.1
3.2
6.2
1995
1996
1997
1998
1999
8.3
-9.3
-5.0
11.0
17.4
4.6
-1.1
8.0
13.1
16.2
11.7
9.2
5.8
9.7
14.6
------25.8
22.6
8.2
-9.0
17.5
13.8
18.4
-----------
-----------
11.5
6.9
13.2
-0.2
16.3
10.0
-0.3
15.0
5.7
17.2
1.9
-4.1
-9.2
6.1
6.6
2.2
-0.3
-6.7
7.2
4.6
2.1
-2.3
-8.0
6.6
5.6
2000
2001
2002
2003
2004
21.2
16.4
9.2
6.2
8.3
1.4
9.0
15.8
12.7
4.7
19.1
20.1
13.5
16.4
16.4
24.2
11.4
17.1
32.5
5.8
21.3
15.2
11.1
12.3
7.6
-----------
-----------
12.0
8.1
11.6
7.5
9.8
16.3
11.5
11.4
9.9
8.7
-4.3
4.4
2.3
0.4
5.2
-2.9
1.7
2.0
-0.7
2.8
-3.6
3.0
2.2
-0.2
4.0
2005
2006
2007
2008
2009 f
2010 f
6.5
8.2
9.9
7.6
6.2
7.3
6.3
8.2
5.6
5.8
0.3
3.5
8.3
14.2
11.1
9.9
9.0
9.0
-0.1
7.6
0.4
11.8
-3.1
1.3
4.8
8.1
7.5
8.5
3.9
5.9
-------------
-------------
5.1
8.1
6.1
3.4
4.6
4.9
4.9
8.1
6.8
6.0
4.2
5.4
14.0
2.6
4.9
5.0
8.5
5.8
8.6
3.2
0.1
3.9
3.5
8.5
11.3
2.9
2.6
4.5
6.2
7.0
1985
1986
1987
1988
1989
--12.7
8.7
9.6
7.8
--4.9
3.2
16.0
13.9
--23.6
13.1
-4.4
1.2
-----------
--12.6
8.5
9.6
7.9
-----------
-----------
--31.5
-5.1
6.7
5.3
--23.3
0.3
8.0
6.4
-----------
-----------
--9.7
10.0
15.7
15.1
1990
1991
1992
1993
1994
10.8
16.3
5.8
3.3
6.5
14.9
5.7
6.3
14.5
7.1
16.4
12.9
1.4
-2.2
10.1
-----------
10.9
16.0
5.8
3.6
6.5
-----------
-----------
5.5
7.3
6.8
12.3
0.2
7.9
11.2
6.3
8.2
3.0
-------0.2
3.0
------4.1
7.5
1.1
10.4
4.9
1.8
5.2
1995
1996
1997
1998
1999
6.0
-11.0
-6.0
11.4
15.6
2.2
-2.7
7.0
13.5
14.4
9.3
7.6
4.8
10.1
12.8
------26.3
20.8
5.9
-10.6
16.6
14.2
16.6
-----------
-----------
9.2
5.3
12.2
0.2
14.5
7.7
-1.9
14.0
6.2
15.4
-0.4
-5.7
-10.2
6.5
4.8
-0.1
-2.0
-7.7
7.6
2.8
-0.3
-3.9
-9.0
7.1
3.8
2000
2001
2002
2003
2004
17.1
15.1
8.2
3.3
5.7
-2.7
7.6
14.8
9.8
2.1
15.0
18.8
12.5
13.5
13.8
20.1
10.1
16.1
29.6
3.2
17.2
13.8
10.0
9.4
5.0
-----------
-----------
7.9
6.7
10.6
4.6
7.2
12.2
10.1
10.3
7.0
6.1
-8.4
3.0
1.3
-2.5
2.6
-7.0
0.4
1.0
-3.6
0.2
-7.7
1.7
1.1
-3.1
1.4
2005
2006
2007
2008
2009 f
2010 f
3.5
5.5
6.3
2.8
8.3
3.9
3.2
5.4
2.0
1.0
2.4
0.1
5.3
11.5
7.5
5.1
11.1
5.6
-3.1
4.9
-3.2
7.1
-1.0
-2.1
1.8
5.4
3.9
3.8
6.0
2.5
-------------
-------------
2.1
5.4
2.5
-1.4
6.7
1.4
1.9
5.4
3.2
1.2
6.3
2.0
11.0
-0.1
1.3
0.3
10.6
2.4
5.6
0.5
-3.5
-0.8
5.6
5.1
8.3
0.2
-1.0
-0.2
8.3
3.6
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
80
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Que.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Quebec, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
Year
(1997 = 100)
1985
1986
1987
1988
1989
39.00
45.00
50.98
58.20
65.44
85.97
107.92
113.42
130.18
148.26
124.97
152.93
164.40
188.37
213.70
1,189.31
1,200.16
1,273.33
1,378.61
1,458.95
315.70
370.59
388.08
416.85
459.21
1,505.01
1,570.76
1,661.41
1,795.46
1,918.16
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
74.58
88.56
94.78
99.55
107.16
158.07
176.07
188.75
206.20
213.01
232.66
264.62
283.53
305.75
320.17
1,544.02
1,672.46
1,721.23
1,741.32
1,762.32
499.35
540.63
582.66
621.16
647.05
2,043.36
2,213.09
2,303.89
2,362.48
2,409.37
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
116.00
105.61
124.14
141.28
167.27
229.23
236.87
249.53
254.56
286.77
345.22
342.48
373.67
395.84
454.04
1,760.37
1,691.02
1,792.30
1,936.45
1,974.83
645.98
652.41
684.03
685.38
757.99
2,406.35
2,343.43
2,476.32
2,621.83
2,732.82
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
202.86
233.69
259.59
291.60
313.71
306.95
327.28
356.76
376.53
408.14
509.82
560.97
616.35
668.13
721.85
2,134.79
2,297.15
2,399.89
2,524.13
2,667.46
802.69
887.04
950.78
1,014.97
1,037.62
2,937.47
3,184.20
3,350.67
3,539.09
3,705.09
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
328.74
355.52
382.06
414.61
430.63
456.21
434.82
464.57
489.20
506.94
532.01
560.57
763.56
820.09
871.26
921.55
962.64
1,016.78
2,792.11
2,950.87
3,105.72
3,284.64
3,487.14
3,640.57
1,120.48
1,186.05
1,236.73
1,318.13
1,393.85
1,455.54
3,912.59
4,136.92
4,342.46
4,602.76
4,880.99
5,096.11
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--15.4
13.3
14.1
12.4
--25.5
5.1
14.8
13.9
--22.4
7.5
14.6
13.4
--0.9
6.1
8.3
5.8
--17.4
4.7
7.4
10.2
--4.4
5.8
8.1
6.8
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
14.0
18.7
7.0
5.0
7.6
6.6
11.4
7.2
9.2
3.3
8.9
13.7
7.1
7.8
4.7
5.8
8.3
2.9
1.2
1.2
8.7
8.3
7.8
6.6
4.2
6.5
8.3
4.1
2.5
2.0
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
8.2
-9.0
17.5
13.8
18.4
7.6
3.3
5.3
2.0
12.7
7.8
-0.8
9.1
5.9
14.7
-0.1
-3.9
6.0
8.0
2.0
-0.2
1.0
4.8
0.2
10.6
-0.1
-2.6
5.7
5.9
4.2
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
21.3
15.2
11.1
12.3
7.6
7.0
6.6
9.0
5.5
8.4
12.3
10.0
9.9
8.4
8.0
8.1
7.6
4.5
5.2
5.7
5.9
10.5
7.2
6.8
2.2
7.5
8.4
5.2
5.6
4.7
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
4.8
8.1
7.5
8.5
3.9
5.9
6.5
6.8
5.3
3.6
4.9
5.4
5.8
7.4
6.2
5.8
4.5
5.6
4.7
5.7
5.2
5.8
6.2
4.4
8.0
5.9
4.3
6.6
5.7
4.4
5.6
5.7
5.0
6.0
6.0
4.4
3.0
2.7
3.6
4.7
-2.1
3.4
Que.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--12.6
8.5
9.6
7.9
--22.7
0.4
10.3
9.3
--19.6
2.8
10.1
8.9
---1.9
1.4
3.7
1.3
--14.6
0.0
2.9
5.6
--1.6
1.0
3.5
2.3
1990
1991
1992
1993
1994
10.9
16.0
5.8
3.6
6.5
3.6
8.6
5.9
7.8
2.2
5.8
11.0
5.9
6.4
3.6
2.8
5.6
1.7
-0.3
0.1
5.7
5.5
6.5
5.2
3.1
3.5
5.5
2.8
1.1
0.9
1995
1996
1997
1998
1999
5.9
-10.6
16.6
14.2
16.6
5.3
1.7
4.4
2.5
10.8
5.5
-2.5
8.1
6.4
12.9
-2.4
-5.6
5.0
8.5
0.2
-2.5
-0.7
3.9
0.6
8.8
-2.5
-4.3
4.7
6.3
2.4
2000
2001
2002
2003
2004
17.2
13.8
10.0
9.4
5.0
2.9
5.3
8.0
2.6
5.8
8.2
8.7
8.8
5.5
5.5
4.0
6.3
3.4
2.3
3.1
1.8
9.2
6.1
3.9
-0.4
3.4
7.0
4.2
2.7
2.1
2005
2006
2007
2008
2009 f
2010 f
1.8
5.4
3.9
3.8
6.0
2.5
3.5
4.1
1.7
-1.1
7.1
2.0
2.8
4.7
2.6
1.0
6.6
2.2
1.7
3.0
1.7
1.0
8.3
1.0
5.0
3.1
0.7
1.8
7.9
1.0
2.6
3.0
1.4
1.3
8.2
1.0
f: forecast.
Canadian Institute for Health Information, 2010.
81
Drug Expenditure in Canada, 1985 to 2010
Table B Ont.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Ontario, 1985 to 2010
Provincial
Federal
Year
Ont.
Prescribed Drugs
Public
Private
Social Security Funds
Insurers*
Out-ofSubtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
399.4
481.2
574.4
663.8
749.5
13.8
14.5
15.4
24.5
30.7
7.2
8.8
10.1
12.0
13.5
-----------
420.5
504.5
599.9
700.4
793.8
-----------
-----------
579.4
706.8
748.2
845.3
951.9
999.9
1,211.2
1,348.1
1,545.6
1,745.7
-----------
-----------
487.9
552.4
640.6
711.0
789.2
1990
1991
1992
1993
1994
881.2
1,012.7
1,183.6
1,248.0
1,235.8
36.2
37.9
41.0
46.7
50.7
16.2
20.2
23.3
24.2
18.5
-----------
933.6
1,070.8
1,247.8
1,318.9
1,305.1
-----------
-----------
1,089.7
1,201.1
1,376.9
1,482.1
1,508.7
2,023.3
2,271.9
2,624.8
2,801.0
2,813.7
----521.5
558.9
616.3
----455.3
478.5
516.1
816.5
883.5
976.7
1,037.5
1,132.4
1995
1996
1997
1998
1999
1,379.6
1,362.7
1,407.6
1,550.0
1,700.0
52.9
53.9
57.6
65.9
73.7
19.5
21.6
22.3
23.9
25.4
-----------
1,452.0
1,438.2
1,487.5
1,639.8
1,799.2
-----------
-----------
1,660.0
1,735.3
2,103.4
2,466.3
2,387.7
3,112.0
3,173.5
3,590.9
4,106.1
4,186.9
615.7
641.2
710.3
750.6
799.7
528.8
540.5
603.4
646.0
679.7
1,144.5
1,181.7
1,313.7
1,396.6
1,479.4
2000
2001
2002
2003
2004
1,943.4
2,212.6
2,536.2
2,829.4
3,141.0
72.6
83.0
94.5
106.6
108.8
31.1
35.4
41.4
51.9
63.3
-----------
2,047.0
2,330.9
2,672.1
2,987.8
3,313.0
-----------
-----------
2,719.9
3,016.0
3,344.4
3,766.1
4,034.1
4,767.0
5,346.9
6,016.5
6,753.9
7,347.1
824.7
840.5
887.8
910.1
954.0
699.8
719.6
740.5
728.3
750.1
1,524.6
1,560.1
1,628.3
1,638.4
1,704.1
2005
2006
2007
2008
2009 f
2010 f
3,439.1
3,693.4
3,813.7
4,063.1
4,405.8
4,579.1
121.3
131.2
135.1
135.1
134.7
133.2
71.7
79.4
83.5
88.8
96.6
102.1
-------------
3,632.1
3,904.0
4,032.3
4,287.0
4,637.1
4,814.4
-------------
-------------
4,290.8
4,637.8
4,905.2
5,353.2
5,683.1
5,868.7
7,922.9
8,541.8
8,937.5
9,640.2
10,320.2
10,683.1
978.4
1,017.9
1,104.2
1,101.9
1,165.9
1,193.4
770.5
800.6
852.7
842.6
869.1
918.8
1,748.9
1,818.4
1,956.9
1,944.5
2,035.0
2,112.2
1985
1986
1987
1988
1989
--20.5
19.4
15.6
12.9
--4.8
5.9
59.4
25.3
--20.8
15.2
19.2
12.6
-----------
--20.0
18.9
16.7
13.3
-----------
-----------
--22.0
5.9
13.0
12.6
--21.1
11.3
14.6
12.9
-----------
-----------
--13.2
16.0
11.0
11.0
1990
1991
1992
1993
1994
17.6
14.9
16.9
5.4
-1.0
18.0
4.8
8.0
13.9
8.7
19.8
24.4
15.4
3.9
-23.3
-----------
17.6
14.7
16.5
5.7
-1.0
-----------
-----------
14.5
10.2
14.6
7.6
1.8
15.9
12.3
15.5
6.7
0.5
------7.2
10.3
------5.1
7.8
3.5
8.2
10.6
6.2
9.1
1995
1996
1997
1998
1999
11.6
-1.2
3.3
10.1
9.7
4.3
1.8
7.0
14.4
11.9
5.1
10.9
2.9
7.4
6.3
-----------
11.3
-1.0
3.4
10.2
9.7
-----------
-----------
10.0
4.5
21.2
17.3
-3.2
10.6
2.0
13.2
14.3
2.0
-0.1
4.1
10.8
5.7
6.5
2.5
2.2
11.6
7.1
5.2
1.1
3.3
11.2
6.3
5.9
2000
2001
2002
2003
2004
14.3
13.9
14.6
11.6
11.0
-1.6
14.3
13.9
12.8
2.0
22.3
13.8
17.0
25.2
22.0
-----------
13.8
13.9
14.6
11.8
10.9
-----------
-----------
13.9
10.9
10.9
12.6
7.1
13.9
12.2
12.5
12.3
8.8
3.1
1.9
5.6
2.5
4.8
3.0
2.8
2.9
-1.6
3.0
3.1
2.3
4.4
0.6
4.0
2005
2006
2007
2008
2009 f
2010 f
9.5
7.4
3.3
6.5
8.4
3.9
11.5
8.1
3.0
0.0
-0.3
-1.1
13.3
10.7
5.2
6.3
8.8
5.7
-------------
9.6
7.5
3.3
6.3
8.2
3.8
-------------
-------------
6.4
8.1
5.8
9.1
6.2
3.3
7.8
7.8
4.6
7.9
7.1
3.5
2.6
4.0
8.5
-0.2
5.8
2.4
2.7
3.9
6.5
-1.2
3.1
5.7
2.6
4.0
7.6
-0.6
4.7
3.8
1985
1986
1987
1988
1989
26.8
27.3
28.9
29.4
29.6
0.9
0.8
0.8
1.1
1.2
0.5
0.5
0.5
0.5
0.5
-----------
28.3
28.6
30.2
31.0
31.3
-----------
-----------
38.9
40.1
37.6
37.5
37.6
67.2
68.7
67.8
68.5
68.9
-----------
-----------
32.8
31.3
32.2
31.5
31.1
1990
1991
1992
1993
1994
31.0
32.1
32.9
32.5
31.3
1.3
1.2
1.1
1.2
1.3
0.6
0.6
0.6
0.6
0.5
-----------
32.9
33.9
34.6
34.4
33.1
-----------
-----------
38.4
38.1
38.2
38.6
38.2
71.2
72.0
72.9
73.0
71.3
----14.5
14.6
15.6
----12.6
12.5
13.1
28.8
28.0
27.1
27.0
28.7
1995
1996
1997
1998
1999
32.4
31.3
28.7
28.2
30.0
1.2
1.2
1.2
1.2
1.3
0.5
0.5
0.5
0.4
0.4
-----------
34.1
33.0
30.3
29.8
31.8
-----------
-----------
39.0
39.8
42.9
44.8
42.1
73.1
72.9
73.2
74.6
73.9
14.5
14.7
14.5
13.6
14.1
12.4
12.4
12.3
11.7
12.0
26.9
27.1
26.8
25.4
26.1
2000
2001
2002
2003
2004
30.9
32.0
33.2
33.7
34.7
1.2
1.2
1.2
1.3
1.2
0.5
0.5
0.5
0.6
0.7
-----------
32.5
33.7
35.0
35.6
36.6
-----------
-----------
43.2
43.7
43.7
44.9
44.6
75.8
77.4
78.7
80.5
81.2
13.1
12.2
11.6
10.8
10.5
11.1
10.4
9.7
8.7
8.3
24.2
22.6
21.3
19.5
18.8
2005
35.6
1.3
0.7
--2006
35.6
1.3
0.8
--2007
35.0
1.2
0.8
--2008
35.1
1.2
0.8
--2009 f
35.7
1.1
0.8
--2010 f
35.8
1.0
0.8
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
37.6
37.7
37.0
37.0
37.5
37.6
-------------
-------------
44.4
44.8
45.0
46.2
46.0
45.9
81.9
82.4
82.0
83.2
83.5
83.5
10.1
9.8
10.1
9.5
9.4
9.3
8.0
7.7
7.8
7.3
7.0
7.2
18.1
17.6
18.0
16.8
16.5
16.5
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
82
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Ont.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Ontario, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
420.5
504.5
599.9
700.4
793.8
1,067.2
1,259.2
1,388.9
1,556.3
1,741.1
1,487.7
1,763.7
1,988.8
2,256.7
2,534.9
10,443.3
11,730.2
13,011.9
14,497.9
16,093.9
3,999.5
4,367.1
4,854.5
5,321.9
5,876.9
14,442.8
16,097.2
17,866.4
19,819.8
21,970.8
4.0
4.3
4.6
4.8
4.9
26.7
28.8
28.6
29.2
29.6
10.3
11.0
11.1
11.4
11.5
1990
1991
1992
1993
1994
933.6
1,070.8
1,247.8
1,318.9
1,305.1
1,906.2
2,084.6
2,353.7
2,519.6
2,641.0
2,839.8
3,155.4
3,601.5
3,838.5
3,946.1
17,332.8
19,156.1
20,001.5
19,821.7
20,008.0
6,466.2
7,038.2
7,573.7
8,253.2
8,740.7
23,799.1
26,194.3
27,575.2
28,074.9
28,748.7
5.4
5.6
6.2
6.7
6.5
29.5
29.6
31.1
30.5
30.2
11.9
12.0
13.1
13.7
13.7
1995
1996
1997
1998
1999
1,452.0
1,438.2
1,487.5
1,639.8
1,799.2
2,804.5
2,917.0
3,417.2
3,862.9
3,867.1
4,256.5
4,355.2
4,904.7
5,502.8
5,666.3
19,874.7
20,038.0
20,480.8
22,029.7
23,344.6
9,411.7
9,655.3
10,314.0
11,054.0
12,033.6
29,286.4
29,693.3
30,794.8
33,083.7
35,378.2
7.3
7.2
7.3
7.4
7.7
29.8
30.2
33.1
34.9
32.1
14.5
14.7
15.9
16.6
16.0
2000
2001
2002
2003
2004
2,047.0
2,330.9
2,672.1
2,987.8
3,313.0
4,244.5
4,576.2
4,972.6
5,404.4
5,738.2
6,291.5
6,907.1
7,644.8
8,392.3
9,051.2
25,957.7
27,606.2
29,563.0
33,141.2
35,582.1
13,023.2
14,136.1
15,796.5
16,404.9
17,667.2
38,981.0
41,742.3
45,359.5
49,546.1
53,249.3
7.9
8.4
9.0
9.0
9.3
32.6
32.4
31.5
32.9
32.5
16.1
16.5
16.9
16.9
17.0
2005
2006
2007
2008
2009 f
2010 f
3,632.1
3,904.0
4,032.3
4,287.0
4,637.1
4,814.4
6,039.7
6,456.3
6,862.1
7,297.7
7,718.1
7,980.9
9,671.8
10,360.2
10,894.4
11,584.7
12,355.2
12,795.3
37,870.0
40,183.0
43,093.6
45,914.3
48,527.5
50,269.0
18,698.5
19,924.5
20,980.4
21,815.6
23,054.1
24,360.2
56,568.5
60,107.5
64,074.0
67,729.9
71,581.5
74,629.2
9.6
9.7
9.4
9.3
9.6
9.6
32.3
32.4
32.7
33.5
33.5
32.8
17.1
17.2
17.0
17.1
17.3
17.1
1985
1986
1987
1988
1989
--20.0
18.9
16.7
13.3
--18.0
10.3
12.1
11.9
--18.6
12.8
13.5
12.3
--12.3
10.9
11.4
11.0
--9.2
11.2
9.6
10.4
--11.5
11.0
10.9
10.9
1990
1991
1992
1993
1994
17.6
14.7
16.5
5.7
-1.0
9.5
9.4
12.9
7.0
4.8
12.0
11.1
14.1
6.6
2.8
7.7
10.5
4.4
-0.9
0.9
10.0
8.8
7.6
9.0
5.9
8.3
10.1
5.3
1.8
2.4
1995
1996
1997
1998
1999
11.3
-1.0
3.4
10.2
9.7
6.2
4.0
17.1
13.0
0.1
7.9
2.3
12.6
12.2
3.0
-0.7
0.8
2.2
7.6
6.0
7.7
2.6
6.8
7.2
8.9
1.9
1.4
3.7
7.4
6.9
2000
2001
2002
2003
2004
13.8
13.9
14.6
11.8
10.9
9.8
7.8
8.7
8.7
6.2
11.0
9.8
10.7
9.8
7.9
11.2
6.4
7.1
12.1
7.4
8.2
8.5
11.7
3.9
7.7
10.2
7.1
8.7
9.2
7.5
2005
2006
2007
2008
2009 f
2010 f
9.6
7.5
3.3
6.3
8.2
3.8
5.3
6.9
6.3
6.3
5.8
3.4
6.9
7.1
5.2
6.3
6.7
3.6
6.4
6.1
7.2
6.5
5.7
3.6
5.8
6.6
5.3
4.0
5.7
5.7
6.2
6.3
6.6
5.7
5.7
4.3
Ont.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
28.3
28.6
30.2
31.0
31.3
71.7
71.4
69.8
69.0
68.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.9
33.9
34.6
34.4
33.1
67.1
66.1
65.4
65.6
66.9
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
34.1
33.0
30.3
29.8
31.8
65.9
67.0
69.7
70.2
68.2
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
32.5
33.7
35.0
35.6
36.6
67.5
66.3
65.0
64.4
63.4
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
37.6
37.7
37.0
37.0
37.5
37.6
62.4
62.3
63.0
63.0
62.5
62.4
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
83
Drug Expenditure in Canada, 1985 to 2010
Table B Ont.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Ontario, 1985 to 2010
Provincial
Federal
Year
Ont.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
42.96
50.99
59.56
67.45
74.16
1.49
1.54
1.59
2.49
3.04
0.78
0.93
1.05
1.22
1.34
-----------
45.23
53.45
62.20
71.16
78.53
-----------
-----------
62.31
74.88
77.58
85.88
94.18
107.54
128.33
139.78
157.04
172.71
-----------
-----------
52.47
58.53
66.43
72.24
78.08
1990
1991
1992
1993
1994
85.57
97.11
111.98
116.76
114.23
3.52
3.64
3.88
4.37
4.69
1.58
1.93
2.20
2.26
1.71
-----------
90.66
102.68
118.06
123.39
120.64
-----------
-----------
105.82
115.18
130.27
138.67
139.46
196.48
217.86
248.33
262.06
260.09
----49.33
52.29
56.97
----43.07
44.77
47.71
79.29
84.72
92.41
97.06
104.67
1995
1996
1997
1998
1999
125.99
122.95
125.36
136.36
147.75
4.83
4.86
5.13
5.80
6.41
1.78
1.95
1.98
2.10
2.21
-----------
132.60
129.76
132.48
144.26
156.37
-----------
-----------
151.60
156.57
187.33
216.97
207.51
284.20
286.34
319.81
361.23
363.88
56.23
57.86
63.26
66.04
69.50
48.29
48.77
53.74
56.83
59.07
104.52
106.63
117.00
122.87
128.57
2000
2001
2002
2003
2004
166.31
185.97
209.57
230.73
252.89
6.21
6.97
7.81
8.69
8.76
2.66
2.97
3.42
4.23
5.09
-----------
175.18
195.91
220.80
243.65
266.74
-----------
-----------
232.76
253.50
276.35
307.12
324.80
407.94
449.41
497.15
550.77
591.54
70.58
70.64
73.36
74.22
76.81
59.89
60.49
61.19
59.39
60.39
130.47
131.13
134.54
133.61
137.20
2005
2006
2007
2008
2009 f
2010 f
273.69
291.62
298.07
314.09
337.11
346.11
9.66
10.36
10.56
10.44
10.30
10.07
5.71
6.27
6.53
6.86
7.39
7.72
-------------
289.06
308.24
315.16
331.39
354.81
363.90
-------------
-------------
341.47
366.18
383.38
413.82
434.85
443.59
630.53
674.42
698.53
745.21
789.66
807.49
77.86
80.37
86.30
85.18
89.21
90.20
61.32
63.21
66.64
65.13
66.50
69.45
139.18
143.58
152.94
150.31
155.71
159.65
1985
1986
1987
1988
1989
--18.7
16.8
13.2
9.9
--3.3
3.6
56.2
22.0
--19.0
12.8
16.8
9.6
-----------
--18.2
16.4
14.4
10.4
-----------
-----------
--20.2
3.6
10.7
9.7
--19.3
8.9
12.3
10.0
-----------
-----------
1990
1991
1992
1993
1994
15.4
13.5
15.3
4.3
-2.2
15.8
3.5
6.5
12.6
7.4
17.6
22.8
13.8
2.7
-24.2
-----------
15.4
13.3
15.0
4.5
-2.2
-----------
-----------
12.4
8.8
13.1
6.4
0.6
13.8
10.9
14.0
5.5
-0.8
------6.0
8.9
------3.9
6.6
1.5
6.9
9.1
5.0
7.8
1995
1996
1997
1998
1999
10.3
-2.4
2.0
8.8
8.4
3.1
0.6
5.6
13.0
10.5
3.9
9.6
1.6
6.1
5.0
-----------
9.9
-2.1
2.1
8.9
8.4
-----------
-----------
8.7
3.3
19.6
15.8
-4.4
9.3
0.8
11.7
13.0
0.7
-1.3
2.9
9.3
4.4
5.2
1.2
1.0
10.2
5.7
3.9
-0.1
2.0
9.7
5.0
4.6
2000
2001
2002
2003
2004
12.6
11.8
12.7
10.1
9.6
-3.1
12.3
12.0
11.3
0.7
20.4
11.8
15.1
23.6
20.5
-----------
12.0
11.8
12.7
10.4
9.5
-----------
-----------
12.2
8.9
9.0
11.1
5.8
12.1
10.2
10.6
10.8
7.4
1.5
0.1
3.8
1.2
3.5
1.4
1.0
1.2
-2.9
1.7
1.5
0.5
2.6
-0.7
2.7
2005
2006
2007
2008
2009 f
2010 f
8.2
6.5
2.2
5.4
7.3
2.7
10.3
7.3
1.9
-1.1
-1.3
-2.3
12.0
9.8
4.2
5.1
7.7
4.4
-------------
8.4
6.6
2.2
5.2
7.1
2.6
-------------
-------------
5.1
7.2
4.7
7.9
5.1
2.0
6.6
7.0
3.6
6.7
6.0
2.3
1.4
3.2
7.4
-1.3
4.7
1.1
1.5
3.1
5.4
-2.3
2.1
4.4
1.4
3.2
6.5
-1.7
3.6
2.5
1985
1986
1987
1988
1989
--15.9
12.1
8.7
5.4
--0.5
-1.1
51.6
17.4
--16.2
8.0
12.3
5.0
-----------
--15.4
11.6
9.9
5.8
-----------
-----------
--17.4
-1.1
6.2
5.1
--16.5
4.2
7.8
5.4
-----------
-----------
--8.8
8.7
4.2
3.5
1990
1991
1992
1993
1994
12.4
10.7
14.1
2.8
-3.3
12.8
0.7
5.3
11.2
6.3
14.6
20.0
12.6
1.3
-25.3
-----------
12.4
10.5
13.7
3.1
-3.3
-----------
-----------
9.3
6.1
11.8
5.0
-0.5
10.7
8.1
12.7
4.1
-1.8
------4.6
7.8
------2.5
5.5
-1.5
4.1
7.8
3.6
6.7
1995
1996
1997
1998
1999
8.0
-4.1
1.0
9.2
6.5
0.7
-1.1
4.6
13.4
8.7
1.5
7.9
0.6
6.6
3.2
-----------
7.6
-3.8
1.1
9.3
6.6
-----------
-----------
6.4
1.6
18.7
16.3
-6.2
6.9
-0.9
10.7
13.4
-1.1
-3.6
1.2
8.3
4.8
3.4
-1.1
-0.7
9.2
6.2
2.1
-2.5
0.3
8.7
5.5
2.8
2000
2001
2002
2003
2004
8.5
10.5
11.6
7.2
7.0
-7.2
10.9
10.9
8.4
-1.9
16.3
10.4
14.0
20.7
17.9
-----------
7.9
10.5
11.7
7.5
6.9
-----------
-----------
8.1
7.6
8.0
8.2
3.2
8.0
8.8
9.6
7.9
4.8
-2.6
-1.3
2.8
-1.7
0.9
-2.7
-0.4
0.1
-5.8
-0.9
-2.6
-0.8
1.6
-3.6
0.1
2005
2006
2007
2008
2009 f
2010 f
5.2
3.8
-1.4
0.6
9.4
-0.7
7.2
4.6
-1.7
-5.8
0.8
-5.7
9.0
7.1
0.6
0.4
9.8
1.0
-------------
5.4
3.9
-1.4
0.4
9.2
-0.9
-------------
-------------
2.1
4.5
1.1
3.2
7.2
-1.4
3.6
4.2
0.0
1.9
8.1
-1.2
-1.6
0.5
3.8
-6.0
6.8
-2.3
-1.5
0.4
1.8
-7.0
4.2
1.0
-1.6
0.4
2.9
-6.5
5.7
-0.9
(Annual Percentage Change)
--11.6
13.5
8.8
8.1
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
84
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Ont.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Ontario, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
Year
(1997 = 100)
1985
1986
1987
1988
1989
45.23
53.45
62.20
71.16
78.53
114.79
133.42
144.01
158.13
172.26
160.01
186.87
206.21
229.28
250.79
1,123.23
1,242.85
1,349.18
1,473.03
1,592.27
430.17
462.71
503.36
540.72
581.43
1,553.40
1,705.55
1,852.54
2,013.75
2,173.70
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
90.66
102.68
118.06
123.39
120.64
185.11
199.90
222.68
235.73
244.13
275.77
302.58
340.74
359.12
364.76
1,683.15
1,836.97
1,892.32
1,854.51
1,849.47
627.92
674.92
716.54
772.16
807.95
2,311.07
2,511.89
2,608.87
2,626.67
2,657.43
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
132.60
129.76
132.48
144.26
156.37
256.12
263.20
304.34
339.84
336.08
388.72
392.96
436.81
484.10
492.45
1,815.04
1,807.99
1,824.04
1,938.04
2,028.84
859.52
871.18
918.57
972.46
1,045.82
2,674.56
2,679.17
2,742.61
2,910.50
3,074.66
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
175.18
195.91
220.80
243.65
266.74
363.23
384.63
410.89
440.73
462.00
538.41
580.54
631.69
684.38
728.74
2,221.39
2,320.31
2,442.81
2,702.64
2,864.84
1,114.49
1,188.14
1,305.28
1,337.80
1,422.45
3,335.87
3,508.45
3,748.09
4,040.44
4,287.28
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
289.06
308.24
315.16
331.39
354.81
363.90
480.66
509.76
536.32
564.13
590.56
603.24
769.71
818.00
851.48
895.52
945.37
967.14
3,013.82
3,172.68
3,368.09
3,549.26
3,713.12
3,799.62
1,488.09
1,573.15
1,639.77
1,686.39
1,764.00
1,841.29
4,501.91
4,745.82
5,007.86
5,235.65
5,477.13
5,640.91
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--18.2
16.4
14.4
10.4
--16.2
7.9
9.8
8.9
--16.8
10.4
11.2
9.4
--10.6
8.6
9.2
8.1
--7.6
8.8
7.4
7.5
--9.8
8.6
8.7
7.9
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
15.4
13.3
15.0
4.5
-2.2
7.5
8.0
11.4
5.9
3.6
10.0
9.7
12.6
5.4
1.6
5.7
9.1
3.0
-2.0
-0.3
8.0
7.5
6.2
7.8
4.6
6.3
8.7
3.9
0.7
1.2
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
9.9
-2.1
2.1
8.9
8.4
4.9
2.8
15.6
11.7
-1.1
6.6
1.1
11.2
10.8
1.7
-1.9
-0.4
0.9
6.2
4.7
6.4
1.4
5.4
5.9
7.5
0.6
0.2
2.4
6.1
5.6
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
12.0
11.8
12.7
10.4
9.5
8.1
5.9
6.8
7.3
4.8
9.3
7.8
8.8
8.3
6.5
9.5
4.5
5.3
10.6
6.0
6.6
6.6
9.9
2.5
6.3
8.5
5.2
6.8
7.8
6.1
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
8.4
6.6
2.2
5.2
7.1
2.6
4.0
6.1
5.2
5.2
4.7
2.1
5.6
6.3
4.1
5.2
5.6
2.3
5.2
5.3
6.2
5.4
4.6
2.3
4.6
5.7
4.2
2.8
4.6
4.4
5.0
5.4
5.5
4.5
4.6
3.0
3.0
2.7
3.6
4.7
-2.1
3.4
Ont.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--15.4
11.6
9.9
5.8
--13.4
3.2
5.3
4.4
--14.0
5.6
6.7
4.8
--7.8
3.8
4.7
3.5
--4.8
4.0
2.9
3.0
--7.0
3.9
4.2
3.4
1990
1991
1992
1993
1994
12.4
10.5
13.7
3.1
-3.3
4.4
5.2
10.1
4.4
2.5
6.9
7.0
11.3
4.0
0.5
2.7
6.4
1.8
-3.4
-1.4
5.0
4.7
4.9
6.3
3.5
3.3
5.9
2.6
-0.8
0.1
1995
1996
1997
1998
1999
7.6
-3.8
1.1
9.3
6.6
2.6
1.1
14.6
12.1
-2.9
4.2
-0.6
10.2
11.3
-0.1
-4.2
-2.1
-0.1
6.7
2.9
4.0
-0.3
4.4
6.3
5.7
-1.7
-1.5
1.4
6.6
3.8
2000
2001
2002
2003
2004
7.9
10.5
11.7
7.5
6.9
4.0
4.5
5.8
4.4
2.2
5.2
6.5
7.8
5.4
3.9
5.4
3.1
4.2
7.7
3.4
2.5
5.3
8.8
-0.4
3.7
4.4
3.8
5.8
4.9
3.5
2005
2006
2007
2008
2009 f
2010 f
5.4
3.9
-1.4
0.4
9.2
-0.9
1.0
3.3
1.6
0.4
6.8
-1.3
2.6
3.6
0.5
0.4
7.7
-1.1
2.2
2.6
2.6
0.6
6.7
-1.1
1.6
3.0
0.6
-1.9
6.7
1.0
2.0
2.7
1.9
-0.2
6.7
-0.4
f: forecast.
Canadian Institute for Health Information, 2010.
85
Drug Expenditure in Canada, 1985 to 2010
Table B Man.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2010
Provincial
Federal
Year
Man.
Prescribed Drugs
Public
Private
Insurers*
Out-ofSocial Security Funds
Subtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
32.5
34.6
42.3
47.5
45.5
6.5
7.2
7.7
9.3
11.5
0.3
0.4
0.4
0.5
0.6
-----------
39.2
42.2
50.4
57.3
57.6
-----------
-----------
60.0
68.2
61.9
68.1
74.9
99.2
110.4
112.3
125.4
132.5
-----------
-----------
61.0
69.1
80.1
75.4
70.9
1990
1991
1992
1993
1994
48.5
55.4
68.1
68.1
61.1
13.8
16.2
18.6
21.9
24.6
0.7
0.7
0.8
0.7
0.8
-----------
62.9
72.4
87.5
90.7
86.5
-----------
-----------
86.2
95.8
101.6
118.5
129.1
149.1
168.2
189.1
209.2
215.6
----51.5
50.4
52.3
----41.6
41.9
42.5
75.3
81.5
93.2
92.2
94.8
1995
1996
1997
1998
1999
79.6
73.8
73.7
85.9
105.6
27.8
28.6
31.3
33.7
36.9
0.8
0.9
1.0
1.0
1.1
-----------
108.3
103.2
106.0
120.5
143.6
-----------
-----------
148.0
163.4
186.7
189.0
180.5
256.3
266.7
292.7
309.5
324.2
50.8
54.2
48.1
55.3
58.4
41.7
47.3
43.7
50.9
50.8
92.5
101.5
91.8
106.3
109.3
2000
2001
2002
2003
2004
130.9
160.8
189.6
217.7
234.6
38.4
44.5
52.0
60.7
65.3
1.3
1.6
1.7
2.1
2.3
-----------
170.7
207.0
243.3
280.4
302.2
-----------
-----------
205.3
212.3
239.4
266.7
277.2
376.0
419.3
482.7
547.1
579.4
60.8
64.0
65.6
68.3
71.9
52.6
53.6
54.8
56.3
58.0
113.3
117.6
120.4
124.6
129.9
2005
2006
2007
2008
2009 f
2010 f
249.5
260.2
271.6
279.6
282.8
290.3
70.9
79.4
83.8
85.9
91.8
98.1
2.4
2.6
2.7
3.2
3.3
3.5
-------------
322.7
342.3
358.2
368.6
377.9
392.0
-------------
-------------
293.3
344.8
362.5
375.1
398.2
431.0
616.1
687.0
720.6
743.7
776.1
823.0
74.2
78.5
82.0
87.6
95.8
99.0
60.3
63.2
62.8
66.0
70.2
74.8
134.4
141.7
144.8
153.6
166.0
173.8
1985
1986
1987
1988
1989
--6.6
22.2
12.4
-4.1
--11.1
7.4
19.8
24.1
--23.4
10.2
25.2
8.5
-----------
--7.4
19.6
13.6
0.5
-----------
-----------
--13.7
-9.3
10.1
10.1
--11.3
1.7
11.7
5.7
-----------
-----------
--13.2
16.0
-5.9
-5.9
1990
1991
1992
1993
1994
6.5
14.3
22.9
-0.1
-10.2
19.7
17.8
14.4
17.9
12.1
16.1
7.1
17.9
-10.4
5.3
-----------
9.3
15.0
20.9
3.6
-4.7
-----------
-----------
15.0
11.2
6.1
16.6
8.9
12.5
12.8
12.5
10.6
3.0
-------2.3
3.8
------0.6
1.6
6.2
8.2
14.4
-1.0
2.8
1995
1996
1997
1998
1999
30.2
-7.3
-0.1
16.5
22.9
13.3
2.8
9.6
7.4
9.7
9.2
4.7
7.9
2.5
13.8
-----------
25.2
-4.6
2.7
13.7
19.2
-----------
-----------
14.6
10.4
14.2
1.2
-4.5
18.9
4.1
9.7
5.7
4.7
-2.9
6.7
-11.2
15.0
5.6
-1.9
13.3
-7.6
16.6
-0.2
-2.4
9.7
-9.5
15.8
2.8
2000
2001
2002
2003
2004
24.0
22.8
17.9
14.8
7.7
4.0
16.0
16.7
16.7
7.7
20.6
18.0
7.9
19.9
13.0
-----------
18.8
21.3
17.6
15.3
7.8
-----------
-----------
13.7
3.4
12.8
11.4
4.0
16.0
11.5
15.1
13.3
5.9
4.1
5.3
2.4
4.1
5.3
3.4
2.0
2.2
2.8
3.0
3.7
3.8
2.3
3.5
4.3
2005
2006
2007
2008
2009 f
2010 f
6.4
4.3
4.4
2.9
1.2
2.7
8.5
12.1
5.5
2.5
6.9
6.9
1.4
10.9
5.2
15.0
3.7
6.5
-------------
6.8
6.0
4.6
2.9
2.5
3.7
-------------
-------------
5.8
17.5
5.1
3.5
6.2
8.2
6.3
11.5
4.9
3.2
4.4
6.0
3.2
5.9
4.4
6.8
9.4
3.3
3.8
4.8
-0.6
5.1
6.4
6.5
3.5
5.4
2.2
6.1
8.1
4.7
1985
1986
1987
1988
1989
20.3
19.3
22.0
23.7
22.4
4.1
4.0
4.0
4.6
5.7
0.2
0.2
0.2
0.3
0.3
-----------
24.5
23.5
26.2
28.5
28.3
-----------
-----------
37.4
38.0
32.2
33.9
36.8
61.9
61.5
58.4
62.5
65.1
-----------
-----------
38.1
38.5
41.6
37.5
34.9
1990
1991
1992
1993
1994
21.6
22.2
24.1
22.6
19.7
6.1
6.5
6.6
7.3
7.9
0.3
0.3
0.3
0.2
0.2
-----------
28.0
29.0
31.0
30.1
27.9
-----------
-----------
38.4
38.4
36.0
39.3
41.6
66.4
67.4
67.0
69.4
69.5
----18.3
16.7
16.8
----14.7
13.9
13.7
33.6
32.6
33.0
30.6
30.5
1995
1996
1997
1998
1999
22.8
20.0
19.2
20.7
24.4
8.0
7.8
8.2
8.1
8.5
0.2
0.2
0.2
0.2
0.3
-----------
31.0
28.0
27.6
29.0
33.1
-----------
-----------
42.4
44.4
48.6
45.4
41.7
73.5
72.4
76.1
74.4
74.8
14.6
14.7
12.5
13.3
13.5
12.0
12.8
11.4
12.2
11.7
26.5
27.6
23.9
25.6
25.2
2000
2001
2002
2003
2004
26.8
30.0
31.4
32.4
33.1
7.8
8.3
8.6
9.0
9.2
0.3
0.3
0.3
0.3
0.3
-----------
34.9
38.5
40.3
41.7
42.6
-----------
-----------
42.0
39.5
39.7
39.7
39.1
76.8
78.1
80.0
81.4
81.7
12.4
11.9
10.9
10.2
10.1
10.7
10.0
9.1
8.4
8.2
23.2
21.9
20.0
18.6
18.3
2005
33.2
9.4
0.3
--2006
31.4
9.6
0.3
--2007
31.4
9.7
0.3
--2008
31.2
9.6
0.4
--2009 f
30.0
9.7
0.3
--2010 f
29.1
9.8
0.3
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
43.0
41.3
41.4
41.1
40.1
39.3
-------------
-------------
39.1
41.6
41.9
41.8
42.3
43.2
82.1
82.9
83.3
82.9
82.4
82.6
9.9
9.5
9.5
9.8
10.2
9.9
8.0
7.6
7.3
7.4
7.5
7.5
17.9
17.1
16.7
17.1
17.6
17.4
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
86
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Man.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
39.2
42.2
50.4
57.3
57.6
121.0
137.3
141.9
143.4
145.8
160.2
179.4
192.4
200.7
203.4
1,310.9
1,425.8
1,530.2
1,634.3
1,773.2
415.6
463.9
449.9
435.4
484.2
1,726.5
1,889.7
1,980.2
2,069.6
2,257.4
3.0
3.0
3.3
3.5
3.2
29.1
29.6
31.5
32.9
30.1
9.3
9.5
9.7
9.7
9.0
1990
1991
1992
1993
1994
62.9
72.4
87.5
90.7
86.5
161.5
177.3
194.8
210.8
223.9
224.4
249.6
282.3
301.5
310.4
1,951.1
2,006.0
2,099.3
2,088.9
2,115.7
533.2
570.0
602.6
660.2
689.2
2,484.3
2,576.0
2,701.9
2,749.1
2,804.9
3.2
3.6
4.2
4.3
4.1
30.3
31.1
32.3
31.9
32.5
9.0
9.7
10.4
11.0
11.1
1995
1996
1997
1998
1999
108.3
103.2
106.0
120.5
143.6
240.5
264.9
278.5
295.2
289.8
348.8
368.2
384.5
415.8
433.4
2,179.4
2,185.3
2,251.9
2,388.6
2,714.9
736.1
786.8
848.6
893.3
979.7
2,915.5
2,972.1
3,100.5
3,281.9
3,694.6
5.0
4.7
4.7
5.0
5.3
32.7
33.7
32.8
33.0
29.6
12.0
12.4
12.4
12.7
11.7
2000
2001
2002
2003
2004
170.7
207.0
243.3
280.4
302.2
318.6
329.9
359.8
391.3
407.1
489.3
536.9
603.1
671.7
709.4
3,005.3
3,184.5
3,360.1
3,645.2
3,889.4
1,040.4
1,173.0
1,224.8
1,264.5
1,322.0
4,045.7
4,357.6
4,584.9
4,909.8
5,211.4
5.7
6.5
7.2
7.7
7.8
30.6
28.1
29.4
30.9
30.8
12.1
12.3
13.2
13.7
13.6
2005
2006
2007
2008
2009 f
2010 f
322.7
342.3
358.2
368.6
377.9
392.0
427.8
486.5
507.2
528.7
564.3
604.8
750.5
828.7
865.4
897.3
942.2
996.8
4,190.9
4,431.2
4,684.9
5,029.8
5,360.8
5,819.3
1,408.5
1,523.7
1,578.0
1,707.7
1,789.3
1,888.5
5,599.4
5,954.9
6,262.9
6,737.5
7,150.1
7,707.8
7.7
7.7
7.6
7.3
7.0
6.7
30.4
31.9
32.1
31.0
31.5
32.0
13.4
13.9
13.8
13.3
13.2
12.9
1985
1986
1987
1988
1989
--7.4
19.6
13.6
0.5
--13.5
3.4
1.1
1.7
--12.0
7.2
4.4
1.4
--8.8
7.3
6.8
8.5
--11.6
-3.0
-3.2
11.2
--9.5
4.8
4.5
9.1
1990
1991
1992
1993
1994
9.3
15.0
20.9
3.6
-4.7
10.7
9.8
9.9
8.2
6.2
10.3
11.2
13.1
6.8
3.0
10.0
2.8
4.7
-0.5
1.3
10.1
6.9
5.7
9.6
4.4
10.1
3.7
4.9
1.7
2.0
1995
1996
1997
1998
1999
25.2
-4.6
2.7
13.7
19.2
7.4
10.1
5.1
6.0
-1.8
12.4
5.6
4.4
8.1
4.3
3.0
0.3
3.0
6.1
13.7
6.8
6.9
7.9
5.3
9.7
3.9
1.9
4.3
5.8
12.6
2000
2001
2002
2003
2004
18.8
21.3
17.6
15.3
7.8
10.0
3.5
9.0
8.8
4.1
12.9
9.7
12.3
11.4
5.6
10.7
6.0
5.5
8.5
6.7
6.2
12.7
4.4
3.2
4.5
9.5
7.7
5.2
7.1
6.1
2005
2006
2007
2008
2009 f
2010 f
6.8
6.0
4.6
2.9
2.5
3.7
5.1
13.7
4.3
4.2
6.7
7.2
5.8
10.4
4.4
3.7
5.0
5.8
7.8
5.7
5.7
7.4
6.6
8.6
6.5
8.2
3.6
8.2
4.8
5.5
7.4
6.4
5.2
7.6
6.1
7.8
Man.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
24.5
23.5
26.2
28.5
28.3
75.5
76.5
73.8
71.5
71.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
28.0
29.0
31.0
30.1
27.9
72.0
71.0
69.0
69.9
72.1
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
31.0
28.0
27.6
29.0
33.1
69.0
72.0
72.4
71.0
66.9
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
34.9
38.5
40.3
41.7
42.6
65.1
61.5
59.7
58.3
57.4
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
43.0
41.3
41.4
41.1
40.1
39.3
57.0
58.7
58.6
58.9
59.9
60.7
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
87
Drug Expenditure in Canada, 1985 to 2010
Table B Man.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2010
Provincial
Federal
Year
Man.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
29.98
31.68
38.48
43.10
41.26
6.00
6.60
7.05
8.42
10.44
0.28
0.34
0.38
0.47
0.51
-----------
36.26
38.62
45.91
51.99
52.20
-----------
-----------
55.40
62.48
56.33
61.78
67.91
91.67
101.10
102.25
113.77
120.11
-----------
-----------
56.35
63.26
72.94
68.38
64.25
1990
1991
1992
1993
1994
43.87
49.95
61.22
60.90
54.43
12.47
14.63
16.69
19.59
21.86
0.59
0.63
0.74
0.66
0.69
-----------
56.92
65.21
78.65
81.15
76.99
-----------
-----------
77.93
86.34
91.33
106.06
114.94
134.85
151.55
169.98
187.21
191.92
----46.32
45.06
46.55
----37.42
37.46
37.86
68.11
73.41
83.73
82.52
84.41
1995
1996
1997
1998
1999
70.49
65.03
64.88
75.51
92.43
24.65
25.22
27.59
29.60
32.32
0.75
0.78
0.84
0.86
0.98
-----------
95.89
91.03
93.31
105.97
125.72
-----------
-----------
131.08
144.10
164.30
166.11
158.03
226.97
235.13
257.61
272.09
283.75
44.97
47.77
42.34
48.64
51.13
36.96
41.69
38.45
44.77
44.50
81.93
89.46
80.79
93.41
95.63
2000
2001
2002
2003
2004
114.11
139.70
164.09
187.38
200.39
33.47
38.69
45.00
52.22
55.82
1.17
1.38
1.48
1.77
1.98
-----------
148.75
179.77
210.57
241.36
258.19
-----------
-----------
178.93
184.40
207.17
229.51
236.82
327.68
364.18
417.74
470.87
495.01
52.97
55.61
56.75
58.77
61.42
45.82
46.57
47.43
48.48
49.58
98.79
102.18
104.18
107.26
111.00
2005
2006
2007
2008
2009 f
2010 f
212.51
219.78
227.52
231.79
231.44
235.39
60.36
67.07
70.17
71.23
75.12
79.58
2.00
2.20
2.30
2.61
2.68
2.82
-------------
274.87
289.06
299.98
305.63
309.24
317.79
-------------
-------------
249.84
291.19
303.59
311.00
325.90
349.46
524.71
580.25
603.58
616.63
635.15
667.25
63.18
66.33
68.67
72.62
78.42
80.29
51.32
53.35
52.59
54.71
57.45
60.63
114.50
119.68
121.26
127.33
135.87
140.93
1985
1986
1987
1988
1989
--5.6
21.5
12.0
-4.3
--10.1
6.8
19.4
23.9
--22.4
9.5
24.8
8.3
-----------
--6.5
18.9
13.2
0.4
-----------
-----------
--12.8
-9.8
9.7
9.9
--10.3
1.1
11.3
5.6
-----------
-----------
--12.3
15.3
-6.3
-6.0
1990
1991
1992
1993
1994
6.3
13.9
22.6
-0.5
-10.6
19.5
17.3
14.1
17.4
11.6
15.9
6.8
17.5
-10.8
4.8
-----------
9.0
14.6
20.6
3.2
-5.1
-----------
-----------
14.8
10.8
5.8
16.1
8.4
12.3
12.4
12.2
10.1
2.5
-------2.7
3.3
------0.1
1.1
6.0
7.8
14.1
-1.4
2.3
1995
1996
1997
1998
1999
29.5
-7.7
-0.2
16.4
22.4
12.7
2.3
9.4
7.3
9.2
8.7
4.2
7.8
2.4
13.3
-----------
24.6
-5.1
2.5
13.6
18.6
-----------
-----------
14.0
9.9
14.0
1.1
-4.9
18.3
3.6
9.6
5.6
4.3
-3.4
6.2
-11.4
14.9
5.1
-2.4
12.8
-7.8
16.4
-0.6
-2.9
9.2
-9.7
15.6
2.4
2000
2001
2002
2003
2004
23.5
22.4
17.5
14.2
6.9
3.5
15.6
16.3
16.1
6.9
20.1
17.6
7.5
19.2
12.1
-----------
18.3
20.9
17.1
14.6
7.0
-----------
-----------
13.2
3.1
12.3
10.8
3.2
15.5
11.1
14.7
12.7
5.1
3.6
5.0
2.0
3.6
4.5
3.0
1.6
1.8
2.2
2.3
3.3
3.4
2.0
3.0
3.5
2005
2006
2007
2008
2009 f
2010 f
6.0
3.4
3.5
1.9
-0.1
1.7
8.1
11.1
4.6
1.5
5.5
5.9
1.1
9.9
4.3
13.8
2.4
5.5
-------------
6.5
5.2
3.8
1.9
1.2
2.8
-------------
-------------
5.5
16.6
4.3
2.4
4.8
7.2
6.0
10.6
4.0
2.2
3.0
5.1
2.9
5.0
3.5
5.8
8.0
2.4
3.5
3.9
-1.4
4.0
5.0
5.5
3.2
4.5
1.3
5.0
6.7
3.7
1985
1986
1987
1988
1989
--2.8
16.7
7.5
-8.8
--7.3
2.0
14.9
19.4
--19.6
4.8
20.2
3.8
-----------
--3.7
14.1
8.7
-4.2
-----------
-----------
--10.0
-14.6
5.1
5.3
--7.5
-3.6
6.7
1.0
-----------
-----------
1990
1991
1992
1993
1994
3.3
11.1
21.3
-2.0
-11.7
16.4
14.6
12.8
16.0
10.5
12.9
4.0
16.3
-12.2
3.7
-----------
6.0
11.8
19.4
1.7
-6.2
-----------
-----------
11.7
8.0
4.5
14.7
7.3
9.3
9.6
10.9
8.7
1.4
-------4.2
2.2
-------1.3
0.0
3.0
5.0
12.8
-2.9
1.2
1995
1996
1997
1998
1999
27.2
-9.4
-1.2
16.8
20.6
10.4
0.6
8.4
7.7
7.4
6.3
2.6
6.8
2.8
11.5
-----------
22.2
-6.7
1.5
14.0
16.8
-----------
-----------
11.7
8.3
13.0
1.5
-6.7
15.9
1.9
8.6
6.1
2.5
-5.7
4.6
-12.4
15.3
3.3
-4.7
11.1
-8.8
16.9
-2.4
-5.3
7.5
-10.7
16.1
0.6
2000
2001
2002
2003
2004
19.4
21.1
16.4
11.3
4.4
-0.6
14.3
15.2
13.2
4.3
16.0
16.2
6.4
16.3
9.6
-----------
14.2
19.5
16.1
11.7
4.4
-----------
-----------
9.1
1.7
11.3
7.9
0.6
11.4
9.8
13.7
9.8
2.5
-0.5
3.6
1.0
0.7
1.9
-1.2
0.3
0.8
-0.7
-0.3
-0.8
2.1
0.9
0.1
0.9
2005
2006
2007
2008
2009 f
2010 f
3.0
0.7
-0.1
-2.9
2.0
-1.7
5.1
8.4
1.0
-3.2
7.6
2.5
-1.9
7.2
0.7
9.1
4.5
2.1
-------------
3.5
2.4
0.2
-2.9
3.3
-0.7
-------------
-------------
2.5
13.8
0.7
-2.3
6.9
3.8
3.0
7.9
0.4
-2.6
5.1
1.6
-0.1
2.3
-0.1
1.0
10.1
-1.0
0.5
1.2
-5.0
-0.7
7.1
2.1
0.1
1.8
-2.3
0.3
8.8
0.3
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
88
--9.5
10.6
-10.8
-10.6
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Man.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Year
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
(1997 = 100)
1985
1986
1987
1988
1989
36.26
38.62
45.91
51.99
52.20
111.76
125.74
129.27
130.16
132.15
148.02
164.36
175.18
182.14
184.35
1,211.28
1,306.04
1,393.62
1,482.95
1,606.82
383.98
424.97
409.78
395.06
438.77
1,595.25
1,731.01
1,803.40
1,878.01
2,045.59
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
56.92
65.21
78.65
81.15
76.99
146.04
159.76
175.06
188.58
199.34
202.96
224.97
253.71
269.73
276.33
1,764.67
1,807.82
1,886.70
1,869.05
1,883.55
482.25
513.71
541.56
590.76
613.62
2,246.92
2,321.53
2,428.27
2,459.81
2,497.17
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
95.89
91.03
93.31
105.97
125.72
213.01
233.57
245.09
259.52
253.66
308.90
324.60
338.40
365.50
379.38
1,930.11
1,926.73
1,982.07
2,099.82
2,376.29
651.90
693.69
746.91
785.30
857.55
2,582.01
2,620.42
2,728.98
2,885.12
3,233.84
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
148.75
179.77
210.57
241.36
258.19
277.72
286.58
311.35
336.76
347.82
426.47
466.36
521.92
578.13
606.02
2,619.32
2,766.07
2,907.70
3,137.33
3,322.66
906.78
1,018.88
1,059.91
1,088.33
1,129.39
3,526.10
3,784.95
3,967.61
4,225.66
4,452.06
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
274.87
289.06
299.98
305.63
309.24
317.79
364.34
410.87
424.85
438.32
461.77
490.38
639.21
699.92
724.84
743.95
771.01
808.17
3,569.28
3,742.48
3,923.92
4,170.28
4,387.03
4,718.06
1,199.58
1,286.90
1,321.70
1,415.90
1,464.30
1,531.14
4,768.86
5,029.38
5,245.62
5,586.18
5,851.33
6,249.20
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--6.5
18.9
13.2
0.4
--12.5
2.8
0.7
1.5
--11.0
6.6
4.0
1.2
--7.8
6.7
6.4
8.4
--10.7
-3.6
-3.6
11.1
--8.5
4.2
4.1
8.9
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
9.0
14.6
20.6
3.2
-5.1
10.5
9.4
9.6
7.7
5.7
10.1
10.8
12.8
6.3
2.4
9.8
2.4
4.4
-0.9
0.8
9.9
6.5
5.4
9.1
3.9
9.8
3.3
4.6
1.3
1.5
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
24.6
-5.1
2.5
13.6
18.6
6.9
9.7
4.9
5.9
-2.3
11.8
5.1
4.3
8.0
3.8
2.5
-0.2
2.9
5.9
13.2
6.2
6.4
7.7
5.1
9.2
3.4
1.5
4.1
5.7
12.1
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
18.3
20.9
17.1
14.6
7.0
9.5
3.2
8.6
8.2
3.3
12.4
9.4
11.9
10.8
4.8
10.2
5.6
5.1
7.9
5.9
5.7
12.4
4.0
2.7
3.8
9.0
7.3
4.8
6.5
5.4
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
6.5
5.2
3.8
1.9
1.2
2.8
4.7
12.8
3.4
3.2
5.3
6.2
5.5
9.5
3.6
2.6
3.6
4.8
7.4
4.9
4.8
6.3
5.2
7.5
6.2
7.3
2.7
7.1
3.4
4.6
7.1
5.5
4.3
6.5
4.7
6.8
3.0
2.7
3.6
4.7
-2.1
3.4
Man.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--3.7
14.1
8.7
-4.2
--9.7
-1.9
-3.8
-3.0
--8.2
1.8
-0.5
-3.4
--5.0
2.0
1.9
3.8
--7.9
-8.3
-8.1
6.5
--5.7
-0.6
-0.4
4.4
1990
1991
1992
1993
1994
6.0
11.8
19.4
1.7
-6.2
7.5
6.6
8.3
6.3
4.6
7.1
8.1
11.5
4.9
1.3
6.8
-0.3
3.1
-2.4
-0.3
6.9
3.8
4.2
7.6
2.8
6.8
0.6
3.3
-0.1
0.4
1995
1996
1997
1998
1999
22.2
-6.7
1.5
14.0
16.8
4.5
8.0
3.9
6.3
-4.1
9.4
3.4
3.3
8.4
2.0
0.1
-1.8
1.9
6.4
11.4
3.9
4.7
6.7
5.6
7.4
1.1
-0.2
3.2
6.2
10.3
2000
2001
2002
2003
2004
14.2
19.5
16.1
11.7
4.4
5.4
1.8
7.6
5.3
0.7
8.3
8.0
10.9
7.9
2.2
6.1
4.2
4.1
5.0
3.3
1.6
11.0
3.0
-0.2
1.2
4.9
6.0
3.8
3.6
2.8
2005
2006
2007
2008
2009 f
2010 f
3.5
2.4
0.2
-2.9
3.3
-0.7
1.7
10.1
-0.2
-1.6
7.5
2.8
2.5
6.8
0.0
-2.1
5.8
1.4
4.4
2.1
1.3
1.5
7.3
4.1
3.2
4.6
-0.9
2.4
5.5
1.2
4.1
2.8
0.7
1.8
6.9
3.4
f: forecast.
Canadian Institute for Health Information, 2010.
89
Drug Expenditure in Canada, 1985 to 2010
Table B Sask.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2010
Provincial
Federal
Year
Sask.
Prescribed Drugs
Public
Private
Insurers*
Out-ofSocial Security Funds
Subtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
67.6
81.1
67.8
63.0
74.8
6.3
7.1
7.7
9.7
12.2
0.1
0.1
0.2
0.3
0.2
-----------
74.0
88.3
75.7
73.1
87.2
-----------
-----------
26.8
33.8
42.5
53.5
67.3
100.8
122.1
118.2
126.5
154.5
-----------
-----------
35.3
40.0
46.4
58.3
73.2
1990
1991
1992
1993
1994
88.7
93.5
85.0
57.8
56.2
14.5
16.8
19.0
22.4
25.0
0.3
0.3
0.3
0.4
0.4
-----------
103.5
110.6
104.3
80.6
81.6
-----------
-----------
79.5
89.2
99.5
126.7
141.3
183.0
199.8
203.8
207.3
222.9
----40.6
49.9
51.7
----35.6
44.9
45.5
74.4
73.0
76.2
94.8
97.2
1995
1996
1997
1998
1999
63.8
66.6
69.3
78.9
89.1
28.0
28.8
31.2
33.7
38.8
0.5
0.8
0.8
0.9
1.1
-----------
92.2
96.2
101.3
113.6
129.0
-----------
-----------
146.8
148.1
161.2
167.4
174.0
239.0
244.3
262.5
280.9
303.0
50.1
47.4
48.9
47.6
52.8
44.7
44.8
47.3
46.7
48.7
94.8
92.2
96.2
94.4
101.5
2000
2001
2002
2003
2004
100.2
116.3
133.9
151.4
168.1
42.3
48.1
55.2
62.5
64.9
1.3
1.6
1.9
2.2
2.5
-----------
143.8
165.9
191.0
216.1
235.5
-----------
-----------
185.6
216.1
222.5
252.3
274.1
329.4
382.1
413.6
468.4
509.6
55.9
57.1
58.1
57.4
60.4
51.0
50.5
51.3
50.0
51.8
106.9
107.7
109.4
107.4
112.3
2005
2006
2007
2008
2009 f
2010 f
185.4
201.9
241.0
269.0
310.0
324.9
68.2
73.1
75.7
78.5
79.8
87.1
2.7
2.9
3.0
3.8
3.5
3.6
-------------
256.3
277.9
319.7
351.2
393.3
415.6
-------------
-------------
286.1
282.5
300.9
289.2
307.6
323.0
542.4
560.4
620.7
640.5
700.9
738.5
61.7
63.0
65.2
69.0
75.8
80.0
53.4
54.0
53.2
54.5
58.2
63.0
115.2
117.0
118.4
123.5
133.9
143.0
1985
1986
1987
1988
1989
--20.0
-16.4
-7.1
18.7
--13.1
8.9
26.1
25.3
--2.4
42.4
58.9
-28.9
-----------
--19.3
-14.2
-3.5
19.4
-----------
-----------
--25.8
25.8
25.8
25.8
--21.1
-3.2
7.0
22.1
-----------
-----------
--13.2
16.0
25.6
25.6
1990
1991
1992
1993
1994
18.7
5.4
-9.1
-32.0
-2.8
18.6
16.1
12.9
18.1
11.7
9.8
5.4
20.3
32.9
-2.2
-----------
18.6
6.9
-5.7
-22.7
1.3
-----------
-----------
18.2
12.2
11.5
27.3
11.5
18.5
9.2
2.0
1.7
7.5
------22.7
3.6
------26.3
1.3
1.6
-1.9
4.5
24.4
2.5
1995
1996
1997
1998
1999
13.6
4.4
4.0
13.9
12.9
11.7
3.0
8.3
8.1
15.1
16.1
63.1
4.3
9.6
22.0
-----------
13.0
4.3
5.3
12.1
13.6
-----------
-----------
3.9
0.9
8.8
3.9
3.9
7.2
2.2
7.4
7.0
7.8
-3.0
-5.4
3.1
-2.5
10.8
-1.9
0.4
5.5
-1.2
4.1
-2.5
-2.7
4.3
-1.9
7.5
2000
2001
2002
2003
2004
12.4
16.1
15.1
13.1
11.0
9.0
13.8
14.9
13.1
3.8
16.4
18.5
20.9
14.4
17.3
-----------
11.4
15.4
15.1
13.1
9.0
-----------
-----------
6.7
16.4
3.0
13.4
8.6
8.7
16.0
8.2
13.2
8.8
5.8
2.2
1.7
-1.3
5.3
4.9
-1.0
1.5
-2.6
3.7
5.4
0.7
1.6
-1.9
4.5
2005
2006
2007
2008
2009 f
2010 f
10.3
8.9
19.4
11.6
15.2
4.8
5.1
7.3
3.5
3.7
1.7
9.1
5.4
8.4
3.8
25.5
-6.4
2.1
-------------
8.8
8.5
15.0
9.8
12.0
5.7
-------------
-------------
4.4
-1.3
6.5
-3.9
6.4
5.0
6.4
3.3
10.7
3.2
9.4
5.4
2.2
2.1
3.5
5.9
9.8
5.6
3.1
1.1
-1.4
2.4
6.7
8.4
2.6
1.6
1.2
4.3
8.4
6.8
1985
1986
1987
1988
1989
49.6
50.0
41.2
34.1
32.8
4.6
4.4
4.7
5.3
5.4
0.1
0.1
0.1
0.2
0.1
-----------
54.4
54.5
46.0
39.5
38.3
-----------
-----------
19.7
20.8
25.8
28.9
29.5
74.1
75.3
71.8
68.5
67.9
-----------
-----------
25.9
24.7
28.2
31.5
32.1
1990
1991
1992
1993
1994
34.5
34.3
30.3
19.1
17.5
5.6
6.2
6.8
7.4
7.8
0.1
0.1
0.1
0.1
0.1
-----------
40.2
40.5
37.2
26.7
25.5
-----------
-----------
30.9
32.7
35.5
41.9
44.1
71.1
73.3
72.8
68.6
69.6
----14.5
16.5
16.1
----12.7
14.9
14.2
28.9
26.7
27.2
31.4
30.4
1995
1996
1997
1998
1999
19.1
19.8
19.3
21.0
22.0
8.4
8.6
8.7
9.0
9.6
0.1
0.2
0.2
0.2
0.3
-----------
27.6
28.6
28.2
30.3
31.9
-----------
-----------
44.0
44.0
44.9
44.6
43.0
71.6
72.6
73.2
74.9
74.9
15.0
14.1
13.6
12.7
13.1
13.4
13.3
13.2
12.4
12.0
28.4
27.4
26.8
25.1
25.1
2000
2001
2002
2003
2004
23.0
23.7
25.6
26.3
27.0
9.7
9.8
10.6
10.9
10.4
0.3
0.3
0.4
0.4
0.4
-----------
32.9
33.9
36.5
37.5
37.9
-----------
-----------
42.5
44.1
42.6
43.8
44.1
75.5
78.0
79.1
81.3
81.9
12.8
11.7
11.1
10.0
9.7
11.7
10.3
9.8
8.7
8.3
24.5
22.0
20.9
18.7
18.1
2005
28.2
10.4
0.4
--2006
29.8
10.8
0.4
--2007
32.6
10.2
0.4
--2008
35.2
10.3
0.5
--2009 f
37.1
9.6
0.4
--2010 f
36.9
9.9
0.4
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
39.0
41.0
43.3
46.0
47.1
47.1
-------------
-------------
43.5
41.7
40.7
37.9
36.8
36.6
82.5
82.7
84.0
83.8
84.0
83.8
9.4
9.3
8.8
9.0
9.1
9.1
8.1
8.0
7.2
7.1
7.0
7.1
17.5
17.3
16.0
16.2
16.0
16.2
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
90
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Sask.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
74.0
88.3
75.7
73.1
87.2
62.1
73.7
88.9
111.7
140.4
136.1
162.0
164.6
184.8
227.7
1,195.5
1,325.9
1,372.2
1,468.3
1,629.2
333.2
377.7
395.5
369.3
423.7
1,528.8
1,703.6
1,767.8
1,837.6
2,052.9
6.2
6.7
5.5
5.0
5.4
18.6
19.5
22.5
30.2
33.1
8.9
9.5
9.3
10.1
11.1
1990
1991
1992
1993
1994
103.5
110.6
104.3
80.6
81.6
153.9
162.2
175.8
221.5
238.5
257.4
272.8
280.1
302.1
320.1
1,792.1
1,828.9
1,819.5
1,727.8
1,778.8
460.1
490.9
505.8
574.1
606.4
2,252.2
2,319.8
2,325.4
2,301.9
2,385.2
5.8
6.0
5.7
4.7
4.6
33.4
33.0
34.7
38.6
39.3
11.4
11.8
12.0
13.1
13.4
1995
1996
1997
1998
1999
92.2
96.2
101.3
113.6
129.0
241.6
240.4
257.4
261.8
275.4
333.8
336.6
358.6
375.3
404.5
1,820.8
1,862.3
1,976.1
2,103.5
2,250.4
621.5
627.7
680.1
673.3
725.0
2,442.3
2,490.0
2,656.2
2,776.8
2,975.4
5.1
5.2
5.1
5.4
5.7
38.9
38.3
37.8
38.9
38.0
13.7
13.5
13.5
13.5
13.6
2000
2001
2002
2003
2004
143.8
165.9
191.0
216.1
235.5
292.5
323.8
332.0
359.7
386.3
436.3
489.7
523.0
575.8
621.8
2,381.2
2,581.5
2,719.3
2,887.2
3,097.5
773.9
869.6
899.0
971.2
1,021.4
3,155.1
3,451.1
3,618.3
3,858.5
4,118.8
6.0
6.4
7.0
7.5
7.6
37.8
37.2
36.9
37.0
37.8
13.8
14.2
14.5
14.9
15.1
2005
2006
2007
2008
2009 f
2010 f
256.3
277.9
319.7
351.2
393.3
415.6
401.3
399.5
419.4
412.8
441.5
466.0
657.6
677.5
739.1
764.0
834.8
881.6
3,365.8
3,595.0
3,877.9
4,219.6
4,534.5
4,739.3
1,049.8
1,159.5
1,213.1
1,235.5
1,325.2
1,391.4
4,415.6
4,754.5
5,091.1
5,455.1
5,859.7
6,130.7
7.6
7.7
8.2
8.3
8.7
8.8
38.2
34.5
34.6
33.4
33.3
33.5
14.9
14.2
14.5
14.0
14.2
14.4
1985
1986
1987
1988
1989
--19.3
-14.2
-3.5
19.4
--18.7
20.5
25.7
25.7
--19.0
1.6
12.3
23.2
--10.9
3.5
7.0
11.0
--13.4
4.7
-6.6
14.7
--11.4
3.8
4.0
11.7
1990
1991
1992
1993
1994
18.6
6.9
-5.7
-22.7
1.3
9.6
5.4
8.4
26.0
7.7
13.0
6.0
2.7
7.9
5.9
10.0
2.1
-0.5
-5.0
3.0
8.6
6.7
3.0
13.5
5.6
9.7
3.0
0.2
-1.0
3.6
1995
1996
1997
1998
1999
13.0
4.3
5.3
12.1
13.6
1.3
-0.5
7.1
1.7
5.2
4.3
0.8
6.6
4.6
7.8
2.4
2.3
6.1
6.4
7.0
2.5
1.0
8.3
-1.0
7.7
2.4
2.0
6.7
4.5
7.2
2000
2001
2002
2003
2004
11.4
15.4
15.1
13.1
9.0
6.2
10.7
2.5
8.3
7.4
7.9
12.2
6.8
10.1
8.0
5.8
8.4
5.3
6.2
7.3
6.7
12.4
3.4
8.0
5.2
6.0
9.4
4.8
6.6
6.7
2005
2006
2007
2008
2009 f
2010 f
8.8
8.5
15.0
9.8
12.0
5.7
3.9
-0.4
5.0
-1.6
7.0
5.5
5.7
3.0
9.1
3.4
9.3
5.6
8.7
6.8
7.9
8.8
7.5
4.5
2.8
10.4
4.6
1.8
7.3
5.0
7.2
7.7
7.1
7.2
7.4
4.6
Sask.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
54.4
54.5
46.0
39.5
38.3
45.6
45.5
54.0
60.5
61.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
40.2
40.5
37.2
26.7
25.5
59.8
59.5
62.8
73.3
74.5
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
27.6
28.6
28.2
30.3
31.9
72.4
71.4
71.8
69.7
68.1
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
32.9
33.9
36.5
37.5
37.9
67.1
66.1
63.5
62.5
62.1
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
39.0
41.0
43.3
46.0
47.1
47.1
61.0
59.0
56.7
54.0
52.9
52.9
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
91
Drug Expenditure in Canada, 1985 to 2010
Table B Sask.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2010
Provincial
Federal
Year
Sask.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
65.90
78.76
65.64
61.28
73.37
6.11
6.89
7.48
9.47
11.97
0.14
0.14
0.20
0.32
0.23
-----------
72.15
85.79
73.32
71.08
85.58
-----------
-----------
26.16
32.80
41.13
52.00
66.00
98.31
118.59
114.45
123.08
151.57
-----------
-----------
34.43
38.85
44.90
56.67
71.80
1990
1991
1992
1993
1994
88.11
93.26
84.66
57.37
55.63
14.37
16.75
18.90
22.26
24.80
0.26
0.27
0.33
0.44
0.43
-----------
102.73
110.29
103.88
80.07
80.85
-----------
-----------
78.97
89.00
99.15
125.84
139.94
181.70
199.30
203.03
205.90
220.79
----40.47
49.53
51.18
----35.45
44.64
45.12
73.85
72.76
75.92
94.17
96.29
1995
1996
1997
1998
1999
62.89
65.33
68.04
77.57
87.81
27.57
28.25
30.62
33.12
38.23
0.49
0.80
0.83
0.91
1.12
-----------
90.94
94.39
99.49
111.61
127.15
-----------
-----------
144.72
145.37
158.31
164.51
171.45
235.66
239.76
257.80
276.12
298.60
49.43
46.51
48.02
46.83
52.05
44.05
44.00
46.46
45.92
47.95
93.48
90.51
94.48
92.75
100.01
2000
2001
2002
2003
2004
99.38
116.26
134.44
152.23
168.98
41.95
48.10
55.48
62.83
65.19
1.31
1.56
1.90
2.18
2.55
-----------
142.64
165.92
191.82
217.24
236.72
-----------
-----------
184.19
216.10
223.47
253.61
275.48
326.83
382.02
415.28
470.85
512.20
55.45
57.12
58.36
57.69
60.72
50.65
50.52
51.52
50.26
52.11
106.09
107.64
109.88
107.95
112.84
2005
2006
2007
2008
2009 f
2010 f
187.28
203.49
241.01
265.37
300.90
312.04
68.87
73.72
75.68
77.42
77.45
83.60
2.70
2.92
3.01
3.73
3.43
3.47
-------------
258.85
280.13
319.70
346.52
381.78
399.11
-------------
-------------
289.02
284.76
300.90
285.34
298.61
310.14
547.87
564.90
620.61
631.86
680.39
709.25
62.36
63.51
65.20
68.11
73.56
76.82
53.97
54.44
53.23
53.76
56.45
60.53
116.33
117.95
118.43
121.88
130.01
137.35
1985
1986
1987
1988
1989
--19.5
-16.7
-6.6
19.7
--12.7
8.5
26.6
26.4
--2.1
41.9
59.6
-28.3
-----------
--18.9
-14.5
-3.1
20.4
-----------
-----------
--25.4
25.4
26.4
26.9
--20.6
-3.5
7.5
23.2
-----------
-----------
--12.8
15.6
26.2
26.7
1990
1991
1992
1993
1994
20.1
5.9
-9.2
-32.2
-3.0
20.0
16.6
12.8
17.8
11.4
11.1
5.9
20.1
32.6
-2.4
-----------
20.0
7.4
-5.8
-22.9
1.0
-----------
-----------
19.7
12.7
11.4
26.9
11.2
19.9
9.7
1.9
1.4
7.2
------22.4
3.3
------25.9
1.1
2.8
-1.5
4.3
24.0
2.3
1995
1996
1997
1998
1999
13.1
3.9
4.1
14.0
13.2
11.1
2.5
8.4
8.2
15.4
15.6
62.3
4.4
9.7
22.3
-----------
12.5
3.8
5.4
12.2
13.9
-----------
-----------
3.4
0.5
8.9
3.9
4.2
6.7
1.7
7.5
7.1
8.1
-3.4
-5.9
3.3
-2.5
11.1
-2.4
-0.1
5.6
-1.2
4.4
-2.9
-3.2
4.4
-1.8
7.8
2000
2001
2002
2003
2004
13.2
17.0
15.6
13.2
11.0
9.8
14.6
15.3
13.3
3.7
17.2
19.4
21.4
14.6
17.2
-----------
12.2
16.3
15.6
13.3
9.0
-----------
-----------
7.4
17.3
3.4
13.5
8.6
9.5
16.9
8.7
13.4
8.8
6.5
3.0
2.2
-1.2
5.3
5.6
-0.3
2.0
-2.4
3.7
6.1
1.5
2.1
-1.8
4.5
2005
2006
2007
2008
2009 f
2010 f
10.8
8.7
18.4
10.1
13.4
3.7
5.6
7.1
2.7
2.3
0.0
7.9
5.9
8.1
3.0
23.9
-7.9
1.0
-------------
9.3
8.2
14.1
8.4
10.2
4.5
-------------
-------------
4.9
-1.5
5.7
-5.2
4.6
3.9
7.0
3.1
9.9
1.8
7.7
4.2
2.7
1.8
2.7
4.5
8.0
4.4
3.6
0.9
-2.2
1.0
5.0
7.2
3.1
1.4
0.4
2.9
6.7
5.6
1985
1986
1987
1988
1989
--16.7
-21.4
-11.2
15.2
--9.9
3.7
22.1
21.9
---0.7
37.2
55.1
-32.9
-----------
--16.1
-19.3
-7.6
15.8
-----------
-----------
--22.6
20.7
21.9
22.4
--17.8
-8.2
3.0
18.6
-----------
-----------
--10.0
10.8
21.7
22.1
1990
1991
1992
1993
1994
17.1
3.1
-10.5
-33.7
-4.1
17.0
13.8
11.5
16.3
10.3
8.1
3.1
18.9
31.1
-3.5
-----------
17.0
4.6
-7.1
-24.4
-0.1
-----------
-----------
16.6
10.0
10.1
25.5
10.1
16.8
6.9
0.6
0.0
6.1
------20.9
2.2
------24.5
0.0
-0.2
-4.2
3.1
22.6
1.2
1995
1996
1997
1998
1999
10.7
2.2
3.2
14.4
11.4
8.8
0.8
7.4
8.6
13.6
13.3
60.6
3.4
10.1
20.5
-----------
10.1
2.1
4.4
12.6
12.1
-----------
-----------
1.1
-1.2
7.9
4.4
2.4
4.4
0.1
6.5
7.5
6.3
-5.7
-7.6
2.3
-2.0
9.3
-4.7
-1.8
4.6
-0.7
2.6
-5.3
-4.8
3.4
-1.4
6.0
2000
2001
2002
2003
2004
9.1
15.6
14.6
10.3
8.4
5.7
13.3
14.3
10.4
1.2
13.1
18.0
20.4
11.7
14.6
-----------
8.1
15.0
14.6
10.4
6.4
-----------
-----------
3.3
16.0
2.4
10.6
6.0
5.4
15.5
7.7
10.5
6.2
2.4
1.7
1.1
-4.0
2.7
1.5
-1.6
0.9
-5.3
1.1
2.0
0.1
1.0
-4.7
1.9
2005
2006
2007
2008
2009 f
2010 f
7.9
5.8
15.1
5.5
15.3
1.6
2.7
4.2
-0.7
-2.4
1.9
5.8
3.0
5.2
-0.4
19.2
-6.0
-1.1
-------------
6.4
5.3
10.8
3.7
12.1
2.4
-------------
-------------
2.0
-4.4
2.3
-9.8
6.5
1.7
4.0
0.2
6.5
-2.8
9.6
2.1
-0.2
-1.1
-0.7
-0.2
9.9
2.3
0.6
-2.0
-5.5
-3.7
6.9
5.1
0.2
-1.5
-2.9
-1.7
8.6
3.5
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
92
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Sask.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
Year
(1997 = 100)
1985
1986
1987
1988
1989
72.15
85.79
73.32
71.08
85.58
60.60
71.65
86.03
108.66
137.80
132.75
157.44
159.35
179.74
223.37
1,165.85
1,288.21
1,328.72
1,428.29
1,598.43
324.93
366.97
383.01
359.28
415.71
1,490.78
1,655.19
1,711.73
1,787.57
2,014.15
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
102.73
110.29
103.88
80.07
80.85
152.81
161.76
175.07
220.01
236.23
255.54
272.06
278.95
300.07
317.09
1,779.42
1,824.01
1,812.37
1,716.06
1,762.05
456.84
489.59
503.84
570.20
600.67
2,236.27
2,313.60
2,316.20
2,286.26
2,362.72
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
90.94
94.39
99.49
111.61
127.15
238.20
235.89
252.79
257.26
271.46
329.14
330.27
352.28
368.86
398.61
1,795.42
1,827.39
1,941.01
2,067.33
2,217.77
612.84
615.97
668.05
661.74
714.53
2,408.26
2,443.36
2,609.05
2,729.07
2,932.30
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
142.64
165.92
191.82
217.24
236.72
290.28
323.74
333.35
361.56
388.31
432.93
489.66
525.17
578.80
625.04
2,362.85
2,581.17
2,730.52
2,902.53
3,113.36
767.94
869.48
902.69
976.39
1,026.59
3,130.79
3,450.65
3,633.21
3,878.91
4,139.95
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
258.85
280.13
319.70
346.52
381.78
399.11
405.36
402.71
419.34
407.22
428.62
447.49
664.20
682.85
739.04
753.74
810.40
846.60
3,399.68
3,623.53
3,877.41
4,162.95
4,401.86
4,551.31
1,060.37
1,168.72
1,212.98
1,218.86
1,286.45
1,336.25
4,460.05
4,792.25
5,090.38
5,381.81
5,688.31
5,887.56
117.4
120.8
124.8
130.6
128.2
130.9
1985
1986
1987
1988
1989
--18.9
-14.5
-3.1
20.4
--18.2
20.1
26.3
26.8
--18.6
1.2
12.8
24.3
--10.5
3.1
7.5
11.9
--12.9
4.4
-6.2
15.7
--11.0
3.4
4.4
12.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
20.0
7.4
-5.8
-22.9
1.0
10.9
5.9
8.2
25.7
7.4
14.4
6.5
2.5
7.6
5.7
11.3
2.5
-0.6
-5.3
2.7
9.9
7.2
2.9
13.2
5.3
11.0
3.5
0.1
-1.3
3.3
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
12.5
3.8
5.4
12.2
13.9
0.8
-1.0
7.2
1.8
5.5
3.8
0.3
6.7
4.7
8.1
1.9
1.8
6.2
6.5
7.3
2.0
0.5
8.5
-0.9
8.0
1.9
1.5
6.8
4.6
7.4
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
12.2
16.3
15.6
13.3
9.0
6.9
11.5
3.0
8.5
7.4
8.6
13.1
7.3
10.2
8.0
6.5
9.2
5.8
6.3
7.3
7.5
13.2
3.8
8.2
5.1
6.8
10.2
5.3
6.8
6.7
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
9.3
8.2
14.1
8.4
10.2
4.5
4.4
-0.7
4.1
-2.9
5.3
4.4
6.3
2.8
8.2
2.0
7.5
4.5
9.2
6.6
7.0
7.4
5.7
3.4
3.3
10.2
3.8
0.5
5.5
3.9
7.7
7.4
6.2
5.7
5.7
3.5
2.9
2.9
3.3
4.7
-1.9
2.1
Sask.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--16.1
-19.3
-7.6
15.8
--15.4
15.3
21.8
22.2
--15.8
-3.5
8.3
19.7
--7.7
-1.6
3.0
7.3
--10.1
-0.4
-10.7
11.1
--8.2
-1.3
-0.1
8.1
1990
1991
1992
1993
1994
17.0
4.6
-7.1
-24.4
-0.1
7.9
3.1
7.0
24.2
6.3
11.4
3.7
1.3
6.1
4.6
8.3
-0.3
-1.9
-6.8
1.6
6.9
4.4
1.6
11.7
4.2
8.0
0.7
-1.1
-2.7
2.2
1995
1996
1997
1998
1999
10.1
2.1
4.4
12.6
12.1
-1.5
-2.6
6.2
2.2
3.7
1.5
-1.3
5.7
5.1
6.3
-0.4
0.1
5.2
6.9
5.5
-0.3
-1.2
7.5
-0.5
6.2
-0.4
-0.2
5.8
5.0
5.6
2000
2001
2002
2003
2004
8.1
15.0
14.6
10.4
6.4
2.8
10.2
1.9
5.6
4.8
4.5
11.8
6.2
7.3
5.4
2.4
7.9
4.7
3.4
4.7
3.4
11.9
2.8
5.3
2.6
2.7
8.9
4.2
3.9
4.1
2005
2006
2007
2008
2009 f
2010 f
6.4
5.3
10.8
3.7
12.1
2.4
1.5
-3.5
0.8
-7.5
7.1
2.3
3.3
-0.1
4.9
-2.7
9.4
2.3
6.3
3.7
3.7
2.7
7.6
1.3
0.4
7.3
0.5
-4.2
7.4
1.7
4.8
4.6
2.9
1.1
7.6
1.4
f: forecast.
Canadian Institute for Health Information, 2010.
93
Drug Expenditure in Canada, 1985 to 2010
Table B Alta.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Alberta, 1985 to 2010
Provincial
Federal
Year
Alta.
Prescribed Drugs
Public
Private
Insurers*
Out-ofSocial Security Funds
Subtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
69.5
83.2
95.7
108.0
159.7
6.4
7.0
7.4
9.1
11.1
0.9
1.2
1.5
1.6
1.8
-----------
76.7
91.4
104.6
118.7
172.7
-----------
-----------
134.5
147.9
153.1
172.6
194.5
211.2
239.3
257.7
291.3
367.2
-----------
-----------
113.1
128.1
148.5
163.3
179.6
1990
1991
1992
1993
1994
179.5
189.2
205.6
205.8
208.1
13.2
15.3
17.1
20.4
22.8
2.2
2.7
3.0
3.7
3.3
-----------
194.9
207.1
225.6
229.9
234.2
-----------
-----------
219.0
241.2
256.8
297.0
309.4
413.9
448.3
482.4
526.9
543.7
----103.3
114.2
119.3
----91.2
98.7
106.1
184.3
192.8
194.4
213.0
225.4
1995
1996
1997
1998
1999
212.5
232.6
254.8
278.1
328.2
26.0
26.3
29.3
32.8
41.2
3.1
3.5
3.5
4.2
5.2
-----------
241.5
262.4
287.6
315.0
374.6
-----------
-----------
323.6
360.2
403.5
430.1
494.4
565.1
622.6
691.1
745.1
869.1
119.8
128.3
144.5
153.1
167.1
108.9
112.5
125.9
135.0
136.7
228.6
240.8
270.4
288.1
303.8
2000
2001
2002
2003
2004
387.1
451.0
515.2
588.2
646.8
45.1
51.4
57.7
64.9
67.8
5.7
7.7
8.7
10.2
10.9
-----------
437.8
510.1
581.7
663.2
725.5
-----------
-----------
556.5
617.5
686.9
754.3
800.9
994.3
1,127.7
1,268.6
1,417.5
1,526.4
173.4
190.6
199.0
220.0
236.8
150.0
160.8
169.6
177.3
187.2
323.4
351.4
368.6
397.3
424.0
709.3
758.9
792.5
827.7
933.4
1,002.4
71.6
75.3
76.8
76.9
77.3
77.5
10.9
11.6
11.3
11.4
10.9
11.1
-------------
791.7
845.8
880.6
916.0
1,021.6
1,091.0
-------------
-------------
848.5
995.1
1,045.1
1,118.0
1,173.5
1,237.1
1,640.2
1,840.9
1,925.7
2,034.0
2,195.1
2,328.0
240.8
270.6
292.0
302.1
320.3
339.8
194.9
212.9
222.7
227.6
231.7
256.0
435.6
483.6
514.7
529.7
552.1
595.8
1985
1986
1987
1988
1989
--19.8
15.1
12.7
48.0
--9.8
6.1
22.8
22.5
--33.7
23.4
13.0
10.2
-----------
--19.1
14.5
13.5
45.5
-----------
-----------
--10.0
3.5
12.7
12.7
--13.3
7.7
13.0
26.1
-----------
-----------
--13.2
16.0
10.0
10.0
1990
1991
1992
1993
1994
12.4
5.4
8.7
0.1
1.1
18.0
16.1
11.8
19.6
11.9
22.6
19.6
11.9
23.9
-11.4
-----------
12.9
6.3
8.9
1.9
1.9
-----------
-----------
12.6
10.1
6.5
15.7
4.2
12.7
8.3
7.6
9.2
3.2
------10.6
4.5
------8.3
7.4
2.7
4.6
0.8
9.5
5.8
1995
1996
1997
1998
1999
2.1
9.5
9.6
9.1
18.0
13.7
1.3
11.5
11.8
25.8
-5.1
11.9
-0.3
21.3
22.9
-----------
3.1
8.6
9.6
9.5
18.9
-----------
-----------
4.6
11.3
12.0
6.6
15.0
3.9
10.2
11.0
7.8
16.6
0.4
7.1
12.6
6.0
9.2
2.6
3.3
11.9
7.2
1.3
1.4
5.3
12.3
6.5
5.5
2000
2001
2002
2003
2004
17.9
16.5
14.2
14.2
10.0
9.2
14.1
12.2
12.4
4.5
9.8
36.1
13.6
16.2
6.9
-----------
16.9
16.5
14.0
14.0
9.4
-----------
-----------
12.6
11.0
11.2
9.8
6.2
14.4
13.4
12.5
11.7
7.7
3.8
9.9
4.4
10.5
7.6
9.7
7.3
5.4
4.6
5.6
6.4
8.7
4.9
7.8
6.7
2005
2006
2007
2008
2009 f
2010 f
9.7
7.0
4.4
4.4
12.8
7.4
5.6
5.2
2.0
0.2
0.5
0.2
0.1
6.7
-2.6
0.6
-4.2
1.7
-------------
9.1
6.8
4.1
4.0
11.5
6.8
-------------
-------------
5.9
17.3
5.0
7.0
5.0
5.4
7.5
12.2
4.6
5.6
7.9
6.1
1.7
12.4
7.9
3.4
6.1
6.1
4.1
9.3
4.6
2.2
1.8
10.5
2.7
11.0
6.4
2.9
4.2
7.9
1985
1986
1987
1988
1989
21.4
22.6
23.6
23.7
29.2
2.0
1.9
1.8
2.0
2.0
0.3
0.3
0.4
0.4
0.3
-----------
23.7
24.9
25.8
26.1
31.6
-----------
-----------
41.5
40.3
37.7
38.0
35.6
65.1
65.1
63.4
64.1
67.2
-----------
-----------
34.9
34.9
36.6
35.9
32.8
1990
1991
1992
1993
1994
30.0
29.5
30.4
27.8
27.1
2.2
2.4
2.5
2.8
3.0
0.4
0.4
0.4
0.5
0.4
-----------
32.6
32.3
33.3
31.1
30.5
-----------
-----------
36.6
37.6
37.9
40.1
40.2
69.2
69.9
71.3
71.2
70.7
----15.3
15.4
15.5
----13.5
13.3
13.8
30.8
30.1
28.7
28.8
29.3
1995
1996
1997
1998
1999
26.8
26.9
26.5
26.9
28.0
3.3
3.0
3.1
3.2
3.5
0.4
0.4
0.4
0.4
0.4
-----------
30.4
30.4
29.9
30.5
31.9
-----------
-----------
40.8
41.7
42.0
41.6
42.2
71.2
72.1
71.9
72.1
74.1
15.1
14.9
15.0
14.8
14.2
13.7
13.0
13.1
13.1
11.7
28.8
27.9
28.1
27.9
25.9
2000
2001
2002
2003
2004
29.4
30.5
31.5
32.4
33.2
3.4
3.5
3.5
3.6
3.5
0.4
0.5
0.5
0.6
0.6
-----------
33.2
34.5
35.5
36.5
37.2
-----------
-----------
42.2
41.7
42.0
41.6
41.1
75.5
76.2
77.5
78.1
78.3
13.2
12.9
12.2
12.1
12.1
11.4
10.9
10.4
9.8
9.6
24.5
23.8
22.5
21.9
21.7
2005
34.2
3.4
0.5
--2006
32.6
3.2
0.5
--2007
32.5
3.1
0.5
--2008
32.3
3.0
0.4
--2009 f
34.0
2.8
0.4
--2010 f
34.3
2.7
0.4
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
38.1
36.4
36.1
35.7
37.2
37.3
-------------
-------------
40.9
42.8
42.8
43.6
42.7
42.3
79.0
79.2
78.9
79.3
79.9
79.6
11.6
11.6
12.0
11.8
11.7
11.6
9.4
9.2
9.1
8.9
8.4
8.8
21.0
20.8
21.1
20.7
20.1
20.4
2005
2006
2007
2008
2009 f
2010 f
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
94
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Alta.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Alberta, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
76.7
91.4
104.6
118.7
172.7
247.6
276.0
301.6
335.9
374.0
324.3
367.4
406.2
454.6
546.7
3,239.1
3,537.9
3,514.4
3,645.6
4,031.0
831.3
910.6
985.5
1,184.9
1,318.8
4,070.4
4,448.5
4,499.9
4,830.6
5,349.8
2.4
2.6
3.0
3.3
4.3
29.8
30.3
30.6
28.3
28.4
8.0
8.3
9.0
9.4
10.2
1990
1991
1992
1993
1994
194.9
207.1
225.6
229.9
234.2
403.4
434.0
451.2
510.0
534.8
598.3
641.1
676.9
739.8
769.1
4,326.9
4,557.5
4,846.4
4,800.5
4,527.8
1,422.5
1,505.1
1,584.2
1,719.9
1,785.7
5,749.4
6,062.5
6,430.7
6,520.4
6,313.4
4.5
4.5
4.7
4.8
5.2
28.4
28.8
28.5
29.7
30.0
10.4
10.6
10.5
11.3
12.2
1995
1996
1997
1998
1999
241.5
262.4
287.6
315.0
374.6
552.2
601.0
673.9
718.1
798.3
793.8
863.4
961.5
1,033.2
1,172.9
4,283.5
4,466.5
4,942.0
5,354.0
6,140.2
1,809.0
1,854.2
2,140.1
2,251.1
2,539.9
6,092.5
6,320.6
7,082.1
7,605.1
8,680.1
5.6
5.9
5.8
5.9
6.1
30.5
32.4
31.5
31.9
31.4
13.0
13.7
13.6
13.6
13.5
2000
2001
2002
2003
2004
437.8
510.1
581.7
663.2
725.5
879.9
968.9
1,055.5
1,151.6
1,224.9
1,317.7
1,479.1
1,637.2
1,814.8
1,950.4
6,792.9
7,745.0
8,456.7
9,108.2
9,965.6
2,822.9
3,258.1
3,385.4
3,563.2
3,928.7
9,615.8
11,003.2
11,842.1
12,671.3
13,894.3
6.4
6.6
6.9
7.3
7.3
31.2
29.7
31.2
32.3
31.2
13.7
13.4
13.8
14.3
14.0
791.7
845.8
880.6
916.0
1,021.6
1,091.0
1,284.1
1,478.7
1,559.8
1,647.7
1,725.5
1,832.8
2,075.8
2,324.5
2,440.4
2,563.6
2,747.1
2,923.8
11,065.3
12,181.7
13,390.4
14,891.8
16,158.2
17,284.6
4,177.2
4,889.3
5,177.9
5,603.9
5,859.8
6,298.7
15,242.5
17,071.0
18,568.3
20,495.7
22,018.0
23,583.3
7.2
6.9
6.6
6.2
6.3
6.3
30.7
30.2
30.1
29.4
29.4
29.1
13.6
13.6
13.1
12.5
12.5
12.4
1985
1986
1987
1988
1989
--19.1
14.5
13.5
45.5
--11.5
9.3
11.3
11.4
--13.3
10.6
11.9
20.3
--9.2
-0.7
3.7
10.6
--9.5
8.2
20.2
11.3
--9.3
1.2
7.3
10.7
1990
1991
1992
1993
1994
12.9
6.3
8.9
1.9
1.9
7.8
7.6
4.0
13.0
4.9
9.4
7.2
5.6
9.3
4.0
7.3
5.3
6.3
-0.9
-5.7
7.9
5.8
5.3
8.6
3.8
7.5
5.4
6.1
1.4
-3.2
1995
1996
1997
1998
1999
3.1
8.6
9.6
9.5
18.9
3.3
8.8
12.1
6.6
11.2
3.2
8.8
11.4
7.5
13.5
-5.4
4.3
10.6
8.3
14.7
1.3
2.5
15.4
5.2
12.8
-3.5
3.7
12.0
7.4
14.1
2000
2001
2002
2003
2004
16.9
16.5
14.0
14.0
9.4
10.2
10.1
8.9
9.1
6.4
12.3
12.2
10.7
10.8
7.5
10.6
14.0
9.2
7.7
9.4
11.1
15.4
3.9
5.3
10.3
10.8
14.4
7.6
7.0
9.7
2005
2006
2007
2008
2009 f
2010 f
9.1
6.8
4.1
4.0
11.5
6.8
4.8
15.2
5.5
5.6
4.7
6.2
6.4
12.0
5.0
5.1
7.2
6.4
11.0
10.1
9.9
11.2
8.5
7.0
6.3
17.0
5.9
8.2
4.6
7.5
9.7
12.0
8.8
10.4
7.4
7.1
2005
2006
2007
2008
2009 f
2010 f
Alta.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
23.7
24.9
25.8
26.1
31.6
76.3
75.1
74.2
73.9
68.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.6
32.3
33.3
31.1
30.5
67.4
67.7
66.7
68.9
69.5
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
30.4
30.4
29.9
30.5
31.9
69.6
69.6
70.1
69.5
68.1
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
33.2
34.5
35.5
36.5
37.2
66.8
65.5
64.5
63.5
62.8
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
38.1
36.4
36.1
35.7
37.2
37.3
61.9
63.6
63.9
64.3
62.8
62.7
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
95
Drug Expenditure in Canada, 1985 to 2010
Table B Alta.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Alberta, 1985 to 2010
Provincial
Federal
Year
Alta.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
28.91
34.23
39.32
43.98
64.01
2.65
2.87
3.04
3.71
4.47
0.37
0.48
0.60
0.67
0.73
-----------
31.93
37.59
42.96
48.36
69.20
-----------
-----------
55.96
60.86
62.87
70.31
77.94
87.89
98.44
105.83
118.67
147.14
-----------
-----------
47.07
52.69
60.99
66.53
71.96
1990
1991
1992
1993
1994
70.48
72.98
78.09
77.14
77.07
5.16
5.89
6.48
7.65
8.46
0.87
1.02
1.13
1.38
1.21
-----------
76.52
79.89
85.70
86.18
86.74
-----------
-----------
86.00
93.03
97.53
111.35
114.58
162.51
172.92
183.24
197.53
201.32
----39.22
42.82
44.18
----34.62
37.01
39.28
72.36
74.37
73.84
79.83
83.46
1995
1996
1997
1998
1999
77.70
83.81
90.05
95.90
111.14
9.50
9.49
10.37
11.31
13.97
1.13
1.25
1.22
1.45
1.74
-----------
88.33
94.55
101.64
108.66
126.85
-----------
-----------
118.34
129.79
142.56
148.33
167.42
206.67
224.34
244.20
256.98
294.27
43.80
46.23
51.05
52.80
56.59
39.81
40.53
44.49
46.55
46.29
83.62
86.77
95.55
99.36
102.88
2000
2001
2002
2003
2004
128.81
147.55
165.33
186.05
201.62
15.00
16.82
18.51
20.52
21.13
1.88
2.52
2.81
3.22
3.39
-----------
145.69
166.89
186.65
209.79
226.14
-----------
-----------
185.19
202.01
220.43
238.59
249.65
330.88
368.91
407.08
448.38
475.78
57.71
62.35
63.86
69.59
73.81
49.90
52.62
54.41
56.09
58.34
107.62
114.96
118.28
125.68
132.16
2005
2006
2007
2008
2009 f
2010 f
216.20
221.83
225.59
230.17
253.11
266.35
21.81
22.00
21.85
21.40
20.97
20.59
3.31
3.39
3.22
3.16
2.95
2.95
-------------
241.33
247.22
250.65
254.73
277.04
289.89
-------------
-------------
258.63
290.87
297.50
310.92
318.21
328.70
499.96
538.09
548.15
565.65
595.25
618.59
73.38
79.10
83.12
84.00
86.87
90.30
59.40
62.24
63.39
63.29
62.84
68.01
132.78
141.34
146.50
147.29
149.70
158.31
1985
1986
1987
1988
1989
--18.4
14.9
11.9
45.5
--8.6
5.9
21.8
20.5
--32.2
23.2
12.1
8.4
-----------
--17.7
14.3
12.6
43.1
-----------
-----------
--8.7
3.3
11.8
10.9
--12.0
7.5
12.1
24.0
-----------
-----------
--11.9
15.8
9.1
8.2
1990
1991
1992
1993
1994
10.1
3.5
7.0
-1.2
-0.1
15.6
14.0
10.1
18.0
10.5
20.1
17.5
10.2
22.3
-12.5
-----------
10.6
4.4
7.3
0.6
0.6
-----------
-----------
10.3
8.2
4.8
14.2
2.9
10.4
6.4
6.0
7.8
1.9
------9.2
3.2
------6.9
6.1
0.6
2.8
-0.7
8.1
4.5
1995
1996
1997
1998
1999
0.8
7.9
7.4
6.5
15.9
12.3
-0.2
9.3
9.1
23.5
-6.3
10.3
-2.2
18.4
20.6
-----------
1.8
7.0
7.5
6.9
16.7
-----------
-----------
3.3
9.7
9.8
4.0
12.9
2.7
8.6
8.9
5.2
14.5
-0.8
5.5
10.4
3.4
7.2
1.4
1.8
9.8
4.6
-0.6
0.2
3.8
10.1
4.0
3.6
2000
2001
2002
2003
2004
15.9
14.6
12.0
12.5
8.4
7.4
12.2
10.1
10.8
3.0
7.9
33.8
11.4
14.6
5.4
-----------
14.9
14.6
11.8
12.4
7.8
-----------
-----------
10.6
9.1
9.1
8.2
4.6
12.4
11.5
10.3
10.1
6.1
2.0
8.0
2.4
9.0
6.1
7.8
5.4
3.4
3.1
4.0
4.6
6.8
2.9
6.3
5.2
2005
2006
2007
2008
2009 f
2010 f
7.2
2.6
1.7
2.0
10.0
5.2
3.3
0.9
-0.7
-2.1
-2.0
-1.8
-2.2
2.3
-5.1
-1.7
-6.6
-0.3
-------------
6.7
2.4
1.4
1.6
8.8
4.6
-------------
-------------
3.6
12.5
2.3
4.5
2.3
3.3
5.1
7.6
1.9
3.2
5.2
3.9
-0.6
7.8
5.1
1.1
3.4
3.9
1.8
4.8
1.8
-0.2
-0.7
8.2
0.5
6.4
3.7
0.5
1.6
5.7
1985
1986
1987
1988
1989
--15.6
10.1
7.3
41.0
--5.8
1.1
17.3
15.9
--29.4
18.5
7.6
3.8
-----------
--14.9
9.5
8.1
38.5
-----------
-----------
--5.9
-1.4
7.3
6.3
--9.2
2.8
7.6
19.4
-----------
-----------
--9.1
11.0
4.6
3.6
1990
1991
1992
1993
1994
7.1
0.8
5.7
-2.6
-1.2
12.6
11.3
8.8
16.6
9.4
17.1
14.8
8.9
20.8
-13.6
-----------
7.5
1.6
6.0
-0.9
-0.4
-----------
-----------
7.3
5.4
3.6
12.7
1.8
7.4
3.6
4.7
6.4
0.8
------7.7
2.1
------5.5
5.0
-2.5
0.0
-2.0
6.7
3.4
1995
1996
1997
1998
1999
-1.5
6.2
6.5
6.9
14.1
10.0
-1.9
8.3
9.5
21.7
-8.6
8.6
-3.2
18.8
18.8
-----------
-0.5
5.4
6.5
7.3
14.9
-----------
-----------
0.9
8.0
8.8
4.5
11.1
0.3
6.9
7.9
5.7
12.7
-3.2
3.9
9.4
3.9
5.4
-1.0
0.1
8.8
5.1
-2.4
-2.1
2.1
9.1
4.4
1.7
2000
2001
2002
2003
2004
11.8
13.2
11.0
9.6
5.8
3.3
10.8
9.0
7.9
0.4
3.8
32.4
10.4
11.7
2.8
-----------
10.7
13.2
10.8
9.5
5.2
-----------
-----------
6.5
7.7
8.1
5.3
2.0
8.3
10.1
9.3
7.2
3.5
-2.1
6.7
1.4
6.1
3.5
3.7
4.1
2.4
0.2
1.4
0.5
5.5
1.8
3.4
2.6
2005
2006
2007
2008
2009 f
2010 f
4.2
-0.1
-1.9
-2.7
12.1
1.8
0.2
-1.9
-4.3
-6.8
0.1
-5.2
-5.2
-0.4
-8.7
-6.5
-4.5
-3.7
-------------
3.7
-0.3
-2.2
-3.1
10.9
1.2
-------------
-------------
0.6
9.8
-1.3
-0.2
4.5
-0.1
2.1
4.9
-1.7
-1.5
7.3
0.5
-3.6
5.1
1.5
-3.7
5.5
0.5
-1.2
2.1
-1.8
-4.9
1.4
4.8
-2.5
3.7
0.1
-4.2
3.7
2.3
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
96
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Alta.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Alberta, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Year
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
(1997 = 100)
1985
1986
1987
1988
1989
31.93
37.59
42.96
48.36
69.20
103.03
113.54
123.86
136.84
149.90
134.95
151.13
166.81
185.20
219.10
1,347.98
1,455.36
1,443.08
1,485.33
1,615.48
345.94
374.58
404.68
482.78
528.50
1,693.92
1,829.95
1,847.76
1,968.11
2,143.98
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
76.52
79.89
85.70
86.18
86.74
158.36
167.40
171.37
191.18
198.04
234.87
247.29
257.08
277.36
284.78
1,698.71
1,757.86
1,840.71
1,799.67
1,676.53
558.47
580.52
601.71
644.78
661.19
2,257.18
2,338.38
2,442.42
2,444.45
2,337.72
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
88.33
94.55
101.64
108.66
126.85
201.95
216.56
238.11
247.68
270.31
290.28
311.11
339.75
356.34
397.16
1,566.45
1,609.44
1,746.27
1,846.54
2,079.12
661.54
668.13
756.21
776.39
860.03
2,227.99
2,277.57
2,502.48
2,622.93
2,939.15
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
145.69
166.89
186.65
209.79
226.14
292.81
316.98
338.71
364.28
381.80
438.50
483.87
525.36
574.06
607.94
2,260.58
2,533.75
2,713.67
2,881.08
3,106.31
939.41
1,065.89
1,086.35
1,127.09
1,224.59
3,199.99
3,599.64
3,800.01
4,008.17
4,330.91
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
241.33
247.22
250.65
254.73
277.04
289.89
391.41
432.21
444.00
458.21
467.92
487.01
632.74
679.43
694.65
712.94
744.95
776.89
3,372.80
3,560.60
3,811.55
4,141.37
4,381.69
4,592.69
1,273.26
1,429.10
1,473.87
1,558.42
1,589.04
1,673.63
4,646.06
4,989.71
5,285.43
5,699.79
5,970.73
6,266.32
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--17.7
14.3
12.6
43.1
--10.2
9.1
10.5
9.5
--12.0
10.4
11.0
18.3
--8.0
-0.8
2.9
8.8
--8.3
8.0
19.3
9.5
--8.0
1.0
6.5
8.9
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
10.6
4.4
7.3
0.6
0.6
5.6
5.7
2.4
11.6
3.6
7.2
5.3
4.0
7.9
2.7
5.2
3.5
4.7
-2.2
-6.8
5.7
3.9
3.7
7.2
2.5
5.3
3.6
4.4
0.1
-4.4
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
1.8
7.0
7.5
6.9
16.7
2.0
7.2
10.0
4.0
9.1
1.9
7.2
9.2
4.9
11.5
-6.6
2.7
8.5
5.7
12.6
0.1
1.0
13.2
2.7
10.8
-4.7
2.2
9.9
4.8
12.1
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
14.9
14.6
11.8
12.4
7.8
8.3
8.3
6.9
7.5
4.8
10.4
10.3
8.6
9.3
5.9
8.7
12.1
7.1
6.2
7.8
9.2
13.5
1.9
3.8
8.7
8.9
12.5
5.6
5.5
8.1
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
6.7
2.4
1.4
1.6
8.8
4.6
2.5
10.4
2.7
3.2
2.1
4.1
4.1
7.4
2.2
2.6
4.5
4.3
8.6
5.6
7.0
8.7
5.8
4.8
4.0
12.2
3.1
5.7
2.0
5.3
7.3
7.4
5.9
7.8
4.8
5.0
3.0
2.7
3.6
4.7
-2.1
3.4
Alta.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--14.9
9.5
8.1
38.5
--7.4
4.3
6.0
5.0
--9.2
5.6
6.5
13.7
--5.2
-5.6
-1.6
4.2
--5.5
3.3
14.8
4.9
--5.2
-3.8
2.0
4.4
1990
1991
1992
1993
1994
7.5
1.6
6.0
-0.9
-0.4
2.6
3.0
1.1
10.1
2.5
4.2
2.5
2.7
6.5
1.6
2.1
0.7
3.5
-3.7
-7.9
2.6
1.2
2.4
5.7
1.4
2.3
0.8
3.2
-1.4
-5.5
1995
1996
1997
1998
1999
-0.5
5.4
6.5
7.3
14.9
-0.4
5.6
9.0
4.5
7.3
-0.4
5.5
8.2
5.3
9.6
-8.9
1.1
7.5
6.2
10.8
-2.3
-0.7
12.2
3.1
9.0
-7.0
0.6
8.9
5.3
10.2
2000
2001
2002
2003
2004
10.7
13.2
10.8
9.5
5.2
4.2
6.9
5.8
4.7
2.2
6.3
9.0
7.5
6.4
3.3
4.6
10.7
6.1
3.3
5.2
5.1
12.1
0.9
0.9
6.1
4.8
11.1
4.5
2.6
5.5
2005
2006
2007
2008
2009 f
2010 f
3.7
-0.3
-2.2
-3.1
10.9
1.2
-0.5
7.7
-0.9
-1.5
4.2
0.7
1.1
4.7
-1.4
-2.1
6.6
0.9
5.6
2.9
3.5
3.9
7.9
1.4
1.0
9.5
-0.5
1.0
4.1
1.9
4.3
4.7
2.3
3.1
6.9
1.5
f: forecast.
Canadian Institute for Health Information, 2010.
97
Drug Expenditure in Canada, 1985 to 2010
Table B B.C.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2010
Provincial
Federal
Year
B.C.
Prescribed Drugs
Public
Private
Social Security Funds
Insurers*
Out-ofSubtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
128.5
151.4
153.5
169.8
196.5
7.8
8.6
9.2
14.0
18.0
1.4
1.5
1.7
2.0
2.1
-----------
137.7
161.5
164.4
185.7
216.7
-----------
-----------
121.1
105.6
134.9
159.6
188.9
258.8
267.0
299.2
345.3
405.6
-----------
-----------
157.7
178.5
207.0
219.3
232.3
1990
1991
1992
1993
1994
232.6
275.4
311.8
346.0
339.4
21.2
24.4
26.5
32.1
35.8
2.4
2.7
3.1
3.5
4.0
-----------
256.3
302.4
341.5
381.6
379.2
-----------
-----------
216.8
241.1
268.1
303.1
323.2
473.0
543.5
609.5
684.7
702.5
----149.5
164.4
183.5
----134.7
146.0
156.9
248.6
266.2
284.2
310.4
340.4
1995
1996
1997
1998
1999
349.5
379.4
418.7
457.8
515.6
40.5
44.2
45.3
49.5
54.2
4.2
3.9
4.0
5.1
5.9
-----------
394.1
427.5
468.0
512.4
575.7
-----------
-----------
353.5
374.9
412.2
480.0
505.7
747.6
802.4
880.2
992.4
1,081.5
186.0
192.2
196.5
208.5
226.4
163.8
166.3
172.7
185.0
196.7
349.7
358.4
369.2
393.5
423.1
2000
2001
2002
2003
2004
595.4
659.1
670.3
657.7
700.4
58.2
65.6
76.0
88.0
92.6
6.8
7.4
7.2
7.6
9.0
-----------
660.4
732.1
753.4
753.3
801.9
-----------
-----------
570.1
641.0
759.4
881.4
1,009.6
1,230.5
1,373.1
1,512.8
1,634.7
1,811.5
235.6
245.1
257.5
278.3
295.6
199.6
209.6
220.3
225.5
231.6
435.3
454.7
477.8
503.7
527.2
2005
2006
2007
2008
2009 f
2010 f
750.0
793.8
825.6
856.0
884.3
928.8
96.5
101.4
104.5
107.1
102.3
103.9
9.8
10.8
11.3
12.0
11.5
11.5
-------------
856.3
906.0
941.4
975.0
998.1
1,044.2
-------------
-------------
1,035.5
1,224.0
1,232.4
1,375.4
1,512.6
1,554.3
1,891.8
2,130.0
2,173.8
2,350.4
2,510.6
2,598.6
299.1
308.1
286.1
292.7
308.0
324.3
239.4
244.2
221.3
224.2
231.3
253.0
538.5
552.3
507.4
516.8
539.3
577.3
1985
1986
1987
1988
1989
--17.8
1.4
10.6
15.8
--9.6
7.3
51.5
29.1
--4.7
15.5
16.5
9.0
-----------
--17.2
1.8
13.0
16.7
-----------
-----------
---12.8
27.8
18.4
18.4
--3.2
12.1
15.4
17.5
-----------
-----------
--13.2
16.0
5.9
5.9
1990
1991
1992
1993
1994
18.3
18.4
13.2
11.0
-1.9
17.9
14.6
9.0
21.0
11.6
14.0
10.1
16.1
11.6
14.1
-----------
18.2
18.0
12.9
11.7
-0.6
-----------
-----------
14.7
11.3
11.2
13.1
6.6
16.6
14.9
12.1
12.3
2.6
------10.0
11.6
------8.4
7.4
7.1
7.1
6.8
9.2
9.7
1995
1996
1997
1998
1999
3.0
8.6
10.3
9.4
12.6
12.9
9.1
2.6
9.2
9.6
5.7
-6.0
2.1
25.6
17.2
-----------
3.9
8.5
9.5
9.5
12.4
-----------
-----------
9.4
6.1
10.0
16.4
5.4
6.4
7.3
9.7
12.7
9.0
1.4
3.3
2.3
6.1
8.6
4.4
1.5
3.9
7.1
6.3
2.7
2.5
3.0
6.6
7.5
2000
2001
2002
2003
2004
15.5
10.7
1.7
-1.9
6.5
7.3
12.7
15.8
15.8
5.1
15.1
8.3
-3.0
6.4
17.9
-----------
14.7
10.9
2.9
0.0
6.4
-----------
-----------
12.7
12.4
18.5
16.1
14.5
13.8
11.6
10.2
8.1
10.8
4.1
4.0
5.1
8.1
6.2
1.5
5.0
5.1
2.3
2.7
2.9
4.5
5.1
5.4
4.7
2005
2006
2007
2008
2009 f
2010 f
7.1
5.8
4.0
3.7
3.3
5.0
4.3
5.0
3.1
2.5
-4.4
1.5
8.8
10.4
4.9
5.7
-4.3
0.5
-------------
6.8
5.8
3.9
3.6
2.4
4.6
-------------
-------------
2.6
18.2
0.7
11.6
10.0
2.8
4.4
12.6
2.1
8.1
6.8
3.5
1.2
3.0
-7.2
2.3
5.2
5.3
3.3
2.0
-9.4
1.3
3.2
9.4
2.1
2.6
-8.1
1.9
4.3
7.0
1985
1986
1987
1988
1989
30.9
34.0
30.3
30.1
30.8
1.9
1.9
1.8
2.5
2.8
0.3
0.3
0.3
0.3
0.3
-----------
33.1
36.2
32.5
32.9
34.0
-----------
-----------
29.1
23.7
26.6
28.3
29.6
62.1
59.9
59.1
61.2
63.6
-----------
-----------
37.9
40.1
40.9
38.8
36.4
1990
1991
1992
1993
1994
32.2
34.0
34.9
34.8
32.5
2.9
3.0
3.0
3.2
3.4
0.3
0.3
0.3
0.3
0.4
-----------
35.5
37.3
38.2
38.3
36.4
-----------
-----------
30.0
29.8
30.0
30.5
31.0
65.5
67.1
68.2
68.8
67.4
----16.7
16.5
17.6
----15.1
14.7
15.0
34.5
32.9
31.8
31.2
32.6
1995
1996
1997
1998
1999
31.8
32.7
33.5
33.0
34.3
3.7
3.8
3.6
3.6
3.6
0.4
0.3
0.3
0.4
0.4
-----------
35.9
36.8
37.5
37.0
38.3
-----------
-----------
32.2
32.3
33.0
34.6
33.6
68.1
69.1
70.5
71.6
71.9
16.9
16.6
15.7
15.0
15.0
14.9
14.3
13.8
13.4
13.1
31.9
30.9
29.5
28.4
28.1
2000
2001
2002
2003
2004
35.7
36.1
33.7
30.8
29.9
3.5
3.6
3.8
4.1
4.0
0.4
0.4
0.4
0.4
0.4
---------
39.6
40.1
37.8
35.2
34.3
-----------
-----------
34.2
35.1
38.1
41.2
43.2
73.9
75.1
76.0
76.4
77.5
14.1
13.4
12.9
13.0
12.6
12.0
11.5
11.1
10.5
9.9
26.1
24.9
24.0
23.6
22.5
2005
30.9
4.0
0.4
--2006
29.6
3.8
0.4
--2007
30.8
3.9
0.4
--2008
29.9
3.7
0.4
--2009 f
29.0
3.4
0.4
--2010 f
29.2
3.3
0.4
--* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
35.2
33.8
35.1
34.0
32.7
32.9
-------------
-------------
42.6
45.6
46.0
48.0
49.6
48.9
77.8
79.4
81.1
82.0
82.3
81.8
12.3
11.5
10.7
10.2
10.1
10.2
9.9
9.1
8.3
7.8
7.6
8.0
22.2
20.6
18.9
18.0
17.7
18.2
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
98
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B B.C.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
137.7
161.5
164.4
185.7
216.7
278.8
284.1
341.9
378.9
421.2
416.5
445.6
506.3
564.6
637.9
3,410.1
3,666.0
3,895.3
4,241.2
4,736.0
1,227.1
1,317.2
1,444.9
1,597.1
1,773.0
4,637.3
4,983.3
5,340.3
5,838.3
6,509.0
4.0
4.4
4.2
4.4
4.6
22.7
21.6
23.7
23.7
23.8
9.0
8.9
9.5
9.7
9.8
1990
1991
1992
1993
1994
256.3
302.4
341.5
381.6
379.2
465.4
507.3
552.2
613.5
663.6
721.7
809.7
893.7
995.1
1,042.9
5,386.7
5,967.2
6,477.9
6,869.8
7,237.5
1,986.0
2,159.5
2,291.2
2,427.0
2,533.2
7,372.6
8,126.7
8,769.1
9,296.8
9,770.7
4.8
5.1
5.3
5.6
5.2
23.4
23.5
24.1
25.3
26.2
9.8
10.0
10.2
10.7
10.7
1995
1996
1997
1998
1999
394.1
427.5
468.0
512.4
575.7
703.2
733.3
781.4
873.5
928.8
1,097.3
1,160.9
1,249.4
1,385.9
1,504.6
7,538.4
7,688.7
7,942.6
8,304.5
8,969.4
2,574.3
2,689.4
2,889.4
3,102.8
3,299.8
10,112.7
10,378.1
10,832.0
11,407.3
12,269.2
5.2
5.6
5.9
6.2
6.4
27.3
27.3
27.0
28.2
28.1
10.9
11.2
11.5
12.1
12.3
2000
2001
2002
2003
2004
660.4
732.1
753.4
753.3
801.9
1,005.4
1,095.7
1,237.2
1,385.1
1,536.8
1,665.8
1,827.7
1,990.6
2,138.4
2,338.7
9,825.9
10,820.5
11,452.4
11,924.7
12,229.0
3,556.5
3,815.4
4,162.6
4,405.2
4,840.2
13,382.4
14,635.9
15,614.9
16,329.9
17,069.2
6.7
6.8
6.6
6.3
6.6
28.3
28.7
29.7
31.4
31.8
12.4
12.5
12.7
13.1
13.7
856.3
906.0
941.4
975.0
998.1
1,044.2
1,574.0
1,776.3
1,739.7
1,892.2
2,051.9
2,131.6
2,430.3
2,682.3
2,681.2
2,867.3
3,050.0
3,175.8
13,005.8
13,548.7
14,372.9
15,647.5
16,254.4
17,181.4
5,043.0
5,850.7
5,857.8
6,543.9
6,710.9
7,077.5
18,048.8
19,399.4
20,230.7
22,191.3
22,965.3
24,258.9
6.6
6.7
6.6
6.2
6.1
6.1
31.2
30.4
29.7
28.9
30.6
30.1
13.5
13.8
13.3
12.9
13.3
13.1
1985
1986
1987
1988
1989
--17.2
1.8
13.0
16.7
--1.9
20.3
10.8
11.2
--7.0
13.6
11.5
13.0
--7.5
6.3
8.9
11.7
--7.3
9.7
10.5
11.0
--7.5
7.2
9.3
11.5
1990
1991
1992
1993
1994
18.2
18.0
12.9
11.7
-0.6
10.5
9.0
8.9
11.1
8.2
13.1
12.2
10.4
11.3
4.8
13.7
10.8
8.6
6.0
5.4
12.0
8.7
6.1
5.9
4.4
13.3
10.2
7.9
6.0
5.1
1995
1996
1997
1998
1999
3.9
8.5
9.5
9.5
12.4
6.0
4.3
6.6
11.8
6.3
5.2
5.8
7.6
10.9
8.6
4.2
2.0
3.3
4.6
8.0
1.6
4.5
7.4
7.4
6.3
3.5
2.6
4.4
5.3
7.6
2000
2001
2002
2003
2004
14.7
10.9
2.9
0.0
6.4
8.2
9.0
12.9
12.0
11.0
10.7
9.7
8.9
7.4
9.4
9.5
10.1
5.8
4.1
2.6
7.8
7.3
9.1
5.8
9.9
9.1
9.4
6.7
4.6
4.5
2005
2006
2007
2008
2009 f
2010 f
6.8
5.8
3.9
3.6
2.4
4.6
2.4
12.9
-2.1
8.8
8.4
3.9
3.9
10.4
0.0
6.9
6.4
4.1
6.4
4.2
6.1
8.9
3.9
5.7
4.2
16.0
0.1
11.7
2.6
5.5
5.7
7.5
4.3
9.7
3.5
5.6
2005
2006
2007
2008
2009 f
2010 f
B.C.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
33.1
36.2
32.5
32.9
34.0
66.9
63.8
67.5
67.1
66.0
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
35.5
37.3
38.2
38.3
36.4
64.5
62.7
61.8
61.7
63.6
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
35.9
36.8
37.5
37.0
38.3
64.1
63.2
62.5
63.0
61.7
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
39.6
40.1
37.8
35.2
34.3
60.4
59.9
62.2
64.8
65.7
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
35.2
33.8
35.1
34.0
32.7
32.9
64.8
66.2
64.9
66.0
67.3
67.1
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
99
Drug Expenditure in Canada, 1985 to 2010
Table B B.C.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2010
Provincial
Federal
Year
B.C.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
43.21
50.41
50.32
54.50
61.46
2.63
2.86
3.02
4.48
5.64
0.47
0.49
0.55
0.63
0.67
-----------
46.31
53.75
53.89
59.62
67.77
-----------
-----------
40.72
35.14
44.21
51.23
59.07
87.03
88.89
98.11
110.85
126.84
-----------
-----------
53.01
59.43
67.88
70.39
72.63
1990
1991
1992
1993
1994
70.67
81.63
89.90
96.98
92.34
6.46
7.22
7.65
9.01
9.75
0.74
0.79
0.90
0.97
1.08
-----------
77.87
89.64
98.45
106.96
103.18
-----------
-----------
65.87
71.48
77.29
84.97
87.94
143.74
161.12
175.73
191.93
191.11
----43.10
46.07
49.92
----38.83
40.93
42.69
75.56
78.90
81.93
87.01
92.60
1995
1996
1997
1998
1999
92.52
97.94
106.03
114.95
128.53
10.72
11.40
11.47
12.42
13.52
1.11
1.02
1.02
1.27
1.48
-----------
104.35
110.35
118.52
128.63
143.52
-----------
-----------
93.59
96.76
104.40
120.51
126.07
197.94
207.12
222.92
249.15
269.60
49.24
49.60
49.77
52.34
56.44
43.36
42.91
43.73
46.45
49.04
92.59
92.51
93.50
98.79
105.48
2000
2001
2002
2003
2004
147.40
161.60
162.87
158.27
166.60
14.41
16.09
18.47
21.19
22.02
1.69
1.81
1.74
1.83
2.14
-----------
163.50
179.50
183.07
181.29
190.76
-----------
-----------
141.14
157.17
184.53
212.11
240.15
304.64
336.66
367.60
393.40
430.91
58.34
60.09
62.57
66.96
70.31
49.42
51.39
53.53
54.26
55.10
107.76
111.48
116.10
121.22
125.41
2005
2006
2007
2008
2009 f
2010 f
176.04
187.07
191.59
195.27
198.48
205.04
22.66
23.89
24.25
24.42
22.97
22.94
2.29
2.54
2.63
2.73
2.57
2.54
-------------
201.00
213.50
218.46
222.42
224.02
230.52
-------------
-------------
243.07
288.43
285.97
313.74
339.51
343.13
444.06
501.93
504.43
536.16
563.53
573.65
70.20
72.61
66.38
66.76
69.13
71.59
56.19
57.55
51.35
51.14
51.92
55.84
126.39
130.16
117.73
117.90
121.05
127.43
1985
1986
1987
1988
1989
--16.7
-0.2
8.3
12.8
--8.5
5.7
48.3
25.7
--3.7
13.7
14.1
6.2
-----------
--16.1
0.3
10.6
13.7
-----------
-----------
---13.7
25.8
15.9
15.3
--2.1
10.4
13.0
14.4
-----------
-----------
1990
1991
1992
1993
1994
15.0
15.5
10.1
7.9
-4.8
14.5
11.8
6.0
17.7
8.3
10.8
7.4
12.9
8.5
10.7
-----------
14.9
15.1
9.8
8.6
-3.5
-----------
-----------
11.5
8.5
8.1
9.9
3.5
13.3
12.1
9.1
9.2
-0.4
------6.9
8.3
------5.4
4.3
4.0
4.4
3.8
6.2
6.4
1995
1996
1997
1998
1999
0.2
5.9
8.3
8.4
11.8
9.9
6.4
0.6
8.2
8.9
2.8
-8.4
0.2
24.5
16.4
-----------
1.1
5.8
7.4
8.5
11.6
-----------
-----------
6.4
3.4
7.9
15.4
4.6
3.6
4.6
7.6
11.8
8.2
-1.4
0.7
0.3
5.2
7.8
1.6
-1.0
1.9
6.2
5.6
0.0
-0.1
1.1
5.7
6.8
2000
2001
2002
2003
2004
14.7
9.6
0.8
-2.8
5.3
6.6
11.6
14.8
14.7
3.9
14.3
7.3
-3.9
5.3
16.6
-----------
13.9
9.8
2.0
-1.0
5.2
-----------
-----------
11.9
11.4
17.4
14.9
13.2
13.0
10.5
9.2
7.0
9.5
3.4
3.0
4.1
7.0
5.0
0.8
4.0
4.2
1.3
1.6
2.2
3.4
4.1
4.4
3.5
2005
2006
2007
2008
2009 f
2010 f
5.7
6.3
2.4
1.9
1.6
3.3
2.9
5.4
1.5
0.7
-5.9
-0.1
7.3
10.9
3.3
3.9
-5.8
-1.2
-------------
5.4
6.2
2.3
1.8
0.7
2.9
-------------
-------------
1.2
18.7
-0.9
9.7
8.2
1.1
3.1
13.0
0.5
6.3
5.1
1.8
-0.2
3.4
-8.6
0.6
3.6
3.6
2.0
2.4
-10.8
-0.4
1.5
7.5
0.8
3.0
-9.5
0.1
2.7
5.3
1985
1986
1987
1988
1989
--13.9
-4.9
3.8
8.2
--5.7
1.0
43.8
21.2
--0.9
9.0
9.6
1.6
-----------
--13.3
-4.5
6.1
9.1
-----------
-----------
---16.5
21.1
11.4
10.7
---0.7
5.6
8.5
9.9
-----------
-----------
--9.3
9.5
-0.8
-1.4
1990
1991
1992
1993
1994
12.0
12.7
8.9
6.4
-5.9
11.5
9.0
4.8
16.3
7.2
7.8
4.6
11.6
7.0
9.6
-----------
11.9
12.4
8.6
7.2
-4.6
-----------
-----------
8.5
5.8
6.9
8.5
2.4
10.3
9.3
7.8
7.8
-1.5
------5.5
7.2
------4.0
3.2
1.0
1.7
2.6
4.8
5.3
1995
1996
1997
1998
1999
-2.1
4.2
7.3
8.8
10.0
7.6
4.7
-0.4
8.7
7.1
0.5
-10.1
-0.8
25.0
14.6
-----------
-1.2
4.1
6.4
9.0
9.8
-----------
-----------
4.1
1.7
6.9
15.9
2.8
1.2
3.0
6.6
12.2
6.4
-3.7
-0.9
-0.7
5.6
6.0
-0.8
-2.7
0.9
6.7
3.8
-2.3
-1.8
0.1
6.1
5.0
2000
2001
2002
2003
2004
10.6
8.3
-0.3
-5.7
2.7
2.5
10.3
13.8
11.8
1.3
10.2
5.9
-4.9
2.4
14.0
-----------
9.8
8.4
0.9
-3.9
2.6
-----------
-----------
7.8
10.0
16.4
12.1
10.6
8.9
9.2
8.1
4.1
6.9
-0.7
1.6
3.1
4.1
2.4
-3.3
2.6
3.1
-1.5
-1.0
-1.9
2.1
3.1
1.5
0.9
2005
2006
2007
2008
2009 f
2010 f
2.7
3.6
-1.2
-2.8
3.8
-0.1
-0.1
2.7
-2.1
-4.0
-3.8
-3.6
4.3
8.2
-0.3
-0.8
-3.7
-4.6
-------------
2.4
3.5
-1.3
-2.9
2.8
-0.5
-------------
-------------
-1.8
15.9
-4.4
5.0
10.3
-2.3
0.0
10.3
-3.1
1.5
7.2
-1.6
-3.2
0.7
-12.2
-4.2
5.7
0.1
-1.0
-0.3
-14.4
-5.2
3.6
4.1
-2.2
0.3
-13.1
-4.6
4.8
1.9
(Annual Percentage Change)
--12.1
14.2
3.7
3.2
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting provincial-level insurance data.
f: forecast.
100
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B B.C.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
Year
(1997 = 100)
1985
1986
1987
1988
1989
46.31
53.75
53.89
59.62
67.77
93.73
94.57
112.09
121.62
131.70
140.04
148.32
165.99
181.24
199.47
1,146.55
1,220.34
1,277.10
1,361.37
1,480.99
412.58
438.48
473.72
512.66
554.42
1,559.13
1,658.82
1,750.82
1,874.03
2,035.41
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
77.87
89.64
98.45
106.96
103.18
141.42
150.38
159.22
171.97
180.54
219.29
240.03
257.66
278.93
283.72
1,636.89
1,768.85
1,867.66
1,925.71
1,969.00
603.48
640.15
660.58
680.33
689.18
2,240.37
2,409.00
2,528.24
2,606.03
2,658.18
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
104.35
110.35
118.52
128.63
143.52
186.18
189.28
197.90
219.30
231.55
290.53
299.63
316.42
347.94
375.08
1,995.86
1,984.56
2,011.53
2,084.95
2,236.02
681.57
694.17
731.75
779.00
822.61
2,677.43
2,678.72
2,743.29
2,863.94
3,058.63
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
163.50
179.50
183.07
181.29
190.76
248.90
268.64
300.63
333.33
365.57
412.40
448.14
483.70
514.61
556.32
2,432.62
2,653.08
2,782.80
2,869.72
2,909.02
880.50
935.51
1,011.46
1,060.12
1,151.39
3,313.13
3,588.60
3,794.26
3,929.83
4,060.40
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
201.00
213.50
218.46
222.42
224.02
230.52
369.46
418.59
403.70
431.63
460.56
470.56
570.45
632.09
622.16
654.05
684.58
701.08
3,052.83
3,192.76
3,335.20
3,569.35
3,648.41
3,792.88
1,183.73
1,378.71
1,359.29
1,492.72
1,506.31
1,562.39
4,236.56
4,571.46
4,694.49
5,062.07
5,154.72
5,355.28
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--16.1
0.3
10.6
13.7
--0.9
18.5
8.5
8.3
--5.9
11.9
9.2
10.1
--6.4
4.7
6.6
8.8
--6.3
8.0
8.2
8.1
--6.4
5.5
7.0
8.6
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
14.9
15.1
9.8
8.6
-3.5
7.4
6.3
5.9
8.0
5.0
9.9
9.5
7.3
8.3
1.7
10.5
8.1
5.6
3.1
2.2
8.8
6.1
3.2
3.0
1.3
10.1
7.5
4.9
3.1
2.0
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
1.1
5.8
7.4
8.5
11.6
3.1
1.7
4.6
10.8
5.6
2.4
3.1
5.6
10.0
7.8
1.4
-0.6
1.4
3.6
7.2
-1.1
1.8
5.4
6.5
5.6
0.7
0.0
2.4
4.4
6.8
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
13.9
9.8
2.0
-1.0
5.2
7.5
7.9
11.9
10.9
9.7
9.9
8.7
7.9
6.4
8.1
8.8
9.1
4.9
3.1
1.4
7.0
6.2
8.1
4.8
8.6
8.3
8.3
5.7
3.6
3.3
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
5.4
6.2
2.3
1.8
0.7
2.9
1.1
13.3
-3.6
6.9
6.7
2.2
2.5
10.8
-1.6
5.1
4.7
2.4
4.9
4.6
4.5
7.0
2.2
4.0
2.8
16.5
-1.4
9.8
0.9
3.7
4.3
7.9
2.7
7.8
1.8
3.9
3.0
2.7
3.6
4.7
-2.1
3.4
B.C.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--13.3
-4.5
6.1
9.1
---1.9
13.8
4.0
3.7
--3.1
7.2
4.7
5.5
--3.6
-0.1
2.1
4.2
--3.5
3.3
3.7
3.6
--3.6
0.8
2.5
4.0
1990
1991
1992
1993
1994
11.9
12.4
8.6
7.2
-4.6
4.4
3.6
4.6
6.6
3.9
6.9
6.7
6.1
6.8
0.6
7.5
5.3
4.3
1.7
1.2
5.8
3.3
1.9
1.6
0.2
7.0
4.8
3.7
1.6
0.9
1995
1996
1997
1998
1999
-1.2
4.1
6.4
9.0
9.8
0.8
0.0
3.6
11.3
3.8
0.1
1.5
4.6
10.4
6.0
-1.0
-2.2
0.4
4.1
5.4
-3.4
0.2
4.4
6.9
3.8
-1.6
-1.6
1.4
4.8
5.0
2000
2001
2002
2003
2004
9.8
8.4
0.9
-3.9
2.6
3.4
6.6
10.9
8.0
7.1
5.8
7.3
6.9
3.5
5.5
4.7
7.7
3.8
0.2
-1.2
2.9
4.9
7.1
1.9
6.0
4.2
7.0
4.7
0.7
0.7
2005
2006
2007
2008
2009 f
2010 f
2.4
3.5
-1.3
-2.9
2.8
-0.5
-1.9
10.6
-7.1
2.2
8.8
-1.2
-0.5
8.1
-5.2
0.4
6.8
-1.0
1.9
1.9
0.9
2.3
4.3
0.5
-0.2
13.8
-5.0
5.1
3.0
0.3
1.3
5.2
-0.9
3.1
3.9
0.5
f: forecast.
Canadian Institute for Health Information, 2010.
101
Drug Expenditure in Canada, 1985 to 2010
Table B Y.T.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Yukon, 1985 to 2010
Territorial
Federal
Year
Y.T.
Prescribed Drugs
Public
Private
Insurers*
Out-ofSocial Security Funds
Subtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
0.2
0.3
0.7
1.0
1.2
0.3
0.3
0.4
0.6
0.8
0.0
0.0
0.0
0.0
0.0
-----------
0.5
0.7
1.1
1.7
2.1
-----------
-----------
1.3
1.2
1.2
1.0
1.0
1.8
1.9
2.3
2.7
3.1
-----------
-----------
1.3
1.3
1.2
1.1
1.1
1990
1991
1992
1993
1994
1.3
1.6
2.0
2.3
2.1
1.0
1.2
1.3
1.5
1.7
0.0
0.0
0.0
0.0
0.0
-----------
2.3
2.8
3.4
3.8
3.8
-----------
-----------
1.0
1.2
1.2
2.3
1.6
3.3
4.0
4.5
6.1
5.4
----1.2
1.3
1.4
----1.1
1.1
1.1
1.0
1.3
2.3
2.4
2.4
1995
1996
1997
1998
1999
1.5
1.5
1.9
2.2
2.7
1.8
1.9
2.0
2.1
3.1
0.0
0.0
0.0
0.0
0.0
-----------
3.4
3.4
4.0
4.4
5.8
-----------
-----------
1.7
2.2
3.4
2.9
3.0
5.1
5.6
7.4
7.3
8.8
1.4
1.7
1.7
1.8
1.9
1.2
1.5
1.5
1.6
1.7
2.6
3.1
3.3
3.4
3.6
2000
2001
2002
2003
2004
3.3
3.9
4.5
5.1
5.9
3.0
3.0
3.5
3.8
3.8
0.05
0.08
0.09
0.10
0.11
-----------
6.4
7.0
8.1
9.0
9.8
-----------
-----------
3.2
3.6
3.9
4.8
4.9
9.6
10.5
12.1
13.8
14.7
1.9
2.0
2.0
2.2
2.4
2.1
2.1
2.1
1.9
2.0
3.9
4.0
4.1
4.1
4.3
2005
2006
2007
2008
2009 f
2010 f
6.5
7.2
7.0
7.6
8.2
8.0
4.1
4.2
5.0
4.6
4.6
4.8
0.10
0.11
0.10
0.15
0.11
0.11
-------------
10.7
11.5
12.1
12.4
13.0
13.0
-------------
-------------
5.2
5.9
6.6
6.5
6.8
7.3
15.9
17.3
18.7
18.9
19.8
20.2
2.5
2.6
2.5
2.6
2.8
2.8
2.0
2.1
2.0
2.0
2.1
2.3
4.4
4.7
4.5
4.6
4.9
5.1
1985
1986
1987
1988
1989
--53.7
126.4
41.8
15.4
--10.9
6.7
72.7
37.4
---18.3
32.5
32.5
-42.2
-----------
--27.7
65.5
51.6
23.0
-----------
-----------
---6.2
-2.6
-13.2
-0.3
--3.5
21.4
18.0
14.1
1990
1991
1992
1993
1994
5.9
26.2
23.5
13.2
-8.4
17.1
16.5
15.7
14.3
10.1
98.0
-54.9
303.9
-9.1
-3.4
-----------
10.8
21.5
21.0
13.5
-1.0
-----------
-----------
-6.5
25.0
-4.1
95.5
-29.3
1995
1996
1997
1998
1999
-26.3
-2.3
26.0
17.8
21.9
9.1
3.8
7.0
4.0
44.5
40.5
3.9
4.8
-10.8
28.0
-----------
-10.1
1.1
15.2
10.4
32.9
-----------
-----------
2000
2001
2002
2003
2004
21.4
17.7
17.6
12.1
15.0
-0.9
0.4
14.9
10.0
-1.2
15.1
59.6
10.3
15.7
0.2
-----------
9.6
9.8
16.4
11.2
7.9
-----------
2005
2006
2007
2008
2009 f
2010 f
11.1
10.2
-2.9
9.7
7.4
-2.1
8.7
1.2
19.6
-7.2
0.2
4.4
-2.0
4.6
-2.9
42.9
-28.4
2.5
-------------
10.0
6.7
5.3
3.0
4.3
0.3
-------------
1985
1986
1987
1988
1989
6.7
10.3
20.9
27.6
28.9
9.5
10.6
10.0
16.2
20.2
0.3
0.3
0.3
0.4
0.2
-----------
16.6
21.2
31.2
44.1
49.3
-----------
1990
1991
1992
1993
1994
30.0
30.7
29.4
26.7
26.5
23.1
21.9
19.6
18.0
21.5
0.4
0.1
0.4
0.3
0.3
-----------
53.5
52.7
49.4
45.1
48.3
1995
1996
1997
1998
1999
19.8
17.0
17.7
20.9
21.8
23.7
21.7
19.1
19.9
24.6
0.5
0.4
0.4
0.3
0.4
-----------
2000
2001
2002
2003
2004
24.3
26.5
28.1
28.5
30.9
22.4
20.8
21.6
21.5
20.0
0.4
0.6
0.6
0.6
0.6
(Annual Percentage Change)
-----------
-----------
---5.0
-1.6
-12.6
0.2
5.1
22.5
13.4
34.5
-11.5
------6.7
4.3
------2.4
-0.1
-6.2
25.2
77.9
4.7
2.3
8.0
27.6
55.4
-15.7
4.8
-4.7
10.0
31.0
-1.7
21.7
2.1
19.9
3.3
3.3
7.5
13.0
20.2
3.9
4.6
4.7
7.0
20.0
3.6
3.9
6.2
-----------
6.0
10.7
10.8
20.7
3.0
8.4
10.1
14.5
14.3
6.3
-1.8
5.6
2.9
9.0
6.8
22.3
0.3
1.7
-10.4
4.3
9.5
2.8
2.3
-0.8
5.7
-------------
5.1
13.7
13.1
-2.7
5.3
6.8
8.4
9.0
7.9
1.0
4.6
2.5
3.4
6.7
-2.9
2.8
6.9
-0.7
0.6
7.9
-5.8
1.9
3.6
10.3
2.2
7.2
-4.2
2.4
5.5
4.0
-----------
41.3
38.8
33.6
27.2
24.6
57.8
59.9
64.9
71.4
73.9
-----------
-----------
42.2
40.1
35.1
28.6
26.1
-----------
-----------
22.6
22.9
17.0
26.7
20.5
76.1
75.7
66.5
71.8
68.8
----17.9
15.4
17.4
----15.6
12.8
13.9
23.9
24.3
33.5
28.2
31.2
43.9
39.1
37.2
41.1
46.7
-----------
-----------
22.3
25.1
32.3
27.2
24.4
66.2
64.3
69.4
68.3
71.1
17.9
18.9
16.2
16.7
15.4
15.9
16.8
14.4
15.1
13.5
33.8
35.7
30.6
31.7
28.9
-----------
47.1
47.9
50.2
50.5
51.4
-----------
-----------
23.8
24.4
24.3
26.6
25.8
70.9
72.3
74.5
77.1
77.2
13.9
13.6
12.6
12.4
12.5
15.2
14.1
12.9
10.5
10.3
29.1
27.7
25.5
22.9
22.8
2005
32.0
20.3
0.5
--2006
32.5
18.9
0.5
--2007
30.0
21.5
0.5
--2008
32.5
19.7
0.6
--2009 f
33.3
18.8
0.4
--2010 f
31.7
19.1
0.4
--* Confidentiality precludes reporting territorial-level insurance data.
f: forecast.
52.9
52.0
51.9
52.8
52.6
51.3
-------------
-------------
25.4
26.6
28.5
27.4
27.5
28.6
78.2
78.5
80.5
80.2
80.1
79.9
12.1
11.9
10.9
11.1
11.3
10.9
9.7
9.6
8.6
8.7
8.6
9.2
21.8
21.5
19.5
19.8
19.9
20.1
(Percentage Share of Total Drug Expenditure)
102
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Y.T.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Yukon, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
0.5
0.7
1.1
1.7
2.1
2.6
2.5
2.4
2.1
2.1
3.2
3.2
3.5
3.8
4.2
32.9
37.0
39.1
40.6
44.2
6.8
5.6
5.6
5.2
5.3
39.7
42.6
44.7
45.8
49.5
1.6
1.8
2.8
4.1
4.7
38.9
44.4
43.3
40.8
40.3
8.0
7.4
7.9
8.3
8.5
1990
1991
1992
1993
1994
2.3
2.8
3.4
3.8
3.8
2.0
2.5
3.4
4.7
4.0
4.3
5.3
6.8
8.5
7.8
48.5
56.5
60.6
69.0
83.3
5.0
6.1
6.9
10.6
9.9
53.6
62.6
67.5
79.6
93.2
4.7
4.9
5.6
5.5
4.5
39.6
41.0
49.7
44.1
40.7
8.0
8.4
10.1
10.6
8.4
1995
1996
1997
1998
1999
3.4
3.4
4.0
4.4
5.8
4.3
5.3
6.7
6.3
6.6
7.7
8.8
10.6
10.6
12.4
84.4
91.3
85.4
87.3
91.8
10.5
18.2
17.3
16.3
16.9
94.9
109.5
102.7
103.7
108.7
4.0
3.8
4.6
5.0
6.3
41.2
29.3
38.7
38.4
39.2
8.2
8.0
10.4
10.3
11.4
2000
2001
2002
2003
2004
6.4
7.0
8.1
9.0
9.8
7.1
7.6
8.1
8.9
9.2
13.5
14.6
16.2
17.9
19.0
98.9
115.9
123.3
124.4
132.0
24.8
27.5
33.2
32.3
35.5
123.6
143.4
156.5
156.8
167.5
6.4
6.0
6.6
7.3
7.4
28.8
27.7
24.3
27.4
26.0
10.9
10.2
10.4
11.4
11.3
2005
2006
2007
2008
2009 f
2010 f
10.7
11.5
12.1
12.4
13.0
13.0
9.6
10.6
11.2
11.1
11.7
12.4
20.3
22.1
23.2
23.5
24.7
25.3
151.1
177.5
179.1
191.0
217.3
215.0
36.6
39.4
51.9
50.3
53.8
57.1
187.7
216.9
231.0
241.3
271.0
272.0
7.1
6.5
6.7
6.5
6.0
6.0
26.2
26.9
21.5
22.1
21.8
21.6
10.8
10.2
10.1
9.8
9.1
9.3
1985
1986
1987
1988
1989
--27.7
65.5
51.6
23.0
---5.6
-2.1
-12.9
-0.1
---0.1
12.2
7.3
10.1
--12.3
5.8
3.8
9.1
---17.3
0.4
-7.5
1.2
--7.2
5.1
2.3
8.2
1990
1991
1992
1993
1994
10.8
21.5
21.0
13.5
-1.0
-6.3
25.1
38.2
35.3
-13.1
2.1
23.2
29.1
24.5
-7.6
9.7
16.4
7.2
14.0
20.7
-4.8
20.9
14.1
52.5
-6.0
8.2
16.8
7.9
17.9
17.1
1995
1996
1997
1998
1999
-10.1
1.1
15.2
10.4
32.9
7.4
23.0
25.0
-6.1
5.5
-1.1
13.4
21.2
0.0
16.8
1.3
8.2
-6.4
2.2
5.1
6.1
73.0
-5.2
-5.4
3.3
1.8
15.4
-6.2
0.9
4.8
2000
2001
2002
2003
2004
9.6
9.8
16.4
11.2
7.9
7.9
6.4
6.3
9.7
4.2
8.7
8.0
11.1
10.5
6.1
7.7
17.3
6.3
0.9
6.1
46.7
10.9
20.8
-2.6
10.0
13.8
16.0
9.1
0.2
6.9
2005
2006
2007
2008
2009 f
2010 f
10.0
6.7
5.3
3.0
4.3
0.3
3.7
10.7
5.4
-0.6
5.4
5.6
7.0
8.6
5.3
1.2
4.8
2.8
14.5
17.4
0.9
6.6
13.8
-1.1
2.8
7.8
31.7
-3.1
6.9
6.1
12.0
15.6
6.5
4.5
12.3
0.4
Y.T.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
16.6
21.2
31.2
44.1
49.3
83.4
78.8
68.8
55.9
50.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
53.5
52.7
49.4
45.1
48.3
46.5
47.3
50.6
54.9
51.7
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
43.9
39.1
37.2
41.1
46.7
56.1
60.9
62.8
58.9
53.3
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
47.1
47.9
50.2
50.5
51.4
52.9
52.1
49.8
49.5
48.6
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
52.9
52.0
51.9
52.8
52.6
51.3
47.1
48.0
48.1
47.2
47.4
48.7
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
103
Drug Expenditure in Canada, 1985 to 2010
Table B Y.T.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Yukon, 1985 to 2010
Territorial
Federal
Year
Y.T.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
8.73
13.36
28.81
39.46
44.68
12.38
13.65
13.87
23.14
31.20
0.40
0.33
0.41
0.53
0.30
-----------
21.51
27.34
43.10
63.12
76.17
-----------
-----------
53.66
50.07
46.44
38.94
38.08
75.17
77.41
89.54
102.06
114.25
-----------
-----------
54.79
51.78
48.51
40.97
40.28
1990
1991
1992
1993
1994
46.19
56.02
66.44
74.64
69.86
35.65
39.91
44.31
50.24
56.56
0.58
0.25
0.97
0.87
0.86
-----------
82.41
96.18
111.72
125.74
127.28
-----------
-----------
34.77
41.78
38.47
74.59
53.92
117.18
137.95
150.19
200.34
181.20
----40.52
42.89
45.73
----35.28
35.83
36.58
36.89
44.38
75.80
78.72
82.32
1995
1996
1997
1998
1999
50.23
47.63
59.26
71.27
87.87
60.17
60.58
63.97
67.89
99.30
1.18
1.19
1.23
1.12
1.45
-----------
111.59
109.40
124.46
140.28
188.62
-----------
-----------
56.82
70.33
107.92
92.92
98.53
168.41
179.73
232.38
233.20
287.15
45.56
53.00
54.06
57.00
62.00
40.31
47.00
48.20
51.46
54.53
85.88
100.00
102.26
108.45
116.54
2000
2001
2002
2003
2004
107.91
128.25
150.84
166.67
189.79
99.59
100.91
115.93
125.70
122.99
1.69
2.73
3.01
3.43
3.41
-----------
209.19
231.89
269.78
295.81
316.19
-----------
-----------
105.64
118.12
130.84
155.61
158.79
314.83
350.02
400.62
451.43
474.98
61.61
65.69
67.55
72.57
76.78
67.49
68.33
69.46
61.37
63.36
129.10
134.02
137.01
133.94
140.14
2005
2006
2007
2008
2009 f
2010 f
209.60
222.31
213.74
230.38
243.99
235.72
132.99
129.48
153.35
139.76
137.99
142.13
3.32
3.34
3.22
4.51
3.19
3.22
-------------
345.91
355.14
370.31
374.65
385.16
381.08
-------------
-------------
165.98
181.62
203.48
194.48
201.85
212.69
511.90
536.76
573.79
569.13
587.01
593.77
78.96
81.03
77.96
78.71
82.97
81.31
63.41
65.79
61.36
61.42
62.73
68.29
142.37
146.82
139.31
140.13
145.70
149.60
1985
1986
1987
1988
1989
--52.9
115.7
36.9
13.2
--10.3
1.6
66.8
34.8
---18.7
26.2
28.0
-43.3
-----------
--27.1
57.6
46.5
20.7
-----------
-----------
---6.7
-7.2
-16.2
-2.2
--3.0
15.7
14.0
12.0
-----------
-----------
1990
1991
1992
1993
1994
3.4
21.3
18.6
12.3
-6.4
14.3
11.9
11.0
13.4
12.6
93.3
-56.6
287.7
-9.8
-1.2
-----------
8.2
16.7
16.2
12.6
1.2
-----------
-----------
-8.7
20.1
-7.9
93.9
-27.7
2.6
17.7
8.9
33.4
-9.6
------5.8
6.6
------1.6
2.1
-8.4
20.3
70.8
3.9
4.6
1995
1996
1997
1998
1999
-28.1
-5.2
24.4
20.3
23.3
6.4
0.7
5.6
6.1
46.3
37.1
0.8
3.5
-9.0
29.5
-----------
-12.3
-2.0
13.8
12.7
34.5
-----------
-----------
5.4
23.8
53.5
-13.9
6.0
-7.1
6.7
29.3
0.4
23.1
-0.4
16.3
2.0
5.4
8.8
10.2
16.6
2.6
6.7
6.0
4.3
16.4
2.3
6.1
7.5
2000
2001
2002
2003
2004
22.8
18.9
17.6
10.5
13.9
0.3
1.3
14.9
8.4
-2.2
16.5
61.1
10.3
14.1
-0.8
-----------
10.9
10.9
16.3
9.6
6.9
-----------
-----------
7.2
11.8
10.8
18.9
2.0
9.6
11.2
14.5
12.7
5.2
-0.6
6.6
2.8
7.4
5.8
23.8
1.2
1.7
-11.6
3.2
10.8
3.8
2.2
-2.2
4.6
2005
2006
2007
2008
2009 f
2010 f
10.4
6.1
-3.9
7.8
5.9
-3.4
8.1
-2.6
18.4
-8.9
-1.3
3.0
-2.5
0.6
-3.8
40.3
-29.4
1.2
-------------
9.4
2.7
4.3
1.2
2.8
-1.1
-------------
-------------
4.5
9.4
12.0
-4.4
3.8
5.4
7.8
4.9
6.9
-0.8
3.1
1.2
2.8
2.6
-3.8
1.0
5.4
-2.0
0.1
3.8
-6.7
0.1
2.1
8.9
1.6
3.1
-5.1
0.6
4.0
2.7
1985
1986
1987
1988
1989
--50.1
110.9
32.4
8.7
--7.5
-3.2
62.3
30.3
---21.5
21.5
23.5
-47.9
-----------
--24.3
52.9
41.9
16.1
-----------
-----------
---9.5
-12.0
-20.7
-6.8
--0.2
10.9
9.5
7.4
-----------
-----------
---8.3
-11.1
-20.1
-6.2
1990
1991
1992
1993
1994
0.4
18.5
17.3
10.9
-7.5
11.2
9.2
9.8
11.9
11.5
90.3
-59.4
286.5
-11.3
-2.3
-----------
5.2
13.9
14.9
11.1
0.1
-----------
-----------
-11.7
17.4
-9.2
92.5
-28.8
-0.5
15.0
7.6
31.9
-10.7
------4.4
5.5
------0.1
1.0
-11.4
17.5
69.5
2.4
3.5
1995
1996
1997
1998
1999
-30.4
-6.9
23.4
20.7
21.5
4.1
-1.0
4.6
6.6
44.4
34.7
-0.9
2.5
-8.5
27.7
-----------
-14.7
-3.6
12.8
13.2
32.7
-----------
-----------
3.0
22.1
52.5
-13.5
4.2
-9.4
5.1
28.3
0.8
21.3
-2.7
14.6
1.0
5.9
7.0
7.9
14.9
1.6
7.2
4.2
2.0
14.8
1.3
6.5
5.6
2000
2001
2002
2003
2004
18.7
17.5
16.6
7.6
11.3
-3.8
0.0
13.8
5.5
-4.7
12.4
59.8
9.2
11.2
-3.4
-----------
6.8
9.5
15.3
6.8
4.3
-----------
-----------
3.1
10.5
9.7
16.0
-0.6
5.5
9.8
13.4
9.8
2.6
-4.7
5.3
1.8
4.5
3.2
19.7
-0.1
0.6
-14.5
0.6
6.7
2.5
1.2
-5.1
2.0
2005
2006
2007
2008
2009 f
2010 f
7.4
3.4
-7.4
3.0
8.0
-6.8
5.1
-5.3
14.8
-13.6
0.8
-0.4
-5.6
-2.1
-7.4
35.6
-27.3
-2.3
-------------
6.4
0.0
0.7
-3.6
4.9
-4.5
-------------
-------------
1.5
6.7
8.4
-9.2
5.9
2.0
4.8
2.1
3.3
-5.6
5.3
-2.3
-0.2
-0.1
-7.4
-3.8
7.5
-5.4
-2.9
1.1
-10.3
-4.6
4.3
5.4
-1.4
0.4
-8.7
-4.2
6.1
-0.7
(Annual Percentage Change)
---5.5
-6.3
-15.5
-1.7
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting territorial-level insurance data.
f: forecast.
104
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Y.T.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Yukon, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Year
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
(1997 = 100)
1985
1986
1987
1988
1989
21.51
27.34
43.10
63.12
76.17
108.45
101.85
94.95
79.90
78.36
129.96
129.19
138.05
143.03
154.53
1,351.18
1,510.29
1,521.49
1,524.93
1,632.10
278.89
229.51
219.52
196.03
194.61
1,630.07
1,739.80
1,741.02
1,720.95
1,826.71
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
82.41
96.18
111.72
125.74
127.28
71.66
86.16
114.27
153.32
136.24
154.07
182.33
225.99
279.06
263.52
1,747.95
1,954.71
2,011.98
2,274.52
2,805.59
180.81
210.04
230.03
347.90
334.47
1,928.76
2,164.74
2,242.01
2,622.42
3,140.06
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
111.59
109.40
124.46
140.28
188.62
142.69
170.33
210.18
201.37
215.07
254.28
279.73
334.64
341.66
403.69
2,771.86
2,908.40
2,687.26
2,804.53
2,981.92
346.09
580.94
543.38
524.56
548.37
3,117.96
3,489.34
3,230.64
3,329.10
3,530.29
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
209.19
231.89
269.78
295.81
316.19
234.73
252.14
267.85
289.56
298.92
443.93
484.04
537.63
585.37
615.12
3,250.61
3,848.40
4,090.57
4,069.99
4,274.69
813.89
911.33
1,100.78
1,056.96
1,151.06
4,064.50
4,759.73
5,191.35
5,126.95
5,425.75
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
345.91
355.14
370.31
374.65
385.16
381.08
308.35
328.44
342.79
334.61
347.55
362.29
654.27
683.58
713.10
709.26
732.71
743.37
4,867.57
5,498.87
5,495.75
5,757.51
6,456.47
6,303.87
1,177.12
1,220.89
1,592.96
1,516.39
1,597.63
1,673.45
6,044.70
6,719.76
7,088.71
7,273.90
8,054.10
7,977.33
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--27.1
57.6
46.5
20.7
---6.1
-6.8
-15.8
-1.9
---0.6
6.9
3.6
8.0
--11.8
0.7
0.2
7.0
---17.7
-4.4
-10.7
-0.7
--6.7
0.1
-1.2
6.1
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
8.2
16.7
16.2
12.6
1.2
-8.5
20.2
32.6
34.2
-11.1
-0.3
18.3
23.9
23.5
-5.6
7.1
11.8
2.9
13.0
23.3
-7.1
16.2
9.5
51.2
-3.9
5.6
12.2
3.6
17.0
19.7
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
-12.3
-2.0
13.8
12.7
34.5
4.7
19.4
23.4
-4.2
6.8
-3.5
10.0
19.6
2.1
18.2
-1.2
4.9
-7.6
4.4
6.3
3.5
67.9
-6.5
-3.5
4.5
-0.7
11.9
-7.4
3.0
6.0
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
10.9
10.9
16.3
9.6
6.9
9.1
7.4
6.2
8.1
3.2
10.0
9.0
11.1
8.9
5.1
9.0
18.4
6.3
-0.5
5.0
48.4
12.0
20.8
-4.0
8.9
15.1
17.1
9.1
-1.2
5.8
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
9.4
2.7
4.3
1.2
2.8
-1.1
3.2
6.5
4.4
-2.4
3.9
4.2
6.4
4.5
4.3
-0.5
3.3
1.5
13.9
13.0
-0.1
4.8
12.1
-2.4
2.3
3.7
30.5
-4.8
5.4
4.7
11.4
11.2
5.5
2.6
10.7
-1.0
3.0
2.7
3.6
4.7
-2.1
3.4
Y.T.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--24.3
52.9
41.9
16.1
---8.9
-11.5
-20.4
-6.5
---3.4
2.1
-0.9
3.5
--9.0
-4.0
-4.3
2.5
---20.5
-9.1
-15.2
-5.3
--3.9
-4.7
-5.7
1.6
1990
1991
1992
1993
1994
5.2
13.9
14.9
11.1
0.1
-11.6
17.5
31.4
32.7
-12.2
-3.3
15.6
22.7
22.0
-6.7
4.1
9.1
1.7
11.6
22.3
-10.1
13.4
8.3
49.8
-5.0
2.6
9.5
2.3
15.5
18.6
1995
1996
1997
1998
1999
-14.7
-3.6
12.8
13.2
32.7
2.4
17.7
22.4
-3.8
5.0
-5.8
8.3
18.6
2.5
16.3
-3.5
3.3
-8.6
4.8
4.5
1.1
66.2
-7.5
-3.0
2.7
-3.0
10.2
-8.4
3.5
4.2
2000
2001
2002
2003
2004
6.8
9.5
15.3
6.8
4.3
5.0
6.1
5.2
5.2
0.6
5.9
7.7
10.0
6.0
2.5
4.9
17.0
5.2
-3.4
2.4
44.3
10.6
19.7
-6.9
6.3
11.0
15.8
8.0
-4.1
3.2
2005
2006
2007
2008
2009 f
2010 f
6.4
0.0
0.7
-3.6
4.9
-4.5
0.1
3.8
0.8
-7.1
6.0
0.8
3.4
1.8
0.7
-5.3
5.4
-2.0
10.9
10.3
-3.7
0.0
14.3
-5.8
-0.7
1.0
26.9
-9.5
7.5
1.3
8.4
8.5
1.9
-2.1
12.8
-4.4
f: forecast.
Canadian Institute for Health Information, 2010.
105
Drug Expenditure in Canada, 1985 to 2010
Table B N.W.T.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2010
Territorial
Federal
Year
N.W.T.
Prescribed Drugs
Public
Private
Insurers*
Out-ofSocial Security Funds
Subtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Total
Prescribed
Drugs
1985
1986
1987
1988
1989
1.1
1.4
1.7
1.9
2.1
2.4
2.7
3.0
3.2
3.7
0.0
0.0
0.0
0.0
0.0
-----------
3.5
4.1
4.7
5.1
5.8
-----------
-----------
2.3
2.7
3.0
3.4
3.9
5.8
6.8
7.7
8.6
9.7
1990
1991
1992
1993
1994
2.4
3.0
3.6
2.5
1.2
4.3
4.9
5.7
6.4
7.1
0.0
0.0
0.0
0.0
0.1
-----------
6.6
7.9
9.3
8.9
8.3
-----------
-----------
3.9
5.0
4.9
4.7
3.5
1995
1996
1997
1998
1999
1.1
1.3
1.4
1.7
1.8
7.7
8.0
8.5
8.8
7.6
0.1
0.0
0.0
0.0
0.0
-----------
8.9
9.3
10.0
10.5
9.4
-----------
-----------
2000
2001
2002
2003
2004
1.9
2.2
2.4
3.2
3.6
7.6
8.8
10.7
9.0
8.1
0.0
0.0
0.0
0.0
0.1
-----------
9.5
11.0
13.1
12.3
11.8
-----------
2005
2006
2007
2008
2009 f
2010 f
3.7
4.3
4.9
5.1
5.4
5.5
6.2
6.3
8.3
8.5
8.8
8.9
0.06
0.06
0.07
0.07
0.08
0.07
-------------
10.0
10.6
13.2
13.7
14.3
14.4
-------------
1985
1986
1987
1988
1989
--30.3
22.0
12.6
7.6
--12.3
8.5
6.9
17.3
---5.7
6.9
67.7
-6.6
-----------
--17.7
13.1
9.2
13.5
-----------
1990
1991
1992
1993
1994
13.9
25.2
21.7
-31.8
-50.0
14.8
16.0
14.9
13.3
10.0
-0.9
13.9
1.0
27.0
32.1
-----------
14.4
19.2
17.4
-4.2
-6.5
1995
1996
1997
1998
1999
-8.1
15.1
9.9
16.1
9.8
9.1
3.3
6.5
3.3
-13.7
0.9
-15.9
-3.6
1.1
-14.2
-----------
2000
2001
2002
2003
2004
6.6
13.6
7.4
34.8
12.8
-0.1
16.2
21.8
-15.7
-9.6
0.1
22.9
4.0
1.7
56.6
2005
2006
2007
2008
2009 f
2010 f
3.7
13.6
14.2
5.6
5.0
1.7
-24.4
2.4
31.2
3.2
3.5
0.6
1985
1986
1987
1988
1989
10.9
12.6
13.9
14.2
13.7
1990
1991
1992
1993
1994
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
-----------
-----------
4.1
4.4
4.7
5.1
5.4
10.6
12.9
14.2
13.6
11.8
----2.4
2.6
2.8
----2.1
2.2
2.3
5.1
6.0
4.5
4.7
5.1
3.8
3.5
4.4
4.5
3.3
12.6
12.8
14.4
15.0
12.7
2.9
2.7
3.1
3.2
2.3
2.5
2.4
2.8
2.9
2.1
5.4
5.1
5.9
6.2
4.4
-----------
3.4
3.6
4.0
5.3
5.4
13.0
14.7
17.2
17.5
17.2
2.3
2.2
2.3
2.2
2.2
1.4
1.4
1.5
1.5
1.4
3.7
3.6
3.7
3.7
3.5
-------------
7.0
7.9
8.6
8.4
8.9
9.1
17.0
18.5
21.8
22.2
23.2
23.5
2.0
1.9
2.5
2.5
2.6
2.6
1.4
1.4
1.9
1.9
2.0
2.1
3.4
3.3
4.4
4.4
4.6
4.7
-----------
--14.6
12.7
15.4
14.2
--16.5
12.9
11.6
13.8
-----------
-----------
0.2
25.8
-1.1
-4.2
-25.9
6.5
4.7
7.0
5.1
-10.0
-----------
-----------
-----------
1.2
15.7
18.9
-6.5
-3.5
-----------
-14.2
-3.2
13.5
7.7
7.6
-11.2
-------------
-15.7
6.6
24.3
4.1
4.1
0.9
-------------
24.5
24.3
23.9
23.2
24.4
0.2
0.1
0.1
0.2
0.2
-----------
35.6
37.1
38.0
37.6
38.3
-----------
15.1
15.7
19.3
13.4
7.3
27.1
26.1
30.3
34.9
41.8
0.2
0.2
0.2
0.2
0.3
-----------
42.4
41.9
49.7
48.6
49.4
1995
1996
1997
1998
1999
6.3
7.3
7.1
7.9
10.7
42.7
44.5
41.8
41.4
44.2
0.3
0.2
0.2
0.2
0.2
-----------
2000
2001
2002
2003
2004
11.7
12.1
11.4
15.1
17.4
45.2
48.0
51.2
42.4
39.3
0.2
0.2
0.2
0.2
0.3
(Annual Percentage Change)
-----------
-----------
--8.2
6.2
8.6
7.2
8.7
21.7
10.3
-4.2
-13.2
------7.3
9.0
------3.0
4.3
-6.0
17.8
-25.1
5.3
6.9
7.8
-6.7
27.0
1.7
-27.4
6.9
1.3
12.4
4.1
-15.2
1.5
-6.2
15.7
4.2
-27.8
12.3
-6.0
16.3
5.4
-29.6
6.3
-6.1
16.0
4.8
-28.7
-----------
5.1
5.8
11.0
30.7
1.7
2.2
13.1
16.9
2.2
-1.9
-0.9
-6.5
4.2
-2.3
-1.9
-32.0
2.7
3.0
1.4
-8.7
-15.5
-3.0
3.7
-0.8
-4.6
-------------
30.9
11.7
10.0
-2.8
5.4
2.8
-1.2
8.7
18.2
1.4
4.6
1.6
-7.8
-2.8
26.8
1.4
4.7
-1.2
1.8
0.3
38.3
0.5
1.5
5.4
-4.1
-1.5
31.6
1.0
3.3
1.6
-----------
23.4
23.7
24.2
25.3
25.9
59.0
60.7
62.2
62.8
64.2
-----------
-----------
41.0
39.3
37.8
37.2
35.8
-----------
-----------
25.1
26.2
26.2
25.6
20.6
67.5
68.2
75.9
74.1
70.0
----12.9
14.1
16.7
----11.2
11.8
13.3
32.5
31.8
24.1
25.9
30.0
49.3
52.1
49.1
49.5
55.1
-----------
-----------
20.8
19.6
21.9
21.4
19.2
70.1
71.6
71.0
70.9
74.3
15.9
15.0
15.3
15.3
13.7
14.0
13.3
13.7
13.8
12.0
29.9
28.4
29.0
29.1
25.7
-----------
57.1
60.4
62.8
57.7
57.0
-----------
-----------
20.6
19.9
19.4
24.9
25.9
77.8
80.3
82.1
82.6
83.0
13.9
11.8
10.8
10.4
10.4
8.4
7.9
7.1
7.1
6.6
22.2
19.7
17.9
17.4
17.0
2005
18.4
30.2
0.3
--2006
19.5
28.9
0.3
--2007
18.5
31.5
0.3
--2008
19.3
32.1
0.3
--2009 f
19.4
31.9
0.3
--2010 f
19.4
31.5
0.2
--* Confidentiality precludes reporting territorial-level insurance data.
f: forecast.
48.9
48.7
50.3
51.7
51.6
51.2
-------------
-------------
34.5
36.0
33.0
31.6
31.9
32.3
83.4
84.7
83.3
83.3
83.5
83.5
9.8
8.9
9.4
9.4
9.4
9.1
6.8
6.4
7.4
7.3
7.1
7.4
16.6
15.3
16.7
16.7
16.5
16.5
(Percentage Share of Total Drug Expenditure)
106
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.W.T.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
3.5
4.1
4.7
5.1
5.8
6.4
7.0
7.7
8.5
9.4
9.9
11.2
12.3
13.6
15.2
118.9
145.2
157.4
183.9
203.6
19.6
21.7
23.9
27.3
29.3
138.5
166.9
181.3
211.2
232.9
3.0
2.9
3.0
2.8
2.9
32.4
32.5
32.1
31.2
31.9
7.1
6.7
6.8
6.5
6.5
1990
1991
1992
1993
1994
6.6
7.9
9.3
8.9
8.3
9.0
11.0
9.4
9.4
8.6
15.7
18.9
18.7
18.4
16.9
218.5
247.2
249.9
258.7
259.5
28.4
32.3
29.7
28.3
26.8
246.8
279.5
279.6
287.1
286.3
3.0
3.2
3.7
3.4
3.2
31.9
34.0
31.7
33.3
32.0
6.4
6.8
6.7
6.4
5.9
1995
1996
1997
1998
1999
8.9
9.3
10.0
10.5
9.4
9.1
8.6
10.3
10.7
7.7
18.0
17.9
20.3
21.1
17.1
270.3
250.9
262.6
283.8
201.9
24.7
26.7
26.4
26.0
21.1
295.0
277.7
289.0
309.9
223.1
3.3
3.7
3.8
3.7
4.7
37.0
32.0
39.1
41.0
36.3
6.1
6.4
7.0
6.8
7.7
2000
2001
2002
2003
2004
9.5
11.0
13.1
12.3
11.8
7.2
7.2
7.8
9.0
8.9
16.7
18.3
20.9
21.2
20.7
188.9
213.6
236.8
233.2
253.7
19.6
26.3
28.7
29.9
30.3
208.5
240.0
265.5
263.1
284.0
5.0
5.2
5.5
5.3
4.7
36.5
27.5
27.1
30.1
29.4
8.0
7.6
7.9
8.1
7.3
2005
2006
2007
2008
2009 f
2010 f
10.0
10.6
13.2
13.7
14.3
14.4
10.4
11.2
13.0
12.8
13.4
13.8
20.4
21.8
26.2
26.6
27.7
28.2
268.0
285.6
315.8
344.3
358.0
337.2
50.4
58.2
68.9
62.1
65.2
68.6
318.4
343.8
384.8
406.4
423.3
405.8
3.7
3.7
4.2
4.0
4.0
4.3
20.7
19.2
18.9
20.7
20.6
20.1
6.4
6.3
6.8
6.5
6.6
6.9
1985
1986
1987
1988
1989
--17.7
13.1
9.2
13.5
--10.5
8.7
11.3
10.0
--13.1
10.3
10.5
11.3
--22.2
8.4
16.8
10.7
--10.5
10.0
14.4
7.5
--20.5
8.6
16.5
10.3
1990
1991
1992
1993
1994
14.4
19.2
17.4
-4.2
-6.5
-3.4
21.3
-14.2
0.3
-9.4
3.4
20.4
-1.0
-1.9
-8.0
7.3
13.2
1.1
3.5
0.3
-3.3
13.7
-7.9
-4.7
-5.5
6.0
13.2
0.1
2.7
-0.3
1995
1996
1997
1998
1999
6.5
4.7
7.0
5.1
-10.0
6.9
-6.4
20.5
3.4
-28.1
6.7
-0.9
13.4
4.3
-19.2
4.1
-7.2
4.6
8.1
-28.9
-7.8
8.3
-1.4
-1.3
-18.8
3.0
-5.9
4.1
7.2
-28.0
2000
2001
2002
2003
2004
1.2
15.7
18.9
-6.5
-3.5
-6.7
1.2
7.4
15.6
-0.9
-2.3
9.5
14.3
1.7
-2.4
-6.5
13.1
10.9
-1.5
8.8
-7.0
34.1
9.0
4.1
1.4
-6.5
15.1
10.7
-0.9
8.0
2005
2006
2007
2008
2009 f
2010 f
-15.7
6.6
24.3
4.1
4.1
0.9
17.0
7.4
16.4
-1.5
4.7
2.4
-1.7
7.0
20.2
1.3
4.4
1.6
5.6
6.6
10.6
9.0
4.0
-5.8
66.2
15.4
18.5
-10.0
5.1
5.1
12.1
8.0
11.9
5.6
4.2
-4.1
N.W.T.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
35.6
37.1
38.0
37.6
38.3
64.4
62.9
62.0
62.4
61.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
42.4
41.9
49.7
48.6
49.4
57.6
58.1
50.3
51.4
50.6
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
49.3
52.1
49.1
49.5
55.1
50.7
47.9
50.9
50.5
44.9
100.0
100.0
100.0
100.0
100.0
2000
2001
2002
2003
2004
57.1
60.4
62.8
57.7
57.0
42.9
39.6
37.2
42.3
43.0
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
48.9
48.7
50.3
51.7
51.6
51.2
51.1
51.3
49.7
48.3
48.4
48.8
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
107
Drug Expenditure in Canada, 1985 to 2010
Table B N.W.T.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2010
Territorial
Federal
Year
N.W.T.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
19.87
25.75
31.22
34.75
36.51
44.58
49.79
53.68
56.71
64.93
0.30
0.29
0.30
0.50
0.46
-----------
64.76
75.83
85.21
91.96
101.90
-----------
-----------
42.52
48.45
54.27
61.91
69.02
107.28
124.28
139.47
153.87
170.93
-----------
-----------
74.63
80.32
84.79
91.01
95.30
1990
1991
1992
1993
1994
40.26
48.72
57.90
38.77
18.92
72.19
80.93
90.80
101.02
108.39
0.44
0.48
0.48
0.60
0.77
-----------
112.88
130.14
149.18
140.39
128.08
-----------
-----------
66.93
81.44
78.63
73.95
53.43
179.82
211.58
227.81
214.34
181.52
----38.63
40.71
43.27
----33.63
34.01
34.62
86.68
98.76
72.26
74.73
77.89
1995
1996
1997
1998
1999
17.01
19.28
21.15
24.75
44.90
115.69
117.78
125.16
130.34
185.89
0.76
0.63
0.60
0.62
0.87
-----------
133.46
137.69
146.92
155.71
231.66
-----------
-----------
56.36
51.79
65.59
67.25
80.64
189.82
189.48
212.51
222.96
312.31
43.00
39.74
45.87
48.16
57.48
38.04
35.24
40.90
43.48
50.56
81.04
74.98
86.77
91.64
108.04
2000
2001
2002
2003
2004
48.07
54.18
57.23
75.78
84.28
186.46
215.04
257.78
213.37
190.26
0.88
1.07
1.10
1.09
1.69
-----------
235.41
270.29
316.11
290.24
276.23
-----------
-----------
85.11
89.29
97.51
125.19
125.54
320.51
359.58
413.62
415.44
401.76
57.16
53.05
54.38
52.20
50.49
34.51
35.15
35.62
35.49
31.97
91.67
88.20
90.01
87.70
82.47
2005
2006
2007
2008
2009 f
2010 f
87.63
98.49
111.54
117.36
124.01
125.06
144.25
146.08
190.07
195.43
203.59
203.07
1.45
1.39
1.57
1.68
1.82
1.60
-------------
233.33
245.96
303.18
314.47
329.42
329.73
-------------
-------------
164.70
181.98
198.54
192.26
203.91
207.90
398.03
427.94
501.71
506.73
533.33
537.63
46.65
44.84
56.41
56.95
60.04
58.80
32.61
32.35
44.40
44.44
45.39
47.46
79.27
77.19
100.81
101.39
105.43
106.26
1985
1986
1987
1988
1989
--29.6
21.2
11.3
5.1
--11.7
7.8
5.6
14.5
---6.3
6.3
65.8
-8.8
-----------
--17.1
12.4
7.9
10.8
-----------
-----------
--14.0
12.0
14.1
11.5
--15.8
12.2
10.3
11.1
-----------
-----------
1990
1991
1992
1993
1994
10.3
21.0
18.8
-33.0
-51.2
11.2
12.1
12.2
11.3
7.3
-4.0
10.2
-1.4
24.8
28.8
-----------
10.8
15.3
14.6
-5.9
-8.8
-----------
-----------
-3.0
21.7
-3.4
-6.0
-27.7
5.2
17.7
7.7
-5.9
-15.3
------5.4
6.3
------1.1
1.8
-9.1
13.9
-26.8
3.4
4.2
1995
1996
1997
1998
1999
-10.1
13.4
9.7
17.0
81.4
6.7
1.8
6.3
4.1
42.6
-1.3
-17.1
-3.8
1.9
41.8
-----------
4.2
3.2
6.7
6.0
48.8
-----------
-----------
5.5
-8.1
26.7
2.5
19.9
4.6
-0.2
12.2
4.9
40.1
-0.6
-7.6
15.4
5.0
19.3
9.9
-7.4
16.1
6.3
16.3
4.0
-7.5
15.7
5.6
17.9
2000
2001
2002
2003
2004
7.1
12.7
5.6
32.4
11.2
0.3
15.3
19.9
-17.2
-10.8
0.5
22.0
2.3
-0.1
54.4
-----------
1.6
14.8
17.0
-8.2
-4.8
-----------
-----------
5.5
4.9
9.2
28.4
0.3
2.6
12.2
15.0
0.4
-3.3
-0.6
-7.2
2.5
-4.0
-3.3
-31.7
1.9
1.3
-0.4
-9.9
-15.2
-3.8
2.0
-2.6
-6.0
2005
2006
2007
2008
2009 f
2010 f
4.0
12.4
13.3
5.2
5.7
0.8
-24.2
1.3
30.1
2.8
4.2
-0.3
-14.0
-4.2
12.6
7.3
8.3
-11.9
-------------
-15.5
5.4
23.3
3.7
4.8
0.1
-------------
-------------
31.2
10.5
9.1
-3.2
6.1
2.0
-0.9
7.5
17.2
1.0
5.2
0.8
-7.6
-3.9
25.8
1.0
5.4
-2.1
2.0
-0.8
37.2
0.1
2.1
4.6
-3.9
-2.6
30.6
0.6
4.0
0.8
1985
1986
1987
1988
1989
--26.8
16.5
6.8
0.5
--8.9
3.1
1.1
9.9
---9.1
1.5
61.2
-13.4
-----------
--14.3
7.6
3.4
6.2
-----------
-----------
--11.2
7.3
9.6
6.9
--13.0
7.5
5.8
6.5
-----------
-----------
--4.8
0.8
2.8
0.1
1990
1991
1992
1993
1994
7.2
18.3
17.6
-34.5
-52.3
8.1
9.4
10.9
9.8
6.2
-7.1
7.4
-2.6
23.3
27.7
-----------
7.7
12.5
13.4
-7.3
-9.9
-----------
-----------
-6.1
18.9
-4.7
-7.4
-28.8
2.2
14.9
6.4
-7.4
-16.4
------4.0
5.2
-------0.3
0.7
-12.1
11.2
-28.1
2.0
3.1
1995
1996
1997
1998
1999
-12.4
11.7
8.7
17.5
79.6
4.4
0.1
5.3
4.6
40.8
-3.6
-18.8
-4.8
2.3
40.0
-----------
1.9
1.5
5.7
6.4
47.0
-----------
-----------
3.1
-9.8
25.7
3.0
18.1
2.2
-1.9
11.2
5.4
38.3
-3.0
-9.3
14.4
5.4
17.5
7.6
-9.0
15.1
6.7
14.5
1.7
-9.1
14.7
6.1
16.1
2000
2001
2002
2003
2004
3.0
11.4
4.6
29.5
8.6
-3.8
14.0
18.8
-20.1
-13.4
-3.6
20.6
1.2
-3.0
51.8
-----------
-2.5
13.5
15.9
-11.1
-7.4
-----------
-----------
1.4
3.6
8.2
25.5
-2.3
-1.5
10.8
14.0
-2.5
-5.9
-4.7
-8.5
1.5
-6.9
-5.9
-35.8
0.5
0.3
-3.3
-12.5
-19.3
-5.1
1.0
-5.5
-8.6
2005
2006
2007
2008
2009 f
2010 f
1.0
9.7
9.7
0.5
7.8
-2.6
-27.2
-1.4
26.5
-1.9
6.3
-3.7
-17.0
-7.0
9.0
2.5
10.4
-15.3
-------------
-18.5
2.7
19.7
-1.0
6.9
-3.3
-------------
-------------
28.2
7.8
5.5
-7.9
8.2
-1.5
-3.9
4.8
13.6
-3.7
7.4
-2.6
-10.6
-6.6
22.2
-3.8
7.5
-5.5
-1.0
-3.5
33.6
-4.6
4.3
1.1
-6.9
-5.3
27.0
-4.2
6.1
-2.6
(Annual Percentage Change)
--7.6
5.6
7.3
4.7
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting territorial-level insurance data.
f: forecast.
108
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B N.W.T.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Public
Health Expenditure
Private
GDP Implicit
Price Index—Canada
Total
($ per Capita)
Year
(1997 = 100)
1985
1986
1987
1988
1989
64.76
75.83
85.21
91.96
101.90
117.15
128.77
139.05
152.93
164.33
181.91
204.59
224.26
244.89
266.23
2,185.68
2,655.45
2,859.77
3,302.40
3,570.18
361.05
396.69
433.59
490.09
514.33
2,546.73
3,052.14
3,293.37
3,792.49
4,084.51
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
112.88
130.14
149.18
140.39
128.08
153.61
180.20
150.89
148.68
131.32
266.49
310.34
300.07
289.07
259.40
3,708.35
4,057.16
4,004.30
4,071.51
3,983.42
481.64
529.44
476.22
445.89
410.95
4,190.00
4,586.61
4,480.52
4,517.40
4,394.37
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
133.46
137.69
146.92
155.71
231.66
137.40
126.77
152.36
158.89
188.69
270.86
264.46
299.28
314.60
420.35
4,060.01
3,713.59
3,876.75
4,224.37
4,967.45
370.96
395.82
389.36
387.25
519.57
4,430.96
4,109.41
4,266.11
4,611.62
5,487.01
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
235.41
270.29
316.11
290.24
276.23
176.78
177.49
187.52
212.89
208.00
412.19
447.78
503.63
503.13
484.23
4,664.19
5,232.80
5,708.20
5,522.20
5,924.66
484.88
645.24
692.07
708.13
708.29
5,149.07
5,878.03
6,400.27
6,230.33
6,632.95
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
233.33
245.96
303.18
314.47
329.42
329.73
243.96
259.17
299.34
293.66
309.34
314.16
477.29
505.13
602.52
608.13
638.76
643.90
6,273.08
6,611.61
7,252.92
7,875.18
8,242.56
7,699.54
1,179.97
1,346.79
1,582.85
1,419.50
1,501.64
1,565.51
7,453.05
7,958.40
8,835.77
9,294.68
9,744.21
9,265.05
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
--17.1
12.4
7.9
10.8
--9.9
8.0
10.0
7.5
--12.5
9.6
9.2
8.7
--21.5
7.7
15.5
8.1
--9.9
9.3
13.0
4.9
--19.8
7.9
15.2
7.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
10.8
15.3
14.6
-5.9
-8.8
-6.5
17.3
-16.3
-1.5
-11.7
0.1
16.5
-3.3
-3.7
-10.3
3.9
9.4
-1.3
1.7
-2.2
-6.4
9.9
-10.1
-6.4
-7.8
2.6
9.5
-2.3
0.8
-2.7
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
4.2
3.2
6.7
6.0
48.8
4.6
-7.7
20.2
4.3
18.8
4.4
-2.4
13.2
5.1
33.6
1.9
-8.5
4.4
9.0
17.6
-9.7
6.7
-1.6
-0.5
34.2
0.8
-7.3
3.8
8.1
19.0
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
1.6
14.8
17.0
-8.2
-4.8
-6.3
0.4
5.6
13.5
-2.3
-1.9
8.6
12.5
-0.1
-3.8
-6.1
12.2
9.1
-3.3
7.3
-6.7
33.1
7.3
2.3
0.0
-6.2
14.2
8.9
-2.7
6.5
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
-15.5
5.4
23.3
3.7
4.8
0.1
17.3
6.2
15.5
-1.9
5.3
1.6
-1.4
5.8
19.3
0.9
5.0
0.8
5.9
5.4
9.7
8.6
4.7
-6.6
66.6
14.1
17.5
-10.3
5.8
4.3
12.4
6.8
11.0
5.2
4.8
-4.9
3.0
2.7
3.6
4.7
-2.1
3.4
N.W.T.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--14.3
7.6
3.4
6.2
--7.1
3.2
5.5
2.9
--9.7
4.9
4.7
4.2
--18.7
3.0
11.0
3.5
--7.1
4.6
8.5
0.4
--17.0
3.2
10.6
3.1
1990
1991
1992
1993
1994
7.7
12.5
13.4
-7.3
-9.9
-9.5
14.5
-17.5
-2.9
-12.8
-2.9
13.7
-4.6
-5.1
-11.4
0.8
6.6
-2.6
0.2
-3.3
-9.4
7.2
-11.3
-7.8
-8.9
-0.4
6.7
-3.6
-0.6
-3.8
1995
1996
1997
1998
1999
1.9
1.5
5.7
6.4
47.0
2.3
-9.4
19.2
4.7
16.9
2.1
-4.0
12.2
5.6
31.8
-0.4
-10.2
3.4
9.4
15.8
-12.1
5.0
-2.6
-0.1
32.4
-1.5
-8.9
2.8
8.5
17.2
2000
2001
2002
2003
2004
-2.5
13.5
15.9
-11.1
-7.4
-10.4
-0.9
4.6
10.6
-4.9
-6.0
7.3
11.4
-3.0
-6.3
-10.2
10.8
8.0
-6.2
4.7
-10.8
31.7
6.2
-0.6
-2.6
-10.3
12.8
7.8
-5.6
3.9
2005
2006
2007
2008
2009 f
2010 f
-18.5
2.7
19.7
-1.0
6.9
-3.3
14.3
3.5
11.9
-6.6
7.5
-1.9
-4.4
3.1
15.7
-3.8
7.2
-2.6
2.9
2.7
6.1
3.8
6.8
-10.0
63.6
11.4
13.9
-15.1
7.9
0.8
9.4
4.1
7.4
0.5
6.9
-8.3
f: forecast.
Canadian Institute for Health Information, 2010.
109
Drug Expenditure in Canada, 1985 to 2010
Table B Nun.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2010
Territorial
Federal
Year
Nun.
Prescribed Drugs
Public
Private
Social Security Funds
Insurers*
Out-ofSubtotal
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Subtotal
Private
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
Total
Prescribed
Drugs
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------1.0
--------0.0
--------0.0
-----------
--------1.1
-----------
-----------
--------1.3
--- --- --- --- 2.4
--------1.5
--------1.3
--------2.9
2000
2001
2002
2003
2004
1.2
1.2
1.5
2.1
2.2
0.2
0.4
0.8
4.1
5.1
0.0
0.0
0.0
0.0
0.1
-----------
1.4
1.7
2.4
6.3
7.4
-----------
-----------
1.5
1.5
2.1
3.3
4.1
2.8
3.2
4.5
9.6
11.5
1.6
1.5
1.6
1.5
1.5
0.9
1.0
1.0
1.0
0.9
2.5
2.5
2.6
2.6
2.4
2005
2006
2007
2008
2009 f
2010 f
2.4
2.8
2.9
2.1
1.9
1.9
7.7
8.9
7.7
8.8
7.8
8.0
0.0
0.0
0.0
0.1
0.1
0.1
-------------
10.2
11.7
10.7
11.0
9.8
10.0
-------------
-------------
3.7
4.3
5.1
4.9
5.2
5.3
14.0
16.1
15.8
15.9
15.0
15.3
1.4
1.4
1.8
1.8
1.9
1.9
1.0
1.0
1.4
1.4
1.5
1.5
2.4
2.5
3.2
3.2
3.4
3.4
(Annual Percentage Change)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
2000
2001
2002
2003
2004
21.7
3.7
23.4
36.7
6.3
289.9
174.5
88.4
421.2
22.9
3.1
24.7
4.5
1.4
57.0
-----------
31.3
23.1
39.2
165.5
17.5
-----------
-----------
9.4
4.7
36.1
56.6
25.1
19.1
13.6
37.7
114.5
20.1
1.1
-4.8
6.0
-2.7
-1.6
-30.6
4.5
4.7
1.0
-8.4
-13.7
-1.3
5.5
-1.3
-4.4
2005
2006
2007
2008
2009 f
2010 f
8.6
17.2
3.3
-27.0
-10.4
-2.0
52.0
14.3
-13.3
14.9
-11.7
2.9
-13.5
-0.5
13.7
8.5
10.2
-11.5
-------------
38.4
14.9
-9.2
3.3
-11.4
1.9
-------------
-------------
-8.5
15.4
19.1
-4.6
6.0
2.3
21.7
15.0
-1.6
0.8
-6.0
2.0
-7.1
2.4
23.9
2.1
7.3
-1.9
2.6
5.7
35.1
1.2
4.0
4.7
-3.4
3.8
28.6
1.7
5.8
0.9
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------18.8
--------0.7
--------0.4
-----------
--------19.9
-----------
-----------
--------25.4
--------45.3
--------29.1
--------25.6
--------54.7
2000
2001
2002
2003
2004
22.6
21.9
21.9
17.4
16.1
2.9
7.4
11.3
34.2
36.6
0.5
0.5
0.4
0.3
0.4
-----------
25.9
29.9
33.6
51.9
53.1
-----------
-----------
27.4
26.9
29.6
27.0
29.4
53.3
56.8
63.2
78.9
82.4
29.1
26.0
22.2
12.6
10.8
17.6
17.2
14.6
8.5
6.8
46.7
43.2
36.8
21.1
17.6
2005
14.9
47.5
0.3
--2006
15.4
47.8
0.2
--2007
15.5
40.5
0.3
--2008
11.2
46.1
0.3
--2009 f
10.5
42.4
0.3
--2010 f
10.1
42.9
0.3
--* Confidentiality precludes reporting territorial-level insurance data.
f: forecast.
62.6
63.4
56.3
57.6
53.2
53.2
-------------
-------------
22.9
23.3
27.1
25.6
28.3
28.5
85.5
86.8
83.4
83.2
81.5
81.7
8.5
7.7
9.3
9.4
10.5
10.1
6.0
5.5
7.3
7.3
8.0
8.2
14.5
13.2
16.6
16.8
18.5
18.3
(Percentage Share of Total Drug Expenditure)
110
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Nun.—Total
Expenditure on Drugs by Type, by Source of Finance, and as a Share of Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Public
Private
Total
Total
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------1.1
--------4.2
--------5.3
--------133.6
--------9.1
--------142.6
--------0.8
--------46.5
--------3.7
2000
2001
2002
2003
2004
1.4
1.7
2.4
6.3
7.4
4.0
4.0
4.7
5.8
6.5
5.3
5.7
7.0
12.1
13.9
159.2
173.7
203.7
279.2
294.0
9.3
10.6
11.2
13.3
13.9
168.5
184.3
214.9
292.5
307.9
0.9
1.0
1.2
2.3
2.5
42.5
37.5
41.9
43.8
47.0
3.2
3.1
3.3
4.1
4.5
2005
2006
2007
2008
2009 f
2010 f
10.2
11.7
10.7
11.0
9.8
10.0
6.1
6.8
8.3
8.1
8.6
8.7
16.3
18.5
19.0
19.1
18.4
18.7
287.6
317.3
332.8
346.1
359.2
377.9
16.7
17.6
21.0
21.0
24.3
24.8
304.3
335.0
353.7
367.2
383.5
402.8
3.6
3.7
3.2
3.2
2.7
2.6
36.6
38.4
39.6
38.6
35.3
35.2
5.4
5.5
5.4
5.2
4.8
4.6
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
2000
2001
2002
2003
2004
31.3
23.1
39.2
165.5
17.5
-6.4
0.9
17.2
24.6
12.1
1.1
6.6
23.8
71.9
14.9
19.2
9.1
17.3
37.0
5.3
2.5
14.4
4.9
19.1
4.5
18.1
9.4
16.6
36.1
5.3
2005
2006
2007
2008
2009 f
2010 f
38.4
14.9
-9.2
3.3
-11.4
1.9
-6.6
10.9
22.5
-2.2
5.9
1.7
17.3
13.4
2.4
0.9
-4.0
1.8
-2.2
10.3
4.9
4.0
3.8
5.2
20.0
5.7
18.9
0.3
15.7
2.1
-1.2
10.1
5.6
3.8
4.5
5.0
Nun.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------19.9
--------80.1
--------100.0
2000
2001
2002
2003
2004
25.9
29.9
33.6
51.9
53.1
74.1
70.1
66.4
48.1
46.9
100.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009 f
2010 f
f: forecast.
62.6
63.4
56.3
57.6
53.2
53.2
37.4
36.6
43.7
42.4
46.8
46.8
100.0
100.0
100.0
100.0
100.0
100.0
Canadian Institute for Health Information, 2010.
111
Drug Expenditure in Canada, 1985 to 2010
Table B Nun.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2010
Territorial
Federal
Year
Nun.
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out-ofWCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out-of-Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------36.87
--------1.47
--------0.87
-----------
--------39.22
-----------
-----------
--------49.87
--------89.09
--------57.22
--------50.33
--------107.55
2000
2001
2002
2003
2004
43.76
44.37
53.59
72.19
75.53
5.60
15.02
27.68
142.15
172.02
0.88
1.07
1.10
1.09
1.69
-----------
50.24
60.46
82.36
215.44
249.24
-----------
-----------
53.24
54.52
72.60
112.06
137.95
103.47
114.97
154.96
327.50
387.20
56.42
52.52
54.45
52.19
50.53
34.07
34.80
35.67
35.49
32.00
90.49
87.32
90.12
87.68
82.53
2005
2006
2007
2008
2009 f
2010 f
80.98
92.52
94.10
67.92
59.78
57.85
258.19
287.53
245.39
278.90
241.96
245.84
1.44
1.40
1.57
1.68
1.82
1.59
-------------
340.62
381.45
341.06
348.50
303.57
305.28
-------------
-------------
124.68
140.20
164.42
155.16
161.60
163.20
465.30
521.65
505.48
503.66
465.17
468.48
46.34
46.24
56.41
56.95
60.04
58.13
32.40
33.37
44.40
44.44
45.39
46.90
78.74
79.61
100.81
101.39
105.43
105.03
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
2000
2001
2002
2003
2004
18.7
1.4
20.8
34.7
4.6
280.3
168.4
84.3
413.6
21.0
0.5
22.0
2.3
-0.1
54.5
-----------
28.1
20.3
36.2
161.6
15.7
-----------
-----------
6.7
2.4
33.2
54.4
23.1
16.1
11.1
34.8
111.3
18.2
-1.4
-6.9
3.7
-4.1
-3.2
-32.3
2.2
2.5
-0.5
-9.8
-15.9
-3.5
3.2
-2.7
-5.9
2005
2006
2007
2008
2009 f
2010 f
7.2
14.2
1.7
-27.8
-12.0
-3.2
50.1
11.4
-14.7
13.7
-13.2
1.6
-14.6
-3.1
12.0
7.3
8.3
-12.7
-------------
36.7
12.0
-10.6
2.2
-12.9
0.6
-------------
-------------
-9.6
12.5
17.3
-5.6
4.2
1.0
20.2
12.1
-3.1
-0.4
-7.6
0.7
-8.3
-0.2
22.0
1.0
5.4
-3.2
1.2
3.0
33.1
0.1
2.1
3.3
-4.6
1.1
26.6
0.6
4.0
-0.4
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
2000
2001
2002
2003
2004
14.6
0.0
19.7
31.8
2.0
276.2
167.0
83.3
410.7
18.4
-3.6
20.6
1.2
-3.0
52.0
-----------
24.0
19.0
35.2
158.7
13.1
-----------
-----------
2.6
1.0
32.1
51.5
20.5
12.0
9.8
33.7
108.4
15.6
-5.5
-8.3
2.6
-7.0
-5.8
-36.4
0.8
1.4
-3.4
-12.4
-20.0
-4.9
2.2
-5.6
-8.5
2005
2006
2007
2008
2009 f
2010 f
4.2
11.5
-1.9
-32.6
-9.9
-6.6
47.1
8.6
-18.2
8.9
-11.1
-1.8
-17.6
-5.8
8.4
2.5
10.4
-16.1
-------------
33.7
9.3
-14.2
-2.6
-10.8
-2.8
-------------
-------------
-12.6
9.7
13.7
-10.4
6.3
-2.4
17.2
9.4
-6.7
-5.1
-5.5
-2.7
-11.3
-2.9
18.4
-3.8
7.5
-6.6
-1.8
0.3
29.5
-4.6
4.3
-0.1
-7.6
-1.6
23.0
-4.2
6.1
-3.8
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
* Confidentiality precludes reporting territorial-level insurance data.
f: forecast.
112
Canadian Institute for Health Information, 2010.
Drug Expenditure in Canada, 1985 to 2010
Table B Nun.—per Capita
Expenditure on Drugs Per Capita by Type, by Source of Finance, and Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2010 (cont’d)
All Drugs
Private
Public
Year
Total
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
($ per Capita)
(1997 = 100)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
--------39.22
--------157.43
--------196.64
--------4,979.28
--------338.43
--------5,317.71
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
50.24
60.46
82.36
215.44
249.24
143.73
141.83
162.72
199.74
220.48
193.96
202.29
245.08
415.18
469.73
5,787.57
6,175.93
7,088.56
9,572.26
9,921.71
338.32
378.42
388.55
456.07
469.23
6,125.90
6,554.35
7,477.11
10,028.33
10,390.94
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009 f
2010 f
340.62
381.45
341.06
348.50
303.57
305.28
203.41
219.81
265.22
256.56
267.04
268.23
544.03
601.26
606.29
605.06
570.60
573.51
9,583.75
10,303.08
10,640.62
10,946.08
11,161.09
11,593.33
556.13
572.83
670.48
665.23
756.35
762.16
10,139.88
10,875.91
11,311.11
11,611.30
11,917.43
12,355.49
117.5
120.7
125.0
131.0
128.2
132.6
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
2.3
1.7
1.0
-0.4
1.8
2000
2001
2002
2003
2004
28.1
20.3
36.2
161.6
15.7
-8.7
-1.3
14.7
22.7
10.4
-1.4
4.3
21.2
69.4
13.1
16.2
6.7
14.8
35.0
3.7
0.0
11.9
2.7
17.4
2.9
15.2
7.0
14.1
34.1
3.6
4.1
1.4
1.0
2.9
2.6
2005
2006
2007
2008
2009 f
2010 f
36.7
12.0
-10.6
2.2
-12.9
0.6
-7.7
8.1
20.7
-3.3
4.1
0.4
15.8
10.5
0.8
-0.2
-5.7
0.5
-3.4
7.5
3.3
2.9
2.0
3.9
18.5
3.0
17.0
-0.8
13.7
0.8
-2.4
7.3
4.0
2.7
2.6
3.7
3.0
2.7
3.6
4.7
-2.1
3.4
Nun.
(Annual Percentage Change)
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
2000
2001
2002
2003
2004
24.0
19.0
35.2
158.7
13.1
-12.8
-2.7
13.7
19.9
7.8
-5.5
2.9
20.1
66.5
10.5
12.1
5.4
13.7
32.1
1.1
-4.1
10.5
1.6
14.5
0.3
11.1
5.6
13.0
31.2
1.0
2005
2006
2007
2008
2009 f
2010 f
33.7
9.3
-14.2
-2.6
-10.8
-2.8
-10.8
5.4
17.1
-8.0
6.2
-3.0
12.8
7.8
-2.8
-4.9
-3.6
-2.9
-6.4
4.8
-0.3
-1.9
4.1
0.5
15.5
0.3
13.5
-5.5
15.8
-2.6
-5.4
4.5
0.4
-2.1
4.7
0.3
f: forecast.
Canadian Institute for Health Information, 2010.
113
Series C—International Comparisons
Drug Expenditure in Canada, 1985 to 2010
Table C.1
The Share of Pharmaceutical Goods* in Total Expenditure on Health,
in Descending Order, OECD Countries Reporting, 1985, 2007, 2008
1985
Portugal
Korea
Spain
Japan
Iceland
France
Belgium
Luxembourg
United Kingdom
Germany
New Zealand
Turkey
Switzerland
Ireland
Finland
Canada
Netherlands
Norway
Australia
United States
Sweden
Denmark
2007
(%)
25.4
25.2
20.3
18.0
16.6
16.2
15.7
14.7
14.1
13.8
13.3
13.0
11.3
9.9
9.7
9.6
9.3
9.1
9.0
8.8
7.0
6.6
Hungary
Mexico
Slovak Republic
Greece
Korea
Poland
Czech Republic
Estonia
Spain
Japan
Slovenia
Italy
Ireland
Canada
France
Germany
Belgium
Australia
Finland
Iceland
Sweden
Austria
United Kingdom
United States
Switzerland
New Zealand
Luxembourg
Denmark
Norway
OECD
2008
(%)
31.1
28.2
27.9
24.8
24.5
24.5
21.5
21.4
21.0
20.1
19.8
19.3
17.7
17.2
16.5
15.1
15.0
14.3
14.1
13.5
13.4
13.3
12.2
12.0
10.3
10.2
9.1
8.6
8.0
Hungary
Mexico
Slovak Republic
Korea
Poland
Estonia
Spain
Czech Republic
Slovenia
Italy
Ireland
Canada
France
Belgium
Germany
Finland
Iceland
Austria
Sweden
United States
United Kingdom
New Zealand
Luxembourg
Norway
(%)
31.6
28.3
27.6
23.9
22.6
20.7
20.5
20.4
18.7
18.4
17.3
17.2
16.4
15.1
15.1
14.4
13.9
13.3
13.2
11.9
11.8
9.6
9.1
7.6
Notes
* The OECD proposes the following standard definition: Includes prescribed medicines and self-medication,
often referred to as over-the-counter (OTC) products. Also includes other medical non-durables comprising
a wide range of items such as bandages, elasticated stockings, incontinence articles, condoms and other
mechanical contraceptive devices. Excludes pharmaceutical consumption in hospitals.
Country-specific definitions differ from the OECD proposed standard definition as follows:
Greece:
Excludes other medical non-durables.
Hungary:
Excludes subsidies by local governments.
Switzerland:
Excludes other medical non-durables.
Turkey:
Includes pharmaceutical consumption in hospitals.
New Zealand
Includes cost of care provided in prison and military facilities; excludes subsidies from
charitable not-for-profit organisations and regional and local governments.
Source
Organisation for Economic Co-operation and Development and IRDES, OECD Health Data 2010
(Paris, France: OECD and IRDES, October 2010).
117
Drug Expenditure in Canada, 1985 to 2010
Table C.2
OECD
The Share of Public Expenditure in Total Expenditure on Pharmaceutical
Goods and Other Medical Non-Durables,* OECD Reporting Countries,
1985, 2007, 2008
1985
Turkey
Luxembourg
New Zealand
Germany
Sweden
France
Portugal
United Kingdom
Netherlands
Spain
Iceland
Ireland
Japan
Belgium
Australia
Denmark
Finland
Norway
Canada
Korea
United States
2007
(%)
90.0
86.0
80.4
71.9
70.1
67.1
64.7
64.1
63.3
62.5
61.9
60.8
60.6
51.0
47.2
45.5
44.5
43.2
29.4
13.2
9.3
Luxembourg
United Kingdom
Greece
Germany
Ireland
Spain
Japan
Slovak Republic
France
Switzerland
Czech Republic
Austria
New Zealand
Slovenia
Hungary
Sweden
Denmark
Belgium
Finland
Korea
Australia
Norway
Italy
Iceland
Estonia
Canada
Poland
United States
Mexico
2008
(%)
84.9
83.6
79.0
75.9
72.9
72.7
71.5
69.1
68.5
67.6
66.0
65.5
64.2
59.9
58.5
58.4
55.8
55.6
55.1
54.6
54.0
53.7
48.3
44.8
42.7
38.5
37.5
31.2
18.6
United Kingdom
Luxembourg
Germany
Ireland
Spain
Slovak Republic
Austria
France
New Zealand
Czech Republic
Belgium
Slovenia
Sweden
Hungary
Finland
Korea
Norway
Iceland
Italy
Estonia
Canada
Poland
United States
Mexico
Notes
* The OECD proposes the following standard definition: Includes prescribed medicines and self-medication,
often referred to as over-the-counter (OTC) products. Also includes other medical non-durables comprising
a wide range of items such as bandages, elasticated stockings, incontinence articles, condoms and other
mechanical contraceptive devices. Excludes pharmaceutical consumption in hospitals.
Country-specific definitions differ from the OECD proposed standard definition as follows:
Greece:
Excludes other medical non-durables.
Hungary:
Excludes subsidies by local governments.
Switzerland:
Excludes other medical non-durables.
Turkey:
Includes pharmaceutical consumption in hospitals.
New Zealand
Includes cost of care provided in prison and military facilities; excludes subsidies from
charitable not-for-profit organisations and regional and local governments.
Source
Organisation for Economic Co-operation and Development and IRDES, OECD Health Data 2010
(Paris, France: OECD and IRDES, October 2010).
118
(%)
84.7
84.0
76.6
74.6
72.9
71.4
67.0
66.5
64.8
61.6
59.3
59.3
58.1
56.7
55.7
55.4
53.4
50.8
47.2
42.9
38.4
38.3
32.8
20.1
Drug Expenditure in Canada, 1985 to 2010
Table C.3
The Share of Pharmaceutical Goods* in Public Expenditure on Health,
in Descending Order, OECD Countries Reporting, 1985, 2007, 2008
1985
Portugal
Turkey
Spain
Japan
Luxembourg
France
Germany
New Zealand
Iceland
Korea
United Kingdom
Netherlands
Ireland
Australia
Finland
Sweden
Norway
Canada
Denmark
United States
2007
(%)
30.1
23.1
15.7
15.4
14.2
13.8
12.8
12.3
11.8
11.3
10.5
8.3
7.9
6.0
5.5
5.4
4.6
3.8
3.5
2.1
Greece
Slovak Republic
Hungary
Korea
Spain
Japan
Ireland
Czech Republic
Slovenia
Germany
France
Poland
United Kingdom
Italy
Estonia
Switzerland
Mexico
Australia
Austria
Finland
Sweden
Canada
Luxembourg
New Zealand
United States
Iceland
Denmark
Norway
OECD
2008
(%)
32.5
28.9
25.9
24.2
21.3
17.5
16.8
16.6
16.5
14.9
14.5
13.0
12.4
12.2
12.1
11.8
11.6
11.5
11.4
10.4
9.6
9.4
9.2
8.2
8.2
7.3
5.7
5.1
Slovak Republic
Hungary
Korea
Spain
Ireland
Slovenia
Czech Republic
Germany
France
Mexico
United Kingdom
Poland
Austria
Estonia
Italy
Finland
Canada
Sweden
Luxembourg
Iceland
United States
New Zealand
Norway
(%)
29.1
25.2
23.9
20.7
16.8
15.3
15.2
15.0
14.0
12.1
12.1
12.0
11.6
11.4
11.2
10.8
9.4
9.3
9.1
8.5
8.4
7.7
4.8
Notes
* The OECD proposes the following standard definition: Includes prescribed medicines and self-medication,
often referred to as over-the-counter (OTC) products. Also includes other medical non-durables comprising
a wide range of items such as bandages, elasticated stockings, incontinence articles, condoms and other
mechanical contraceptive devices. Excludes pharmaceutical consumption in hospitals.
OECD: Organisation for Economic Co-operation and Development.
Country-specific definitions differ from the OECD proposed standard definition as follows:
Greece:
Excludes other medical non-durables.
Hungary:
Excludes subsidies by local governments.
Switzerland:
Excludes other medical non-durables.
Turkey:
Includes pharmaceutical consumption in hospitals.
New Zealand:
Includes cost of care provided in prison and military facilities; excludes subsidies from
charitable not-for-profit organizations and regional and local governments.
Source
Organisation for Economic Co-operation and Development and IRDES, OECD Health Data 2010
(Paris, France: OECD and IRDES, October 2010).
119
Drug Expenditure in Canada, 1985 to 2010
Appendix A—Comparison of Provincial
and Territorial Drug Subsidy Programs
Comparison of Provincial and Territorial Drug
Subsidy Programs
Table 8 gives an overview of provincial and territorial drug subsidy programs as of
December 31, 2010. The table was verified for accuracy with provincial/territorial
programs. Information is also available from the following websites:
British Columbia Pharmacare
www.health.gov.bc.ca/pharmacare/
Alberta Prescription Drug Program
www.health.alberta.ca/AHCIP/prescription-program.html
Saskatchewan Drug Plan
www.health.gov.sk.ca/prescription-drugs
Manitoba Pharmacare Program
www.gov.mb.ca/health/pharmacare/index.html
Ontario Drug Benefits
www.health.gov.on.ca/en/public/programs/drugs/funded_drug/default.aspx
Régime général d’assurance médicaments du Québec (RGAM)
www.ramq.gouv.qc.ca/en/citoyens/assurancemedicaments/index.shtml
New Brunswick Prescription Drug Program
www.gnb.ca/0212/intro-e.asp
Nova Scotia Pharmacare
http://www.gov.ns.ca/health/pharmacare/
Prince Edward Island Pharmacy Services
www.healthpei.ca/index.php3?number=1026180&lang=E
Newfoundland and Labrador Prescription Drug Program
www.health.gov.nl.ca/health/prescription/nlpdp_plan_overview.html
Yukon Pharmacare
www.hss.gov.yk.ca/insured_services.php
Northwest Territories
www.hlthss.gov.nt.ca/english/services/health_care_plan/default.htm
Nunavut
www.drugcoverage.ca/p_benefit_nu.asp
121
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010
Province/
Territory
Program/
Plan
British
Columbia
Fair
Pharmacare
Enhanced
Assistance
None
Families in which
at least one family
member is born in
1939 or earlier and
is not covered by
other plans
Fair
Pharmacare
Families in
which all family
members are
born in 1940
or later and are
not covered by
other plans
None
Pharmacare
Plan B
Permanent
residents of
licensed residential
care facilities
Recipients of
B.C. Income
Assistance
Cystic fibrosis
patients registered
with a provincial
cystic fibrosis clinic
Severely
handicapped
children registered
in the At Home
Program
Clients of mental
health service
centres meeting
clinical and lowincome criteria
Palliative care
patients treated
at home
Pharmacare
Plan C
Pharmacare
Plan D
Pharmacare
Plan F
Pharmacare
Plan G
Pharmacare
Plan P
122
Beneficiary
Premium
Maximum
Annual
Copay
Deductible
Copay
Pharmacare
pays 75%
1.25%:
<$33K
2%: $33K
to $50K
3%: >$50K
Pharmacare
pays 70%
2%: <$15K
3%: $15K
to $30K
4%: >$30K
None
Based on
family net
income:
$0: <$33K
1%: $33K
to $50K
2%: >$50K
Based on
family net
income:
$0: <$15K
2%: $15K
to $30K
3%: >$30K
None
None
N/A
None
None
None
N/A
None
None
None
N/A
None
None
None
N/A
None
None
None
N/A
None
None
None
N/A
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Alberta
Seniors
Beneficiary
Premium
Maximum
Annual
Copay
Deductible
Copay
Seniors age 65 and None
older and their
eligible dependants
None
30% of
prescription
to a max.
of $25 per
prescription*
N/A
Widows
Residents age 55 to None
64 who qualify for
Alberta Widows’
Pension and
eligible dependants
None
30% of
prescription
to a max.
of $25 per
prescription*
N/A
Palliative
Palliative residents None
treated at home
None
30% of
prescription
to a max. of
$25 per
prescription*
The lifetime
maximum
amount
palliative
patients pay
out of
pocket
is $1,000
Non-Group
A universal plan
available to all
residents under
the age of 65
Monthly rate
is $63.50 for
singles and
$118.00 for
families.
Subsidized
rates are
available at
$44.45 for
singles and
$82.60 for
families.
None
30% of
prescription
to a max.
of $25 per
prescription*
N/A
Province-Wide
Services
Residents
with specific
conditions may
be eligible for
high-cost drugs,
mostly transplant
and HIV drugs
None
None
None
N/A
Income Support Residents receiving None
social assistance
and eligible
dependants
None
None
N/A
Note
* Costs incurred by the client choosing a high-cost product where cheaper alternatives are available are borne by the client.
123
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Deductible
Copay
Maximum
Annual
Copay
Residents receiving None
AISH (an incomesupport program
for adults with
a permanent
disability that
severely impairs
their ability to earn
a living) and
eligible dependants
None
None
N/A
Alberta Adult
Health Benefit
Qualified clients
leaving Income
Support for work
None
None
None
N/A
Alberta Child
Health Benefit
Children in lowincome families
None
None
None
N/A
All residents with
Saskatchewan
health coverage
(application
required)
None
Income-tested
(annual
threshold
based on
3.4% of
adjusted
family income)
Income-tested N/A
(based on
benefit drug
costs, to help
spread cost
out evenly over
the year)
None
Maximum
$15 per
prescription
Province/
Territory
Program/
Plan
Alberta
(cont’d)
Assured
Income for
the Severely
Handicapped
(AISH)
Saskatchewan† Saskatchewan
Drug Plan—
Special Support
Program
Seniors’
Drug Plan
Beneficiary
Premium
None
Saskatchewan
residents 65 and
older. Individual
annual net income
must be below the
limit for the federal
age credit to be
eligible for the
cap of $15 per
prescription
(application
required to
determine
eligibility)
Note
† To be eligible for drug plan coverage, the resident must not be covered under another provincial or federal
government program, such as the Non-Insured Health Benefits Program. For all residents who are eligible
for more than one drug plan program, the best coverage for each prescription will be applied.
124
N/A
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
†
Saskatchewan Seniors
(cont’d)
(Deductible
Programs)
Beneficiary
Premium
Maximum
Annual
Copay
Deductible
Copay
Seniors receiving None
the Seniors Income
Plan supplement
or receiving the
federal Guaranteed
Income
Supplement
and residing in a
special care home
$100 semiannual family
deductible
35% consumer N/A
copayment after
deductible has
been paid
Seniors receiving
the Guaranteed
Income
Supplement
and living in
the community
$200 semiannual family
deductible
35% consumer N/A
copayment after
deductible has
been paid
None
Emergency
Assistance
Program
None
Residents who
require immediate
treatment with
covered
prescription drugs
and are unable to
cover their share of
the cost. This is a
one-time benefit,
and individuals are
encouraged to
apply for incometested coverage for
future assistance
None
The level of
assistance
provided is
in accordance
with the
consumer’s
ability to pay
N/A
Family Health
Benefits
Eligibility is
None
established by the
Department of
Social Services,
based on the
number of children
in the family and
the family’s annual
income
$100 semiannual family
deductible
N/A
No charge
for benefit
prescriptions for
children; 35%
consumer
copayment after
deductible has
been paid for
adult benefit
prescriptions
Note
† To be eligible for drug plan coverage, the resident must not be covered under another provincial or federal government program,
such as the Non-Insured Health Benefits Program. For all residents who are eligible for more than one drug plan program, the
best coverage for each prescription will be applied.
125
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Beneficiary
Premium
Deductible
Copay
Saskatchewan Supplementary Persons nominated None
by Saskatchewan
(cont’d)
Health
Social Services for
special coverage,
including persons
on social
assistance, wards,
inmates, etc.
None
N/A
Up to $2 per
prescription
(some drugs
covered at
no charge;
individuals
younger than 18
and certain
other categories
receive benefit
prescriptions at
no charge)
Saskatchewan
Aids to
Independent
Living (SAIL)
Persons registered None
under the following
SAIL programs
receive formulary
and approved nonformulary drugs
at no charge:
Paraplegia
Program, Cystic
Fibrosis Program
and Chronic
End-Stage Renal
Disease Program
None
None
N/A
Palliative Care
Program
Residents who
are in the late
stages of a
terminal illness
None
None
None
N/A
Children’s
Insulin Pump
Program
None
Type 1 diabetic
children (younger
than 18) who
require pumps to
adequately stabilize
blood sugar levels
and are not eligible
for benefits
under a federal
government
program (such as
the Non-Insured
Health Benefits
Program)
None
No charge for
N/A
insulin pump.
Insulin pump
supplies subject
to coverage
(family
deductible/
copay).
None
Maximum $15 N/A
per prescription
†
Children’s Drug Children 14 and
Plan
younger
None
Note
† To be eligible for drug plan coverage, the resident must not be covered under another provincial or federal
government program, such as the Non-Insured Health Benefits Program. For all residents who are eligible
for more than one drug plan program, the best coverage for each prescription will be applied.
126
Maximum
Annual
Copay
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Maximum
Annual
Copay
Province/
Territory
Program/
Plan
Manitoba
Pharmacare
All provincial
None
residents who
are eligible for
benefits under The
Prescription Drug
Cost Assistance Act
Ranging from None
2.71% to
6.12% based
on total
adjusted
family income.
Credit of
$3,000 for
a spouse
and each
dependant
younger
than 18.
N/A
Employment
and Income
Assistance
Program
Individual
Manitobans who
are receiving
drug benefits
pursuant to the
Employment
and Income
Assistance
Program
None
None
None
N/A
Personal Care
Home/Nursing
Home
Manitoba residents None
of personal care
homes
None
None
N/A
Palliative Care
Drug Access
Program
Residents who are None
terminally ill and
wish to remain
at home
None
None
N/A
$100
per recipient
After deductible, N/A
up to
$6.11 per
prescription
None
Up to $2 per
prescription
Ontario
Beneficiary
Premium
Ontario Drug
Seniors (65 and
None
Benefit Program older). Single
seniors with annual
income ≥$16,018
or seniors in
couples with
combined annual
income of
≥$24,175.
None
Seniors (65 and
older). Single
seniors with annual
income <$16,018
or seniors in
couples with
combined annual
income of
<$24,175.
Deductible
Copay
N/A
127
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Ontario
(cont’d)
Trillium Drug
Program
Special Drugs
Program
128
Maximum
Annual
Copay
Beneficiary
Premium
Deductible
Copay
Residents of longterm care facilities
None
None
Up to $2 per
prescription
N/A
Residents of homes None
for special care
None
Up to $2 per
prescription
N/A
Residents receiving None
professional
services under
the home care
program
None
Up to $2 per
prescription
N/A
Residents receiving None
social assistance
(Ontario Disability
Support Program
or Ontario
Works Program)
None
Up to $2 per
prescription
N/A
Residents with high None
drug costs in
relation to income
Residents with valid None
Ontario health
insurance.
Coverage is
product-specific
for a limited
number of diseases
or conditions.
Income-based Up to $2 per
prescription
N/A
None
N/A
None
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Quebec
Régime public
Deductible
Copay
Maximum
Annual
Copay
None
Employment
assistance (welfare)
recipients (EAR)
and other holders
of a claim slip
None
None
None
None
None
None
None
$16.00
per month
32% of
prescription
costs
$49.97 per
month
$16.00
per month
32% of
prescription
costs
$80.25 per
month
$16.00
per month
32% of
prescription
costs
$80.25 per
month
Beneficiary
Seniors (65 and
older) receiving at
least 94% of the
maximum
Guaranteed
Income
Supplement (GIS)
Premium
$0 to $600 per
adult per year,
depending on
income
$0 to $600
per adult
per year,
depending on
income
General clientele
$0 to $600 per
(residents younger adult per year,
than 65 without
depending on
access to a
income
group plan).
Adults are subject
to a premium, a
deductible and
a copayment. Their
children (including
students age 18 to
25, under certain
conditions) are
covered free
of charge.
Seniors (65 and
older) receiving
less than 94% of
the maximum GIS
Seniors (65 and
older) without GIS
129
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
New
Brunswick
Prescription
Drug
Program—
Plan A
Prescription
Drug
Program—
Plan B
130
Maximum
Annual
Copay
Beneficiary
Premium
Deductible
Copay
Seniors with
Guaranteed
Income
Supplement (GIS)
Seniors without
GIS who qualify for
benefits based on
annual income as
follows: a single
senior with an
annual income of
$17,198 or less;
a senior couple
(both ≥65) with a
combined annual
income of $26,955
or less; a senior
couple with one
spouse younger
than 65, with a
combined annual
income of $32,390
or less
Cystic fibrosis
patients or patients
with juvenile or
infant sclerosis of
the pancreas
None
None
$9.05 for each
prescription
$250
None
None
$15 per
prescription
N/A
$50 yearly
registration
fee
None
20%
prescription
cost up to a
maximum
of $20
$500
per family
Prescription
Drug
Program—
Plan C
None
Residents who
have seen a health
care provider and
show symptoms of
H1N1 influenza
None
None
N/A
Prescription
Drug
Program—
Plan E
Individuals residing None
in a licensed adult
residential facility
who hold a valid
health card for
prescription drugs
issued by the
Department of
Social
Development
None
$4 for each
prescription
$250
Prescription
Drug
Program—
Plan F
Individuals holding None
a valid health card
for prescription
drugs issued by
the Department
of Social
Development
None
$4 per
$250
prescription for per family
adults (18 and
older) and $2
for children
(younger
than 18)
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Beneficiary
Premium
Deductible
Copay
Maximum
Annual
Copay
Prescription
Drug
Program—
Plan G
Special-needs
children and
children under
the care of the
Minister of Social
Development
None
None
None
N/A
Prescription
Drug
Program—
Plan H
$50 yearly
Residents in
registration
possession of a
prescription written fee
by a neurologist for
the medications
Avonex, Rebif,
Betaseron or
Copaxone are
eligible to apply
for assistance
None
Income-tested
(ranges from
0% to 100%)
N/A
Prescription
Drug
Program—
Plan R
Recipients of an
$50 yearly
organ or bone
registration
marrow transplant fee
who are registered
and qualify with
the NBPDP
None
20%
prescription
cost up to a
maximum
of $20
$500
per family
Prescription
Drug
Program—
Plan T
Individuals with
$50 yearly
growth hormone
registration
deficiency or
fee
hypopituitarism
who are registered
and qualify with
the NBPDP
None
20%
prescription
cost up to
a maximum
of $20
$500
per family
Prescription
Drug
Program—
Plan U
Individuals who are $50 yearly
HIV positive and
registration
are registered with fee
the NBPDP
None
20%
$500
prescription
per family
cost up to a
maximum of $20
Prescription
Drug
Program—
Plan V
Individuals
who reside in
a registered
nursing home
None
None
Province/
Territory
Program/
Plan
New
Brunswick
(cont’d)
None
N/A
131
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Nova Scotia
Seniors
Pharmacare
Program
Department
of Community
Services
Programs
132
Beneficiary
Premium
Maximum
Annual
Copay
Deductible
Copay
None
Seniors (65 and
older) receiving
Guaranteed Income
Supplement (GIS)
and covered by
Medical Services
Insurance (MSI) and
not having coverage
through Veterans
Affairs Canada,
Non-Insured Health
Benefits, Nova
Scotia Family
Pharmacare or any
other public or
private plan that
covers most
medications
and supplies
None
30%
prescription
cost
$382
Up to $424
Seniors (65 and
older) not receiving per year
GIS and covered
by MSI and not
having coverage
through Veterans
Affairs Canada,
Non-Insured Health
Benefits, Nova
Scotia Family
Pharmacare
or any other public
or private plan that
covers most
medications
and supplies
None
30%
prescription
cost
$382
Eligible clients and None
their dependants in
receipt of income
assistance; any
client and/or
dependant having
access to another
drug plan, be it
from a public or
private entity, will
be required to use
that plan and will
not be eligible for
the Pharmacare
program
None
N/A
All incomeassistance
clients and
dependants are
required to
copay a flat fee
of $5 per
prescription,
unless the client
or dependant is
eligible
for copay
exemption
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Deductible
Copay
Maximum
Annual
Copay
Drug
Residents having
None
Assistance for a gross family
Cancer Patients income no greater
than $15,720
per year and
not eligible for
coverage under
other drug
programs
None
None
N/A
Family
Pharmacare
Program
Residents with a
valid Nova Scotia
health card
Income-based 20% of the total Incomeprescription cost based
Nova Scotia
Diabetes
Assistance
Program
Residents younger None
than 65 with a
valid Nova Scotia
health card and
who do not have
drug coverage
through Veterans
Affairs Canada,
First Nations and
Inuit Health or any
private drug plans
that cover diabetes
supplies, who have
a confirmed
diagnosis
of diabetes
Province/
Territory
Program/
Plan
Nova Scotia
(cont’d)
Beneficiary
Premium
None
Prince Edward Seniors Drug
Seniors 65 or older None
Island
Cost Assistance and eligible for
Plan
P.E.I. Medicare
Children-inCare
Persons eligible
None
under the Social
Assistance Act and
persons in the
temporary or
permanent care
of the Director of
Child Welfare
Income-based 20% of the total N/A
prescription
cost
None
First $8.25
N/A
of the
medication
cost plus the
pharmacy
professional fee
for each
prescription
None
None
N/A
133
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Beneficiary
Premium
Prince Edward Family Health Families (parents, None
Island (cont’d) Benefit Program guardians and
children younger
than 18 or younger
than 25 and in fulltime attendance at
a post-secondary
education
institution), eligible
for P.E.I. Medicare
with a total net
family income less
than the threshold.
Families must
apply for coverage
on an annual basis
and provide
income information
to the program.
134
Maximum
Annual
Copay
Deductible
Copay
None
The pharmacy N/A
professional fee
for each
prescription
Financial
Assistance
Program
Persons eligible
under the Social
Assistance Act
None
None
None
N/A
Erythropoietin
Program
Persons eligible
None
for P.E.I. Medicare
who have been
diagnosed with
chronic renal failure
or are receiving
kidney dialysis and
registered with
the program
None
None
N/A
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Prince Edward Diabetes
Island (cont’d) Control
Program
Beneficiary
Premium
Persons with
None
diabetes eligible
for P.E.I. Medicare
and who are
registered with
the program
Maximum
Annual
Copay
Deductible
Copay
None
Blood Glucose N/A
Test Strips: $11
per prescription
to a maximum of
100 strips every
30 days
Oral
Medications and
Urine Testing
Materials: $11
per prescription
High-Cost
Diabetes
Medications:
an incomebased portion
of the
medication plus
the professional
fee for each
high-cost
medication
obtained
None
High Cost
Persons eligible
Drugs Program for P.E.I. Medicare
and approved for
coverage of one
or more of the
medications
included in
the program.
Patients must apply
for coverage on an
annual basis and
provide income
information to
the program.
None
Income-based
portion of the
drug cost plus
the pharmacy
professional
fee for each
prescription
N/A
Community
Mental Health
Program
Approved longterm psychiatric
patients living in
the community
None
None
None
N/A
Sexually
Transmitted
Diseases (STD)
Program
Persons diagnosed None
with sexually
transmitted disease
or identified
contacts of
a person with
a sexually
transmitted disease
None
None
N/A
135
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Deductible
Copay
Maximum
Annual
Copay
Residents in
None
government
manors or private
nursing homes
eligible for
coverage under the
Long-Term Care
Subsidization Act
None
None
N/A
DiseaseSpecific
Programs
(for example,
AIDS/HIV, cystic
fibrosis, growth
hormone,
hepatitis,
tuberculosis,
hairy cell
leukemia,
AIDS-related
Kaposi’s
sarcoma, basal
cell carcinoma,
meningitis,
phenylketonuria
and transplant
drug programs
delivered
through the
government-run
provincial
pharmacy)
Persons diagnosed None
with specific
medical conditions
or at risk for
exposure to
communicable
diseases
None
None
N/A
Quit-Smoking
Program
Persons eligible
None
for P.E.I. Medicare
and who have
registered with
the program
None
Patients are
N/A
responsible for
all medication
costs approved,
except for the
first $75, which
will be paid by
the program
Nutrition
Program
Children and
None
high-risk pregnant
women diagnosed
with a nutritional
deficiency
None
None
Program/
Plan
Prince Edward Nursing Home
Island (cont’d) Program
136
Beneficiary
Premium
N/A
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Deductible
Copay
Seniors (65 and
None
older) who are
in receipt of the
Guaranteed
Income
Supplement and
who are registered
for Old Age
Security benefits
None
Markup and
N/A
professional fee
for identified
benefits
The Foundation Residents of the
None
province who
Plan
qualify for full
benefit coverage
under the
Department
of Human
Resources,
Labour and
Employment, and
certain individuals
receiving services
through the
regional health
authorities,
including children
in the care of Child,
Youth and Family
Services and
individuals in
supervised care
None
None
N/A
None
None
Based on family
net income:
Family (with
children)
Between 20%
and 70%,
depending
on family net
income and
family status
(single,
couple or
family)
Newfoundland The 65Plus
and Labrador Plan
The Access
Plan
Beneficiary
Residents with
low incomes who
access eligible
prescription
medications.
The amount
of coverage
is determined
by family net
income level
and family status.
Premium
Maximum
Annual
Copay
Income
Copay
<$30,009
20.0%
$31,000
23.9%
$32,000
27.7%
$33,000
31.6%
$34,000
35.5%
$35,000
39.4%
$36,000
43.3%
$37,000
47.2%
$38,000
51.1%
$39,000
55.0%
$40,000
58.8%
$41,000
62.7%
$42,000
66.6%
$42,870
70.0%
137
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Beneficiary
Premium
Deductible
Newfoundland
and Labrador
(cont’d)
Maximum
Annual
Copay
Copay
Couple (with
no children)
Income
Copay
<$21,435
20.0%
$22,000
23.3%
$23,000
29.1%
$24,000
35.0%
$25,000
40.8%
$26,000
46.6%
$27,000
52.4%
$28,000
58.3%
$29,000
64.1%
$30,000
69.9%
$30,009
70.0%
Single
individuals
Income
138
None
The Assurance Residents who
experience the
Plan
financial burden of
eligible high drug
costs, whether it be
from the cost of
one extremely
high-cost drug or
the combined cost
of different drugs
None
The Select
Needs Plan
None
Residents with
cystic fibrosis or
growth hormone
deficiency
None
Copay
<$18,577
20.0%
$19,000
22.5%
$20,000
28.3%
$21,000
34.1%
$22,000
40.0%
$23,000
45.8%
$24,000
51.6%
$25,000
57.5%
$26,000
63.3%
$27,000
69.1%
$27,151
70.0%
Based on a
combination
of family net
income and
eligible family
drug costs
Based on
family net
income:
Income
Max.
<$40,000
5.0%
≥$40,000 to 7.5%
<$75,000
≥$75,000 to 10.0%
<$150,000
None, for
identified
benefits
N/A
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Yukon
Pharmacare
Chronic
Disease
Program
Deductible
Copay
Maximum
Annual
Copay
Seniors 65 or older None
(and seniors’
spouses age 60
and older)
registered with
Yukon Health Care
Insurance Plan and
not having
coverage through
First Nations
and Inuit Health.
Residents with
another third-party
or group insurance
must use that plan
first. Program
includes clients
receiving
palliative care.
None
None
N/A
Residents who
None
have a chronic
disease or a
serious functional
disability as
provided under the
Chronic Disease
and Disability
Benefits
Regulations and
not having
coverage through
First Nations and
Inuit Health.
Residents with
another third-party
or group insurance
must use that plan
first. Program
includes clients
receiving palliative
care.
Maximum
$250 per
individual
and $500
per family
(deductible
may be
waived,
depending
on income)
None
N/A
Beneficiary
Premium
139
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Province/
Territory
Program/
Plan
Yukon
(cont’d)
Children’s Drug Children younger
than 19 from lowand Optical
income families
Program
and not having
coverage through
First Nations and
Inuit Health
Northwest
Territories
Extended
Health Benefits
Program for
Specified
Diseases
Premium
Deductible
None
Maximum
None
$250 per child
and $500 per
family
(deductible
may be
waived,
depending
on income)
N/A
Resident, nonNone
native or Métis and
have a specified
disease condition
None
None
N/A
Seniors’ Benefit Resident and non- None
Program
native residents
who are 60 years
and older
None
None
N/A
None
Resident,
registered with
territorial health
care plan,
descendant of
Chipewyan,
Slavey, Gwich’in,
Dogrib, Hare or
Cree people; and
resided in or used
and occupied the
Mackenzie Basin
on or before
January 1, 1921,
or is a Community
Acceptance
Member, or was
adopted as
a minor
None
None
N/A
Indigent
Indigent individuals None
Health Benefits or families resident
of the Northwest
Program
Territories,
who meet
the eligibility
requirements
according to the
Indigent Health
Benefits Policy
None
None
N/A
Métis Health
Benefits
Program
140
Beneficiary
Copay
Maximum
Annual
Copay
Drug Expenditure in Canada, 1985 to 2010
Table 8: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2010 (cont’d)
Premium
Deductible
Copay
Maximum
Annual
Copay
Extended
Non-Aboriginal
Health Benefits residents,
including seniors,
Program
who have a
specific chronic
condition or have
reached the age
of 65
None
None
None
N/A
Indigent
Residents
Health Benefits receiving income
Program
support
None
None
None
N/A
Province/
Territory
Program/
Plan
Nunavut
Beneficiary
141
Drug Expenditure in Canada, 1985 to 2010
References
1.
Canadian Institute for Health Information, National Health Expenditure Trends, 1975 to 2010
(Ottawa, Ont.: CIHI, 2010).
2.
Health Canada, Non-Insured Health Benefits Program—Annual Report 2008/2009 (Ottawa,
Ont.: Health Canada, 2010), catalogue no. H33-1/2-2009E-PDF.
3.
S. Morgan, “Sources of Variation in Provincial Drug Spending,” Canadian Medical Association
Journal 170, 3 (2004): pp. 329–330.
4.
Organisation for Economic Co-operation and Development, OECD.Stat, accessed on
December 16, 2010, from <http://www.ecosante.org>.
5.
M. Aaserud et al., “Pharmaceutical Policies: Effects of Reference Pricing, Other Pricing and
Purchasing Policies (Review),” The Cochrane Collaboration 4 (The Cochrane Library: John Wiley
& Sons, Ltd., 2006): pp. 1–66, Cochrane Library Number CD005979.
6.
S. Morgan et al., “‘Breakthrough’ Drugs and Growth in Expenditure on Prescription Drugs
in Canada,” British Medical Journal 331, 7520 (October 8, 2005): pp. 815–816, accessed
on February 8, 2007, from <http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1246080>, catalogue no. 38582.703866.
7.
Patented Medicine Prices Review Board, Patented Medicine Prices Review Board 2009
Annual Report (Ottawa, Ont.: Patented Medicine Prices Review Board, 2010), pp. 1–60,
accessed November 2010, from <http://www.pmprb-cepmb.gc.ca/english/
view.asp?x=1340&all=true>.
8.
Z. Karaca and S. Wiggins, The Impacts of Breakthrough Drug Classes on Total Health
Expenditures: Empirical Evidence From the 1996–2001 Medical Expenditure Panel Surveys,
eds., Z. Karaca and S. Wiggins (Texas: A&M University, November 11, 2006), pp. 1–40,
accessed on February 14, 2007, from <http://ssrn.com/abstract=947603>, catalogue
no. 947603.
9.
F. R. Lichtenberg, “Are the Benefits of Newer Drugs Worth Their Cost? Evidence From the
1996 MEPS,” Health Affairs 20, 5 (September/October 2001): pp. 241–251.
10.
Canadian Cancer Society, A National Home Care Program, accessed on February 9, 2007,
from <http://www.cancer.ca/ccs/internet/standard/0,3182,3172_335445__langId-en,00.html>.
11.
Statistics Canada, Demography Division, Special Tabulation (Ottawa, Ont.: Statistics
Canada, November 2010).
12.
S. Morgan, “Drug Spending in Canada: Recent Trends and Causes,” Medical Care 42, 7
(July 2004): pp. 635–642.
13.
Health Council of Canada, Generic Drug Pricing and Access in Canada: What Are the
Implications? (Toronto, Ont.: Health Council of Canada, June 2010), accessed on
February 10, 2011, from <http://healthcouncilcanada.ca/en/index.php?page=shop.
product_details&flypage=shop.flypage&product_id=115&category_id=19&manufacturer_
id=0&option=com_virtuemart&Itemid=170>.
14.
Alberta Health and Wellness, “Alberta Pharmaceutical Strategy Phase Two,” (fact sheet)
(Alberta: Alberta Health and Wellness, January 2010), accessed on February 14, 2011,
from <http://www.health.alberta.ca/documents/Pharma-Strategy-2-Generic-Drugs.pdf>.
15.
B. Mintzes et al., “Volume IV: Pills, Persuasion and Public Health Policies,” in An Assessment
of the Health System Impacts of Direct-to-Consumer Advertising of Prescription Medicines
(DTCA), eds., B. Mintzes, A. Kazanjian, K. Bassett and J. Lexchin (Report of an Expert Survey
on Direct-to-Consumer Advertising of Prescription Drugs in Canada, the United States and
New Zealand) (Vancouver, B.C.: Health Policy and Research Unit, Centre for Health Services
and Policy Research, August 2001), pp. 1–48, accessed on February 14, 2007, from
<http://www.chspr.ubc.ca/files/publications/2002/dtca-v4-expertsurvey.pdf>,
catalogue no. HPRU 02:4D.
143
Drug Expenditure in Canada, 1985 to 2010
144
16.
Statistics Canada, Guide to the Income and Expenditure Accounts (Ottawa, Ont.: Statistics
Canada, 2008), p. 23, catalogue no. 13-017.
17.
Organisation for Economic Co-operation and Development, OECD Health Data 2010
(Paris, France: OECD, 2010).
18.
Statistics Canada, Family Expenditure in Canada (Ottawa, Ont.: Statistics Canada),
catalogue no. 65-555-XPB.
19.
Statistics Canada, Your Guide to the Consumer Price Index (Ottawa, Ont.: Statistics Canada,
1996), pp. 7–9, accessed on February 9, 2007, from <http://www.statcan.gc.ca/
imdb-bmdi/document/2301_D6_T9_V1-eng.pdf>, catalogue no. 62-557-XPB.
Production of this report is made possible by financial contributions from Health
Canada and provincial and territorial governments. The views expressed herein
do not necessarily represent the views of Health Canada or any provincial or
territorial government.
All rights reserved.
The contents of this publication may be reproduced unaltered, in whole or in
part and by any means, solely for non-commercial purposes, provided that the
Canadian Institute for Health Information is properly and fully acknowledged as
the copyright owner. Any reproduction or use of this publication or its contents for
any commercial purpose requires the prior written authorization of the Canadian
Institute for Health Information. Reproduction or use that suggests endorsement
by, or affiliation with, the Canadian Institute for Health Information is prohibited.
Requests for permission should be addressed to:
Canadian Institute for Health Information
495 Richmond Road, Suite 600
Ottawa, Ontario K2A 4H6
Phone: 613-241-7860
Fax: 613-241-8120
www.cihi.ca
[email protected]
ISBN 978-1-55465-903-6 (PDF)
© 2011 Canadian Institute for Health Information
How to cite this document:
Canadian Institute for Health Information, Drug Expenditure in Canada, 1985 to 2010
(Ottawa, Ont.: CIHI, 2011).
Cette publication est aussi disponible en français sous le titre Dépenses en
médicaments au Canada, de 1985 à 2010.
ISBN 978-1-55465-904-3 (PDF)
Talk to Us
CIHI Ottawa
495 Richmond Road, Suite 600
Ottawa, Ontario K2A 4H6
Phone: 613-241-7860
CIHI Montréal
1010 Sherbrooke Street West, Suite 300
Montréal, Quebec H3A 2R7
Phone: 514-842-2226
CIHI Toronto
4110 Yonge Street, Suite 300
Toronto, Ontario M2P 2B7
Phone: 416-481-2002
CIHI St. John’s
140 Water Street, Suite 701
St. John’s, Newfoundland and Labrador A1C 6H6
Phone: 709-576-7006
CIHI Victoria
880 Douglas Street, Suite 600
Victoria, British Columbia V8W 2B7
Phone: 250-220-4100
April 2011
www.cihi.ca
Was this manual useful for you? yes no
Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Download PDF

advertisement